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ABSTRACT 
      
     This project describes and analyzes explanatory models of Chagas disease among people in a 
highly endemic area of eastern Bolivia, and examines the role that cultural and structural factors 
play in shaping explanatory models of this disease. Dressler (2001) characterizes medical 
anthropology as divided between two poles; the constructivist, which focuses on the “meaning 
and significance that events have for people,” and the structuralist, which emphasizes the 
relationships between the components of a given society. This project endeavors to synthesize 
structuralist and constructivist perspectives by understanding the interaction between structural 
processes and explanatory models of Chagas disease.  
     The research took place in the spring of 2013, in collaboration with the Centro Medico 
Humberto Parra, a non-profit clinic servicing low income populations in Palacios, Bolivia and 
surrounding communities. Semistructured interviews (n=68) and consensus analysis 
questionnaires (n=48) were administered to people dealing with Chagas disease, and free lists of 
possible treatments were collected.  
     Overall, participants largely accepted the biomedical model, but also emphasized the 
emotional and social aspects of Chagas disease. The consensus analysis procedure indicated a 
clear shared model of Chagas disease, with coherent social, vector, symptoms, and ethnomedical 
domains. Furthermore, the model differed between groups based on ethnicity, gender, income 
and occupation. Significant differences were found in cultural knowledge of the disease based on 
community of residence and occupation status, two clear markers of how people are tied into the 
x 
 
global economy. In the interviews, participants associate their Chagas disease with structural 
factors including poverty, rural living and traditional housing. They describe substantial barriers 
to getting biomedical care for their disease despite the existence of a free treatment program in 
Bolivia. However, participants reported numerous ethnomedical treatments; the study identified 
39 ethnomedical treatments for Chagas disease and 66 for its cardiac symptoms.  
     In sum, explanatory models include structural processes that shape disease, and are in turn 
influenced by these processes. In Bolivia, although structural constraints limit the scope of 
biomedical treatment, ethnomedical approaches to the disease are in a process of dynamic 
growth. The methods used here for assessing the structural component of the explanatory model 
of Chagas disease can be replicated in future research on explanatory models or political 
economy of health.  
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CHAPTER ONE 
 INTRODUCTION 
 
     This introductory chapter outlines the theoretical orientation of the project, which focuses on 
the divide between structuralists and constructivists in medical anthropology. The research 
setting in tropical Bolivia is described, and background on the Centro Medico Humberto Parra 
(CMHP), the local clinic where the research took place, is provided. I present the main research 
objectives and methods utilized in the study. Finally, there is a brief synopsis of Chapters 2-12. 
 
Explanatory Models and the Structural-Constructivist Divide in Medical Anthropology 
     Two main theoretical currents drive research in medical anthropology. On the one hand, 
critical medical anthropology examines the impact of global capitalism and related structural 
processes on human health. Drawing from Marx’s critique of capitalism (Marx and Engels 2006 
[1888]), Engels’s work on health outcomes in working class England (Engels 1998 [1845]), and 
world systems theory (Wallerstein 1974), critical medical anthropologists problematize 
biomedicine’s relationship with dominant power structures and discuss the impact of political 
economic processes on health outcomes (Singer 1989).  
     In contrast with this macro-level approach, cultural constructivist medical anthropology 
examines how ideas about health are locally produced and interpreted in specific contexts 
(Gaines 1991). Medical systems are culturally constructed and shape individual knowledge and 
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perceptions related to health. One of the main heuristic tools of this theoretical branch is 
explanatory models. The explanatory models concept addresses how ideas about health and 
illness are organized in the minds of individuals, a process influenced by local cultural systems, 
including the culture of biomedicine (Kleinman 1980). Originally a tool for comparing patient 
and provider perspectives, the explanatory model has evolved into a mechanism for making 
broader cross-cultural comparisons (Garro 1996, Baer et al. 2004).  
     Each theoretical school has levelled major criticisms at the other. Critical medical 
anthropologists deplore cultural constructivists’ inattention to structural forces and unequal 
power relations (Singer 1989). They view it as subservient to biomedicine and thus incapable of 
problematizing the biomedical enterprise (Singer 1989, Scheper-Hughes 1990). On the other 
hand, those interested in the cultural construction of health have problematized critical medical 
anthropology’s tendency to treat biomedicine as monolithic, while overlooking individual 
agency and specific local contexts out of a tendency to attribute everything to global capitalism 
(Gaines 1991).  
     This split is not unique to anthropology, but reflects an ongoing quandary in social sciences 
that centers on whether to emphasize individual perception and agency or socioeconomic forces 
(Bourdieu 1988). The division is counterproductive, as anthropologists recognize a need to draw 
on both frameworks to accurately depict reality (Roseberry 1988, Farmer 1992, Dressler 2001). 
Dressler (2001) calls for a unified approach that would unite both structural and constructivist 
elements, considering this the next major step in medical anthropology’s theoretical evolution. 
Consequently, the goal of this study is to determine how structural forces impact, and are 
interpreted through, locally constructed explanatory models of health. 
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     While research using explanatory models began as an endeavor in clinically applied medical 
anthropology to assist patient-provider cross-cultural communication, it has increasingly focused 
on broader comparisons at the level of groups and societies (Chavez et al. 1995, Baer et. al 2004, 
Baer et al. 2008, Weller et al. 2012). Moreover, some research has attempted to overtly link 
explanatory models with structural processes. Farmer, founder of the structural violence concept, 
studied under Kleinman and was well versed in explanatory models research (Farmer 1988). 
More recently, Vonarx (2007) discussed how structural processes influenced explanatory models 
in Haiti, while Hewlett and Hewlett (2008) assessed the role of structural violence in explanatory 
models of ebola. McEwen (2005) examined the impact of unequal power relations on 
explanatory models of latent tuberculosis for U.S. providers and Mexican patients. 
     The methodological tool of consensus analysis provides a statistical basis for comparing 
explanatory models at the level of large social groups, even nations or societies (Baer et al. 
2004). It provides a means of measuring cultural knowledge, using the responses of the entire 
group as a “culturally correct answer key” (Weller 2007). It is culturally relative in that 
respondents themselves determine what constitutes knowledge, and this differentiates it from 
public health studies of knowledge, attitudes and beliefs. Consensus analysis allows the 
researcher to test whether a shared explanatory model for a disease or health phenomenon exists 
at a group level, and then to compare how cultural knowledge related to this model is distributed 
among individuals and subgroups. For example, Garro (1996) compares explanatory models of 
diabetes between biomedical providers and Anishinaabe communities in Canada, and Miller 
(2011) assesses the impact of cultural knowledge on maternal/infant health outcomes in three 
communities in Kenya.  
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     In response to medical anthropology’s need for an approach unifying structural and cultural 
constructivist theoretical orientations, this study investigates explanatory models through 
qualitative interviews and consensus analysis. The study accounts for structural factors within 
the research design. A component of this research is to measure respondents’ agreement on 
structural factors that impact health. The central research questions are whether structural factors 
influence the development of explanatory models, and in turn whether respondents incorporate 
ideas about structural factors into their explanatory models of Chagas disease.   
     To answer these questions, I investigated Chagas disease in rural Bolivia. Not only is Chagas 
disease a major health problem in Bolivia, accounting for 13% of all deaths annually (MSF 
2009), but it is inherently related to structural and historical processes (Briceño-León 2009). 
Bolivia has the highest prevalence of Chagas disease in the world, with as much as 28.8% of the 
population infected. Two thirds of the national territory is endemic for the disease (Moncayo and 
Silveira 2009). 
 
Research Setting: Palacios, Bolivia and Surrounding Communities 
     Research took place through the Centro Medico Humberto Parra (CMHP), a health clinic in 
Palacios, Bolivia (http://centromedicohumbertoparra.org/). Two Chicago endocrinologists, Dr. 
Susan Hou and Dr. Mark Molitch, founded the CMHP in 2001 with the support of Bolivian 
doctor Douglas Villarroel. Their vision was to create a clinic that would provide access to 
healthcare for disadvantaged populations in rural Bolivia. The clinic is located 90km from Santa 
Cruz, Bolivia’s second largest city, and 9km from the paved highway that links Santa Cruz to 
Cochabamba and eventually La Paz (Figures 1.1 and 1.2). This land was ceded to the founders in 
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the will of Humberto Parra, a grateful patient. It is located in the midst of a rain forest, and it is 
not unusual to observe monkeys, toucans and macaws from the very doors of the clinic.  
 
 
Figure 1.1: Map of Location of Study Area 
Source: www.wikimapia.org 
 
     Because of its remote location, the CMHP implemented a unique strategy in order to provide 
access to patients throughout the area. Nearby communities maintain patient groups organized by 
health promoters. Each group arranges for transportation to the clinic on specific days according 
to a monthly schedule. Thus, while Palacios is a small community of only 280 people, the 
CMHP is able to serve a wider catchment area of 40,000 patients and twelve main communities. 
For the cost of transportation (which is shared among the group), and a small fee (5 Bolivian 
Study area 
6 
 
pesos, less than $1 US), patients receive consultation and any needed medication. The CMHP 
has a staff of Bolivian doctors, including a dentist, gynecologist and optometrist, and is also 
serviced by medical students and volunteers from the United States. It is thus able to provide a 
comprehensive range of services at very low cost.  
     Chagas disease is one of the major challenges facing the CMHP. The prevalence of the 
disease in Santa Cruz, based on blood bank samples, is an estimated 43%, well above the 
national average (Pirard et al. 2005). Chagas disease disproportionately affects the poor who live 
in rural areas (Chippaux et al. 2008, Briceño-León 2009). The CMHP found that nearly 70% of 
the population in Palacios was positive for the disease (personal communication, Dr. Mark 
Molitch). An examination of records from screenings conducted by the CMHP from 2006-2011 
indicated a prevalence of 57%; this includes patients from the various communities served by the 
clinic. Of these, 30% may develop chronic symptoms which can include heart failure, 
hypertension, and severe enlargement and blockage of the intestines or esophagus (Rassi et al. 
2010).  
      The communities served by the CMHP are diverse. Table 1 provides a demographic 
comparison of the four communities which provided the most participants for the study: 
Palacios, Buena Vista, Warnes and Yapacani. These communities are geographically represented 
in Figure 1.2. 
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Table 1.1: Demographic Comparison of Four CMHP Communities 
Community Population* % of population with 
inadequate 
water/sanitation** 
% of population with 
inadequate housing** 
Buena Vista 14,930 77.3 61.6 
Palacios 280 Nd Nd 
Warnes 52,888 55.0 28.2 
Yapacani 44,189 76.1 45.9 
* Bolivian National Institute of Statistics, 2010 census data for Buena Vista, Warnes, Yapacani. 
Palacios data from http://centromedicohumbertoparra.org 
** Bolivian National Institute of Statistics, 2001 data 
 
 
Figure 1.2: Map of Palacios and Surrounding Communities 
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Following is a brief summary of principal economic activities in each of the four communities.  
Buena Vista: This town of nearly 15,000 is a gateway for ecotourism in the nearby Amboró 
National Park. Cultivation of rice is a major economic activity, and the town boasts of a complex 
of silos where rice is processed for market. Other important crops are plantains, bananas, cacao, 
coffee and sugar cane. Extraction of petroleum and natural gas is a major nonagricultural 
activity. The Departmental government also notes Buena Vista “has a variety of medicinal plants 
whose curative properties are known and utilized by the population” 
(http://www.soysantacruz.gob.bo). 
Palacios: Most of the land in the area is owned by a few families that live in Santa Cruz. The 
majority of people in Palacios work as agricultural laborers and earn $40 monthly on average. 
The main crops grown in Palacios are sugar cane, yuca, and plantains.  The town is 5km away 
from the nearest paved road (the Santa Cruz-Cochabamba Highway).  
Warnes: Warnes is the location of the Viru Viru international airport that serves nearby Santa 
Cruz, Bolivia’s second city. Its proximity to Santa Cruz makes it an ideal location for industries, 
including a large dairy processing plant and beer bottling operations. An Iranian-funded defense 
school was established here in 2012. Sugar cane, soy and other crops are grown in outlying 
areas.  
Yapacaní: Strategically situated on the highway connecting Santa Cruz with Cochabamba and 
La Paz, Yapacaní is a major center of rice, corn, soy and coca production. Cattle ranching and 
exploitation of forest resources are also important economic activities. Yapacaní often serves as a 
destination for internal migrants from Cochabamba and other parts of western Bolivia.  
Source: (http://www.soysantacruz.gob.bo, http://centromedicohumbertoparra.org) 
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Research Objectives and Methods  
     This is an exploratory investigation of explanatory models of Chagas disease in the 
department of Santa Cruz, Bolivia. The main goal of the study is to determine the relationship 
between structual factors and explanatory models of Chagas disease, thus unifying constructivist 
and structuralist interpretations of health in medical anthropology. The main research objectives 
are as follows: 
1) Gather qualitative data on explanatory models of Chagas disease.  
2) Gather quantitative data on explanatory models of Chagas disease.  
3) Compare qualitative data on explanatory models of Chagas disease with the biomedical 
model. 
4) Compare quantitative data on explanatory models of Chagas disease with the biomedical 
model. 
5) Describe the structural context of Chagas disease in the region. 
       I developed a consensus analysis questionnaire on Chagas disease based on exhaustive 
research as well as pilot interviews at the CMHP with 20 patients. I then administered the 
questionnaire to 48 people with Chagas disease from different communities. While the 
questionnaire focused on all the components of the explanatory model recommended by 
Kleinman (1978), including causes, symptoms and treatment, it also asked respondents about 
structural factors such as the role of poverty in shaping risk for the disease. Moreover, I gathered 
extensive qualitative data related to explanatory models of Chagas disease by administering 
semistructured interviews to 68 respondents. As part of the qualitative interviews, respondents 
free listed possible treatments for Chagas disease. I engaged in participant observation on the 
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premises of the CMHP and also through visits to patient groups in different communities. I spoke 
with providers and officials involved in Chagas disease treatment in the area, including the 
Director of the Departmental Chagas Program and the Head of Entomology at the Center for 
Tropical Disease. The methods used are described in detail in Chapter 5. 
 
Synopsis of Findings 
     I conducted a comprehensive literature review which focused on three main areas. Chapter 2 
describes key literature related to explanatory models and the structuralist-constructive divide in 
medical anthropology. The case is made that explanatory models do not inherently exclude a 
political economic perspective. Chapter 3 discusses literature related to medical pluralism, 
ethnomedical systems of healing, and structural processes that impact health in Bolivia and the 
Andes. Chapter 4 reviews public health and anthropological literature on Chagas disease, and 
outlines the biomedical model of the disease. Chapter 5 explains the methods used to gather 
quantitative and qualitative data in the field.    
     The system of care for Chagas disease in Bolivia is described in detail in Chapter 6, 
addressing Research Objective 5. Through participant observation data, review of government 
reports and documentation, and analysis of relevant studies, the historical development of 
Chagas disease control efforts in Bolivia is traced. The chapter discusses two key structural 
factors: the crucial impact (or lack of impact) of international pharmaceutical companies’ 
research and development priorities, and the lack of biomedical infrastructure in Bolivia, creating 
dependence on international financing for major Chagas control initiatives. These factors have 
11 
 
shaped the way the health system confronts Chagas disease, with key implications for 
explanatory models.  
          Qualitative findings based on interviews (n=68) and participant observation are discussed 
in Chapters 7-10 (Research Objectives 1 and 3). Chapter 7 recounts the difficulties participants 
face in accessing care for Chagas disease, despite the existence of a free treatment program in 
Santa Cruz. There are overtly structural barriers, such as high costs for laboratory analyses and 
other procedures. An impediment which appears mental on the surface – the idea that Chagas 
disease is incurable – is put into political economic context. Chapter 8 contains respondents’ 
views on causes, symptoms and progression of Chagas disease. More respondents attributed their 
Chagas disease to social factors, such as housing and poverty, than to biological factors such as 
the vector or climate. The vector (vinchucas), the past, the countryside, and poverty were 
strongly linked in participants’ narratives. Chapter 9 contains extensive information that 
participants provided on ethnomedical treatments for Chagas disease. The study identified 39 
remedies directly for Chagas disease and 66 more that could alleviate its cardiac symptoms.  
     Quantitative findings from the consensus analysis procedure are detailed in Chapter 10. Data 
from the consensus analysis questionnaires were analyzed in Anthropac 4.0 (Borgatti 1996) and 
Ucinet 6.491 (Borgatti and Freeman 2002). The hypothesis of a shared model of Chagas disease 
held true, based on the high eigenvalue result. Moreover, there was strong agreement on the 
vector, ethnomedical, and social domains of the disease within the model, with moderate 
agreement on symptoms. Thus, there is evidence that respondents’ explanatory model of Chagas 
disease has a structural component (Research Objective 5). Answers on the culturally correct 
answer keys for different groups according to gender, ethnicity, income, and occupation revealed 
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some distinctions, particularly related to curability of the disease and attitudes toward biomedical 
providers.  
     Furthermore, the cultural consensus procedure provides an individual competence score for 
each participant on a scale of 0 to 1. This reflects how well their answers to the questionnaire 
correlate with the culturally correct answer key. Using Kruskal-Wallis and Mann-Whitney tests 
in SPSS 21.0, I compared mean competence overall and for the vector, ethnomedical, symptoms 
and social domains. There were significant differences in overall, vector and ethnomedical 
knowledge based on community of residence and occupation, both key indicators of how people 
fit into the political economic system. Thus, there is evidence that structural processes shape how 
explanatory models form in different groups. 
     The main findings of the study, discussed in Chapter 11, are that structural factors do 
influence explanatory models of Chagas disease, while participants account for structural 
processes within their explanatory models. Chapter 11 ties the findings in this study to the wider 
anthropological literature. The study fills two important gaps in medical anthropology, by 
investigating an anthropologically neglected disease, and by unifying structural and interpretive 
perspectives into a single research design.  A major public health implication of the research is 
that even free treatment options can still be inaccessible for disadvantaged rural populations. In 
the study area, many people who could have met the criteria for Chagas treatment continue to go 
untreated. Other recommendations are provided in Chapter 12.  
      
     In conclusion, the present study describes explanatory models of Chagas disease in Bolivia 
based on qualitative and quantitative research. A major aim of the study is to explore the 
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interconnection between structural processes and explanatory models. Field work took place 
from March-June 2013 at the Centro Medico Humberto Parra in Palacios, Bolivia, as well as 
nearby communities. Both the qualitative and quantitative interviews provide strong evidence 
that social processes play an important role in the formation of explanatory models of Chagas 
disease.  
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CHAPTER TWO 
EXPLANATORY MODELS AND THE CONSTRUCTIVIST-STRUCTURALIST 
DIVIDE IN MEDICAL ANTHROPOLOGY 
 
     As research using explanatory models emerged beginning in the 1970’s (Kleinman, Eisenberg 
and Good 1978), medical anthropology became increasingly polarized between two theoretical 
orientations. On the one hand, the constructivist camp focused on the cultural construction of 
ideas and meanings about health. On the other, structuralists emphasized the social, political and 
economic processes that created differential health outcomes in societies. This chapter traces the 
development of explanatory models research in the context of the constructivist-structuralist 
divide in medical anthropology, and argues that explanatory models research and a structuralist 
theoretical orientation are not incompatible.  
  
Explanatory Models and Synthesis of Interpretive and Structuralist Approaches in 
Anthropological Research on Health 
     Contemporary social sciences research is driven by two principal currents, which Bourdieu 
(1988, p. 780) describes as “objectivism and subjectivism.” The subjective current condenses 
social life to “the mere representations that agents have of it”, whereas the objective standpoint 
emphasizes the deeper structures and processes that govern social existence, largely to the 
exclusion of individuals’ interpretation of events. Bourdieu warns that this is a misleading 
dichotomy which must be overcome through combining both the experiences and representations 
15 
 
of individual agents, and the overarching structures shaping these, into a single model of 
analysis. 
     Anthropological research on health is still largely polarized by the subjective and objective 
currents Bourdieu describes. Dressler (2001), borrowing from Bourdieu, describes these two 
camps as “structuralist” and “constructivists”, and for the sake of clarity this study will do the 
same. However, Dressler’s use of each term encompasses a broad range of theoretical factions. 
The constructivists include such diverse groups as clinically applied medical anthropologists, 
cognitive anthropologists, and others using interpretive approaches. The structuralist camp 
includes Farmer’s structural violence, critical medical anthropology, and other political 
economic perspectives. Thus, while it is an intentional simplification on Dressler’s part to 
dichotomize medical anthropology into two schools, it is a useful way of discussing the two 
major currents of thought that drive the discipline. On the one hand, constructivist 
anthropologists, drawing heavily from Geertz’s semiotic concept of culture (Geertz 1973/2006), 
have explored the ways in which culturally framed perceptions of the world have influenced 
development of models of health and impacted care-seeking, the sickness experience, and the 
dynamics of healing. On the other hand, incorporating elements of Marxism as well as world 
systems theory, structuralist anthropologists have examined the role of global economic and 
political processes, especially world capitalism, in shaping access to health care, distribution of 
disease and morbidity, and power relationships in health care encounters. 
     While these two academic factions have engaged in internecine conflict throughout the last 
three decades, Dressler (2001, p. 456) notes that most anthropologists are “theoretical 
pragmatists” who tend to borrow from both schools of thought to a greater or lesser degree. 
Despite this, Dressler (2001), Bourdieu (1988), and others (Ortner 1984, Marcus and Fischer 
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1986, Lock and Scheper-Hughes 1990, Farmer 1992) have called for a unified approach which 
provides the proper balance between social structure, historical processes, power relations, 
symbolic meaning, and individual agency. 
     In the cultural constructivist approach, local experiences and perceptions in specific contexts 
are what shape reality and produce ethnomedical systems and knowledge (Gaines 1991). 
Following Geertz, it takes the Weberian view “that man is an animal suspended in webs of 
significance that he himself has spun” (Geertz 1973/2006, p. 319).  In contrast, critical medical 
anthropology aims to “root its study of health-related issues within the context of the class and 
imperialist relations inherent in the capitalist world system” (Baer et al. 2004). This represents 
Bourdieu’s objective camp, with the emphasis on the ways that larger political and economic 
forces impact health. 
     Practice theory seeks to resolve this quandary by characterizing the relationship between 
social structure and individual agency as “dialectical.” Ortner (2003) describes this as “the 
simple, yet very complex, idea that history makes people, but people make history” (p. 277). In 
other words, while structural forces shape individual development, they do not obliterate agency, 
as Scott’s (1985) weapons of the weak aptly demonstrates. Nonetheless, practice theory as 
proposed by Bourdieu is plagued by an inattention to history, as well as an overemphasis on 
relations of domination and power (Ortner 1984). As a result, Ortner was moved to call for a 
renewed emphasis on meaning and interpretation in the tradition of Geertz (Ortner 1999). 
 
Kleinman’s Explanatory Models  
     Explanatory models developed within clinically applied anthropology. Clinically applied 
anthropologists are interested in examining how “illness and clinical reality are organized in 
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particular local cultural systems of meanings, norms, and power” (Kleinman 1985, p. 69). As 
such, explanatory models represent the constructivist or interpretive school of thought in 
anthropology. Arthur Kleinman, a practicing psychiatrist and medical anthropologist, developed 
the concept of explanatory models as a tool that would “privilege the voices of patients and 
families” involved in clinical encounters (Kleinman 1995, p. 8). Deploring the ethnocentrism of 
most biomedical practitioners involved in treating ethnically diverse patients, Kleinman hoped to 
create a system that would illuminate gaps between the ways providers and patients characterize 
health problems, while drawing attention to the fact that biomedical practices, concepts and 
meanings are just as culturally derived as those of patients (Kleinman 1995). Kleinman posited 
that each individual patient and practitioner brought their own ideas to each health care 
encounter about how an individual health condition formed and how it could best be ameliorated. 
By comparing these explanatory models, miscommunications could be corrected, with the 
ultimate aim of optimizing the efficacy of care. The idea of improving patient-provider 
communication is a central feature of clinically applied medical anthropology.  
     Two central principles formed the foundation of Kleinman’s explanatory models concept. 
First, all patients and healers operate within health care systems that comprise a broad range of 
beliefs ranging from how illnesses form to who controls how care is provided. Patients, as well 
as practitioners, are “embedded in specific configurations of cultural meanings and social 
relationships” (Kleinman 1980, p. 25). Health care systems are cultural systems of interwoven 
symbols, meanings, patterns and relationships that are constructed to combat disease and 
maintain health. 
     Cross-culturally, every health care system consists of at least two components: a popular 
sector, consisting of individuals, families and communities, and a folk sector consisting of 
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healers. In some societies, systems of folk healing have organized into professional sectors, 
creating a third component to the health sector. This is the case not only for allopathic medicine 
in the United States, but for Ayurvedic and Chinese medicine. Episodes of poor health emerge 
and are first evaluated within the popular sector. If the condition remains unresolved, the sufferer 
may resort to either the folk or the professional sector (Kleinman 1980). 
     The second core principle concerns the distinction between “illness” and “disease”. Whereas 
disease embodies the actual physical interruption of health through infection, injury or the 
breakdown of normal bodily functions, illness embodies the “human experience of sickness” that 
patients suffer, or their “personal, interpersonal, and cultural reactions to disease or discomfort” 
(Kleinman, Eisenberg and Good 1978, p. 252). Biomedical practitioners are primarily concerned 
with treating disease, yet disease may either emerge from or contribute to a host of social 
conditions experienced by patients – Kleinman’s “illness.” The patient is concerned less with 
restoring normal biological functioning and more with resuming their role in the social 
framework, which a disease has interrupted. Moreover, while only individuals experience 
disease, illness affects patients as well as their family members. Importantly, disease and illness 
are simply different ways of interpreting the same reality (Kleinman 1980).  
     There are bound to be differences in interpreting health issues, both within and among health 
care systems. If unacknowledged, such differences will prevent practitioners from providing 
proper care. Kleinman wanted to develop an analytical tool that would allow immediate 
comparison of the ways in which providers and patients interpret health conditions. This gave 
rise to explanatory models, the “notions about an episode of sickness and its treatment that are 
employed by all those engaged in the clinical process” (Kleinman 1980, p. 105). For the 
practitioner, the explanatory model (EM) guides diagnosis as well as provision of treatment. The 
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patient’s EM, in turn, shapes how they conceive of an illness and influences how they seek help 
(Kleinman 1980). 
     Kleinman identifies five major components of EMs: 1) etiology, 2) time and mode of 
symptom onset, 3) pathophysiology, 4) the course of sickness, and 5) how sickness should be 
treated. He notes that provider EMs tend to be well defined, whereas patient EM’s may not 
include all five of these components. He also maintains that an EM is a response to a specific 
illness episode, and a person’s EM is likely to change depending on context and experience.  
 
Anthropological Research Using Explanatory Models 
     Kleinman utilized EMs as a tool to conduct comparative research among practitioners and 
patients, both in Taiwan and in the United States. He demonstrated that even culturally similar 
patients and practitioners, such as middle class Americans and their physicians, could have 
divergent EMs leading to miscommunication and misdiagnosis. Differences between biomedical 
practitioners and non-Western patients could often be profound, whereas patients and folk 
practitioner EM’s often converged more closely (Kleinman 1978). 
     Friedl (1982) examined the EM for black lung among retired coal miners in Appalachia. 
Miners had a pessimistic or fatalistic view of black lung, and were skeptical of claims by 
practitioners that treatment could mitigate the condition. This led to a high drop-out rate and 
frequent noncompliance in state programs designed to treat miners. Friedl noted that the fatalism 
of the miners stemmed from experiences of tragedy – such as accidents or cave-ins – over which 
they perceived little control, and that they had often heard from mining company doctors that 
black lung could not be treated.  Friedl’s research differed in some ways from Kleinman’s 
original design. Rather than interviewing physicians, Friedl bases his biomedical explanatory 
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model on medical textbooks. Also, he creates a combined explanatory model based on common 
themes that emerged in interviews with 17 different miners. Thus, he takes the explanatory 
model to a group level. Both of these practices foreshadow the ways future researchers would 
modify Kleinman’s original EM concept.  
     Whereas Kleinman had originally envisioned EMs as a tool for examining specific illness 
episodes involving individual patients and practitioners, anthropologists began utilizing the EM 
framework to make cross-cultural and intra-cultural comparisons based on shared features of 
EMs at group levels. This was a direct response to concern that researchers using the individual 
unit of analysis would “often fail to address the interpenetration of individual and current cultural 
knowledge” (Garro 1994, p. 776). The development of cultural consensus theory (Romney et al. 
1986, Weller 2007) complemented these efforts. Weller (2007) defined cultural consensus theory 
as a set of “analytical techniques and models that can be used to estimate cultural beliefs” and 
the degree to which these are shared among and between groups and individuals (p. 339). 
Cultural consensus theory can enhance the use of EMs by expanding the analysis from the 
individual to the cultural level, providing “an explanatory model at the level of the community” 
(Baer et al. 2004, p. 18). In addition, cultural consensus analysis provides a statistical basis for 
measurement of agreement among different models.  
     Consensus analysis grew out of cognitive anthropological research, with its interest in how 
systems of knowledge influence individual behavior, often on a subconscious level. In cognitive 
anthropological research, “observable behavioral phenomena are recognized as expressions of 
more basic and fundamental underlying organizational order and principles” (Blount 2011, p. 
12). Furthermore, cognitive anthropology places a strong emphasis on empirical, measurable 
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data, in contrast to other schools of cultural anthropology which are more purely qualitative 
(Blount 2011).  
     In an early example using the combined EM-consensus analysis framework, Garro (1996) 
compared provider models of diabetes with those in three Anishinaabe (Ojibway) communities 
in Canada. Garro (1994) had earlier problematized current EM research as focused “somewhat 
narrowly on the issues of illness cause, process and treatment to the exclusion of broader 
contextual meanings” (p. 776). Explanatory models were elicited through interviews, which 
provided key concepts for use in consensus analysis. Garro found agreement in the models of 
diabetes between the communities, despite some differences in linguistic and historical context. 
She also observed some key divergences between the shared model of diabetes in the community 
and that of providers. 
     While not specifically referencing Kleinman’s EM concept, Chavez et al. (1995) used a 
similar approach to compare beliefs about cervical and breast cancer among Chicanas, Mexican 
and Salvadoran-born women living in the U.S., Anglo women, and U.S. physicians. They 
identified a “Latina immigrant model” of cancer which contrasted significantly with the 
biomedical model shared by physicians, Anglo women, and to some extent Chicanas. In this 
study, main causes and risk factors of these cancers were identified and then rank-ordered by 
participants. 
     Miller (2011) used consensus analysis to compare maternal health knowledge in three 
communities in Kenya. She was able not only to compare knowledge between communities, but 
to link this data to social variables and infant health biomarkers. She found that women with 
higher cultural competence scores in the domain of traditional medicine were more likely to 
utilize biomedical clinics, and their children tended to have better health outcomes.  
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     Baer et al. (2004) investigated EMs of AIDS among communities and physicians in Mexico 
and the United States. One of the goals of the study was to determine if shared models would 
develop according to a cultural, professional, or “null” pattern. A cultural pattern would indicate 
the greatest agreement between samples within the same country, whereas in a professional 
pattern physicians from the U.S. and Mexico would share a model with each other to a greater 
extent than with community samples in their respective countries. In a null scenario, each sample 
would have a unique pattern. The resulting analysis found a widely shared model among all four 
groups, with differences greatest along cultural lines; physicians agreed more with lay samples in 
their own countries than with other physicians across national boundaries.  
     In a subsequent study, Baer et al. (2008) used this type of approach to compare EMs of the 
common cold among physicians and lay samples in the U.S. and Mexico. In this study, a core 
EM of the common cold emerged between all four samples. There were slight differences in 
subthemes, such as the influence of hot-cold etiology, which was more prominent in the lay 
samples. The overall trend revealed a “professional” pattern where provider-lay differences were 
more prominent than cross-cultural differences. The professional pattern also emerged as most 
significant when Weller et al. (2012) examined models of diabetes among physicians and lay 
samples in Mexico and the U.S. Again, this study utilized consensus analysis to identify and 
measure agreement of participants on shared explanatory models.  
     Other research has attempted to characterize the flexibility and dynamism of explanatory 
models in different intercultural contexts, while also linking them to broader sociocultural 
meanings. This builds upon Kleinman’s earlier assertion that Taiwanese patients incorporated 
elements of folk, popular and professional sectors in developing EMs, and often navigated freely 
between different types of EMs (Kleinman 1980). For example, Poss and Jezewski (2002) found 
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that Mexican Americans living near the border often linked the onset of their diabetes to susto, a 
folk concept or “culture-bound syndrome.” For respondents, susto referred to a frightening or 
traumatic event. This concept was integrated with the biomedical model of diabetes. However, 
the authors do not explain how they were able to assess and identify a biomedical model in this 
context.  
     Hunt and Arar (2001) lamented the lack of attention to the provider perspective in some EM 
studies. This inattention delegitimizes the patient perspective by treating it as the only viewpoint 
which needs to be examined, questioned or diagnosed. Furthermore, they discussed the dynamic 
nature of EMs over the course of long-term treatment histories, such as for chronic disease. They 
noted that through repeated interactions with providers, patient EM models begin to converge 
with the biomedical models, although some differences remain or even become exacerbated. 
They expanded Kleinman’s EM framework by adding the domains of goals, strategies and 
objectives to highlight areas of difference between patients and providers. While patients largely 
agreed with physicians’ goals and strategies for controlling diabetes, they found the physicians’ 
recommendations impractical to implement in many cases.  
     Hunt (1998) found that “causal models” of breast and cervical cancer in southern Mexico 
were predominately shaped by a moral understanding of the disease. This mirrors Kleinman’s 
later interest in “local moral worlds” and the anthropology of suffering (Kleinman 1992). In 
Hunt’s research, the specific moral configuration of the disease differed between middle-class 
providers and working class patients. In the case of providers, class and gender strongly 
influenced conceptual models of how patients were likely to have developed cancer. In assigning 
moral causes to the development of cancer, both providers and patients made sense of an 
otherwise arbitrary affliction.   
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     In other cases, people modify their EMs in complex ways to deal with conflicting messages 
about health. For instance, in Erickson’s study of health mines in Montana, people must confront 
contrasting characterizations of radon as a toxin and as a therapeutic substance. Erickson 
demonstrates how people visiting Montana health mines consolidate these conflicting views in a 
way that enables them to feel it is a rational choice to engage in radon therapy, despite the 
warnings of the EPA about the deleterious effects of the gas (Erickson 2007).  
     In research on Hansen’s disease (leprosy) in Brazil, White also found patients’ explanatory 
models to be highly flexible (White 2005). As was the case in Poss’s investigation of diabetes, 
patients combined elements of the biomedical model with their own local constructions of the 
illness. White emphasized the transitory nature of explanatory models and identified three main 
points when they were most likely to be reformulated: 1) initial diagnosis, 2) during the 
experience of adverse reactions from medication, and 3) during reaction of the disease due to 
dead bacilli in the body. Whereas providers considered the disease “cured” after completion of 
the drug regimen, patients often continued to suffer reactivations for years following treatment. 
Their models of the illness thus initially converged with practitioners, but began to diverge when 
reactions suggested a “cure” had not been realized.  
      
Critical Medical Anthropology versus Constructivist Approaches 
     Explanatory models remain one of the most popular tools in the arsenal of clinically applied 
medical anthropology (Hayden 2006). Nonetheless, even as Kleinman developed the concept of 
explanatory models, other anthropologists were becoming disenchanted with the limitations of 
clinically applied medical anthropology and other constructivist approaches. They considered 
clinically applied medical anthropology as too culturally deterministic, too subservient to 
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biomedicine, and too constrained by its micro-level focus (Singer 1989).  Problems with 
clinically applied medical anthropology included “a narrow understanding of social relations; 
inattention to the political structuring of meaning in the clinical setting; a desocialized approach 
to the human/environment relationship; and far-reaching medicalization” (Singer 1990, p. 179). 
In response to these shortcomings, they advocated for a broader conceptual and theoretical 
framework which would account for the impact of global capitalism on health. Thus, “critical” 
medical anthropology emerged.  
     According to Singer (1989), critical medical anthropology has seven main areas of focus. 
These include: 1) examining the role of the global economic system and social processes in 
shaping health and disease; 2) assessing health policy, state involvement and resource 
distribution in developing countries; 3) critically examining the idea of medical pluralism; 4) 
developing a critique of biomedicine; 5) assessing conflict in health and health care encounters; 
6) recasting micro-level health behavior in light of broader structural processes; and 7) 
investigating health in socialist countries. Critical medical anthropology’s theoretical roots 
ultimately emanate from Marx’s broader critique of capitalism (Marx 1888/2006), from Engels’s 
early research on the health of the working class (Engels 1845/1998) and from dependency 
theory’s analysis of core and peripheral nations in the world capitalist system (Wallerstein 1974). 
Within anthropology, critical medical anthropology follows the lead of Wolf, who sought to 
connect micro-level ethnographic analysis with global forces of capitalism (Wolf 1982).  
     While critical medical anthropology thus has a well-defined theoretical framework and set of 
objectives, its principal task initially was to point out what was wrong with contemporary 
clinical medical anthropology, including Kleinman’s use of explanatory models. One of the main 
criticisms leveled against clinically applied medical anthropology was its intimacy with 
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biomedicine (Singer 1989, Scheper-Hughes 1990). Kleinman, himself a practicing clinician, had 
advocated for a greater presence of anthropology in medical schools, and for greater inclusion of 
anthropologists in clinical practice. In Kleinman’s vision, universities would contain departments 
of “clinical social science,” staffed by physicians with anthropological training as well as 
anthropologists with medical training (Kleinman 1978, p. 257). Kleinman wanted to demonstrate 
that anthropology could enhance clinical practice: “We need to show that the knowledge we 
deploy can be useful to physician and patient in the exigent context of difficult clinical choice. 
We need to make ourselves useful in order to make ourselves heard” (Kleinman 1985, p. 70). On 
a deeper level, Kleinman was championing applied medical anthropology versus the more 
academic orientation of critical medical anthropology. 
     Yet Kleinman’s vision, for critical medical anthropologists, was akin to becoming “a service 
sector for biomedicine” (Singer 1990, p. 179). Further, they likened the relationship of clinically 
applied medical anthropologists with biomedicine to that of early anthropology with colonialism. 
Scheper-Hughes (1990) famously characterized the clinically applied anthropologist as a well-
meaning but unwitting accomplice in maintaining biomedicine’s power and prestige, enabling it 
to continue as a mechanism of social control:  
One has the image of the timid anthropologist-certainly out of his milieu-tip-
toeing through the minefields of the modern clinic trying to mediate or to prevent 
the most potentially pathogenic interactions and miscommunications from hurting 
vulnerable patients. All of which is necessary and praise-worthy. But, as with the 
early colonial anthropologists, what is not being called into question is the 
inevitability (nor the technological superiority) of the whole biomedical health 
enterprise itself. (1990, p. 191) 
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    On a more conceptual plane, critical medical anthropologists worried that the ideas of 
anthropology itself would become reified and oversimplified. For Scheper-Hughes, explanatory 
models represented an attempt to commodify and package medical anthropology for provider 
consumption. Anthropologists have hurled similar criticism at the notion of cultural competence 
(e.g., Taylor 2003). 
     However, it would be inaccurate to state that Kleinman and other clinically applied 
anthropologists never problematized the enterprise of biomedicine. In fact, far from being an 
apologist for the biomedical establishment, Kleinman (1985) lamented the “often myopic focus 
of many health professionals” and the “deplorable ethnocentrism… in professional practice that 
often is indocile to the patient's and the community's viewpoints, with negative consequences for 
health care” (p. 70).  Hahn and Kleinman (1983) called for investigation of biomedicine as a 
cultural system, with its own set of historically derived meanings, rituals, symbols and folk 
concepts. For critical medical anthropologists, though, this did not go far enough. Rather, they 
sought to characterize biomedicine as a key component of the world capitalist system, one which 
has helped reinforce class identities and maintain social control (Singer 1990). 
     Critical medical anthropologists also problematized the micro-level emphasis of Kleinman 
and other constructivist medical anthropologists. The focus on symbolic interpretation and 
cultural production within specific, highly localized health contexts was considered too 
constraining, and overly blind to relationships and structures of power at both the local and 
macrosocial levels that shape health and sickness (Morsy 1996). Ignoring larger structural and 
economic processes creates an illusory sense that individuals in local settings are responsible for 
structuring their own “social dramas” (Singer 1989, p. 1194). In other words, it creates a fallacy 
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of individual agency and shifts the blame for health issues from the socio-political structure, and 
from biomedical practitioners, onto the shoulders of those afflicted.  
     Finally, Kleinman’s characterization of the doctor-patient encounter came under scrutiny. 
Critical medical anthropologists maintained that problems in patient-doctor communication 
stemmed neither from cultural differences, nor from biomedicine’s lack of understanding of folk 
illness models. Instead, they reflected broader social divisions based on race, class and gender 
(Singer 1995, Scheper Hughes 1990). Kleinman’s portrayal of patient-provider relationships as 
“dyadic and egalitarian” was challenged; rather, such interactions are “structured by a wider field 
of class and other power relations embedded within, but not always directly visible from, the 
narrow confines of the clinical setting” (Singer 1990, p. 179). Whereas Kleinman envisions 
patients and doctors negotiating a shared explanatory model, critical medical anthropologists see 
the clinical encounter as an unequal struggle dominated by the biomedical establishment.  
     In response to these critiques, Gaines (1992) deemed it necessary to fire a counter-salvo and 
reassert the premises of the constructivist approach. Gaines deplored critical medical 
anthropology’s abandonment of human experience and “attributions of needs, desires, and 
motives to extrahuman, nonsentient economic systems, structures, and forces” (Gaines 1992, p. 
17). Further, by overemphasizing broader social forces, critical medical anthropology had 
neglected the role of individuals and locally constructed histories and meanings. Gaines also 
problematized critical medical anthropology’s characterization of biomedical practitioners as 
overly homogenous and simplified. Instead of allowing for individual contexts and differences, 
physicians’ motives were simply reduced to enacting the will of global capitalism.  
     Gaines outlined five key tenets of cultural constructivism. First, constructivists problematize 
medical knowledge by accounting for the ways it is locally produced, not simply seeing 
29 
 
biomedicine as a monolithic global entity. Second, ethnomedical knowledge is produced in 
specific encounters through “embodied” as well as “disembodied” discourse (verbal 
communication and texts or media). Next, medical systems are historically constructed and 
constantly in a process of change and reformation. Additionally, they reflect the broader 
culture/society with which they are associated. Finally, ethnomedical systems should be viewed 
in terms of human experience, since looking at macrosocial processes and structures merely 
“anthropomorphizes” such forces while discounting human agency.  
     Perhaps the most damaging critique of explanatory models came from an unexpected source, 
Kleinman himself. By the late 1980’s, Kleinman had distanced himself from the explanatory 
models concept. His focus had become the “anthropology of suffering,” and the production of 
human misery in specific contexts. While this still had a strong interpretive orientation, 
Kleinman showed increasing attention to macro-level forces. He characterized a “double 
dialectic” relationship leading to human suffering, whereby broader social systems worked upon 
micro-level contexts, yet the pressures of structural forces were in turn mitigated or shaped in 
some ways by local dynamics, “shielding some groups of persons, mitigating the pressure on 
others, placing yet others in positions of vulnerability and risk” (Kleinman 1989, p. 19). The 
local context, for its part, influenced psychological and biological processes, ultimately linking 
biology with human experience.  
     By 1995, Kleinman disavowed explanatory models altogether. He had originally crafted the 
concept, he asserted, in the late 1970’s when he was still extensively practicing as a clinician and 
needed a heuristic device. His intention had been to counter the reductionism and ethnocentricity 
he encountered in biomedicine, and to provide a tool that would improve the results of patient-
provider interactions in cross-cultural contexts. However, he now realized that the words and 
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concepts were not really his own; he had simply been restating the ideas of Geertz (Kleinman 
1995, p. 7). What truly interested Kleinman was the “ethnographic interpretation of 
intersubjectivity, which feels more like my own way of proceeding. “He was no longer 
concerned with “systems”: “the very idea, with its impression of formal structures and innate 
divisions” now made him ill at ease (Kleinman 1995, p. 6).  He had shifted his attention from 
models to narratives. He felt “uncomfortable with the style and even the preoccupations of 
‘models,’ ethnocultural or other” (Kleinman 1995, p. 7). Regarding explanatory models, he was 
“ambivalent” and “extremely uncomfortable” when they were applied as “an entification of 
medical meanings and beliefs.” While he believed explanatory models might continue to have 
some utility for clinical practice, he felt ethnographic research had “fortunately moved well 
beyond this early formulation” (Kleinman 1995, p. 8). In short, Kleinman removed himself from 
the entire arena of explanatory models. The loss of its founding father did not prevent the 
concept from continuing to develop in anthropological research, most notably in conjunction 
with cultural consensus theory. Nonetheless, the key question of this paper is whether the 
explanatory models concept can play a heuristic role in building a unified interpretive-
structuralist research design. 
 
Explanatory Models Integrated with Structuralist Approaches 
     Bourdieu (1988, p. 782) decried the false dichotomies in social science between “objective 
and subjective” or “structuralist and constructivist” currents. Building on this, Dressler (2001, 
2007) called for a synthesis of constructivist and structuralist approaches in anthropology, one 
that would give equal voice to each view. Dressler (2001) asserts that medical anthropologists 
“have stumbled into an arena that demands that we understand how structure and cultural 
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construction intersect, because that intersection leaves its mark on the human body” (p. 457). For 
Dressler, this approach would detail how shared cultural constructs both emerge from social 
positions and help create social structure. Dressler’s “cultural consonance” model, similar to 
cultural consensus theory, examines agreement between individuals with shared models. While 
this approach has utility, it is still difficult to determine the role of structural forces in giving rise 
to the cultural models shared by a group in the first place. 
     Explanatory models have also figured in efforts to synthesize constructivist approaches with 
structural determinants. In their original formulation, Kleinman admittedly wanted a 
“microscopic, internal, clinical view,” but never intended to discount “the large scale external 
factors” emphasized by political economic schools of thought (Kleinman 1980, p. 27). Kleinman 
envisioned local cultural systems as transmitters of macro-level social forces and constraints, and 
arenas for conflict over scarce resources where some were privileged and others chronically 
marginalized (Kleinman 1985). However, he did not provide a means of operationalizing how 
broader social structures could be accounted for within the use of explanatory models, as this 
was probably not his intent. Rather, he designed explanatory models to illuminate discrepancies 
between providers’ and patients’ ways of thinking about illnesses in specific, individual 
episodes.  
     In a similar vein, critical medical anthropology never intended to discount micro-social 
context or even constructivist approaches (Baer 1997). Singer (1990) identified one of critical 
medical anthropology’s goals as a synthesis of “the macro-level understandings of political-
economy with the microlevel sensitivity and awareness of conventional anthropology” (p. 181). 
Baer (1990) even suggests that Kleinman’s EM approach could be incorporated into critical 
medical anthropology. Roseberry (1988) identified the constructivist-structuralist divide as one 
32 
 
of the major problems for anthropological research. Each researcher is confronted with the issue 
of how to account for the linkages between local and global processes. Structural forces must not 
be rendered overly deterministic, yet individual agency must not be exaggerated. This tension 
lies at the heart of political economy, and indeed all anthropological inquiry.   
     Ortner (1984) asserts that practice theory reconciles the agency/structural dilemma by treating 
it as a dialectical relationship; structure imposes limitations on individuals yet individuals have 
some openings in which to change structure. However, practice theory is plagued by an 
inattention to history, and an overemphasis on relations of power which tends to exclude analysis 
of symbolic meaning (Ortner 1999). Similarly, Lock and Scheper-Hughes (1996) proposed a 
“critical-interpretive medical anthropology” which would take account of the effects of structural 
forces on individual bodies. Health knowledge is not just culturally constructed but also 
negotiated, and the body is the terrain in which “social truths and social contractions are played 
out” (p. 506). Personal suffering becomes a metaphor for broader social inequalities.  
     Farmer (1988) made the earliest attempt to integrate explanatory models more explicitly into 
the broader structural context. Though mainly known for his macro-level concept of structural 
violence (Farmer 2004), Farmer is well schooled in constructivist approaches, and studied under 
Kleinman and Eisenberg at Harvard. Farmer (1988) utilized explanatory models in an 
investigation of move san and let gaté (literally “bad blood” and “spoiled milk”), two interrelated 
cultural illnesses in Haiti. Farmer elicited explanatory models of the disorder from sufferers as 
well as both a traditional healer and a medical doctor. He noted that explanatory models allow 
researchers to connect “narrators and narratives” and to understand how illness is culturally 
constructed. Farmer (1988), similar to White (2005) and Hunt and Arar (2001) stressed the 
malleable nature of EMs; “Not only are explanatory models reformulated and even recreated 
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during the same illness episode, they may be reshaped in different contexts at the same point in 
the episode” (p. 68). Investigating the explanatory framework of move san was only a first step 
for Farmer. He subsequently examined not only the signification of the disease in the context of 
the local research setting, but tied this to historical and social processes in Haiti and globally. He 
suggested that “an interpretive approach must not only be based on a painstaking 
phenomenology of illness and grounded in epidemiology, but it must incorporate the lessons of 
history and political economy” (Farmer 1988, p. 76) For instance, the growth of move san in the 
research setting paralleled historical processes such as the loss of land tenure due to a 
hydroelectric project, and the increasing entry of women into the work force.  
     Thus, explanatory models and a constructivist perspective figured prominently in Farmer’s 
theoretical orientation, ultimately giving rise to the concept of structural violence. He notes that, 
early in his career, he became disenchanted with “disconnected anthropology” that searched for 
“thick local meaning” while ignoring history and political economy, the impact of which was 
starkly visible in Haiti. Further, an overly emphatic focus on local actors and settings gave a 
misleading impression of agency among the poor and marginalized (Farmer 1999). Instead, he 
envisioned an “interpretive anthropology of affliction, attuned to the ways in which history and 
its calculus of economic and symbolic power impinge on the local and personal,” as well as to 
“culturally evolved responses to illness, fear, pain, hunger and brutality” (Farmer 1988, p. 80). 
Interpretations of illness needed to be grounded in historical research, to illuminate the ways in 
which local understandings might have developed. Farmer thus aims to create an “interpretive 
anthropology of affliction based on complementary ethnographic, historical, epidemiological, 
and political economic analyses” which account for both the narratives and lived experience of 
the afflicted, and the global economic forces shaping their lives (Farmer 1992, p. 13). In sum, 
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Farmers’ concept of structural violence necessitates recounting the ways in which world 
capitalism impacts local and individual contexts (Farmer 2004). 
     In related research, Vonarx (2007) also situates explanatory models within a structural-
historical context. Similar to Farmer (1988), Vonarx outlines explanatory models of voudou 
illness in Haiti, and then traces the historical context in which they emerged. He considers the 
EM approach “incomplete without a critical anthropological approach that addresses the 
relations of domination to which Haiti has been subjected” (Vonarx 2007, p. 18). He thus moves 
from a local analysis to a macro-level examination which demonstrates how historical factors are 
implicated in the construction of meanings of illness.  
     Another study that looks at the historical and structural context of explanatory models is 
Hewlett and Hewlett (2008). The authors investigate explanatory models of ebola in Uganda and 
Congo. In their study, some Gabonese respondents attribute the emergence of ebola to the French 
military, while others in Congo blamed Euroamerican conservationists.  Hewlett and Hewlett cite 
various theoretical influences, including evolutionary theory and clinically applied anthropology, 
but stress the importance of Farmer’s structural violence framework for interpreting the impact 
of political and economic forces or constraints in the development of individual narratives.  
     In another study that examines the historical and structural forces impacting explanatory 
models, McEwen (2005) investigates explanatory models of latent tuberculosis infection (LTBI). 
The study focuses on how profound economic differences between Mexico and the United States 
shape the medical encounter between Mexican patients with LTBI and U.S. doctors.  McEwen 
uses a critical ethnographic approach, which focuses on asymmetrical relationships of power in 
the medical encounter (Simon 1986). The goal is to move “beyond the immediate narrative of the 
participants to the broader processes in which the narratives are embedded” (McEwen 2005, p. 
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349). There is also an interest in determining how cultural symbols uncovered in the narratives of 
respondents contribute to unequal relationships of power. McEwen details how U.S. physicians 
discounted the explanatory models of Mexican-born patients by analyzing them within the U.S. 
biomedical paradigm, “the dominant narrative.” The U.S. physicians’ EM did not take into 
account particular contexts of the patients, such as the role of BCG vaccinations in contributing 
to LTBI diagnosis.   
     While examination of historical processes has been fruitful for underlining the structural 
forces which give rise to certain explanatory models, analysis of discourse is another area that 
offers promise. For example, Briggs and Briggs (2003) discuss how the state and media colluded 
in shifting blame for Venezuela’s cholera epidemic from institutions to “unsanitary” indigenous 
citizens and spaces. They examine both the narratives of marginalized people and those 
promulgated by bureaucracies and media in Venezuela, outlining how the state attempted to 
control the flow of information during the epidemic. In other words, the state sought to control 
the formation of explanatory models related to the cholera outbreak. 
 
     Medical anthropological research often occurs on a continuum, with constructivism on one 
end and structural approaches on the other. Even Kleinman (1980) recognizes the need to 
account for structural processes, while critical medical anthropologists acknowledge the 
importance of a micro-level focus (Singer 1990, Baer 1990). There is a growing literature 
combining constructivist approaches, including explanatory models, with a political economic 
perspective. This effort played a crucial role in the development of Farmers’ structural violence 
framework. As Farmer (1988), McEwen (2005), Vonarx (2007) and Hewlett and Hewett (2008) 
demonstrate, explanatory models of health often integrate structural processes into their 
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etiological component. Furthermore, analyzing explanatory models at the level of groups or 
communities (Chavez et al. 1995, Garro 1996, Baer et al. 2004, Baer et al. 2008) provides an 
opportunity to make meaningful comparisons between different social groups. 
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CHAPTER THREE 
BOLIVIA: ETHNOMEDICINE AND MEDICAL PLURALISM IN POLITICAL 
ECONOMIC CONTEXT 
 
     Ethnomedical systems of healing have flourished in Bolivia since pre-Columbian times, and 
show no signs of abating in the modern era. In part this is due to Bolivia’s strong indigenous 
presence; indigenous movements have become increasingly influential in politics (Canessa 2007, 
Fano 2009), and Evo Morales is Bolivia’s first president who self-identifies as an indigenous 
person. Under Morales’s administration, the Bolivian Ministry of Health has created a Vice 
Ministry of Traditional Medicine and Interculturality, with a goal of safeguarding traditional 
knowledge of healing and incorporating ethnomedical practices into the public health system 
(http://medicinaintercultural.org). It is important to distinguish that while ethnomedical healing 
practices often originate among indigenous societies, they are also present in various groups 
throughout society and are not a strictly indigenous phenomenon (Crandon 1981, Bastien 1996). 
This chapter is divided into two parts. In Part I, I will provide an overview of the current 
anthropological literature on Bolivia’s ethnomedical systems. In Part II, I will examine the 
interaction of these systems with the biomedical establishment and with socio-political forces. 
 
Background 
     Of rural Haiti, Farmer writes “nothing much seemed unhinged from history and political 
economy; the connections, historically deep and geographically broad, came into view with 
minimal effort” (Farmer 1999, p.23). The same observation would be apropos for Bolivia, which 
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consistently vies with Haiti for top ranking in the Western Hemisphere in terms of disease 
incidence and poverty indicators. For instance, life expectancy and daily caloric intake in Bolivia 
are the lowest in Latin America, and the second-lowest in the Western hemisphere behind Haiti. 
Maternal mortality rates and tuberculosis prevalence rates are the highest in Latin America, and 
the second highest in the Western Hemisphere behind Haiti (PAHO 2011).  Nearly two-thirds of 
the population lives in poverty, while more than half of Bolivia’s communities are at risk of food 
insecurity (PAHO 2007).  
     Furthermore, Bolivia shares with Haiti a centuries-long history of exploitation along racial 
and ethnic lines. Poverty and poor health in Bolivia are concentrated among its poor and 
indigenous people, who are largely one and the same. Infant mortality rates are 50% higher in 
rural areas, and are greater in indigenous than nonindigenous populations (O’Rourke et al. 1998, 
Nettleton et al 2007). Compared to the national average, tuberculosis rates are five to eight times 
higher among the Guaraní and other indigenous groups in eastern Bolivia, and infant mortality 
rates are as much as 50% higher in some Quechua communities (PAHO 2002).  
     Nonetheless, Bolivia’s historical development differs in key ways from Haiti, even though the 
two nations share a peripheral status in the global economic system. Most importantly, Bolivia 
experienced a successful revolution in 1952, with a concomitant land reform and incorporation 
of indigenous groups into the national power structure. Although neoliberal reforms 
implemented in the 1990’s eroded some of these gains, they were accompanied by increasing 
decentralization of national power which in some ways expanded opportunities for indigenous 
autonomy (Canessa 2007). Moreover, indigenous movements did not silently endure economic 
restructuring. Dissatisfaction with the neoliberal agenda helped sweep into power Evo Morales, 
the country’s first self-identifying indigenous president, in 2006. Morales’ administration has 
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demonstrated a commitment to empowering indigenous communities further while addressing 
the more glaring inequalities exacerbated by the neoliberal reforms.  
 
Part I: Bolivia’s Ethnomedical Systems 
     Bolivia has the largest proportion of indigenous citizens of any country in the Americas 
(Nettleton et al. 2007). The three largest groups are the Quechua, Aymara and Guaraní, who 
represent 31, 25, and 6 percent of the national population, respectively (PAHO 2011). Each 
group has its own set of ethnomedical beliefs, with significant intra-group variation. While these 
systems can trace their origins to Bolivia’s pre-Columbian past, they are both resilient and 
adaptive in the face of political change and in their interactions with Bolivia’s biomedical 
establishment.  
 
The Kallawaya and the Aymara  
     Bolivia’s famed ethnomedical healers, the Aymara-speaking Kallawaya, have for centuries 
inhabited the mountainous region northeast of Lake Titicaca. They probably began practicing 
during the apogee of the Tiwanaku state, which organized much of Bolivia into a political and 
religious system in the ninth and tenth centuries ACE. There is evidence that they practiced 
trephination and reshaped craniums during the Tiwanaku era (Rosing 1992). They were absorbed 
into the larger Aymara society, which in turn came under the control of the Inca state in the mid-
15th century (Klein 1996). They had a favored status in the Inca state due to their healing ability, 
and even administered to the Inca Emperor (Rosing 1992, Bastien 1998). The Spanish Conquest 
and accompanying epidemics brought an unparalleled calamity to the area of the Inca Empire, 
with the overall population collapsing from a height of 6 to 14 million in 1492 to less than 1 
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million after the Conquest’s completion in 1572.  However, European healing systems at this 
point were unable (and unwilling) to offer anything that might have rivaled the Kallawaya 
system, which possessed an extensive pharmacopeia. The Kallawaya’s reputation endured and 
even expanded after the Conquest. They were even summoned to administer to workers on the 
Panama Canal suffering from yellow fever, which they cured with bark of quinine (Bastien 
1998). In 2003, the Kallawaya culture and ethnomedical knowledge system was placed on the 
United Nations’ List of the Intangible Cultural Heritage of Humanity 
(http://www.unesco.org/culture/ich/RL/00048).  
     The Kallawaya model of health differs from the humoral model employed by the sixteenth 
century Spanish. Bastien (1985) characterizes it as a “topographic-hydraulic” system. The system 
is topographic in that the Kallawaya conceive of the human body in much the same way as their 
mountain home. The Kallawaya’s ayllu is a vertical system of productive land along the slopes 
of their mountain home, and is divided into a high, center, and low level. These correspond with 
the head, trunk, and members of the human body. The function of the body is to circulate blood, 
fat and air, much as the mountain continually transforms plants, lands and water in a cycle of 
death and rebirth. This is also a metaphor for how the ayllu distributes resources from different 
ecological zones. In the Kallawaya community of Kaata, residents conceive of their mountain 
home as a human body, with the peak being the head, lakes as eyes, terraced slopes as heart and 
liver, and the base as the feet. The mountain’s thirteen shrines symbolize different organs of the 
body, and must continually be fed to ensure the health of the community (Bastien 1981). 
     The Kallawaya system is “hydraulic” because of its emphasis on optimal circulation. Bastien 
(1985) points out that this concept is cyclical, not symmetrical like the Greek humoral tradition. 
The body takes in air, water and food, and distills and distributes these substances into useful 
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fluids (blood, semen and milk) or waste (urine, feces and sweat). The goal of healers is to ensure 
the unimpeded circulation and distillation of fluids within the body.  
     However, the Kallawaya health model does not isolate the body from social and 
environmental contexts. Good health depends on maintaining proper reciprocal relationships 
within the community and fulfilling one’s obligation to the land.  Health has organic, spiritual 
and social contexts, and there is not a Cartesian separation of physical and mental health domains 
(Bastien 1981). For example, a person’s souls are also viewed as fluids that flow through the 
body (Bastien 1985).  
     The land is inhabited by spirits who offer protection as long as obligations, in the form of 
ritual sacrifice, are met. Because the land feeds them, the Aymara have an obligation to feed the 
land in return, through sacrifice (Fernández 1995). Sacrifices often take the form of fat, which 
the Aymara consider a symbol of good health and “a medium of creativity and life force” to an 
even greater extent than blood (Canessa 2000, p. 709). For example, burning of llama fetuses, or 
even offering the froth of chicha (corn beer) in a libation, is seen as feeding “fat” to the spirits.  
     Neglecting the obligation to feed the spirits, in contrast, often causes severe health 
consequences. Spirits “expect something in return for their beneficence,” and are capable of 
“great vengeance if not properly feted” (Canessa 2000, p. 711). Even God will withdraw His 
protection if not properly honored and fed (Crandon 1991).   
     Mirroring the obligations one has to the spirits are the reciprocal ties maintained with the 
community. Neglecting social obligations, such as communal or family labor, weakens 
individuals and makes them vulnerable to the spirits who are ever present in the environment. In 
other words, “conflict and dysfunction in families and communities impact productivity, health, 
and the cosmic order that shapes peasant life” (Fernández 1995, p. 159).  Social disharmony 
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leads to loneliness and depression, which makes people more susceptible to the attacks of spirits 
(Crandon-Malamud 1991).  
     Curing sickness for Kallawaya healers depends on restoring the optimal flow of fluids within 
the body, as well as ensuring harmonious relationships between persons and the community, land 
and spirits. It is thus a holistic process which recognizes the link between social processes and 
health and well-being. Kallawaya and other Aymara healers involve the entire family in the 
healing process and mobilize social support for the sick person (Crandon 1983, Bastien 1981). 
Rather than simply asking for symptoms, healers engage in lengthy discussions with the family 
to identify potential sources of ill health, and to phrase questions for divination using coca 
leaves. The patient’s pulse is usually taken and their urine is analyzed (Carter 1981).  
     Healing is largely a symbolic process where the afflicted individual’s acceptance in the larger 
community is reaffirmed (Crandon 1983). Additionally, healers use “use symbols and rituals as 
adaptive mechanisms enabling people to cope with maladies” (Bastien 1996, p. 173). For 
instance, Bastien describes how a Kallawaya healer treated an adolescent girl for nausea and 
fever. The girl’s parents were unaware that she had been raped and was now pregnant. The 
healer told the parents that the coming child was a “gift of the Pachamama,” the sacred mother of 
the earth. Because of the reverence owed to the Pachamama, the parents were more easily to 
accept that their daughter was pregnant out of wedlock (Bastien 1996).  
     Kallawaya healers maintain a vast knowledge of the curative properties of plants. There are 
over 1000 species of medicinal plants in their repertoire, and up to 30% of these (such as quinine 
bark) provide effective treatment in biomedical terms (Bastien 1998).  Bastien (1985) maintains 
that the Kallawaya classify their medicinal plants according to their topographic-hydraulic model 
of health. Within the Kallawaya pharmacopeia, he notes that 42% of plants aim to restore 
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balances of liquids and fluids, 28% pertain to conduits and organs (which impact the circulation 
of fluids), and 30% deal with pain. Mastering this complex system of healing requires eight years 
of apprenticeship (Bastien 1998).Perhaps the most important plant employed by the Kallawaya 
and other ethnomedical healers is coca. Healers typically chew coca throughout the healing 
process and use its leaves for divination. Further, both the Aymara and Quechua typically burn 
coca leaves as an offering (Carter 1981).  
 
The Quechua 
     The Quechua-speaking Incas conquered the territory that is now Bolivia in the mid-15th 
century, absorbing several small Aymara kingdoms. Only a few years later, in 1460, the Aymara 
mounted a major rebellion against Inca rule. To quell resistance, the Incas resettled some of the 
rebellious Aymara to other parts of Tawantinsuyo, the Inca state, and sent Quechua-speaking 
colonists to occupy the newly vacant lands. In this fashion, Quechua came to be the dominant 
language and cultural system in Cochabamba and some of the valleys of western Bolivia, while 
the Aymara still predominate in some areas of the Bolivian altiplano (Klein 1996, Malpass 
2009). 
     Quechua cosmologies of health share many attributes with the Aymara’s, perhaps largely due 
to the extensive contact between the two groups as co-subjects of the Inca state and subsequently 
the Spanish colonial regime. The landscape of the Quechua, like that of the Aymara, is inhabited 
by spirits, some of whom are vengeful if not properly honored. The Quechua, or runa as they 
identify themselves, live in a “sleeping, restless, wakeful, hungry, angry” landscape that is 
“ready to seize people as they stray on dark paths, by springs, or up lonely mountainsides” 
(Greenway 1998, p. 998). Places that are imbalanced, characterized by either too much wind or 
44 
 
too much “wet”, are dangerous and may be the abode of harmful spirits (Crain 1991, Carey 
1993). Accidental disturbing of ancient bones, or overexposure to the wind, produces the folk 
illnesses of Manchu hapiska and Manchu wayra among the Quechua of Nuñoa, Peru (Carey 
1993). In the highlands of Ecuador, the spirits of dead people, or of demons, assume the qualities 
of an icy wind and cause mal aire (McKee 2003). In all of these cases, areas outside of the 
community, such as remote mountain paths, present the greatest danger, especially to solitary 
travelers.  
     Similar to the Aymara, the Quechua view themselves as inextricably linked with the natural 
and social environment. Thus, the body is “an open system that is permeable to and engaged in 
constant reciprocal exchange with natural, social and cosmological forces” (Pedersen, Kienzler, 
& Gamarra 2010, p. 294). Each person is connected with a star that guides their destiny and 
protects them from spirits. The star is identified in a ritual during adolescence, and must be 
honored annually in order to ensure its ongoing protection. Reciprocal obligations to stars and 
mountains must be fulfilled, else they may become angry or hungry and eat or possess a person’s 
heart, fat or souls (Greenway 1998). 
     The body contains multiple souls, or animus, with differing numbers in men (3) and women 
(7). The higher number in women gives them “stronger, more unpredictable, and more volatile 
natures,” but also assures women are “more responsible and harder workers” as a result of the 
greater strength of their animus (Greenway 1998, p. 998). Souls can detach from the body, either 
through emotional outburst, fright (often caused by a spirit or sorcery), or through failure to 
fulfill reciprocal obligations.  
     Quechua healers, like the Aymara, typically fall into two categories: those who heal 
organically with herbs and those who focus on the spirit. The Quechua also make use of 
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extensive plant medicines. In a study in rural Bolivia, Vanderbroek et al. (2008) identified 1166 
different uses of herbal medicine by Quechua healers based on 181 plant species. These treated 
67 different health-related conditions, ranging from general symptoms to specific illnesses. The 
Quechua, like all Bolivians, make extensive use of coca; a survey in 1981 found that 95% of 
Quechua speakers in Bolivia used coca for medicinal purposes, compared with 86.5% in the 
general population (Carter 1981).  
 
Ethnomedical Systems of Indigenous Peoples in Eastern Bolivia 
     The historical experience of indigenous people in eastern Bolivia has differed in key ways 
from that of the Quechua, Aymara and other highlanders. Eastern Bolivia is characterized by vast 
areas of rain forest and savannah, and includes the world’s largest dry tropical forest, the Gran 
Chaco (Wildlife Conservation Society 2014). Partly due to the unfamiliar climate and geography, 
the Incas were unsuccessful in their efforts to integrate the area of eastern Bolivia into their 
political orbit, although trade between the tropical lowlands and the Bolivian-Peruvian altiplano 
had flourished since at least the era of the Tiwanaku state in the ninth and tenth centuries ACE 
(Klein 1996, Malpass 2009). Also, Spanish penetration and control of the area was not as 
comprehensive as it was over the Aymara and Quechua, and many groups were able to escape 
Spanish domination by retreating into the Amazon (Klein 1996). Bolivia’s eastern groups were 
largely integrated into the colonial system through missionary activity, a process that is ongoing 
today. After the revolution of 1952, migration of highlanders into the area has accelerated 
concomitantly with exploitation of the timber, fauna, natural gas and mineral resources both by 
national and international capital (Klein 1996). 
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     Of Bolivia’s 36 officially recognized indigenous groups, 34 inhabit the eastern lowlands, and 
the Guaraní are the largest of these (IWGIA 2014). Guaraní refers to several groups of people 
who share a similar language and culture, and who inhabit parts of eastern Bolivia as well as 
Paraguay, northern Argentina and southern Brazil. In Bolivia, Guarani peoples primarily inhabit 
the large, dry tropical forest known as the Gran Chaco. Bourdy, Chavez de Michel, and Roca-
Coulthard (2003) investigated use of medicinal plants among the Izoceño, a Guaraní group in 
eastern Bolivia. According to the authors, every animal or natural feature, such as rivers, 
mountains and ricks, has a guardian spirit, or iya. Sickness can occur if one of the iya is 
offended, but it can also be induced by an mbaekua. While the paye seek to preserve health, the 
mbaekua is a malevolent sorcerer who causes affliction in its victims by introducing a worm into 
their bodies. When someone falls ill, the paye discerns whether the cause is from an offended 
nature spirit (iya) or the work of an mbaekua. In the latter case, the worm must be removed from 
the victim’s body through a process combining ritual and administration of medicinal plants. 
Bourdy et al. identified 189 plants with medicinal uses among the Izoceños. 
     Another study by Bruno et al. (2011) investigates epilepsy in Guaraní communities in 
Bolivia’s Gran Chaco. They characterize the Guaraní system as both “traditional magical and 
natural” (Bruno et al. 2011, p. 346). Epilepsy is recognized as an illness and generally linked to 
failure to observe Yekauku, a sacred fast, through eating the taboo foods of goat or pork. Local 
healers or paye treat epilepsy with special baths, teas and medicines. Key limitations are the 
study’s reliance on a cross-sectional survey and a biomedical conceptualization of epilepsy, yet it 
aims to dispel misconceptions by local biomedical practitioners that traditional healers are an 
impediment to treatment for epilepsy (Bruno et al. 2011).  
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     The Tsimane’ inhabit a large swath of territory in the department of Beni in eastern Bolivia, 
in the watershed of the Maniqui River, an area dominated by forest and tropical savannah. They 
resisted initial attempts at missionization from the Jesuits, and only in the last century have 
become more engaged in market-driven economic activities (Ringhofer 2009). The Tsimane’ 
maintain a “strong belief that natural and spiritual beings guide the relations between humans 
and nature” (Ringhofer 2009, p. 50). As with the Guaraní, the Tsimane’ expect dire or even fatal 
consequences from offending the spirits of nature. Tsimane’ existence is shaped by the need to 
maintain harmonious relationships with the natural and supernatural worlds (Ringhofer 2009).     
     The Tsimane’ system includes two main categories of illness. Japacjodye, or common 
illnesses, stem from internal imbalances or organic hazards, whereas daracansi, or spiritual 
illnesses result from witchcraft, malevolent spirits, or jichi, guardians of the natural environment.  
Common illnesses are treated primarily with plants, whereas daracansi require a combination of 
medicine and ritual (Calvet-Mir et al. 2008). The Tsimane’ depend heavily on plants harvested 
from the rain forest; wild and domesticated plants account for >50% of household consumption, 
compared with <3% for purchased goods (McDade et al. 2007). In a survey of two Tsimane’ 
communities, respondents identified 47 medicinal plant species (Reyes-Garcia et al. 2006).  
Another study indicates an association between child health and maternal ethnobotanical 
knowledge. Children of mothers with a “high” level of ethnobotanical knowledge had a less than 
10% chance of stunting, compared to about 20% for children of mothers with low knowledge.  
For every standard deviation increase in the mother’s ethnobotanical knowledge, her children’s 
health, as indicated by stature, skinfold thickness, and C-reactive protein concentration, 
improved by a factor of 1.5 (McDade et al. 2007). 
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     Historical developments have also had an effect on the development of ethnomedical systems 
in eastern Bolivia. Thomas (2012) compares plant use knowledge between two indigenous 
groups in eastern Bolivia: the Trinitarios and Yuracaré. The Trinitarios are the descendants of a 
large, complex pre-Columbian society from the Moxos area in the department of Beni. 
Archaeologists have found extensive remains of raised fields, causeways, and other built 
structures in this area, suggesting advanced agricultural techniques and a dense pre-Colombian 
population (Denevan 1963). In fact, Erickson (2010) suggests this part of the Bolivian Amazon is 
a human-engineered landscape. However, the population declined drastically in response to 
pressure from European expansion (Denevan 1992). By the 1880’s, the Trinitario left their 
original homeland to escape encroaching settlers and ranchers, and wandered throughout eastern 
Bolivia in search of a holy land where they could resettle. In the 1970’s, the Trinitario exodus 
ended in the Isiboro Sécure National Park, a territory also inhabited by the Yuracaré, a farming 
and foraging society (Thomas 2012).  
     Thus, while the Trinitario are a refugee remnant of a once extensive agricultural society, the 
Yuracaré still inhabit their original territory, and experienced considerably less pressure from 
missionaries and other nonindigenous groups. Thomas (2012) asserts that this affected their 
development of ethnomedical knowledge. In the study, the Trinitario identified more plants with 
medicinal uses, whereas the Yuracaré used a larger number of edible plants. The Trinitario 
identified more medical uses for cultivated species, whereas the Yuracaré knew more medicinal 
uses for wild species. The Trinitario also had more types of ethnomedical specialists 
(spiritualists, healers and midwives), while such divisions are less common among the Yuracaré. 
Thomas theorizes that this stems from the Yuracaré’s greater dependence on forest resources, 
whereas the Trinitario have a longer history of agriculture. Furthermore, the Trinitario’s earlier 
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contact with Europeans means they had a longer history of dealing with European-introduced 
diseases. Historical structural processes thus profoundly influenced the development of 
ethnomedical systems.  
     In another study, Thomas, Vandebroek, Van Damme, Semo and Noza (2009) describe the 
etiology of susto (soul-loss) among the Trinitario. In a survey, households ranked susto the 
fourth most important health condition in the community after fevers, cough and diarrhea. 
Similar to the Quechua and Aymara, the Trinitario attribute soul-loss to spirits in the natural 
environment. These spirits are either associated with a specific place, or with a “master of animal 
species” (Thomas et al. 2009, p. 299). The latter type of spirit is much like a herder who cares for 
every type of a particular animal. When a Trinitario kills an animal, the master of that species 
becomes angry and exacts vengeance by taking the soul of the killer or, more frequently, one of 
the killer’s children. The Trinitario also believe in multiple souls which are found in front, within 
and behind the body. During susto, the front-soul is lost first, then the internal soul, and finally 
the back soul. With the loss of each soul, the severity of the illness intensifies. Symptoms include 
fever and weakness after the loss of the second soul, and severe vomiting and diarrhea after the 
loss of the third.  
     Trinitario healers often treat susto with millo, a fibrous mineral from the Valley of 
Cochabamba that is often sold in the stores opened by Quechua migrants in the area (who also 
use it to treat susto). This suggests recent or even historical diffusion of an ethnomedical practice 
from the Quechua to a tropical indigenous group. The fibers are wrapped around the patient’s 
arm or trunk, then removed to discern the shape of the vengeful animal. Treatment can then 
proceed by inhaling the smoke from the burnt tissue of the animal, such as fur, feathers or bones 
(Thomas et al. 2009). 
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     The Ayoreo inhabit Bolivia’s border with Paraguay, in the Gran Chaco region, and lived 
primarily in isolation from Bolivian national life, as hunter-gatherers, until the 1950’s (Roca-
Ortiz et al. 2011). Called “bárbaros” or barbarians by the mainstream Bolivian population, the 
Ayoreo have suffered considerable marginalization and violence (Bessire 2014). A study led by 
Bolivian anthropologist Irene Roca-Ortiz notes that Ayoreo traditional healers, daijnane or 
naijnane, cured through biting, blowing and sucking, as well as through healing songs. Health 
for the Ayoreo is based on adherence to taboos, and disease is a consequence of breaking these 
taboos. However, traditional ways of healing began to disappear following contact by 
Evangelical missionaries in the 1950’s. According to Roca-Ortiz et al. (2011), “The Ayoreo 
health system has weakened and continues to lose force among their communities, at the same 
time their experience with the public health system is negative” (p. 2).  
     Renshaw (2006) documents the practice of healing through songs, or sarode, among the 
Ayoreo. In between singing, the shaman also performs daijnane, which in this case means 
“sucking” of the afflicted area. Shamans derive their power for this type of healing from three 
categories: animals of the air, water, or land. Though common during Renshaw’s fieldwork in 
the late 1970’s, the healing songs in the community where he studied appear to have disappeared 
under pressure from Evangelist missionaries, who often discourage ethnomedical healing 
practices among the Ayoreo. Roca-Ortiz et al. (2011) also observe that the traditional taboos 
have largely been abandoned under pressure from missionaries, yet traditional healers continue 
to practice. 
     In sum, there are diverse traditions of ethnomedical healing throughout Bolivia. The practices 
and systems described here are contemporary and active, although those of the Ayoreo are under 
51 
 
intense pressure. Furthermore, they are not static holdovers from a prebiomedical past, but are 
responsive to historical developments and capable of adapting to new sociopolitical realities. 
      
Part II: Ethnomedicine, Biomedicine and the Political Economic Context in Bolivia 
Limitations of Biomedicine in the Bolivian Context 
     Especially in rural areas of Bolivia, there is a severe lack of biomedical infrastructure and 
personnel. Although the government added 80% more rural health workers in the 1970’s 
(Bastien 1996), the ratio of practitioners to people remains very low. There is only one doctor for 
every 7,000 inhabitants, and many medical personnel are poorly trained. Of those who undergo 
medical training in Bolivia, less than half end up practicing for the benefit of Bolivia’s people; 
70% emigrate, often to the United States (Bastien 1996).  The state attempted to provide more 
practitioners for rural areas by mandating that medical school graduates perform a year of service 
in rural clinics. However, some indigenous patients complain that such doctors are young, 
inexperienced, and unfamiliar with local language and culture (Hudelson et al. 1995). Despite 
their scarcity, rural health clinics tend to be underutilized, because of prohibitive costs or 
difficulties in traveling from outlying areas on treacherous roads. Additionally, when poor and 
indigenous patients do make use of biomedical services, they often feel berated by practitioners 
(Crandon 1991, Hudelson et al. 1995, Bastien 2003, Greene 2004).   
     Since Morales’s ascension, the government has attempted to provide universal health 
coverage. However, 64% of Bolivia’s urban employees work in the informal sector, and are thus 
outside of the scope of the national compulsory insurance program. Only 16% of Bolivian 
workers were insured in 2004 (PAHO 2011). Moreover, even state sponsored programs to 
provide “free” treatment often come with hidden costs. For instance, while the national 
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tuberculosis program provides free medication, it does not cover the cost of chest X-rays, or the 
fees physicians charge for interpreting those X-rays. One X-ray/consultation can absorb the 
entire monthly salary of a Bolivian worker (Greene 2004). For the uninsured, costs can be 
especially prohibitive. For example, in 1984 a single injection of penicillin cost ten dollars, or the 
equivalent of several days’ wages for one of Bolivia’s rural poor (Bastien 1998). A month’s 
supply of nifurtimox, one of the medications used to treat Chagas disease, can cost $60 (Bastien 
2003), well beyond the monthly earnings of an agricultural laborer in Palacios.  
      In addition to these structural barriers, indigenous patients frequently find that the form of 
providing care in biomedical clinics conflicts with important ethnomedical practices. Doctors 
typically come from the upper or middle class and do not speak indigenous languages. Bastien 
(1987) found that Aymara patients at a hospital in Oruro felt isolated from family and other 
sources of social support, and associated the white color of staff uniforms and hospital walls with 
the death of infants. Aymara mothers worried that biomedical staff cut the umbilical cords of 
their infant sons too short, diminishing their masculinity. Metal, such as that used for hospital 
equipment, was deemed a lightning-attractor and source of bad luck.  
 
Ethnomedical Beliefs as “Barriers” to Biomedical Treatment 
     Several studies have demonstrated that ethnomedical systems of knowledge do not pose 
serious barriers to biomedical treatment, as Bolivian providers sometimes claim. For instance, 
Bastien examines occurrence of neonatal tetanus (NNT) in three Bolivian cultural orientations: 
the Aymara, the Quechua and the “Tupi-Guaraní” (the term Bastien uses to describe the highly 
Hispanicized, Spanish-speaking community of Montero, which lies just north of Santa Cruz). In 
Bastien’s study, the Quechua often associate NNT with arrebato (susto) or wayra (wind), and 
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attribute it to sorcery. Consequently, they typically consult a curandero before going to a clinic. 
For the Aymara, NNT comes from a jinchukañu or spirit in the form of an owl who steals one of 
the baby’s souls. The Tupi-Guaraní interpret NNT as the result of exposure to miasma or unclean 
air. While Bastien notes that most respondents were largely unaware of the benefits of tetanus 
vaccination for mothers, he also points out that several respondents had had negative experiences 
with other types of immunizations, such as painful injections or dull and unsterilized needles, 
which had diminished their enthusiasm for the procedure (Bastien 1995).  
     In La Paz, Greene (2004) interviewed patients who did not complete treatment in the “free” 
National Tuberculosis Control Program. He notes that patients suffering from tuberculosis often 
experienced susto simultaneously. While some consulted yatiris, they viewed this as a 
complementary treatment rather than a replacement for biomedical treatment. The root cause of 
nonadherence in Greene’s study was hidden costs and other impositions associated with the 
National Tuberculosis Control program. For instance, while medications were provided free of 
charge, patients had to pay for X-rays and consultations. Moreover, Bolivia utilizes the direct 
observed treatment short course (DOTS) system, as recommended by the WHO. This required 
patients to report to the clinic every day for the first month, and then once a week for the 
following five months, where they often spent hours waiting for someone to observe them taking 
their medication. Unemployed patients found the transportation costs burdensome, yet those with 
jobs were frequently unable to miss time from work. Thus, a combination of “poverty, ethnic 
discrimination, access to care, and other structural forces” contributes to patients’ nonadherence, 
rather than a particular preference for ethnomedical healing (Greene 2004, p. 421).  
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Explanatory Models Research in Bolivia 
      Two ethnographic studies have employed Kleinman’s explanatory models framework for 
health research in Bolivia. Hudelson, Huanca, Charaly and Cirpa (1995) describe research on 
acute respiratory infections using the WHO’s focused ethnographic study (FES) methodology. 
One of the goals of FES is to elicit patients’ explanatory models. This underscores the 
popularization of explanatory models beyond anthropology, into disciplines such as public health 
and psychology. Ultimately, this study focuses more on determining if mothers in Quechua and 
Aymara communities are able to recognize ARI symptoms, such as fast breathing, so as to seek 
treatment. Based on the research, postcards and posters were developed to “discourage” harmful 
practices identified in the research and to encourage those that complemented WHO 
recommendations (Hudelson et al. 1995, p. 1682). While the authors acknowledge that 
significant transportation and financial barriers would severely hamper use of clinics, the goal of 
the study is to produce educational materials for health workers to distribute – to encourage 
community members to go to the clinic. The researchers were unable to locate ethnomedical 
healers in either the Quechua or Aymara community, possibly because of reluctance to be 
identified by a WHO- and government-sponsored study.  
     The second study describes naturistas in Sucre, healers who utilize components of both 
biomedical and traditional medicine (Bruun and Elverdam 2007). The naturistas create 
“pluralistic and hybrid explanatory models” which pragmatically make use of multiple systems 
of healing (Bruun and Elverdam 2007, p. 281). For example, the causes of diarrhea include too 
much “cold” as well as “a wrong combination of food and bacteria” (p. 281). Although the study 
points to an interesting convergence of ethnomedical and biomedical healing practices, the social 
and structural context of this development is largely ignored.   
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The Role of Political Economy in the Cultural Construction of Ethnomedical Beliefs 
     Farmer proposes that anthropologists should work against the “erasure of history,” and 
demonstrate the historical process through which structural forces have created suffering and ill 
health in specific local contexts (Farmer 2004, p. 308). This echoes Singer’s call for 
anthropologists to combine their “micro-level sensitivity” with an understanding of political 
economic contexts (Singer 1990, p. 181). Lock and Scheper-Hughes (1996) urge anthropologists 
to examine the ways in which structural inequalities manifest themselves in individual bodies.  In 
this spirit, several anthropological investigations have analyzed the impact of macro-level 
processes on health in Quechua and Aymara communities. 
     Carey (1990, 1993) and Oths (1999) complement ethnographic research in Quechua 
communities in Peru with epidemiological analysis of folk illnesses. The Quechua of Nuñoa, the 
area studied by Carey, face two sources of adaptive stress: the biological challenges of adapting 
to a high-altitude, arid environment, and an oppressive social environment, “which makes it 
difficult for the poor to acquire sufficient land or other economic resources and places many 
campesino families in socially disadvantageous and politically weak positions” (Carey 1990, pp. 
271-272).  He compares the three villages of Sincata, Nuñoa, and Chillihua. From a purely 
biological perspective, Sincata should have experienced less frequent episodes of ill health, due 
to its lower altitude. Carey finds the contrary, however; most morbidity measures in his study are 
worse in Sincata, which is the poorest of the three communities. Biomedical diseases as well as 
folk illnesses have a higher incidence in Sincata. Carey concludes that folk illnesses, like 
biomedical diseases, are more concentrated among socially disadvantaged groups. (Carey 1990). 
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     Subsequently, Carey (1993) examines the distribution of the three most reported folk illnesses 
in the same three communities. Again, the poorest village of Sincata has the highest prevalence. 
The illnesses were manchariska, which resembles susto; machu wayra, or “old wind”; and 
machu hapiska, or “seized by the earth.” He utilizes a prospective cohort design by following 83 
households for a period of a year. There is a definite age and gender-based distribution to the 
three illnesses. Machu wayra is eight times more common for women, and machu hapiska and 
machu wayra are much more common in people older than 46. Manchariska is more prevalent in 
children and young adults. Carey concludes that “culture-bound illnesses are distributed 
according to one's place in the overall social organization” of the community (Carey 1993, p. 
290). 
     Oths, like Carey, uses an epidemiological design along with ethnographic interviews in 
research on debilidad in a different Quechua community: Chugurpampa, Peru (Oths 1999). 
Debilidad is a folk illness embodying complete exhaustion based on continual exposure to life-
related stress. Oths traces the historical development of the community to contextualize the 
political instability and economic distress endured by its members. She views debilidad as “the 
degeneration of the integral body due to the accumulated hardships of productive and 
reproductive labor” (Oths 1999, p. 295) It appears during “culturally constituted vulnerable 
periods” in life (p. 301), and is influenced by the onerous productive and reproductive labor 
demands engendered by centuries of exploitation and by Peru’s contemporary economic crisis.   
     Using the household as the unit of analysis, Oths determines that debilidad strikes more 
frequently in homes where there is an imbalance in the ratio of males and females. Specifically, 
when there are more males than females in a household, it creates stress for mothers who have 
less support from female offspring to perform domestic labor. In households with debilidad, 
57 
 
women had 2.2 more pregnancies and 1.5 more deceased offspring, compared with homes free of 
the illness. Also, women who had gynecological health problems were 2.5 more times likely to 
live in a home where someone suffered from debilidad. While most common in older women, 
the illness sometimes appeared in men or children. In fact, the latter groups were six times more 
likely to suffer the illness if they lived in a home where someone had debilidad.  
     Other research focuses on symbolic expressions of suffering, exploitation and resistance. This 
largely builds on Nash (1979) and Taussig’s (1980) examination of the role of the devil for 
Bolivian tin miners. In Nash’s ethnography, “El Tío” originally takes on the aspects of the 
medieval Christian devil, but by the twentieth century assumes the form of a tall, blond gringo 
overseer. He is a spirit who haunts the mines, yields riches, and takes credit for the various types 
of early deaths a miner can experience, such as accidents or chronic health conditions. The 
miners pay El Tío with blood from llama sacrifices; regale him with cigarettes, alcohol and coca 
leaves; and hope that if his hunger is sated he will not claim them as a victim. As an exploiter, El 
Tío is both a source of lethal danger and a potential pathway to success, although his help always 
entails a cost in blood (Nash 1979). 
     The kharisiri is another spiritual figure who personifies exploitation. In colonial times, the 
kharisiri was dressed as a priest or Franciscan monk, whereas by the latter half of the twentieth 
century, he was more often a doctor, lawyer or politician (Crandon 1991). He is the antithesis of 
one of the central principles of Aymara morality – the reciprocal exchange of fat between people 
and spirits (Canessa 2000). Fat in the Aymara cosmology, much like blood in medieval Europe 
and even the contemporary United States, symbolizes vitality. People offer fat to the spirit world 
through sacrifices, and in turn are blessed with good health.  
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     The kharisiri violates this principle by stealing fat from unsuspecting victims. He typically 
appears outside of the sphere of the community, especially to solitary travelers on lonely roads. 
With prayers and the smoke of burning bones, he puts his victims to sleep, and then using a 
watch-like instrument, he makes an incision near the kidneys, from which he extracts fat. 
Historically, the kharisiri stole fat in order to make holy oils for the bishop. In modern times, the 
fat is used for a soap factory in La Paz, or even exported to the United States where it is 
converted into electricity (Crandon 1991). The kharisiri is thus a culturally produced expression 
of the victimization the Aymara have endured from global exploitative forces, in which Western-
style doctors are implicated. On a more practical level, the idea of the kharisiri creates 
understandable fear of biomedical surgical procedures for many Aymara patients (Bastien 2003).  
     In other contexts, devils and spirits not only symbolize suffering and exploitation, but also 
figure into discourse of resistance. Crain (1991) characterizes women’s narratives about spirit 
possession in Quisma, a Quechua community in Ecuador, as an unconscious form of opposition 
to the commodification of labor. Excluded from the political process, women connect the deaths 
of male workers in the community to spirit possession of machinery, thereby critiquing the 
dominant commercial development model in the area.  
     The suffering of the exploited can also serve as a metaphor for relations of subordination and 
dominance tied to the global economic system. For instance, Tapias (2006) considers the impact 
of Bolivia’s deep political and economic crisis at the beginning of the millennia on Quechua 
market sellers and working class women. Severe stress precipitated by the crisis and the 
difficulties of earning a living produced debilidad, a condition of chronic exhaustion, in some 
women. In others, it gave rise to powerful emotions ranging from anger to despair. Many women 
believed these emotions turned their breast milk toxic, and through this vehicle, caused arrebato 
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in their babies. Arrebato was associated with inconsolable crying, stomach pain and diarrhea in 
infants. This in many ways resembles the illness of let gaté described by Farmer in Haitian 
mothers (Farmer 1988). For the mothers, poverty and marginalization produce tangible effects in 
their own bodies and those of their infants.  
     In another investigation linking structural inequalities to emotional suffering, Wutich (2009) 
assesses the impact of water insecurity on heads of household in Cochabamba, Bolivia. Wutich 
found that the lack of access to municipal water in Villa Israel, a poor neighborhood on the 
outskirts of Cochabamba, led to emotions such as worry (preocupación), fear, (miedo), and anger 
(renegade). Furthermore, female heads of household experienced significantly more emotional 
distress than males.  
     In Peru, economic reforms similarly resonate in the bodies of the poor. Oths (2003) details 
how state policies have squeezed profits from potato-growing farmers in Chugurpampa in the 
highlands of Peru. Because of government pricing structures, growers are compelled to sell 
potatoes in 100-pound bags. This necessitates constant lifting of heavy loads during harvest 
season, interspersed with periods of stooping to dig the potatoes. Consequently, muscoskeletal 
problems are widespread in Chugurpampa. In the absence of biomedical services, several 
componedores, or bonesetters, administer to the aches and pains of the farmers, permitting them 
to continue working. Yet they recognize that this only provides temporary alleviation against a 
cycle of life that progressively degenerates their bodies.  
     Pedersen, Kienzler and Gamarra (2010) examine responses to the trauma endured by Quechua 
people in Ayacucho in the wake of the civil war between the Peruvian government and Sendero 
Luminoso. During the conflict, 10,000 people in Ayacucho, 75% of whom were Quechua, lost 
their lives. The study aims to comprehend “how highland Quechua populations generate, 
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experience and resolve distress and suffering within their specific social context, and how idioms 
of distress are determined by social position, modeled by culture and driven by recent historical 
events” (Pedersen et al. 2010, p. 292) They use the term “idioms of distress” rather than culture-
bound illness to refer to conditions which simultaneously embody personal and social concerns, 
with both physical and emotional impacts.  While they use both a cross-sectional survey and 
ethnographic interviewing, the results of the survey are not explicitly described. Nonetheless, the 
authors identify several idioms of distress linked to the trauma of Peru’s economic crisis and 
civil war, such as Sassachacuy tiempu, which describes the trauma associated with deaths of 
relatives or with fleeing into the mountains to escape Sendero raids. The authors also describe 
the presence of the same idioms in colonial era sources, yet they note that their use and meaning 
constantly evolves. 
          Crandon characterizes medical dialogue in rural Bolivia as a process of negotiating 
identities, which is in turn part of a wider political process. In this view, “symbols can be 
manipulated and negotiated” within different local contexts as the sociopolitical landscape 
changes (Crandon 1986, p. 473). When the revolutionary government redistributed land after 
1952, dynamics of power in rural communities shifted. Mestizos could no longer extract labor 
and credit obligations from indigenous people to the extent that was possible before the reform. 
Deprived of much of their land and social clout, many mestizo families became just as destitute 
as their indigenous neighbors. No longer able to afford biomedical care, some of these families 
have turned to ethnomedical practitioners.  
     During Crandon’s fieldwork, six young adults from mestizo families in a rural community 
were stricken by psychiatric disorders. The first four were institutionalized by psychiatrists, and 
subsequently died. The last two sought treatment from yatiris, largely because their families had 
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lost confidence in biomedical practitioners, and were completely cured. Within this process, the 
mestizo families renegotiated their cultural identity by affirming their equality with their Aymara 
neighbors. In this way, they attained social support and affirmation that was otherwise 
unavailable (Crandon-Malamud 1991, 2003).  
 
Medical Pluralism and Prospects for Integration 
     In the 1950’s, the Bolivian state attempted to enact licensing requirements for anyone 
practicing medicine. Consequently, many ethnomedical practitioners were jailed (Bastien 1996). 
Yet biomedical doctors in Bolivia never succeeded in consolidating a legal monopoly as in the 
United States. This is partly due to the weak presence of doctors. While there is only one doctor 
per every 7,000 people, there is at least one midwife, curandero and herbalist for every 
community with a population over 200 (Bastien 1996). Furthermore, yatiris, midwives and other 
ethnomedical healers practice in areas which would otherwise be completely devoid of any type 
of care.  
     Continuing economic crises since the 1980’s have left large segments of the population 
unable to afford biomedical care. Herbal medicines, which are locally produced and often much 
more inexpensive, are utilized by up to 70% of the population. The number of market stalls 
selling herbal medicine in La Paz grew from 30 in 1965 to 130 in 1985 (Bastien 1998). Many of 
the components in the herbal medicine sold in the market were found to be potent even in 
biomedical terms (Bastien 1996; Macía et al 2004; Malek et al 1995). 
     Others have called for collaboration between Western medicine and local forms of healing. In 
1978, the WHO conference in Alma Ata, USSR, recommended training indigenous practitioners 
in biomedical practices as “allies in organizing efforts to improve the health of the community” 
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(WHO 1978, p. 63). Joseph Bastien, an anthropologist and physician, has engaged in various 
projects aimed at increasing cooperation between ethnomedical and biomedical systems of 
healing. He proposes that ethnomedical healers can actually make biomedical practices more 
palatable for indigenous communities (Bastien 1998). For example, in one community, 
ethnomedical healers, some of whom were also rural health workers, created a story using 
Aymara mythical symbols such as mountain spirits and condors, to promote the use of oral 
rehydration salts. This therapy was then combined with beneficial traditional practices such as 
the use of herbal teas.  
     At a birth clinic in Oruro, midwives met with doctors and nurses and convinced them to allow 
some non-harmful Aymara birth practices, such as a traditional meal of sheep soup following 
delivery (Bastien 1987). In another example, Kallawaya healers partnered with doctors to treat 
jobless miners suffering from tuberculosis – which they had interpreted as susto. In another 
community, 200 children died from a measles epidemic shortly after a Bolivian physician had 
refused to travel to the remote location to administer vaccinations. Local Kallawaya healers were 
then trained to administer vaccinations (Bastien 1996).  
     The process of integration is not without challenges, however. More systematic integration of 
ethnomedical healers with the Bolivian health system would require practices such as testing and 
licensure, threatening the autonomy of traditional practitioners. While recordkeeping might 
enable greater cross-referrals between ethnomedical and biomedical healers, many indigenous 
practitioners are illiterate or reluctant to document practices, especially in light of past legal 
persecution by the state (Bastien 1996). Ethnomedical healers are also reluctant to share 
information on herbal remedies, since pharmaceutical companies have profited by expropriating 
such knowledge in the past (Bastien 1998).     
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     Bolivia contains diverse ethnomedical systems throughout its territory. While strong 
ethnomedical systems exist in indigenous populations, ethnomedical practices are also 
widespread in nonindigenous sectors of society (Crandon 1986, Bastien 1996). Research shows 
that ethnomedical healing practices are often complementary rather than adversarial to 
biomedical care (Crandon-Malamud 1991, Bastien 1985, Bastien 1996, Greene 2004). 
Nonetheless, ethnomedical forms of healing provide an alternative dialogue to biomedicine, 
which has proven unable and often unwilling to provide consistently accessible care for a 
majority of Bolivia’s population. Structural processes have a strong influence on how Bolivians 
seek care, and often shape how ethnomedical systems develop (Crandon 1986, Greene 2004, 
Roca-Ortiz et al. 2011).Ethnomedical systems of healing in Bolivia are “traditional” in the sense 
of maintaining many centuries-old practices, yet in many cases they have also proven adaptive 
and resilient to major social and political change. Far from receding as the pace of development 
in Bolivia intensifies, ethnomedical forms of healing have evolved and expanded, making it 
essential to incorporate them into health-related projects. 
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CHAPTER FOUR 
CHAGAS DISEASE: HISTORICAL, EPIDEMIOLOGICAL AND 
ANTHROPOLOGICAL PATTERNS 
 
Introduction 
     Chagas disease is one of the most widespread health problems in the Americas. Estimates of 
the numbers of people infected range from 10 to 14 million, and 10-15,000 die from the disease 
annually (WHO 2010, MSF 2009). While traditionally the disease has flourished among the rural 
poor from Chile to Mexico, globalization and migration have introduced Chagas into major 
urban centers, and into the public health discourse of countries as distant from the Americas as 
Australia, Spain and Japan (Schmunis et al. 2009). Chagas disease, like HIV/AIDs, is a complex 
phenomenon that encompasses characteristics of both an infectious and a chronic disease. It is 
difficult to diagnose and in certain contexts impossible to cure. This chapter describes the 
biomedical model of Chagas disease based on current biomedical literature, and discusses the 
epidemiology of the disease in Bolivia and globally. Moreover, the current anthropological 
literature on Chagas disease is examined. 
 
The Biomedical Model of Chagas Disease 
Etiology 
     The biological agent that causes Chagas disease is Trypanosoma cruzi, a flagellate protozoan, 
which is transmitted to humans through the bite of the vector, the hemotophagous insects of the 
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Reduviidae family, also known as kissing bugs or vinchucas. The latter two terms refer to the 
behavior of the insects. Photosensitive, they hide in crevices, mattresses, thatched roofs, clothing, 
outhouses, rock piles, and other protected areas during the day, emerging at night to drink blood 
from sleeping victims (Rassi, Rassi and Marin Neto 2010, Stevens, Rizzo, Lucero and Pizarro 
2013). They are often spotted on faces where they appear to be kissing their victims (Bastien 
1998). Vinchuca, the popular term in Bolivia, comes from the Quechua term huinchicuy: 
“something that falls rapidly.” This refers to the manner in which the insects glide down from the 
rafters at night to feed (Bastien 1998).  While the bite itself does not spread the infection, the 
vinchuca typically defecates while feeding, and the feces harbor T. cruzi (Bern et al. 2007). 
When the bitten person scratches their bite, usually subconsciously, they unintentionally 
introduce the infected feces into their bloodstream. In addition to humans, vinchucas can 
transmit T. cruzi infection to 100 other mammals, including bats, dogs, cats, sloths, and rats 
(Gilka, Haberland, Wallukat, and Schimke 2012).  
      Although the vinchuca bite is the most common route of transmission, accounting for 80-
90% of infections (Coura and Castro 2002), the disease can also spread through blood 
transfusions and organ donations. Moreover, in up to 6% of cases, mothers pass the infection to 
their infants through the placenta (Salas et al. 2007). T. Cruzi infection has also occurred through 
ingestion, both of uncooked meat of infected hosts, and foods that contain infected vinchucas 
(Nóbrega et al. 2009).  
 
Symptoms, Pathophysiology and Progression 
     After a brief subclinical period, T. cruzi infection leads to an acute phase that typically lasts 
two weeks. About two-thirds of adults are asymptomatic in the acute phase (Bastien 1998), but 
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others experience fever, a skin lesion (chagoma), chest pain, diarrhea and difficulty breathing. 
The acute phase has a case fatality rate of 2-8%, which is higher in children than in adults (Coura 
and Castro 2002). Fatalities in the acute phase are a result of myocarditis or menincephalitis 
(CDC 2013). During this time, the protozoans pass through the bloodstream and invade heart and 
muscle tissue, the lymphatic system, the digestive system, macrophages and neurons. When the 
acute phase passes, the body attains a degree of immunity to further infections, although the 
T.cruzi parasites from the initial infection are not eliminated (Sadigursky 1999, Coura and 
Borges-Pereira 2010).  
     A latent or indeterminate period follows the acute phase, with no visible symptoms. Years or 
even decades later, about 30% of infected people will enter a chronic phase (Bern et al. 2007, 
Rassi et al. 2010). This proportion varies considerably between regions, and appears to be higher 
in endemic areas like Bolivia, possibly due to recurrent infections (Coura and Borges-Pereira 
2010). The severity of the acute phase, as well as the parasite load in the initial infection, could 
be important in determining which patients develop symptoms in the chronic phase (Coura and 
Borges-Pereira 2010). Among those who experience a symptomatic chronic phase, two-thirds 
suffer heart conditions such as cardiomyopathy, severe fibrosis and lesions in the heart tissue, 
arrhythmia, heart failure and thromboembolism (Bern et al. 2007, Gilka et al. 2012). Of the 
remainder, many suffer a digestive variant of the disease characterized by megacolon or 
megaesophagous, severe constipation and intense abdominal pain (Coura and Borges-Pereira 
2010). Both the chronic variants of Chagas are frequently fatal (Bern et al. 2007, Coura and 
Borges-Pereira 2010, Gilka et al. 2012). 
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Treatment 
     Prospects for curing the disease are more favorable during the acute phase, especially in 
children (Guedes, Silva, Gutierrez and Silva 2011). The only medications known to effectively 
treat Chagas are nifurtimox, developed by Baer in 1967, and benznidazole, created by Roche in 
1972 (Schofield, Jannin and Salvatella 2006). Pre-seropositive acute cases (where the presence 
of T. cruzi antibodies cannot yet be detected in the bloodstream) can successfully be treated with 
2 months of medication (Tornheim et al. 2013). In acute cases that are seropositive, the cure rate 
is slightly better than 70%. In chronic seropositive cases, treatment is only considered successful 
about 30% of the time (Jannin and Vilna 2007). One problem with these medications is that they 
create often painful side effects, which can be moderate to severe in 30% of patients (Tornheim 
et al. 2013). Children experience fewer, less severe side effects than adults (WHO 2010). Many 
aspects of the chronic phase, such as megacolon or cardiac hypertrophy, may also require 
surgical procedures (Rassi et al. 2010).  
     Treatment is complicated by the difficulties of diagnosing the presence of T. cruzi in the body 
(Bern 2011). Infected patients may exhibit evidence of the parasites only on certain occasions. 
Both parasitological and serological tests are hampered by low sensitivity, and there is not yet a 
gold standard for diagnosis (Pirard et al 2005).  
 
Ecological History 
     Chagas disease has endured in the Americas for millennia. Mummified remains from northern 
Chile, some up to 9,000 years old, bear evidence of T. cruzi DNA, megacolon and 
cardiomyopathy (Rothhammer et al. 1985, Guhl et al. 1999, Aufderheide et al. 2005). The spread 
of the disease, both currently and historically, is intimately linked with human settlement and 
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land use patterns (Briceño-León 2009, Cortez, Monteiro and Noireau 2010). The disease exists in 
sylvatic form throughout most of the Americas, with transmission between a wide range of 
mammals and vinchuca vectors. Although vinchucas are just as inclined to feed on human blood 
as that of any other mammal, infection rates were very low prior to the advent of sedentary 
agriculture. The mobility and low population density of hunter-gatherer groups tended to 
discourage high rates of parasitic infections (Coimbra 1988).  
     Human interaction with the natural environment profoundly influenced the development of 
Chagas disease, much as occurred with malaria in tropical Africa. When people began growing 
crops, they cleared the forests where triatomines and their hosts lived, interrupting the sylvatic 
cycle of the disease. At the same time, they began living in larger, more permanent settlements 
and raising llamas, alpacas and guinea pigs in or near their homes, providing an alternative, 
accessible food source for the vectors. Triatoma infestans, the insect responsible for 97% of 
vector-based transmissions in Bolivia (Bastien 1998), originally was a sylvatic species that 
became domiciliary, probably in the vicinity of modern-day Cochabamba, Bolivia (Cortez 2010).  
     Early Andean communities developed a vertical subsistence model. The shifting altitude of 
the region provides diverse ecozones suitable for different types of crops and products. The same 
community often had lands in various ecozones, from tropical forest to the puna or tundra-like 
terrain at the highest altitudes (Klein 1996). This required ongoing traffic, often through llama 
caravans, to transport goods from one zone to the other. The practice intensified and assumed 
greater scale with the emergence of large states like Tiwanaku and Wari, and culminated with the 
vast Inca state, Tiwantinsuyu (Klein 1996, Bastien 1998). 
     In fact, the prevailing theory posits that Chagas disease spread through the Americas via the 
extensive trade infrastructure developed by the Incas (Cortez et al. 2010). When the Incas set up 
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granaries throughout their domain to store maize, they provided habitat for a stable population of 
vinchucas, who could feed on the blood of the rodents who ate the grain as well as the nearby 
settled populations. As the Incas transported grain throughout their territory, they spread 
vinchucas (Cortez et al. 2010). The Inca practice of resettling large populations in the far-flung 
reaches of the empire probably facilitated the spread of vinchucas as well (Bastien 1998). During 
the Colonial era, the Spanish reoriented the Inca trade infrastructure to suit their own mercantilist 
model, and vinchucas profited by establishing themselves throughout much of South America 
(Bastien 1998). 
     Briceño-León (2009) identifies different historical processes that have contributed to the 
spread of Chagas disease in various ecological contexts.  For example, in the nineteenth and 
twentieth centuries, Latin American agricultural production concentrated on a small number of 
crops for export to global markets. The hacienda system which facilitated this production model 
was characterized by two types of housing, that of the owners and that of the peasants. The 
owners’ houses were of more solid construction, with well-sealed walls and tile roofs, while 
those of the peasants were less durable, with exposed cracks and thatched roofs. Additionally, 
the area surrounding the home of the hacendado was typically cleared of brush and forest, and 
animals were not kept inside the home. All of these factors discouraged vinchuca colonization in 
the homes of the hacendados, while favoring infestation of the peasants’ dwellings. Furthermore, 
in order to increase profits, hacienda workers had to constantly clear forested land to plant new 
fields, intensifying the process of driving vinchucas out of their original habitat and into the 
houses of people. This “micro-environmental context” is what enabled Chagas disease to become 
endemic in much of rural Latin America (Briceño-León 2009, p. S73). 
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     Rapid urbanization in the twentieth century created a new context for Chagas disease. While 
in 1900, 80% of Latin America’s population lived in the countryside and 20% in urban areas, 
these proportions had flipped by the end of the twentieth century (Briceño-León 2009). As the 
rural poor migrated to cities seeking employment, or as trucks laden with produce from rural 
areas entered urban markets, they inadvertently carried vinchucas with them. The precarious 
housing of the new urban migrants, coupled with the deterioration of social support and public 
health programs in the latter half of the twentieth century, enabled vinchucas to become well 
established in many peri-urban areas (Briceño-León 2009; Araujo-Jorge and Medrano-Mercado 
2009).  
     Globalization has opened further new pathways for Chagas disease. Severe economic and 
political crises in Chagas-endemic countries have fuelled an unprecedented migration of Latin 
Americans into the core regions of the world economic system, which have benefitted from a 
supply of cheap, plentiful labor. Migrants’ access to health care is severely restricted in receiving 
countries, which in turn are ill prepared to diagnose and treat Chagas disease (Schmunis and 
Yadon 2010).  
     Globalization has also intensified the demand for goods such as lumber, agricultural products 
and cattle from Latin America. Reversing the trend of the twentieth century, many of Latin 
America’s urban poor have migrated to the borders of the rain forest to participate in logging, 
mining, cattle ranching, and production of export crops. Yet they tend to migrate seasonally, 
returning to the towns and cities for part of the year. The clearing of forest and the temporary 
nature of workers’ housing encourage vinchuca infestation, and workers often return to their 
homes carrying both the disease and the vector (Briceño-León 2009). In fact, in very similar 
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circumstances (workers living in temporary housing, clearing forest to build a railroad), Carlos 
Chagas first detected the disease in 1909.  
     The Amazon is now experiencing processes similar to those which originally gave rise to 
Chagas disease in the rest of South America, only at a much more accelerated pace (Briceño-
León 2007). Both the vector and T. cruzi have long existed throughout the Amazon, but the 
social structure of the indigenous population, highlighted by small community sizes and periodic 
relocation, largely discouraged domiciliation of vinchucas. This is no longer the case as many 
communities have settled more permanently, either due to encouragement from missionaries and 
states, or to participate in the market economy (Santos and Coimbra 1996). There is evidence 
that Chagas disease in the region is transitioning from a sylvatic to a domestic cycle. For 
instance, the first autochthonous case of the disease was detected in 1969. Since then, 250 more 
cases have developed, some in countries where Chagas was previously unknown, such as 
Surinam (Briceño-León 2007).  
      Thus, Chagas is profoundly linked to historical processes related to how humans utilize the 
environment. Global capitalism has tended to facilitate the domestic cycle of transmission, which 
now takes place in hitherto unaffected regions: Latin America’s cities and the Amazon. 
Furthermore, large populations of the victims of the disease now inhabit five continents (WHO 
2010). 
 
Epidemiology 
     Farmer (2004) states that anthropological research should “tally body counts” created by 
structural inequalities, using both history and epidemiology (p. 308).  Epidemiological studies 
provide quantitative evidence of the relationship between historical processes and Chagas 
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disease described by Briceño-León (2009). Chagas disease also poses particular challenges for 
epidemiological study, in large part because of the high proportion of people who are 
asymptomatic during the chronic phase (Bern et al. 2007, Rassi et al. 2010).  Because Chagas 
disease has a lengthy latent period, and because the symptoms of both the acute and chronic 
phases are highly variable and easily confused with other afflictions, estimates of prevalence and 
incidence is challenging (Rassi, Rassi and Little 2000, MSF 2012). At least several million 
people throughout the world harbor the disease; the WHO (2010) estimates 10 million, whereas 
Doctors without Borders (2009) puts the figure at 14 million. The WHO considers 25 million 
people at risk of infection. 
     In 1990, an estimated 700,000 people became infected with Chagas disease annually, and 
45,000 died from chronic stage cardiac complications (Moncayo and Silveira 2009). The 
following year, Argentina, Bolivia, Brazil, Chile, Paraguay and Uruguay launched the Southern 
Cone Initiative, aimed at eliminating the disease through interruption of vector transmission. 
These six endemic countries accounted for nearly two-thirds of the global prevalence of the 
disease (Moncayo and Silveira 2009). The Southern Cone Initiative was a formal agreement 
between these countries to enact measures aimed at combatting Chagas transmission into their 
national health programs. Such measures included improvement of blood screening and 
elimination of vectors with pesticide applications (Schofield and Pinto Dias 1999, Pinto Dias 
2007). The initiative succeeded in interrupting vector transmission in Uruguay (1997) and Chile 
(1999), as well as parts of Brazil, Paraguay and Argentina (Moncayo and Silveira 2009). Similar 
regional programs were launched in northern South America, and Mexico and Central America. 
Consequently, estimates of incidence have sharply declined in the last two decades, from 
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700,000 new cases in 1990 to 200,000 in 2000 and slightly over 40,000 in 2006 (Moncayo and 
Silveira 2009). 
     In Bolivia, the impetus of the Southern Cone Initiative contributed to elimination of vector 
transmission in some communities, especially those which were successfully able to implement 
widespread housing improvements (Guillén 2002). For instance, an internationally funded and 
assisted program in Tupiza improved 23,000 homes and sprayed 30,000 with pesticide. 
Infestation of houses and peridomestic areas declined from 85%, in 1984 to less than 5% in 
1992, and seroprevalence in children under five decreased from 37% to 2% in the same period 
(Guillén 2002). By 2005, the National Program for the Prevention and Control of Chagas 
Disease had fumigated 230,000 homes, and the director general at the Ministry of Health hoped 
to apply for certification of vector transmission interruption the following year (PAHO 2005). 
Nonetheless, in some areas efforts at vector control were uncoordinated, and supplies of 
pesticides were irregular as the state endured a severe fiscal crisis and political turmoil (Ribando 
2007, Schmunis 2007). Furthermore, most sustainable improvement in vector reduction resulted 
from structural improvements to housing, while the government strategy tended to rely on 
spraying of unimproved housing (Bastien 1998, Guillén 2002).  
     Consequently, Bolivia continues to have the highest prevalence of Chagas disease in the 
world. Estimates of national prevalence range from 14.7% (Pirard et al. 2005) to 28.8% 
(Moncayo and Silveira 2009). In endemic areas, prevalence can reach 90% (Chippaux et al. 
2008). For example, an analysis of blood bank samples in the endemic department of Santa Cruz 
found 43% infected with T. cruzi (Pirard et al. 2005). Two-thirds of the national territory remains 
endemic, and over 3 million people are at risk of infection (Brutus et al. 2008). The disease 
accounts for 13% of deaths in Bolivia (MSF 2009). 
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Age 
     Age is an important component of Chagas disease morbidity. Up to 300,000 children are 
infected (MSF 2009), and an estimated seven children die each day from the acute phase of the 
disease (Bastien 1998). In a study of 2218 children in Cochabamba, 22% were infected and 46% 
of these had abnormal EKG readings (Mercado-Medrano et al. 2008). However, the disease is 
also most safely and effectively treated in children with the current available medications (WHO 
2010).   
     The longer one lives in an endemic area, the greater the possibility of infection, so older age 
groups tend to have a higher prevalence. In an endemic rural community in the Chaco region, 
Chippaux et al. (2008) found an infection rate of 10.9% in children under 5, 17.6% in children 6-
10, 44.3% in adolescents 11-20, 71.3% in adults 21-49, and 87.9% in adults older than 50. A 
study of heart patients in Santa Cruz reported an association between older age and more severe 
Chagas cardiomyopathy (Hidron et al. 2010). Chagas disease also doubled the risk of stroke in a 
cohort of Brazilian adults over 60 years of age (Lima-Costa et al. 2010).  
 
Gender 
     The relationship between gender and Chagas infection and progression is still unclear. In a 
study of blood samples in Santa Cruz (Pirard et al. 2005) identified a higher prevalence of 
infection among females (50.7 vs. 39.5%). On the other hand, in a study of cardiology patients at 
the Hospital Japonés in Santa Cruz, a regional public health center, there was not a significant 
difference in infection rates based on gender (Hidron et al. 2010). However, the risk of severe 
Chagas cardiomyopathy was higher for males vs. females (OR = 7.06). Interestingly, Hidron et 
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al. found that among the infected cases, males were 2.5 times more likely to have a positive 
polymerase chain reaction (PCR) result for T.cruzi. This provides evidence of a higher level of 
parasitemia in males, which the authors speculate could be due to more repeated exposure to 
vinchucas, or to hormonal factors which inhibit control of the parasite in males when compared 
with females. 
 
Migration 
     Migration from rural to urban areas has profoundly affected the epidemiology of the disease. 
Although Chagas is typically considered an affliction of rural Latin America, internal migration 
has increasingly introduced it into urban contexts. An investigation of a newly formed 
community of rural migrants on the outskirts of Cochabamba detected a prevalence of 12.5% of 
T. cruzi infection. On average, residents had lived in the community for only 6 years. More than 
half of the houses had earth floors and adobe walls -- key risk factors for vinchuca infestation -- 
and 53% of homes were in fact infested (Albarracin-Veizaga et al. 1999). The new community 
thus had all the necessary conditions to maintain a domestic cycle of the disease.  
     Another investigation found a prevalence of 25 and 19%, respectively, among 5-13 year old 
children in two peri-urban communities of Cochabamba. Of these, 46% had abnormal EKG 
readings compared with 23% in the noninfected group. This is attributed to possible cardiac 
trauma from the acute phase of infection (Medrano-Mercado et al. 2008).  
     In Santa Cruz, the prevalence and severity of Chagas disease were associated with prior 
residence in a rural, endemic area. Subjects who had ever lived in a rural area had twice the risk 
of infection compared with those who had not, and this risk was magnified if they had lived in a 
house with adobe walls and dirt floors (Hidron et al. 2010). Moreover, subjects who had ever 
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lived in a house with adobe walls and dirt floors, which is typical of rural housing in Bolivia, had 
more than twice the risk of severe cardiomyopathy when compared with those who had not.  The 
authors speculate that this could stem from a higher parasite load due to repeated attacks from 
the vector (Hidron et al. 2010). 
 
Globalization 
     Chagas disease has also become a global phenomenon. Pintos Dias (2013) asserts that Chagas 
disease has spread from its endemic area in Latin American to various corners of the globe, 
spurred by “multiple bioecological, sociocultural, and political factors” (paragraph 1). 
Globalization has produced both positive and negative impacts on the spread of Chagas disease. 
On the one hand, increased access to wages and resources has allowed for de facto improvement 
of housing in some rural communities, helping reduce infestation by the vector. On the other 
hand, expanding agricultural frontiers have helped introduce vectors and infected individuals into 
new areas (Briceño León 2007, Pinto Dias 2013). Moreover, globalization has entailed a 
significant reduction of the role of central governments in the public health arena, yet the 
marginalized population suffering from Chagas disease depends on state-funded programs to 
provide care or to prevent further transmission (Pinto Dias 2013).  
     Caught between the push and pull of economic crisis at home and the demand for labor in the 
core countries of the global system, nearly 7% of Bolivia’s population has left the country to 
work abroad (World Bank 2010). The same process has occurred in other Chagas-endemic 
nations like Argentina and Mexico. Based on immigration patterns, an estimated 2% of Latin 
American migrants in the United States are likely to be infected with T. cruzi. The estimated 
prevalence for the half million Latin American immigrants in Europe, excluding Spain, is 3%. 
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Japan, Australia and Canada are also likely to have significant populations of individuals with 
Chagas disease (Schmunis and Yadon 2009). In 2007, blood banks in the U.S. began testing 
donations for T. cruzi (Radke 2009). Upwards of 65,000 Latin American immigrants could have 
developed symptoms of advanced chronic Chagas disease in the U.S. in 2007 (Schmunis and 
Yadon 2009).  
     Spain, a major destination country for Bolivian immigrants, has received 1.7 million 
immigrants from Chagas-endemic countries, of whom 5% may have Chagas disease (Schmunis 
and Yadron 2009). An analysis of Latin American patients at a Spanish health center determined 
that 2.9% were positive for Chagas disease. Of these, all but one was from Bolivia (Roca et al. 
2011).  
      
Congenital Transmission 
     Congenital transmission also contributes to the entrenchment of the disease in Bolivia. In a 
study of 2712 pregnant women and 2742 newborns in Yacuiba, Bolivia, the incidence of Chagas 
disease among all newborns was 2.6%. In the sample, 42.2% of the mothers had Chagas disease, 
and 6% of the babies born to them also had the infection (Salas et al. 2007). 
      Exposure to the vector appears to increase the chances that a mother will pass the disease to 
her newborn.  In a sample of mothers and newborns with Chagas disease, those who transmitted 
the T. cruzi infection to their newborns tended to have higher parasite loads (Bern et al. 2009). 
Mothers with greater parasite loads are more likely to have recently been bitten by an infected 
vinchuca. In another example, mothers who lived in a neighborhood with a high density of 
vector infestation (>40% of homes had vinchucas) were more likely to give birth to infants with 
low birth weight or Apgar scores (43%) than mothers in neighborhoods with a low presence of 
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the vector (8%). In neighborhoods without any presence of the vector, no babies had low birth 
weight or Apgar scores (Torrico et al. 2006). This underscores the role of the social environment 
in determining the burden of morbidity.  
 
Anthropological Perspectives on Chagas Disease 
     Anthropological studies of Chagas disease have not materialized in large numbers, despite a 
recognition among many practitioners and public health officials of the role “culture” plays in 
shaping strategies for prevention. In 1988, Coimbra observed that while “epidemiologists feel the 
need for more investigation into the cultural aspects of Chagas’s disease… anthropologists have 
not yet responded to this appeal.” A quarter century later there has been little progress, with the 
notable exception of Joseph Bastien, who has written an entire volume on the anthropology of 
Chagas Disease (The Kiss of Death, 1998). This has largely left other disciplines to fill in the 
void. 
     Public health studies of Chagas disease in Bolivia using indigenous identity as a risk factor 
are scarce, which reflects an overall paucity in literature on infectious diseases in indigenous 
populations (Hurtado et al. 2005). By deduction, a likely hypothesis is that indigenous 
populations would carry a high burden of the disease. The epidemiological literature has 
demonstrated that Chagas disease is concentrated among impoverished populations in rural or 
periurban areas, and indigenous populations are heavily represented in this category. Bolivia’s 
Center for Tropical Diseases (CENETROP) reported that 79% of people in a community of 
Guaraní seasonal laborers were Chagas-positive, with 100% of people over 50 harboring the 
disease (PAHO 2001). This is much higher than the 43% prevalence for the general population 
of Santa Cruz department reported by Pirard et al. (2005).  
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     In neighboring Argentina, researchers examined Chagas disease in three indigenous groups: 
the Toba, Wichi and Pilagá. In a total sample of 455 subjects, 57% were Chagas-positive, 59% of 
the Wichi, 54.5% of the Toba, and 46.8% of the Pilagá. The authors noted that the sanitary and 
medical infrastructure in the study communities was “practically null” and commented: “there 
are few medical professionals capacitated to understand the culture of these groups, which 
hampers communication” (Alonso et al. 2009, p. 177).  
     An investigation by Spanish public health researchers focused principally on cleaning habits 
(Verdú and Ruiz 2002). The investigators found that in a sample of Bolivian Guaraní, only 14% 
recognized the name “Chagas disease,” although 80% realized that a disease was associated with 
the bite of the vinchuca. The authors noted that while homes were highly susceptible to vinchuca 
infestation, “cleaning is seldom done”; only 28.6% of respondents regularly engaged in cleaning 
(Verdú and Ruiz 2002, p. 166). They recommend focusing public health education on women, 
who are less likely to be out of the community for extended periods, but without “losing sight of 
the goal of raising awareness among men of the need to increase their dedication to cleaning” 
peridomestic areas like corrals (Verdú and Ruiz 2002, p. 168). 
     The focus on cleaning behaviors unintentionally shifts the responsibility for prevention of 
Chagas to the Guaraní, without acknowledging the many systemic contributors to the epidemic. 
This is similar to the process described by Briggs and Briggs (2003) for the cholera epidemic 
among indigenous Venezuelans, who were cast as “unsanitary citizens” by the state. In a similar 
vein, a Bolivian public health investigation affirms that members of a Guaraní community 
refused to allow their homes to be sprayed with pesticide (De Muynck and Zamora 1999).  
     In another example, public health researchers assessed beliefs about Chagas in a Quechua-
speaking community in the department of Chuquisaca (De Muynck and Zamora 1999). Based on 
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focus groups conducted with community residents, the report contains substantial details on 
various beliefs about vinchucas and Chagas disease, and recognizes that there are divergent 
views within the community. However, it reads largely as a listing of beliefs rather than an 
analysis. Of note, some participants associated the symptoms of Chagas disease with susto, but 
few accepted that Chagas disease came from vinchucas (De Muynck and Zamora 1999). 
     Vanderbroek et al. (2008) did not encounter mention of Chagas disease in ethnobotanical 
research with healers in a Quechua community in the department of Cochabamba. They 
acknowledged that this may have been due to unfamiliarity with the biomedical name of the 
disease. Furthermore, routine screening for Chagas was unavailable in the research site. 
However, they observed that the local cultural illness of madre involved gastrointestinal 
symptoms highly similar to the megacolon variation of chronic Chagas.  
      Bastien, who has extensively studied Aymara cosmology and ethnomedical healing practices 
(e.g. Bastien 1985, 1996), provides the main anthropological contribution to the study of Chagas 
disease. He examines the impact of Chagas disease principally in Aymara and Quechua speaking 
populations in Bolivia.  Interested in the symbolic aspects of health, Bastien observes that 
“Bolivians compare parasitic capitalists to vinchucas,” in reference to the way foreign powers 
have extracted wealth from Bolivia much as the vinchuca extracts bloods from its victim 
(Bastien 2003, p. 173).  
      Bastien (2003) posits that in the Andean health concept, Chagas is not considered “a single 
disease entity,” primarily because of the diverse range of symptoms (p. 170). In some contexts, 
Chagas disease could be the underlying cause of liquichado, a cultural illness. Characterized by 
gradual weakening and fatigue, liquichado results when a kharisiri steals a victim’s fat. Another 
cultural illness, colico miserere, is characterized by severe constipation and swelling of the belly, 
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much like the gastrointestinal variation of advanced Chagas disease. The cause is typically 
interpreted as an imbalance of hot and cold foods (Bastien 1998, 2003).  An illness with similar 
symptoms, empacho, comes from an accumulation of poisonous fluids in the inner organs 
(Bastien 2003). Bastien also demonstrates how treatment of chronic Chagas is impeded by the 
distance of medical centers from indigenous communities, the cost of surgical procedures, and 
the often condescending attitudes of doctors. 
     On a sociopolitical level, Bastien (1998) provides insight on why some programs aimed at 
interruption of vector transmission have failed to gain ground. In some cases, while projects 
improved houses, they failed to consider the peridomestic areas which continued to harbor 
vinchucas. In other cases, wealthy members of communities manipulated project funds for 
personal gain. In one project, when community members developed Chagas symptoms after their 
houses were improved, it was attributed to mal de ojo and actually discouraged further 
participation in the project. Project personnel failed to consider “peasants’ work habits and 
calendar, ethnomedical beliefs and practices, economic exchange patterns, social and political 
systems, gender relationships, and role structures within the family” (Bastien 1998, pp. 134-135).  
Projects were often isolated actions, such as a one-time spraying of homes, which temporarily 
abated the problem but failed to resolve the deeper causes. 
     Bastien (1998) emphasizes the need to involve ethnomedical healers in programs to combat 
Chagas. His “Cultural Context Triangle Model” for Chagas control projects calls for 
participation between three principal groups: ethnomedical healers and community health 
workers, project personnel, and community members. He contrasts this with the vertical model 
employed in most previous Chagas projects where NGO’s or technocrats dictated project goals. 
He also distinguishes it from “a culturally sensitive model that employs anthropological 
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knowledge as a tool to translate the project’s goals into means acceptable to the community” 
(Bastien 1998, p. 137). Rather, the model promotes sustainability by integrating the culture of 
each community into the project design. For example, he recommends having the community’s 
traditional healers perform prayers and rituals during project activities, as well as utilizing 
proven ethnomedical practices – such as including cow dung in plaster to discourage vinchuca 
infestation. Rather than simply improving houses based on a certain technical model, projects 
should build houses that appeal to community members on a cultural level – he notes the Aymara 
concept of sayaña, where the home is one with the earth. 
     An anthropological study in rural Santiago del Estero, Argentina examines how structural 
processes such as expropriation of land for large-scale agricultural enterprises affected the 
epidemiology of Chagas disease (Mastrangelo 2009). The author notes that practices in the local 
community problematize the use of discrete categories such as “domestic” and “peridomestic” 
for risk factors of the disease, since residents move freely between these different zones. 
Importantly, Mastrangelo outlines the difficulties experienced by patients in attempting to access 
free treatment offered by the government, including distance of medical facilities, lack of 
biomedical staff, an unreliable supply of medication or laboratory reagents, and impractical 
dietary restrictions imposed on people receiving medications. 
     The nexus between migration and Chagas is a central theme of Goldberg’s (2010) research 
among Bolivian immigrants in Barcelona. Goldberg describes a “naturalization” of Chagas in 
seropositive immigrants, whereby they lived in acceptance with the disease as long as it did not 
pose an immediate danger. It was not part of their daily concerns. He considers this the principal 
reason, rather than economic constraints, for why these immigrants did not partake of treatment. 
In fact, immigrants were more concerned about the increasing stereotyping of Bolivians as 
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“Chagasic,” due to heightened attention to the issue in the Spanish public health sector and 
media. Some Spanish employers denied jobs to immigrants when blood analyses revealed 
Chagas seropositivity, regardless of whether applicants were asymptomatic (Goldberg 2010).   
     This suggests a disturbing new context for sufferers of Chagas disease, in which the disease 
status itself becomes a mechanism of exclusion that reinforces the subjugation of the peer. Nor is 
the Spanish case an isolated example. Argentina’s Law 22360requires employers to test 
employees for Chagas (http://www.alcha.org.ar). Although the law was intended to benefit 
people’s health by identifying who needed treatment, it has in practice become an exclusionary 
mechanism which often forces Chagas-positive workers into the informal sector or the most 
marginalized positions (Briceño-Leon 2009). This adds yet another barrier for workers who, like 
many in Argentina or Spain, are also Bolivian and undocumented (MercoPress 2007). In 
Campinas, Brazil, in a sample of workers who had been fired in the previous ten years, 9% 
indicated that they lost their jobs after they were diagnosed with Chagas disease. Also, 9% of the 
sample indicated they had been offered employment, but were then dismissed following initial 
laboratory or medical analyses. In 92% of these cases, the reason given was a positive diagnosis 
of Chagas disease (Guariento, Camila and Camargo 1999). 
     Despite the strong correlation between poverty, indigenous identity, migration, and other 
sociocultural processes with Chagas disease, anthropological investigators have only just begun 
to tackle this phenomenon. New developments in the story of Chagas disease in Bolivia have 
occurred since Bastien completed his last article on the topic in 2003, such as a widespread 
vector elimination campaign and intensified external migration from Bolivia to Spain and 
elsewhere, making it crucial for renewed anthropological attention to this disease. Investigations 
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in Argentina and Brazil have brought to light new issues of importance, such as laboral 
discrimination against Chagas- positive workers and structural barriers to treatment.   
 
     The biomedical model of Chagas disease focuses on its transmission via the insect vector, 
transfusion, organ transplant, and congenital routes (Rassi et al. 2010). Chagas is a life-
threatening disease in both the acute and chronic stages; however, in the latter phase, only 
around a third of those infected develop symptoms (Rassi et al. 2010). It can be difficult to detect 
the presence of the disease during the chronic phase, and biomedical treatment is hampered by 
the toxicity of the medications (Bern 2011). Epidemiological and anthropological studies shed 
light on the way socioeconomic and cultural factors influence the prevalence and incidence of 
the disease (Bastien 1998, Torrico et al. 2006, Hidron et al. 2009). In particular, the rural poor, 
especially those in indigenous communities, bear a disproportionate burden of the disease 
(Alonso et al. 2009). Chagas-positive disease status has begun to emerge as a discriminatory 
factor, intensifying the struggle of marginalized, often undocumented workers with the disease 
(Guariento et al. 1999, Goldberg 2010). While Chagas disease is profoundly interrelated with 
structural and historical processes (Briceño-León 2009), it has so far received only limited 
attention from anthropological investigations.   
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CHAPTER FIVE 
RESEARCH METHODS 
 
      This study used a combination of qualitative and quantitative methods to address the major 
research questions. Following is a description of the theoretical framework, research objectives, 
study design, data collection methods, and process for analyzing data.  
 
Theoretical Framework:  
Structural Context, Explanatory Models, and Chagas Disease Research 
     As various anthropologists have asserted (Roseberry 1988, Farmer 1992, Dressler 2001), a 
central problem for anthropological research is how to account for the intersections between 
local cultural production of knowledge and macro-social dynamics. Moreover, Farmer (1996) 
urges anthropologists to “study both individual experience and the larger social matrix in which 
it is embedded in order to see how various large-scale social forces come to be translated into 
personal distress and disease” (p. 261). As Farmer suggests, I examine the larger structural forces 
that impact Chagas disease in Bolivia while simultaneously investigating the perceptions and 
experience of individuals who suffer from the disease. I accomplish this in three ways.  
     First, following the examples of Farmer (1988), Vonarx (2007), Briceño-Leon (2007), and 
Hewlett and Hewlett (2008), I use historical research of to describe the structural processes 
which help perpetuate Chagas disease in Bolivia. However, not all the structural currents in 
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Bolivia are necessarily oppressive toward Bolivia’s rural poor, given the recent resurgence of 
indigenous power under Morales (Zoomers 2006, Canessa 2007). There are two dialectical 
relationships at play. First, as part of its wider agenda of social reform to counteract previous 
decades of neoliberal policies, Morales’s government has aggressively sought to expand care for 
Chagas disease to Bolivia’s poor (MSF 2007). However, it is constrained from doing so due to 
the inevitable neglect the disease receives from the profit-driven international pharmaceutical 
industry, and because of Bolivia’s marginal position in the global economy (MSF 2009, Coster 
2011, WHO 2014). Yet in Bolivia’s department of Santa Cruz, where the study takes place, 
entrenched elite interests have violently opposed Morales and even threatened succession from 
the national government (Ribando 2007, Hertzler 2010). Both of these dialectical processes have 
to be considered when contemplating how structural factors affect the explanatory models of 
people in the area with Chagas disease.  
     Another way in which I integrate interpretive and structuralist approaches is by considering 
messages circulated by Bolivian public health officials, physicians, media, NGOs, and other 
stakeholders about Chagas disease and the people who suffer from it. This follows the examples 
of Holmes (2007) and Briggs and Briggs (2003). In the latter account, indigenous groups in 
Venezuela were portrayed as “unsanitary citizens,” and notions of hygiene and cleanliness were 
utilized by the state to place blame for the cholera epidemic on the indigenous people 
themselves, rather than the government’s lack of preparedness. Although the Bolivian state under 
Morales is quite distinct from that of pre-Chavez Venezuela, I found that messages about Chagas 
disease were often influenced by structural processes, and then passed from providers to patients.  
This calls to mind Bourdieu’s (1982) description of how oppressed groups internalize, and 
subconsciously replicate, the symbolic domination of their oppressors. Holmes (2007) observes a 
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similar process in the berry farms of the Pacific Northwest. Oaxacan workers internalize 
dominant discourses and racially defined labor hierarchies within U.S. agriculture.  
     The third way I look at both individual experience and the wider social system in which this 
occurs is by asking respondents about the social environment and how this impacts their 
experience of Chagas disease. There is no reason that political economic dimensions cannot be 
incorporated into the explanatory models framework (Baer 1990). Farmer (1990) and Hewlett 
and Hewlett (2008) provide evidence that respondents include structural factors in the etiological 
components of their explanatory models. In Hewlett and Hewlett’s (2008) study, some 
respondents assigned the cause of the ebola outbreak in Congo to Euro-American game park 
administrators. More follow-up by the authors might have revealed more depth about how 
respondents themselves perceived linkages between global powers and health. Farmer describes 
similar linkages; in his ethnographic research, some Haitians place the blame for AIDS 
epidemics on the United States (Farmer 1990), while others attribute the folk illness of move san 
to poverty and economic displacement (Farmer 1988). These studies begin to demonstrate that 
explanatory models are not constrained either to a narrow, biological interpretation of disease, 
nor are they limited to symbolic interpretation; they encompass the larger social milieu in which 
a person suffers a given sickness.  
     The fruits of research depend heavily on what questions are asked. Medical anthropologists 
have had no hesitation to ask about sorcery, vodou or ethnomedical healing, yet have been 
tentative to gather information on socio-political beliefs, despite the fact that the socio-political 
context has a crucial bearing on health and is readily perceived by research subjects. For 
Bourdieu (1982), symbolic domination is sanctioned by institutions but also perpetuated through 
the everyday practices and interactions which censor or encourage different forms of expression. 
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Acceptance of the dominant language, which reinforces the dominant social structure, is not a 
conscious, overt process, but rather is “impalpably inculcated, through a long and slow process 
of acquisition, by the sanctions of the linguistic market” (Bourdieu 1982, p. 408). When Farmer 
(1990) investigated the cultural model of AIDS in Haiti, he noted it “reverberates with 
associations, drawn from the larger political economic context, of North American imperialism, 
a lack of class solidarity among the poor, and the corruption of the ruling elite” (p. 20).  Some 
Haitian respondents expressed the view that the disease had been sent to the island by the United 
States. Do marginalized people internalize dominant discourses related to their health, as in 
Bourdieu’s process of symbolic domination? Or do they develop an alternative discourse, as 
Farmer implies? Who do they hold responsible when preventable diseases are rampant in their 
communities?  
     Kleinman et al. (1978) originally proposed five components of explanatory models: etiology, 
symptom onset, pathophysiology, course of sickness and treatment. The present study analyzes 
these components of the explanatory model of Chagas disease. The goal is to compare how the 
study population’s explanatory model differs from the biomedical model, and to gauge the extent 
to which social processes impact or form part of the model. In the interviews, I included 
components which relate to respondent’s beliefs about the relationship of the state and global 
economics to their health, and more specifically to Chagas disease. This is the key innovation of 
this study toward fully integrating a structuralist perspective in a traditionally constructive 
research design.  
     In sum, medical anthropology has already begun the process of integrating constructivist and 
structuralist theoretical approaches using explanatory models. Pioneers in this process include 
Farmer (1988), McEwen (2005), Vonarx (2007) and Hewlett and Hewlett (2008). Neither 
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Kleinman (1980) nor later researchers using explanatory models intended to discount wider 
sociopolitical processes, just as critical medical anthropologists such as Lock and Scheper 
Hughes (1996) draw heavily on interpretive methods.  
     The context of Chagas disease in Bolivia provides a fertile field for examining the impact of 
structural process on explanatory models. Chagas disease is profoundly influenced by 
sociohistorical processes (Briceño-Leon 2009), and this is particularly evident in Bolivia, a 
country with deep socioeconomic divisions. At the same time, Bolivia has a longstanding and 
widespread tradition of ethnomedical healing and medical pluralism (Crandon 1991, Bastien 
1998), combined with the highest prevalence of Chagas disease in the world (MSF 2009).  
     Farmer’s anthropology of structural violence calls for attention to history and epidemiology 
(Farmer 2004). Yet Farmer’s intent was not to disregard an interpretive approach, but merely to 
contextualize rich ethnographic, micro-level data and narratives within a broader framework that 
accounts for historically created, global-level processes (Farmer 1992). Building on Bastien’s 
work (1998), I examine how ethnomedical systems of healing in Santa Cruz, Bolivia confront 
Chagas disease. Like Bastien, and in the spirit of a constructivist medical anthropological 
approach, I examine how Chagas disease is experienced and symbolically constructed. 
Following Farmer’s lead (Farmer 2004), I detail the history of Chagas control efforts in Bolivia 
and Santa Cruz, looking at both macro-level factors such as the global pharmaceutical industry, 
and micro-level processes including sharing of ethnomedical knowledge between family and 
neighbors. Similar to Ortner (2003), I examine not just the structural constraints faced by people 
with Chagas disease, but the ways in which they interpret and look to circumvent these 
constraints. 
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Research Objectives 
     The primary research objective was to determine how the social environment in the research 
setting impacted the development of explanatory models of Chagas disease among the study 
population. This involved pursuing five lines of inquiry in the investigation, each with its own 
specific research questions.  
1) Gather qualitative data on explanatory models of Chagas disease.  
a. How do respondents describe the etiology, symptoms and progression of the 
disease? 
b. What ethnomedical and biomedical treatments do participants utilize? 
c. What are theobstacles and opportunities for biomedical care that respondents 
encounter? 
2) Gather quantitative data on explanatory models of Chagas disease.  
a. Test the hypothesis that there is a shared model of Chagas disease through 
consensus analysis. 
b. Compare the agreement between participants in different domains: vector, 
symptoms, ethnomedical, and social. 
c. Compare differences in the explanatory model of Chagas disease based on gender, 
income, community of residence, and other social variables. 
3) Compare qualitative data on explanatory models of Chagas disease with the biomedical 
model in the following areas: 
a. Etiology 
b. Symptoms 
c. Progression 
91 
 
d. Treatment 
4) Compare quantitative data on explanatory models of Chagas disease with the biomedical 
model in the following areas: 
a. Etiology 
b. Symptoms 
c. Progression 
d. Treatment 
5) Assess the structural context of Chagas disease in the study area. 
a. Locally and nationally, what systems and programs are in place to prevent and 
treat the disease? 
b. Based on the qualitative data, what structural and sociopolitical factors do people 
with Chagas recognize in their understanding of the disease and their efforts to 
manage and treat it? 
c. Based on the quantitative data, is there a shared concept of how structural factors 
contribute to the disease? 
 
Study Design 
     This is a mixed-methods, cross-sectional study which collects both quantitative and 
qualitative data on Chagas disease. This design is based in part on Garro (1996), who used both 
open-ended interviews and a consensus analysis questionnaire in her investigation of explanatory 
models of diabetes in Ashinaabe communities. She argues that the use of “both interview formats 
leads to a deeper and more finely nuanced representation of understandings about causes of 
diabetes… than could be achieved by using one alone” (Garro 1996, p. 414). The study uses a 
92 
 
convenience sample (n=68) of current or former patients of the Centro Medico Humberto Parra 
(CMHP), a clinic in Palacios, Bolivia that provides low-cost care to patients in various 
communities in the department of Santa Cruz, Bolivia. The different methods of data collection 
are described below. 
 
Qualitative Data Collection  
     Three types of qualitative data were collected. First, 68 respondents took part in 
semistructured interviews which focused on experiences with Chagas disease, beliefs about 
causes, symptoms and treatments of the disease, and opinions about structural context of the 
disease. Questions were developed based on an extensive review of the public health literature 
on Chagas disease and anthropological literature on explanatory models and ethnomedical 
systems in Bolivia. Specifically, I asked participants why they thought Chagas disease was so 
prevalent in the region and what they would do to eliminate the disease if they were in a position 
of authority.  Second, the same 68 respondents provided free lists of causes, symptoms and 
treatments for Chagas disease and its constellation of cardiac symptoms. Specifically, patients 
were asked if they knew of specific treatments for Chagas, and then whether they knew of 
treatments that were “good for the heart.” Third, while I was in the field I collected participation 
observation data while working at the Centro Medico Humberto Parra (CMHP). I was able to 
talk to officials and doctors in Santa Cruz’s Departmental Chagas Program, to visit different 
hospitals and health centers, and to attend patient meetings and other events in various 
communities (see Table 5.1). 
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Quantitative Data Collection 
     Based on a review of the literature on Chagas disease and on the first 20 semistructured 
qualitative interviews, I developed a consensus analysis questionnaire based on guidelines from 
Weller (2007). The questionnaire consisted of 52 yes/no or true/false questions related to Chagas 
disease and its etiology, symptoms, treatment and social context. I administered the 
questionnaire to 48 people with Chagas disease.  
  
Informed Consent 
     The study was approved by the USF Institutional Review Board-Social Behavioral Research 
Division under expedited review. A waiver for written informed consent was also approved. I 
determined this was necessary since I would be working with often semi-literate populations, and 
also wanted to protect the privacy of individuals who might be concerned about stigma or 
employment discrimination associated with Chagas disease. Approval for the qualitative portion 
of the study was granted on March 7, 2013. On April 7, I submitted an amendment for the 
quantitative portion of the study, which was approved on April 15th. A study protocol was also 
submitted to and approved by a local IRB of Bolivian medical staff at the CMHP (Appendix 4).  
 
Background on Methods Used 
     Kleinman et al.’s original concept calls for physicians to ascertain patients’ explanatory 
models, then compare these to their own models to identify divergences that might pose 
problems for treatment. Clinicians can accomplish this by asking “a few simple, direct 
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questions” (Kleinman et al. 1978, p. 256). Doctors would then divulge their own explanatory 
models, at which point both patient and physician could “enter into a negotiation toward shared 
models, especially as those relate to expectations and therapeutic goals” (Kleinman et al. 1978, p. 
256). The authors suggest a set of five basic questions, starting with “What are the most 
important results you hope to receive from this treatment?” (Kleinman et al. 1978, p. 256) There 
are also three follow-up questions which are only necessary if the patient does not fully articulate 
therapeutic goals with the original five queries (Kleinman et al. 1978). 
In Kleinman et al.’s initial formulation, the elicitation and interpretation of the model occur 
practically simultaneously, and ultimately the intervention of an anthropologist is not required. 
This preliminary scheme has been drastically transformed in subsequent anthropological research 
using the concept of explanatory models. Whereas Kleinman envisions explanatory models as 
individual episodes of illness, and stresses that they are not equivalent to general beliefs about 
health (Kleinman 1980), anthropologists doing health research have preferred to adapt the 
concept to the levels of groups and even cultures. For Garro, “The association of explanatory 
models with individuals and not with cultures leads to a situation where researchers working 
within this paradigm often fail to address the interpenetration of individual and current cultural 
knowledge” (Garro 1994, p. 776). Furthermore, the original focus on illness and treatment 
tended to ignore “broader contextual meanings.” (Garro 1994, p. 776) However, when different 
members of a group share an explanatory model, it in essence becomes a “cultural model of 
illness,” or a “representation of the domain of relevant features that may be used to think about 
and act upon the illness” (Weller et al. 2012, p. 1089). The explanatory model thus becomes a 
tool, not merely for negotiation between physicians and patients, but for elucidation of 
divergences between group-level understandings of health in cross-cultural contexts.  
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It is also necessary to distinguish explanatory models from cultural models theory, a subtly 
different interpretive approach stemming from cognitive anthropology, influenced heavily by 
developments in psychology. Explanatory models began as an endeavor by Kleinman (1977) to 
understand how individual patients and providers conceptualized healthcare episodes or 
phenomena. They encompass five key aspects (etiology, onset of symptoms, pathophysiology, 
progression of sickness, and treatment), and are inherently “tied to specific systems of 
knowledge and values centered in the different social sectors and subsectors of the healthcare 
system” (Kleinman et al. 1978). Meanwhile, cultural models are “an intersubjectively shared 
cognitive apparatus or schema that members of a culture draw on to orient themselves to 
themselves and to others, and which they use to communicate” (De Munck et al. 2002). While 
both function as invisible webs of meaning that influence decision making, explanatory models 
are a system of health knowledge emanating from various sources, often shaped by social and 
historical processes, whereas cultural models are subconscious structures that exist among 
groups of individuals, or unwritten, underlying rules which govern behavior.  
The goal of explanatory models research has shifted toward examination of similarities in a 
set of explanatory models to make inferences and comparisons at group levels, not just within 
individual clinical encounters. This requires a more complex process of data collection and 
analysis than Kleinman originally foresaw. Following is a discussion of main approaches in the 
process of gathering and interpreting information for anthropological explanatory models 
research. 
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Free Listing 
     Anthropologists typically begin investigation of explanatory models using free listing 
techniques in unstructured or loosely structured interviews (Pelto and Pelto 1997). Free listing is 
defined as elicitation of “a respondent’s unconstrained, ad libitum listing of items in the form of 
words, phrases, and concepts associated with a single semantic domain” (Robbins and Nolan 
2000). It is usually an exploratory method for situations where the researcher has a limited idea 
of what type of knowledge domains or semantic networks to expect (Thompson and Juan 2006).  
     The goal of free listing is to get subjects to list as much information as they can related to a 
particular category or item. Medical anthropologists want to acquire emic vocabulary and 
terminology related to a particular type of health domain (Pelto and Pelto 1997).  Free listing 
usually begins with an open-ended question such as “what are the causes of illness X?” Yet 
while the anthropologist hopes for an exhaustive list of responses, informants usually do not 
mention everything they know. Brewer (2002) identifies two possible reasons for this. First, 
respondents may not realize that the anthropologist wants a comprehensive listing of every 
possible term, and second, they might not remember everything they know. 
     Brewer recommends three types of follow-up questions to ensure the anthropologist obtains 
as much information as possible. An interviewer can use non-specific prompts, such as “what 
other kinds of X are there?” The prompt, like the original question, should be open-ended and 
not dichotomous. The researcher can also read back the list of terms given initially, as a way of 
checking accuracy as well as jogging the respondent’s memory. Most importantly, Brewer 
recommends using each item the respondent has already given as a semantic clue. For instance, 
if a respondent has mentioned “cactus leaves”, the interviewer can ask “what other things are 
similar to cactus leaves?” 
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     Successive free-listing is another technique designed to acquire more extensive data than 
standard free-listing. The goal of this technique is to gain more insight about the similarity of 
items, enabling anthropologists to “better describe intracultural variation among informants” 
(Ryan et al. 2000). After standard free-listing, the interviewer asks the subject to free-list based 
on each item they originally mentioned. For example, Crandon-Malamud (1991) uses this 
technique in ethnomedical research in Bolivia. During initial interviews, she generated 110 local 
terms related to illness. Then, in a second series of interviews, she had 38 respondents free-list 
the symptoms, etiology, and cures for each illness.  
     One of the main purposes of free-listing is to determine how important or “salient” particular 
items are to a group of people, which provides clues about their shared model of a given 
phenomenon. Investigators can ascertain the importance of an item by simply adding the number 
of times it is mentioned, or they can look at the frequency and priority of the item. Those items 
which are most important will tend to be mentioned earlier (Thompson and Juan 2006).  
     Smith (1993) devised a statistical method that takes into account both frequency and order of 
a given item in a set of free lists. The salience of an item is calculated by adding the mean 
percentile ranks for that item and dividing by the total number of participants who supplied free 
lists. The mean percentile rank for an item is calculated based on an inverse ranking of where it 
appears on a list, divided by the total number of items in the list. For instance, if something is 
mentioned first in a list of four items, its mean rank will be 1, whereas the second item in the list 
will have a rank of 0.75, and so forth (Quinlan 2010). This measure is also supplied through the 
free list procedure in Anthropac (Borgatti 1996).  
    Salience is a useful measure for studies that want to assess the importance of particular 
concepts or items in a cultural group or an explanatory model. For example, Calvet-Mir et al. 
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(2008) examined the salience of gastrointestinal treatments among the Tsimane in Eastern 
Bolivia to determine whether ethnomedical or biomedical treatments were more prevalent. They 
found a higher salience for local plant-based remedies. In a study of explanatory models of 
“fright”, a culture-bound illness in Dominica, Quinlan (2010) examined the salience of 
ethnomedical treatments for the condition. 
 
Cultural Consensus Analysis 
     One of the most widely used techniques to test hypotheses related to explanatory models is 
cultural consensus analysis. Weller (2007) describes cultural consensus theory as a group of 
analytic techniques and models which not only estimate what cultural beliefs a group holds, but 
“the degree to which individuals know or report those beliefs” (p. 339). It provides a culturally 
correct answer key to a series of questions. Correct answers are determined by the response 
patterns of participants, not by the researcher. Cultural consensus analysis permits the researcher 
to measure the level of agreement within a group, and enables comparisons between groups. It 
ultimately provides a model “which transcends individual explanatory models and is, in essence, 
an explanatory model at the level of the community-with systematic assessment of variation and 
statistical evidence to support the description” (Baer et al. 2004, p. 18). In short, it provides a 
statistical basis for a researcher’s claims about the explanatory models of a particular group.  
     Consensus analysis can accommodate various types of data. For categorical or qualitative 
data, responses can be aggregated, with the majority answer representing the one that is 
culturally correct. For ranked or qualitative data, mean values can be calculated. When an 
individual’s responses correspond to the aggregate, it indicates they have a high knowledge or 
cultural competency (Weller 2007). 
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     Weller (2007) describes two main approaches, formal and informal. The formal model only 
accommodates categorical data: one-word or short phrase responses, dichotomous responses, and 
multiple-choice selections. It corrects for guessing by taking into account the number of 
responses an individual could select purely by chance. Also, individual responses are weighted 
according to their cultural competency. This is calculated by comparing the similarity between 
all pairs of informants. The informal approach is less constrained; for example, there is no 
correction for guessing. It is appropriate for ordinal, interval, and ratio-scaled responses. Like the 
formal model, it provides estimates of culturally correct answers and measures individual 
differences. 
       The cultural consensus model maintains three key assumptions. First, there must be a single 
set of answers or a common cultural reality shared by informants. The range of possible 
responses cannot be too broad. Second, each informant responds independently of others. 
Finally, questions must be of the same level of difficulty (Romney et al. 1986, Weller 2007). 
Weller recommends generating at least 20 questions, focused on the topic the researcher wants to 
study. The questions can be generated through prior free-listing interviews. An equal number of 
questions should be phrased that are likely to lead to positive and negative responses, to prevent 
respondents from simply answering yes to every question. Further, even if a respondent does not 
know an answer, they should be encouraged to guess. The use of cultural consensus analysis 
does not necessarily require large sample sizes. For example, by estimating a fairly conservative 
cultural competency of 0.50 in the sample, the investigator would need 30 subjects to achieve a 
high validity (0.95). The higher the competency of the group, the fewer subjects are required 
(Weller 2007).  
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     Cultural consensus analysis also provides a way to test the assumption that a single model is 
shared by a group. Weller recommends assessing the ratio of the eigenvalues for the first and 
second factors from a respondent-by-respondent agreement matrix; a ratio greater than 3 
suggests there is a common model. However, others have observed that “a data set can satisfy the 
standard criteria for the CCM and yet fail to pass more stringent tests of the model assumptions” 
(Hruschka et al. 2008). Other tests may be required to confirm the assumption of respondent 
independence. 
     There may be cases when respondents draw from more than one model. In this scenario, the 
researcher can ascertain which questions account for the differences, then define cut-offs based 
on the proportion of respondents who answer in a certain way. Models can differ based on 
salience or substance. In this case, salience refers to the ability of a model to produce the same 
responses to a set of questions within a group. High salience corresponds with all individuals in a 
group answering the same way to a particular question. Substance refers to a model’s ability to 
produce distinct responses, when the same questions are asked of separate groups (Hruschka et 
al. 2008).  
 
Qualitative Interviews 
     Ethnographic interviews provide a wealth of qualitative data. This can supply clues to 
develop questions for structured instruments, and can shed light on aspects of explanatory 
models that might be harder to capture with categorical questioning. Once interviews are 
transcribed into texts, the researcher can begin to look for themes. Grounded theory (Strauss and 
Glaser 1967) is a common approach that relies on inductive coding; the researcher becomes 
immersed in the texts of the interview in order to see what themes emerge from the data. There 
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are various, often competing approaches with grounded theory (Ryan and Bernard 2003). The 
original concept calls for the researcher to approach coding of texts with as few preconceptions 
as possible (Strauss and Glaser 1967). This study borrows from the “social constructionist” 
version of grounded theory, which acknowledges that researchers are influenced by their own 
“philosophical, theoretical, substantive, and methodological proclivities,” yet should not apply 
preconceived categories to research data without sufficient justification and explanation 
(Charmaz 1990). A specific way in which I used the grounded theory approach was through 
commencing analysis of data while interviews were ongoing (Bernard and Ryan 2003).  
 
Study Timeline 
     Qualitative interviews took place from March 13th-June 7th, 2013. After IRB approval for the 
consensus analysis questionnaire, quantitative interviews began on April 20th and concluded on 
June 7th, 2013. Throughout the study period, I worked as a volunteer at the clinic providing 
Chagas education to patients and coordinating with the National Chagas Program. This provided 
invaluable participant observation data as well as perspectives on the system of care. 
 
Recruitment of Participants 
     Participants were recruited through the Centro Medico Humberto Parra (CMHP). In total, I 
interviewed 68 patients for the qualitative portion of the study; these individuals responded to the 
semistructured interview questionnaire and free-listing questions. From this group, 48 also 
participated in the quantitative portion of the study. The CMHP has a unique care system for its 
catchment area of thirteen communities in northwestern Santa Cruz Department. This is 
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necessitated by the clinic’s remote location; it lies several kilometers via dirt roads from the 
nearest public transportation. Each community’s patients organize into groups, with its own 
group leader and health promoters. The CMHP then schedules regular days each month which 
are dedicated to specific communities. On their allotted days, the groups arrange transport for 
patients who want to travel to the clinic. All the patients wait at the clinic until everyone is 
attended, which usually takes several hours. This system makes it possible for the clinic to serve 
marginalized patients in various communities, despite its remote location in rural Palacios.  
     As a volunteer at the clinic, I provided education on Chagas disease to patients and made 
them aware of diagnostic and treatment options. In this capacity, I was often able to become 
aware of patients with the disease and confidentially ask for an interview. In order not to 
influence patients’ responses to the interview, I administered the interview first and then 
provided Chagas education. The clinic staff also sent patients to me directly if a patient’s chart 
indicated they were Chagas positive. I also attended local meetings of patient groups in several 
communities to give talks on Chagas disease, and with the help of health promoters I was able to 
visit some Chagas positive group members in their communities and ask for interviews. This was 
how I found the remainder of the participants for the study. Specifically, I interviewed 10 
patients on-site in Buena Vista, 7 in Warnes, 1 in Yapacaní, and 1 in Santa Cruz.  
     For the qualitative portion of the study, I interviewed people who could self-report a positive 
test for Chagas disease (n=63) or who had a close family member (a spouse, parent or sibling) 
with the disease (n=5). For the quantitative interviews, all 48 participants could self-report at 
least one positive test for Chagas disease. These criteria were important because people 
diagnosed with the disease, or who had cared for a family member with the disease, would 
naturally devote more time to thinking about it and developing an internal explanatory model. 
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However, no one diagnostic test is sufficient to determine the biological presence of the disease, 
which is why the WHO recommends two distinct types of positive tests before determining that 
someone has Chagas. Most participants in my sample had not had the secondary, confirmatory 
test, which can be difficult to obtain in rural Bolivia, and was not available at CMHP. Further 
complicating diagnosis of Chagas disease is that most cases are asymptomatic, while the cardiac 
symptoms that do emerge can easily be attributed to other causal factors such as diabetes, 
obesity, hypertension and non-Chagasic heart disease, all of which are common for patients at 
CMHP. Thus, while the participants in my sample are highly likely to have Chagas, and had 
been told they had Chagas disease by health professionals, this does not equate to 100 percent 
certainty, in the biological sense, of having the disease.  
     My original aim was to compare agricultural laborers in the communities surrounding the 
clinic with urban laborers in the city of Warnes. This aim was partially achieved, as I was able to 
interview some agricultural laborers or spouses of agricultural laborers, as well as some residents 
of Warnes. Once in Bolivia, however, I began to realize that the very poorest agricultural 
laborers and people from the most marginalized communities, despite the strong likelihood of 
being infected with Trypanasoma cruzi, had typically never been tested for Chagas disease due 
to very limited interaction with the healthcare system. Thus, they could not meet my study 
inclusion criteria of having had at least one positive Chagas test. Also, I was not in Bolivia 
during the sugar harvest, when there would have been a large group of migrant laborers camped 
near the clinic. This would have provided me with a better opportunity to access a large sample 
of agricultural laborers. The final sample includes a mix of income levels and residents from 
several communities: Warnes, Palacios, Yapacani, Minero, El Pilar, Buena Vista, Santa Cruz and 
Portachuelo. This reflects the diversity of communities served by the CMHP.  
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     Oftentimes patients expressed interest in the study but were unable to participate due to being 
called to see physicians or undergo testing and treatments. In some cases, patients were also 
worried they would miss departing transportation to return them to their communities. On other 
days, the need to provide Chagas education to groups of patients would prevent me from talking 
with patients confidentially to secure interviews. However, I was often able to find patients and 
speak with them privately when they made subsequent visits to the clinic. 
     On other occasions, patients were unable to travel to the clinic, or staff was unable to leave 
the clinic, due to torrential rains or strikes that closed the main highways. On April 13th, the road 
leading to the clinic from the highway and the town of Palacios was flooded and became 
impassable, except by foot. Closures of highways due to strikes also prevented me at times from 
travelling to communities to conduct interviews, or kept patients from coming to the clinic. A 
transportation workers’ strike closed the highway between the clinic and Yapacaní for a few days 
in late April, 2013. Striking teachers and medical workers blockaded the highway between the 
clinic and Santa Cruz from May 10th-12th, and a major strike by the COB (Confederation of 
Bolivian Workers) shut down the highway from May 13th-20th. These events completely halted 
transport of people and goods between the major cities of Santa Cruz and Cochabamba and shut 
down the roads connecting the CMHP with the rest of the country. During the COB strike I was 
able to continue to Buena Vista to conduct interviews by leaving my trufi (a form of shared taxi 
common in Bolivia), walking through the picket lines, and boarding another trufi on the other 
side. While these developments posed challenges in obtaining interviews, they also helped me 
gain an appreciation for the difficulties people with Chagas have to overcome in seeking care or 
simply going about their everyday business.  
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Interviews 
     After completing verbal informed consent and agreeing to participate, participants were 
interviewed privately. All but one participant agreed to let the interview be recorded. In two 
cases, patients who were close family members (a mother and daughter, and a brother and sister, 
all with Chagas disease) asked to be interviewed together. Both of these interviews took place in 
the participant’s homes. The brother-sister pair were interviewed in Buena Vista and the mother-
daughter pair in Warnes.  
 
Qualitative Interviews 
     A semistructured interview questionnaire was administered to 68 CMHP patients. The 
questionnaire asked respondents to describe their experiences with Chagas disease and to provide 
opinions about how to prevent and combat the disease.In addition, I asked participants to free list 
all the causes, symptoms, and treatments they were aware of for Chagas disease. The purpose of 
this was two-fold. First, I wanted to acquire emic vocabulary related to Chagas disease, as well 
as identify salient themes of importance to participants. This is similar to the approach 
recommended by Pelto and Pelto (1997) in another explanatory model study in Bolivia. Second, 
free listing provided an opportunity to compare the salience of different terms, an additional way 
to shed light on the effect of the social environment on explanatory models.  Specifically, I 
wanted to determine what types of treatments were most salient for Chagas disease in the study 
population.  
     Some participants were able to articulate specific ethnomedical treatments for Chagas disease, 
while others affirmed that there were none, much as Vanderbroek et al. (2008) observed in 
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Cochabamba. However, typically respondents were able to respond more fully if prompted about 
treatments for the symptoms of Chagas disease (heart conditions or constipation). For example, I 
asked patients, “Do you know of any treatments that are good for the heart?” This question 
usually elicited a more detailed response than simply asking about treatments for Chagas disease.  
 
Quantitative Interviews: The Consensus Analysis Questionnaire 
     Based on information gathered in the first 20 qualitative interviews, I created a 52-item 
consensus analysis questionnaire. The goal of the questionnaire was to determine the culturally 
correct answer key related to Chagas disease and its structural context, and to ascertain whether a 
coherent explanatory model existed, as well as compare thematic differences between subsets of 
participants. Questions asked participants to respond “yes/no” or “true/false”. The questions 
focused on the vector, causes, symptoms, ethnomedical and biomedical treatments, and structural 
factors related to the disease.  As suggested by Weller (2007), a significant number of questions 
were phrased to elicit negative responses, to prevent respondents from falling into a pattern of 
automatically answering “true” or “yes”.  
 
Participant Observation 
     As a volunteer at the clinic, I became familiar with the general health issues confronting 
patients, as well as some of the challenges and difficulties they faced in obtaining care and 
medication. In addition to providing Chagas education, I attended several meetings of patient 
groups affiliated with the clinic in various communities, and helped with a school deparasitation 
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program. I also made contact with local experts in Chagas, included Dr. Zayra Borja at the 
National Center of Tropical Diseases (CENETROP), Dr. Carlos Fuente of the Department of 
Epidemiology-Hospital Japonés, and Dr. Roberto Vargas and Dr. Susana Rios from the National 
Chagas Program. I coordinated a workshop in which the National Chagas Program provided 
training on Chagas treatment to CMHP staff, and I spoke with staff in charge of Chagas 
treatment at hospitals or clinics in Warnes, Buena Vista, Montero, Portachuelo and Santa Cruz. 
     These contacts provided invaluable information on government efforts to eradicate the vector, 
stop vertical transmission, and bring treatment to Bolivians with Chagas disease. Also, by talking 
to community members informally, I was able to learn about various ethnomedical treatments for 
Chagas and other diseases and even to find specimens of various plants used for remedies in the 
local rain forest.  Table 5.2 details some of the main participant observation activities during my 
field research period. The table does not include several trips I made to communities solely to 
interview participants. 
     While working in the clinic or travelling to communities and places of interest in the research 
setting, I kept a detailed journal with notes on important points that I would not have gleaned 
through the regular interviews. I reread the journal while coding themes and added key pieces of 
information as memos. I also took numerous photographs of local plants used in Chagas 
treatment, events such as International Chagas Day, and other items of interest to the study. 
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Table 5.1: Diary of Activities during Field Research 
Date Activity 
3-12-13 Arrival in Bolivia 
3-14-13 Attended patient group meeting in Buena Vista. 
3-25-13 Meeting with Dra. Zaira Borja, Director of Entomology, CENETROP.  
4-2-13 Meeting with Dr. Roberto Vargas, Director of National Chagas Program, Santa 
Cruz.  
4-4-13 Attended patient group meeting in Minero.  
4-11-13 Staff meeting at CMHP 
4-12-13 Deparasitation program, Buena Vista schools. 
4-13-13 Gave a presentation on Chagas at the promotora meeting in Palacios. 
4-14-13 Attended International Chagas Day event at the Parque Urbano in Santa Cruz.  
4-16-13 Deparasitation program, San Juan de Palometilla school 
4-19-13 Chagas Treatment Workshop at CMHP, presented by National Chagas 
Program staff. 
4-24-13 Deparasitation program, Arboleda school 
4-25-13 Attended patient group meeting in Buena Vista, gave talk on Chagas.  
4-26-13 Deparasitation program, San Ignacio schools.  
4-27-13 Community visit for door-to-door Chagas education, El Pilar.  
5-3-13 Staff meeting at CMHP, discussed next steps for Chagas treatment program.  
5-5-13 Attended patient group meeting in Yapacani.  
5-6-13 Meeting with Dr. Carlos Lafuente, Chagas expert, Department of 
Epidemiology, Hospital Japonés, Santa Cruz. 
5-7-13 Meeting with Lic. Pilar Villaroel, head of the Obispo Santiesteban Provincial 
Health Network regarding Chagas treatment. Took place at Nuestra Sra. De 
Rosario Hospital, Warnes.  
5-9-13 Deparasitation program, El Pilar.  
5-18-13 Meeting with Dra. Susana Rios of National Chagas Program.  
5-25-13 Attended patient group meeting in Warnes.  
6-1-13 Attended promotora meeting in Palacios.  
6-2-13 Attended meeting of community group leaders in Arboleda.  
6-7-13 Return to U.S 
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Data Analysis 
     The interviews produced three main types of data. The qualitative interviews provided two 
kinds of data: information about participants’ experiences with and opinions about Chagas 
disease, and free lists. Additionally, the quantitative interviews produced binary data (yes/no and 
true/false) from the consensus analysis questionnaire. As Garro (1996) argues, the combination 
of qualitative data from interviews and consensus analysis data provides a broader, more detailed 
picture of the explanatory model of Chagas disease than a single method would have achieved. 
The analysis of each type of data is described below.  
 
Qualitative Data Analysis 
Semistructured Interviews. Semi-structured interviews provided information related to 
respondents’ views of the etiology, symptoms and progression of Chagas disease (Research 
Objective 1a), as well as their experiences with biomedical care and structural barriers (Research 
Objective 1c). My analysis of interview texts relied on grounded theory (Glazer and Strauss 
1967), drawing in particular from social constructionist grounded theory (Charmaz 1990). I 
transcribed the text from each interview into a Word document, and then imported all the 
interview documents into Atlas.ti 7.1.7. The original group of 68 respondents produced 65 
transcript documents. This is because in one case, the participant gave an interview but did not 
want to be recorded, and in two cases, participants requested to be interviewed together (a 
mother-daughter and a brother-sister pair). I then read and reread the combined texts and began 
to assign codes.  
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     Although I primarily used an inductive process, creating thematic codes as I read through the 
interviews, I had also begun to develop notions of important themes related to my research 
objectives as I conducted the interviews themselves and spoke to people with Chagas in the 
research setting. Codes that I originally created while going through the initial transcripts often 
had to be redefined or amalgamated as I began to code more interviews and gain a bigger-picture 
perspective.  
     Through this process I identified 36 primary themes which I grouped into 6 major domains: 
ethnomedical, biomedical, structural, causes, symptoms, and vector. Most of these themes 
addressed my first two research objectives: describing the overall explanatory model of people 
with Chagas disease, and categorizing structural factors related to the disease in the region. 
However, the qualitative data helped explain particular aspects of research objectives 3 and 4 as 
well, by bringing to light differences between groups as well as people’s political views on 
Chagas disease. 
Analysis of Free Lists. I wanted to measure, in particular, what type of ethnomedical 
treatments patients utilized for Chagas and accompanying symptoms (Research Objective 1b, 
3d,). I decided to limit my analysis to treatments for Chagas or heart-related symptoms, since 
none of the patients I interviewed had the gastrointestinal symptoms that sometimes develop 
from the disease, whereas many had cardiac complications. Thus, if a patient could not mention a 
specific ethnomedical treatment for Chagas disease, I asked them to free list those for heart 
conditions. 
     I reviewed interview transcripts and listed each participant’s responses to this question in 
order. I saved this information as a text document and analyzed it using the free list option in 
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Anthropac 4.0 (Borgatti 1996). This procedure provides the frequency, mean rank, and Smith’s 
salience index of each item. Smith’s salience is a measure combining the frequency with which 
an item is mentioned and the average order in which it is mentioned (Smith 1993).  
Participant Observation Data. During the study period, I maintained field notes on a daily 
basis. Sometimes while talking to patients informally at the clinic or in community meetings, I 
would hear about ethnomedical remedies used for Chagas disease and its cardiac symptoms. I 
included these in Tables 9.1 and 9.2 along with the free listed results of ethnomedical treatments, 
although I did not use them when calculating the salience of the free-listed items. Moreover, 
through talking with officials and coordinating a workshop with the Departmental Chagas 
Program, I learned about the organization of free public treatment of Chagas disease in Santa 
Cruz department, including costs, availability and restrictions. This information is included in 
Chapter 6.  
 
Quantitative Data Analysis: Cultural Consensus 
     I entered respondents’ answers in an Excel spreadsheet as “1” for yes or true, “0” for no or 
false, and left blank if the respondent didn’t provide an answer, as recommended by Borgatti 
(1996). Next, I completed the consensus analysis procedure in Ucinet version 6.491 (Borgatti 
and Freeman 2002).  This procedure provides three types of information. First, it creates a 
“culturally correct” answer key of responses to the questionnaire. The answer key is based in part 
on the proportion of respondents who answered a question a particular way. Additionally, the 
answers of people with more knowledge in the domain are weighted more than those with lower 
knowledge (Weller 2007). Second, the procedure provides individual competence scores, 
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reflecting how knowledgeable each respondent is in comparison to the group and the culturally 
correct answer key. Finally, based on factor analysis of the agreement matrix between 
respondents, it yields eigenvalues, which indicate how much each factor contributes to variance 
in the matrix. The first eigenvalue measures variance due to shared cultural knowledge, whereas 
the second eigenvalue measures variance due to other factors (Miller 2011, Smith et al. 2004). In 
order to ascertain whether respondents have a shared cultural model, the ratio of the first to the 
second eigenvalue should be at least three (Weller 2007). When the ratio is three or greater, it 
supports the assumption that shared cultural knowledge accounts for the greatest variation in the 
data, and not some other factor (Miller 2011).  
    First, I wanted to ascertain if participants shared a measurable, coherent explanatory model of 
Chagas disease (Research Objective 2a). I undertook the cultural analysis procedure with all 48 
respondents, based on all 52 items in the questionnaire, using the covariance method as 
suggested by Weller (2007) for dichotomous data. This produced a first eigenvalue of 20.318 and 
a second of 2.162, for a ratio of 9.398, indicating strong support for a shared cultural model of 
Chagas disease. The mean competence was 0.64. Next, I reran the procedure after eliminating 
the two questions and the two participants with the most missing responses. This did not have an 
appreciable impact on the final ratio – which was just slightly higher at 9.768. 
     Next, I divided the questions into four knowledge domains: ethnomedical, vector, symptoms, 
and sociopolitical. I wanted to determine if the assumption of a shared cultural model held true 
for each of these domains, and to determine each individual’s competence in each subdomain 
(Research Objectives 2b). Then, I examined differences based on sociocultural factors (Research 
Objective 2c). I divided the overall data into submatrices based on income level (low, medium, 
or high), ethnicity (cruceño (camba) or highlander), gender, occupation, and community of 
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residence. In some cases, the size of the subgroups were less than 10 participants. This is 
acceptable, according to Weller (2007), as long as the average competence of participants is 
higher than 0.5. In the subgroups used, the average competence was higher than 0.5 in all cases. 
For the occupation category, married homemakers were classified according to their spouse’s 
occupation. Once the submatrices were created, I determined the culturally correct answer key 
for each group to detect where differences existed. This provided clues as to intragroup 
variations within the larger explanatory model of Chagas disease.  
     Finally, based on the individual competence scores for the overall model of Chagas disease 
for all participants, I compared mean competence for different groups (Research Objective 2c). I 
compared income level (low, medium, or high), occupation, ethnicity (cruceño or highlander), 
gender, and community of residence (Buena Vista, Palacios, Yapacani and Warnes). In SPSS 
version 21.0, I performed a one-sample Kolmogorov-Smirnov Test for normal distribution of the 
data. The assumption of normality held for the overall competence scores, but not for those in the 
different subdomains. Consequently, I decided to compare the mean competence scores using a 
Kruskal-Wallis test, and then Mann Whitney tests to determine which groups were significantly 
different. For purposes of comparison I ran t-tests as well and received the same results. 
      In sum, it was essential to combine free listing, consensus analysis, participant observation, 
and grounded theory analysis of interview texts in order to gain multiple perspectives on 
explanatory models of Chagas in the study population. This was critical given the complex and 
multifaceted nature of the disease, and the myriad experiences and impacts it produces on 
different individuals and communities. Each method provided key insights which are described 
in detail in the results chapter.  
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     This study took place from March through June 2013, with a convenience sample of 68 
patients from the Centro Medico Humberto Parra (CMHP) in rural eastern Bolivia. All but five 
of the patients could report a positive test for Chagas disease, and the remaining five had a close 
relative (parent, spouse or sibling) with the disease. I completed semistructured interviews and 
free listing exercises with 68 patients, and I completed the consensus analysis questionnaire with 
48. During the study period, I became familiar with the local system of care for Chagas disease 
through contact with patient groups, health promoters, physicians, and Bolivian public health 
officials.  
     Explanatory models originally began as a tool to facilitate communication between providers 
and patients (Kleinman et al. 2008). Explanatory models research now focuses on entire groups 
and communities. The consensus analysis procedure provides a way of statistically testing 
whether a shared explanatory model exists and making statistical comparisons between groups 
(Romney et al. 1986, Weller 2007). While this provides key insights, qualitative data from 
ethnographic interviews can help flesh out the skeletal framework provided by consensus 
analysis (Garro 1996). Thus, this study utilizes a mixed-methods approach and incorporates 
interview narratives, free lists, participant observation notes, and consensus analysis data in order 
to build a detailed, multidimensional representation of explanatory models of Chagas disease. 
The results of the research are presented in the ensuring chapters.  
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CHAPTER SIX 
CURRENT STATE OF THE SYSTEM OF CARE FOR CHAGAS DISEASE 
IN BOLIVIA AND THE DEPARTMENT OF SANTA CRUZ 
 
     Bolivia’s national and local governments have made significant strides in reducing the 
transmission of Chagas disease in the last two decades. Nonetheless, complete interruption of 
transmission remains an elusive objective, due to the ubiquity of triatomine vectors in much of 
Bolivia’s national territory, including the department of Santa Cruz, as well as the persistence of 
at-risk housing. Furthermore, treatment of those infected with Chagas is hampered by the lack of 
effective and safe medications as well as the challenges of producing accurate laboratory 
diagnoses of seropositivity. Despite efforts on the part of the national government to provide 
treatment, it continues to be unavailable or inaccessible for most adults with Chagas disease in 
the study area. This chapter traces the historical development and describes the current state of 
care for Chagas disease in Bolivia and the department of Santa Cruz, where the study took place. 
The information in the chapter is based on archival research, literature review, and participation 
observation during the period of fieldwork (March-June 2013).  
 
History of Chagas Control in Bolivia 
     Even after Carlos Chagas’ groundbreaking study on the transmission of the disease among 
railroad workers in Brazil (Chagas 1909), the scope of the pandemic in the Americas was 
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unknown. The Brazilian medical establishment considered Chagas disease a rare, exotic tropical 
malady, despite Chagas’s assertions that it posed a major public health threat (Araujo-Jorge et al. 
2010). Gradually, researchers accumulated evidence of the disease throughout the Americas, 
including Bolivia.  
     In 1916, Brazilian Artur Neiva identified the presence of triatomines (vinchucas) infected 
with Trypanosoma cruzi in the village of Sococha in Bolivia’s highlands department of Potosí 
(Diaz and Torrico 1943). A Bolivian investigator, Felix Veintinillas, asserted he identified 
Trypanosoma cruzi in vinchucas in 1929 in the department of La Paz (Veintinillas 1931). 
Salvador Mazza, the Argentinian researcher who first identified the disease in Argentina, 
performed several studies in Bolivia from 1937-1943. He identified Trypanosoma cruzi in 
vinchuca populations as well as in the blood of an infant girl (Mazza and Chacon 1943).  
     One of the early pioneers in combatting Chagas disease in Bolivia was Rafael Angel Torrico. 
He demonstrated the presence of infected vinchucas in Cochabamba and in 1946 described the 
first case of the acute form of the disease in the country (Torrico 1950). At mid-century he 
warned that the few confirmed cases were “just a pale reflection of the real magnitude of this 
epidemic in Bolivia,” and urged “authorities in charge of public health to give priority to this 
grave widespread scourge that afflicts a large part of the population” (Torrico 1950, p. 827). 
Nonetheless, the full extent of the disease in the Bolivian population remained unknown. 
     In 1961, Bolivia’s delegation to the Conference of Public Health Ministries in Jujuy, 
Argentina, remarked on the creation of a large-scale Chagas control program in Argentina and 
expressed the need for a similar program in Bolivia. The delegation noted that 342 cases of 
Chagas had been confirmed in Bolivia, and urged “a large study to determine both the 
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distribution of the disease and its impact on the Bolivian populace” (Rev Salud Boliviana 1961, 
p. 27). Shortly thereafter, a commission charged with investigating the necessity of creating a 
Chagas control program recommended a national study of the extent of houses infested with 
vinchucas, the level of infection of Trypanosoma cruzi in vinchucas, and the extent of the disease 
in the human population (Villa and Torrez 1962). Nonetheless, such an investigation did not 
materialize until the 1980’s.  
    The National Epidemiological Investigation of Chagas Disease took place between 1980 and 
1985 in 109 localities throughout the country. During these years Bolivia underwent two military 
coups, as well as a return to civilian rule in the midst of one of the worst episodes of 
hyperinflation in world history (Klein 1991). Nevertheless, the study was able to amass 
important baseline data for national Chagas control measures. The investigation confirmed 
Triatoma infestans as the primary species of vinchuca responsible for transmission, with 75-80% 
of households in endemic areas infested. The study also identified a prevalence of 32%, with a 
quarter of those infected showing EKGs typical of Chagasic cardiomyopathy (Valencia et al. 
1990). At the same time, the congenital transmission of Chagas disease was first detected in 
Bolivia at a hospital in Santa Cruz (Azogue et al. 1981). These studies set the stage for creation 
of a national program of Chagas control focusing on elimination of the vector as well as 
interruption of vertical transmission.  
     Meanwhile, Bolivia first launched its National Chagas Program in 1980 (Guillén 2001). With 
financial support from UNICEF, the program initially focused on health education for endemic 
areas and coordinated improvements to 45,000 homes (Guillén 2001). In 1990, with financing 
from USAID, the program took steps to develop standard procedures for diagnosing Chagas, 
improving housing, controlling vinchucas, and treating acute Chagas.  
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     Bolivia joined the Southern Cone Initiative in 1991. This regional collaboration of Bolivia, 
Argentina, Uruguay, Paraguay, Brazil and Chile aimed to interrupt transmission of the disease by 
eliminating the vector and achieving full screening of blood banks (Pinto Dias 2007). Through 
this program Bolivia received technical assistance from Argentina in vector control initiatives. 
However, progress in Bolivia was slow compared to other countries in the initiative. While 
transmission was interrupted in Uruguay (1997) and Chile (1999), as well as parts of Brazil, 
Paraguay and Argentina, Bolivia continued to suffer from the highest prevalence and incidence 
in the region (Moncayo 2009). Commitment to the Chagas Program largely foundered during the 
1990’s (Guillén 2000), a time of extensive privatization and social spending reduction under 
neoliberal President Gonzalo Sanchez de Lozada (1993-1997). 
     In 1998, Bolivia received a loan from the Interamerican Development Bank (IDB) that 
enabled a revitalization of the National Chagas Program, funding efforts through 2007. A new 
“Epidemiological Shield” strategy was implemented that focused on five areas: 1) vector control, 
2) control of blood transfusions, 3) treatment of children under 5 years old, 4) education and 
technical capacitation, and 5) surveillance and study (National Chagas Program 2000). It is 
important to note that treatment of adults with chronic Chagas was not yet a component of the 
program.  
 
The Campaign to Eliminate the Vector 
     The Interamerican Development Bank (IDB) loan enabled the Chagas program to 
dramatically increase its efforts. It is noteworthy that the program emphasized pesticide spraying 
far more than housing improvements. For example, while the number of homes treated with 
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pesticides increased dramatically from 11,740 in 1998 to 332,509 in 2001, the number of houses 
receiving structural improvements to prevent vinchucas actually decreased from 26,757 to 6,150 
(Guillén 2002). The funding enabled the National Chagas Program to hire 1,800 technicians and 
spray over 700,000 homes from 1999-2007, reducing the infestation of vinchucas from 55% to 
3.1% in the endemic area (National Chagas Program 2009).  
 
 
Figure 6.1: Pesticide Applications versus Housing Improvements, Bolivian National Chagas 
Program 1996-2001 
(Source: Guillén 2002, National Chagas Program 2000).  
 
     From 2000-2005, or during five of the seven years of IDB financing for the National Chagas 
Program, political instability jeopardized vector control efforts. Massive protests over 
privatization of water utilities in Cochabamba began in early 2000, and quickly galvanized 
national opposition to neoliberal policies in Bolivia. The political situation remained unstable. In 
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2002, Sanchez de Lozada was reelected with little more than a quarter of the national vote (the 
results came down to a runoff election in the National Congress). National protests erupted the 
following year over a plan to sell Bolivian natural gas to a U.S. company via Chile (through 
territory which Chile infamously annexed in the War of the Pacific in the nineteenth century, 
depriving Bolivia of its access to the sea). Sixty unarmed protesters were killed by military 
forces, and Sanchez de Lozada was forced to flee the country or face charges for murder. He 
found a safe haven in the United States, which refused to extradite him to Bolivia (Canessa 
2007). The national government foundered following Sanchez de Lozada’s resignation, with six 
different presidents from 2001-2005 (Ribando 2007). Meanwhile, a secessionist movement 
emerged in Bolivia’s more affluent eastern departments, centered in Santa Cruz.  
     General strikes and blockades stemming from protests and unrest, combined with periods of 
martial law, shut down much of the country during a critical phase in the spraying campaign.    
This caused a delay in undertaking the second round of pesticide applications necessary to 
eliminate vinchucas (Schmunis 2007). Overall, however, the program was able to achieve a 
substantial reduction in vinchuca infestations (from 55% to 3.1% in the endemic area) despite 
these obstacles (National Chagas Program 2009).  
     The years of unrest culminated in the election victory of Evo Morales, an ethnically Quechua 
leader who gained national prominence organizing coca farmers. His new party, the Movement 
toward Socialism (MAS), emphasized social justice, indigenous identity, and resistance to 
international pressure toward neoliberal economic policies (Canessa 2007, Zoomers 2006). 
Canessa (2007) characterizes the ascension of Morales as a veritable social revolution, noting 
that indigenous leaders have permeated the national government on an unprecedented scale.  
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     As part of an overall effort to enact reforms in favor of Bolivia’s poor, largely indigenous 
majority, Morales signed Law 3374 in early 2006, not long after taking office. This law makes 
the fight against Chagas disease “a national priority” and charges government ministries with 
“securing economic resources to undertake housing improvements and prevention programs” 
(Presidency of the Republic of Bolivia 2006, Article 1).  
     However, 2007 marked the end of the IDB loan for Chagas control efforts, putting the 
financial onus for Chagas control squarely on the Bolivian government. The National Chagas 
Program in 2008 outlined a strategy to combat Chagas based on four platforms: vector control, 
research and surveillance, education, and treatment. The final category also included treatment 
for adults with chronic Chagas. Nonetheless, the annual report for the program warned that it 
lacked the technical and financial resources needed to achieve further reductions in the presence 
of the vector and the disease (National Chagas Program 2009).  
     The program achieved a significant victory in vector control in 2011, when the department of 
La Paz received certification from an international commission of interruption of transmission of 
the disease by the vector (Gaceta Medica Boliviana 2011). The following year, Potosí also 
attained certification (PAHO 2012). The certification criteria took into account low rates of 
households infested with vinchucas and low prevalence of infection in children under 5. While 
this lent some credibility to the National Chagas Program, the notion of certifying absence of 
transmission has received criticism. One study questioned the La Paz certification since in 
Bolivia “native T. infestans populations are common, surveillance is weak and most rural houses 
are still substandard” (Abad-French et al 2013, p. 251). Furthermore, the authors argue that 
certification has the potential effect of weakening interest in continued vector control and 
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surveillance measures, since the problem has essentially been declared nonexistent by 
international authorities.  
     Bolivia faces continued challenges in sustaining control of the vector. Because its strategy 
focused on insecticide application and deemphasized housing improvements, its success hinges 
on the effectiveness of pesticides and depends on their continued application. Recent studies 
have demonstrated the presence of Triatoma infestans, the main vector, in the wild in different 
parts of Bolivia (Richer et al. 2007, Rojas et al 2007). These populations have the potential to 
invade homes (Lardeux 2013). Furthermore, certain populations of the vector have demonstrated 
resistance to pesticides, especially in the Gran Chaco, an area of dry tropical forest in southern 
Bolivia (Germano et al. 2010). After blanket spraying of the Chaco area in 2000, vinchucas 
quickly reinfested homes (Samuels et al 2013). Some communities in the area had infestation 
rates as high as 60% in 2008 (Programa Nacional de Chagas 2012). This has obliged the 
National Chagas Program to purchase different types of insecticides which are 60% more costly 
(Radio Metropolitana 2011).  
 
The Current State of Vector Control in Bolivia and the Study Area 
     At the beginning of the millennia, the Bolivian state received an influx of financing from the 
Interamerican Development Bank (IDB) to implement national Chagas control measures. These 
funds were earmarked for pesticide-based control measures rather than improvement of 
traditional housing in at-risk communities. While pesticide application is, in the short-term, 
much more cost effective than modifying houses (Rojas de Arias et al. 1999), it is not 100% 
effective in eliminating the vector. Studies have demonstrated that after initial blanket sprayings, 
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vinchuca populations decline rapidly but subsequently rebound, even in areas which were once 
thought to be free of the vector (Gurtler et al. 2007, Vazquez-Prokopec et al. 2009, Abad-Franch 
et al. 2011). Further, in Bolivia the danger also exists of sylvatic populations moving into houses 
(Rojas et al. 2007, Lardeux 2013).  
     In the early 2000’s, Bolivia’s initial campaign to spray houses throughout endemic regions 
was interrupted by political unrest; the country had six presidents from 2001-2005. Despite this, 
the program was able to complete over a million actions of home sprayings from 2003-2005, 
reducing the prevalence of infected homes in the endemic area from 55 to 3.1% (National 
Chagas Program 2009). However, the program sprayed far fewer homes in subsequent years, 
reaching a low of 23,466 in 2010 (Figure 6.2). Much of this reduction is due to the fact that less 
pesticide applications were needed following the widespread sprayings of the early 2000’s.  
     
 
Figure 6.2: Homes Sprayed by National Chagas Program, 2001-2010 
Source: National Chagas Program (2012) 
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     Nonetheless, without the IDB funding which ended in 2008, the state no longer had the 
financial capacity to undertake widespread sprayings, without taking out another major loan. As 
Gurtler (2007) points out: “Political and economic support for Chagas control programs wanes 
soon after signs of success appear.” Once housing infestations were drastically reduced, the state 
naturally shifted its attention elsewhere. Yet complete elimination of vinchucas would require a 
sustained, long-term commitment (Gurtler 2007). The fact that the spraying campaign failed to 
completely eliminate vinchucas as a public health threat was evidenced by the rapid reinfestation 
of homes in Bolivia’s Chaco region, just south of the study area, where the vector had become 
resistant to pyrethroid insecticides. One study noted that pesticides are much less effective when 
applied on Bolivian homes with traditional mud walls than on homes of cement, plaster and other 
“modern” materials, contributing to the resurgence of the vector (Samuels et al. 2013). 
     Consequently, the possibility of a resurgence of the vinchuca population – or its replacement 
by other sylvatic species of the vector-- and a subsequent return to high home infestation rates in 
the study area is ever present. Bolivia was not the only country to adapt a pesticide-based 
strategy. Regional programs such as the Southern Cone Initiative emphasized pesticide spraying 
because it could economically achieve a dramatic reduction in vinchuca populations. All Latin 
American countries, except Venezuela, have opted for pesticide spraying over housing 
improvements to eliminate the triatomine vector, because of the much lower cost of this strategy 
(Gurtler 2009). Improving all of the at-risk housing in endemic areas for Chagas disease in Latin 
America would cost an estimated $10 billion (Tarleton et al. 2007).  
     Yet Bolivia has a greater need for housing improvements than Chile or Uruguay, countries 
that have successfully eliminated vector transmission. According to the 2007 census, 72.3% of 
homes in rural areas were constructed of adobe, 66.5% had dirt floors, and 40.4% had roofs of 
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sticks, palm leaves, cane stalks, or a similar material (National Institute of Statistics 2007). These 
are major risk factors for vinchuca infestation (Campbell-Lendrum et al. 2007). This suggests 
that a preponderance of people in rural areas continue to live in homes that can easily be 
reinfested by vinchucas in the absence of regular spraying.  
     In this study, six participants still lived in homes with mud walls and palm-leaf roofs, and 
only eleven people could recall public authorities spraying homes for vinchucas. Throughout 
Palacios and other small rural communities, many of the homes are still made in the traditional 
style, and even when the houses themselves have tile roofs and plaster walls, many of the 
outlying peridomestic structures continue to be constructed of traditional materials. Even while 
staying in a house of modern construction in Palacios, I found two vinchucas of the species 
which were identified in CENETROP as Rhodnius robustus, a sylvatic species which can 
potentially invade homes and transmit the disease.  
     As the IDB funding ended, the National Chagas Program largely decentralized, entrusting 
departmental programs and local municipalities with continuing surveillance and control of the 
vector. Moreover, the prevailing surveillance strategy relies on community participation. A 
brochure from Santa Cruz’s Departmental Chagas Program urges citizens to report any 
vinchucas they detect to their local Information and Vector Post. These are often local health 
centers or government offices. The brochure warns that “Finding and reporting the presence of 
vinchucas in the home depends on you.” In other words, responsibility for surveillance is 
transferred to communities, a strategy lauded by some (Abad-Franch et al. 2011).  
     Nonetheless, decentralization of Chagas control efforts places a heavy burden on rural 
communities and local governments. In Bolivia, difficulties can arise in testing captured insects 
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from rural areas, then alerting authorities to spray. CENETROP in Santa Cruz is the only 
regional laboratory capable of identifying vinchucas and testing them for Chagas. With limited 
resources, authorities may not be able to respond to every report of vinchucas. Elsa, a Quechua 
migrant living in Buena Vista, took vinchucas she captured to the local clinic. They told her 
“We’re going to spray,” but never came. The same community was also unable to afford Chagas 
testing for its local clinic.  
     Tarleton et al. (2007) warn that “decentralization of health services in many endemic 
countries combined with declining funding for control efforts has transferred the burden of 
control to provinces or local communities that are ill-equipped to supply these services.” Dr. 
Faustino Torrico, a prominent Bolivian Chagas researcher and member of the Scientific 
Advisory Board of Drugs for Neglected Diseases, attributes the sharp drop in home infestations 
after 2000 to the IDB financing. He adds, “Unfortunately, the funding finished in 2007 and 
currently there is a transfer of roles and responsibilities from the central level of the Ministry of 
Health to local municipalities, whose contributions differ depending on their circumstances.” In 
other words, smaller more remote municipalities have less resources to carry on the fight against 
the disease, yet these are the communities most in need of continued vector control efforts.  
     While community participation is an idea with merit, and has often worked to strengthen 
indigenous communities in Bolivia (Canessa 2007), it is only effective if community members 
can function in partnership with authorities. By telling citizens, via its brochure, that “Avoiding 
Chagas disease is your responsibility,” the Chagas program, intentionally or not, minimizes its 
own role and obligation. This is not unlike the Venezuelan government targeting indigenous 
citizens’ sanitary practices as the cause of a cholera outbreak (Briggs and Briggs 2003). 
Similarly, Borovoy and Hine (2008) describe the imposition of a biomedical model emphasizing 
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autonomy and individual responsibility on Russian émigrés with diabetes in the U.S. The blame 
for treatment failure becomes the noncompliance of patients rather than the actions of medical 
providers. This is an inherent danger when obligations are decentralized from a place of 
authority to a disadvantaged population. Although decentralization can empower communities, it 
can also free the state of responsibilities or at least allow it to shift blame for negative outcomes.  
 
Biomedical Treatment of Chagas Disease in Bolivia 
Current Medications and International Neglect of Drug Development 
     Providing treatment to citizens with Chagas poses another major challenge. There are only 
two proven medications for Chagas, benznidazole, developed by Roche in 1972, and nifurtimox, 
created by Bayer in 1967. Benznidazole is considered the first-line medication, both due to its 
greater effectiveness (Viotti et al. 2009) and because nifurtimox can produce more frequent side 
effects (Jackson et al. 2010). The production of both medications has experienced interruptions. 
Due to lack of profitability, Bayer stopped producing nifurtimox in 1997, but it agreed to restart 
production a few years later in an accord with the World Health organization. However, Bayer 
did not initially assume the full costs for the marketing and commercialization of the drug 
(Veeken and Pecoul 2000).  
     Roche, the Swiss manufacturer of benznidazole, transferred the production license for this 
drug to the Brazilian state of Pernambuco in 2003. Just as Roche stopped production, there were 
delays in the transfer of technology and approval of the drug’s production in Brazil. This caused 
a disappearance in the regional supply of Chagas medications in 2011, bringing treatment to a 
halt in Bolivia and throughout the region (MSF 2011). The supply was subsequently replenished 
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as production commenced in Brazil and a second manufacturer emerged in Argentina (PAHO 
2013).  
     Nonetheless, the use of these medications is fraught with problems. The severity of side 
effects with both nifurtimox and benznidazole increases with the age of the patient (Cançado 
2002, Bern 2011, WHO 2010). In a study with 162 Bolivian adult patients, 58.6% experienced 
side effects during a course of treatment for chronic Chagas with benznidazole, and 18% had to 
stop treatment (Tornheim et al. 2013). A study of chronic Chagas patients in Spain, of whom 
85% were Bolivian immigrants, reported a proportion of adverse reactions of 57% (Pinazo et al. 
2010). Meanwhile, an Argentinian study of children with Chagas disease reported 41% 
experienced side effects, and that these were more frequent in older children (Altcheh et al. 
2010). Of note, a pediatric formulation for benznidazole did not exist until 2011, despite the fact 
that the drug has primarily been used for treatment in the pediatric population. The benznidazole 
tablets had to be cut into halves or quarters in order to provide the dosage for infants and children 
(DNDI 2011). In a similar vein, in a Swiss investigation of 124 Latin American immigrant 
patients with Chagas disease, of whom 120 were from Bolivia, 95.7% experienced adverse 
reactions to treatment with nifurtimox, although 90.5% of the reactions were mild or moderate 
(Jackson et al 2010).  
     While side effects increase, the efficacy of treatment declines in proportion to the patient’s 
age (Perez-Molina et al. 2009). This is because Trypanosoma cruzi is more susceptible to 
medication during the acute or early chronic phase, and children are typically more recently 
infected (Perez-Molina et al. 2009). For Bolivian infants 0-6 months old who are congenitally 
infected, the cure rate is nearly 100% (Alonso-Vega et al. 2013). A metareview of Chagas 
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treatment studies reported a cure rate of 71.5% in the acute phase, and 57.6% for children in the 
early chronic phase, but only 5.9% for adults in the late chronic phase (Guedes et al. 2011).  
     Nevertheless, ascertaining a “cure” is problematic since it can often take several years before 
a treated chronic patient shows negative laboratory results (Bern 2011). The MSF was unable to 
detect negative seroconversion among 276 children who were treated with benzindazole in 
Sucre, Bolivia, and in only 5.4% of 1,101 children treated in Entre Rios, Bolivia (Yun et al. 
2009). Yet in similar MSF projects in Honduras and Guatemala, seroconversion rates were 87.1 
and 92.7%, respectively. The authors speculate that this could be due to different strains of 
Trypanosoma cruzi in Bolivia compared to Central America.  
     The prospects for developing safer, more effective medicines for Chagas disease are grim 
under the current profit-driven model of global pharmaceuticals. Pharmaceutical companies have 
invested little in drug development for tropical diseases because the market, consisting of 
impoverished rural patients in the developing world, is simply not lucrative (Pecoul, Chirac, 
Trouiller, & Pinel 1999, Trouiller et al. 2002). Six of the ten largest drug companies are located 
in the United States (the other four are in Europe), and 85% of the international market for 
pharmaceuticals is comprised of the United States, Europe and Japan (WHO 2014). According to 
the World Health Organization (2014, para 4), the international pharmaceutical industry chooses 
to develop new drugs that are “most likely to provide a high return on the company's investment. 
As a result, drugs for use in the industrialized world are prioritized over ones for use in the 
South, where many patients would be unable to pay for them.” Medications for diseases affecting 
less developed countries are sorely neglected. Of the 1223 new drugs that were commercialized 
between 1975 and 1996, only 13 (1%) were used in treatment of tropical diseases, with only 4 of 
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those designed specifically for that purpose; some were originally veterinary formulations 
(Trouiller and Olliaro 1999).  
 
Table 6.1: Pharmaceutical Sales and Health: Comparison of US and Bolivia 
 
Country 
Life 
expectancy 
% of deaths- 
communicable 
diseases 
Drug sales 
per capita 
(US$) 
Total drug 
sales ($US 
billions) 
Drug sales  
% of health 
expenditure 
Bolivia 68 55 21 0.214 17.6 
United States 79 9 1077 337.1 12.4 
(Source: WHO 2011) 
 
     In 2012, total global funding for international pharmaceutical research and development 
reached $135 billion, and the cost of developing a new drug was $1.38 billion (IFPMA 2012). 
However, research and development funding for neglected diseases only reached $3.2 billion in 
that same year, and only 525 million of this came from the pharmaceutical industry (the rest was 
supplied by NGOs and the public sector). Only $37.1 million went to developing drugs for 
Chagas disease (G-Finder 2013). Assuming both the cost of developing a new drug and the 
research funding for Chagas disease stay constant, it would take more than 37 years’ worth of 
funding to develop just one new drug for Chagas disease based on the commercial industry 
model. However, only about 10% of new drugs eventually obtain approval (Hay et al 2014). 
Under this system, developing a safe, effective new drug for Chagas disease is virtually 
impossible.  
     Nonetheless, there have been efforts to develop new medications. Two international NGOs, 
Drugs for Neglected Diseases and the Global Health Institute of Barcelona (ISGlobal) 
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collaborated with the Bolivian organization Plataforma Chagas (Chagas Platform) to test an 
experimental new drug, E1224, on chronic Chagas patients in Cochabamba, Bolivia. The 
treatment showed limited effectiveness, but not as much as benznidazole (ISGlobal 2014). 
Posaconazole, an anti-fungal agent that was effective in trials with rodents, was recently 
evaluated in a clinical trial in Spain, but the results were disappointing (Molina et al. 2014). For 
the foreseeable future, benznidazole and nifurtimox are still the only biomedical options.  
 
Overview of the Bolivian Health System 
     In Bolivia’s public health system, care facilities are classified into levels. Level one facilities 
provide basic care, often via a nurse or community health worker, and are more readily available 
in smaller communities. These constitute more than 90% of health facilities in the public system 
(Silva and Batista 2010). Level two facilities are similar to clinics or community hospitals in the 
United States, and are able to provide services such as surgery or internal medicine. Level three 
facilities are the largest hospitals, treat the full range of health issues, and are generally only 
located in urban areas. In the study area, only Santa Cruz had level three facilities. The larger 
communities, Warnes and Yapacani, had level two facilities, while the other communities all had 
level one health centers (Autonomous Departmental Government of Santa Cruz, 
http://www.santacruz.gob.bo/equitativa/salud/centros).   
     Bolivia has taken measures to extend healthcare to all sectors of its population in recent years. 
Basic Health Insurance (SBS), launched in 1997, provided care for certain infectious diseases, 
including Chagas, for all Bolivians (PAHO 2011). In 2003, the Universal Maternal and Child 
Insurance (SUMI) plan began covering mothers and children under five years. Nonetheless, with 
SUMI’s implementation some of the basic services offered in level one facilities were eliminated 
132 
 
in favor of more advanced services. Because such services are only available at level two and 
three facilities, maternal and child health mortality actually worsened in the years following 
SUMI’s implementation (Silva and Batista 2010). The SUMI does continue to cover treatment 
for congenital Chagas. 
     In 2009, Bolivia enacted a new constitution which guaranteed access to health care for its 
citizens (Constitution of the Plurinational State of Bolivia 2009). Yet Bolivia still does not have 
the technical or financial capacity to make this vision a reality. Bolivia only has 4.6 doctors per 
10,000 inhabitants, which is less than half the minimum level recommended by the WHO (Perez 
2012). Moreover, universal health coverage has yet to reach most of the population. Although 
coverage is typically available for Bolivians who work at public and private institutions, the 70% 
of the Bolivian work force that is involved in domestic service, small-scale agriculture, self-
employment or microenterprise is largely excluded (2012). As of 2009, 57.3% of the population 
did not have health insurance (Ledo and Soria 2011).  
 
Treatment through the National Chagas Program 
     The National Chagas Program provides treatment through the system of level one, two and 
three centers. Chagas treatment is typically offered at the larger level two and three centers. For 
example, the congenital component of the program screened 318,479 expectant mothers from 
2004-2009. However, this took place almost entirely in level two and three centers. In a national 
study of congenital Chagas, officials from the National Chagas Program urged “it is necessary to 
include level 1 facilities into the program in order to improve the monitoring capacity of children 
born from positive mothers and increase detection of cases from 6 months of age and older” 
(Alonso-Vega, Billot, & Torrico 2013, p. 11). Level 1 facilities often face a lack of supplies or 
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personnel. This is in part because much of the burden for financing these health centers falls on 
local municipal governments (PAHO 2011). For example, when I inquired at a level one clinic in 
Buena Vista, the staff informed me that they had not been able to provide Chagas diagnosis for 
four months due to a lack of tests, and that there was no room in the municipal budget to order 
further test supplies.  
     Until recently, the National Chagas Program, in line with the recommendations of the WHO, 
only provided treatment to children under 15 years old. The program achieved substantial 
success with this age group. For example, it was able to screen over 300,000 expectant mothers 
and treat 1,093 infants with congenital Chagas from 2004-2009, realizing a cure rate of 96% 
(Alonso-Vega et al. 2013). In 2007, the program examined 94,618 children in the 5-15 age range, 
detecting 7,102 cases of Chagas (Figure 6.3).  
     However, in the following years far fewer children were screened. This in part stems from the 
lower rate of infection in children following the success of the vector campaign, but beginning in 
2008, Bolivia could no longer count on financing from the International Development Bank. In 
2008, only 39,432 children in the 5-15 age range were screened, and this number dropped to 
18,174 by 2011 (Figure 6.3). This represents an 81% decrease from 2007. Similarly, screening of 
children aged 1-5 declined from 16,070 in 2007 to 4,783 in 2011. Whereas 7,102 cases were 
detected in 2007, this number shrank to 945 in 2011 (Figure 6.4). Less than half of children in 
this age group actually received treatment from 2007-2011 (National Chagas Program 2012).   
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Figure 6.3: Children 5-15 Screened for Chagas, 2007-2011, Bolivian National Chagas 
Program 
 (Source: National Chagas Program 2012) 
 
 
Figure 6.4: Positive Cases Detected and Treated, 2007-2011, Children 5-15, Bolivian 
National Chagas Program 
(Source: National Chagas Program 2012) 
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     Treatment of adults with chronic Chagas is still controversial, but has gained momentum of 
late, as research has shown that benznidazole appears to limit progression of the disease in adult 
chronic patients (Viotti et al 2009). In the U.S., the CDC recommends offering treatment to 
adults under 50 who are asymptomatic or only have mild complications (Bern 2007). The Pan 
American Health Organization’s 2010 Chagas strategy asserted that “care of infected adults—
should be a guaranteed part of primary care” (PAHO 2010, p. 6). Doctors without Borders began 
treating adult patients with Chagas in Bolivia in late 2007 (MSF 2007). In its 2008 annual report, 
the National Chagas Program stated it was developing pilot programs to treat adults in 
Cochabamba, Tarija and Potosí. In 2011, the program announced it would begin offering 
treatment to adults via three clinics and two hospitals in Santa Cruz (El Sol de Santa Cruz 2011).  
     According to the National Chagas Program, its screening of adults over 15 rose from 16,676 
in 2007 to 69,679 in 2010, though this number dropped to 35,852 in 2011 (Figure 6.5). Of the 
33,800 individuals older than 15 who tested positive for Chagas from 2007-2011, only 9,952, or 
29.4%, received treatment from the National Chagas Program (Figure 6.6). Still, the program 
treated an increasing number of adults each year (National Chagas Program 2012). There are 
some limitations to who can receive treatment. The patient must be under 60 and must be free of 
diabetes, liver problems, and severe cardiac complications (National Chagas Program 2013). At 
the time of the study, treatment of adults was not available in all areas. 
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Figure 6.5: Population over 15 Screened for Chagas, 2007-2011, Bolivian National Chagas 
Program 
(Source: National Chagas Program 2012) 
 
 
Figure 6.6: Positive Cases Detected and Treated, 2007-2011, Population over 15, 
Bolivian National Chagas Program 
(Source: National Chagas Program 2012) 
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     The difficulty of testing for Chagas disease also poses challenges for the program. Although 
rapid assessments such as Chagas Statpak can be easily used in rural areas of Bolivia (Chippaux 
et al. 2009), these until recently were preferred as screening tools. In line with WHO 
recommendations, the National Chagas Program requires a confirmatory analysis using an 
ELISA (enzyme-linked immunosorbent assay) or IHA (indirect hemagglutination) test. These 
tests require expensive equipment that can cost several thousand dollars (http://www.elisa-
tek.com/laboratory-equipment, http://www.protelecomsupply.com/kaelus-4-watt-pim-analyzer), 
and are thus typically only available in level two and three care facilities. Patients in rural areas 
have to travel to the nearest large town in order to get the confirmatory test, and often wait 
several weeks for results. However, these requirements may soon ease in light of a new study 
performed by the MSF and WHO, which demonstrates testing using rapid field tests is just as 
effective as the ELISA and other laboratory-based methods (MSF 2014).  
     In more remote, rural areas, access to medical facilities and Chagas testing is most limited, 
yet this is precisely where Chagas disease is apt to have a high prevalence. Consequently, the 
bulk of Chagas disease cases in Bolivia are undiagnosed. Less than one percent of Bolivians with 
Chagas are aware that they are infected with the disease, due to its long period of asymptomatic 
dormancy. This means there are one million Bolivians with Chagas disease, or nearly 10% of the 
national population, who are undiagnosed. Most become aware they have the disease through 
blood banks, when they attempt to donate blood for a friend or family member (Steinbach 2013).   
 
The Departmental Chagas Program in Santa Cruz 
     The Department of Santa Cruz achieved a drastic reduction in the infestation rate of homes, 
which declined from 60% in 2002 to 3% in 2012 (El Dia 2013). Nevertheless, vinchucas proved 
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difficult to eradicate in some communities, particularly in the Chaco region in the south of the 
department. In 2011, an investigation detected 80% of homes in the Chaco town of Camiri were 
infested with insecticide-resistant vinchucas (El Deber 2011). Even in Warnes, an urbanized area 
thought to be well controlled, infestations of homes by vinchucas resurged from less than 2% in 
2007 to over 10% in 2012 (National Chagas Program 2013). Still, with vinchucas apparently 
under control in vast swaths of the department, the departmental branch of the National Chagas 
Program shifted its efforts toward diagnosis and treatment. 
     On April 14th, 2013, for International Day of Chagas Disease, the Departmental Chagas 
Program organized a health fair in the Parque Urbano (Urban Park), a large city park in Santa 
Cruz. On this occasion, the program offered free Chagas testing, and received an overwhelming 
response from the local population. Lines of individuals waiting to be tested snaked through the 
park, and program staff had to work until the evening hours to test everyone. Brochures were 
passed out titled “Prevenir el Chagas depende de vos”, or “preventing Chagas depends on you”. 
The use of the word “vos” for “you” is typical of local camba dialect in Santa Cruz. The 
brochure depicts a family dressed in rural camba attire, with sandals and straw hats, plastering 
the walls of their home. After explaining about causes and means of preventing Chagas, the 
brochure emphasizes “Preventing Chagas is your responsibility.” It goes on to state that 
treatment is available for infants, children, and adults, providing the addresses and phone 
numbers of the four health centers in Santa Cruz that provide free Chagas treatment, for the 
departmental Chagas program.  
     However, the toxicity of the available medications, along with other factors such as the 
difficulty of diagnosing infection (Bern 2011) and the continued presence of the vector (Rojas de 
Arias et al. 2012), make providing treatment for adults with Chagas a major logistical challenge. 
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Because of the danger of reinfection from vinchucas, the National Chagas Program only provides 
treatment to communities where there is evidence that less than 5% of homes are infested 
(National Chagas Program 2013). While such data exist for larger cities such as Santa Cruz and 
Warnes, smaller communities in more remote areas have not yet had entomological surveys 
(Zaira Borja, personal communication). This means that a resident of Santa Cruz is eligible to 
receive free treatment, while a resident of a small rural community like El Pilar or Palacios is 
not. The public hospital in Warnes only treated children up to 15 years old. The National Chagas 
Program planned to expand adult treatment to Warnes and other communities, but this had not 
yet taken place at the time of the study (June 2013) (personal communication, Dr. Susana Rios).  
     The Chagas treatment efforts in Santa Cruz received negative publicity when a sixteen year 
old girl with Chagas died from adverse reactions to benznidazole (El Mundo 2007). Although 
she had begun to experience a rash and other signs of a reaction, her parents continued giving her 
the medication, according to an official at the hospital (personal communication, Dr. Carlos 
Lafuente). Following this tragedy, the departmental Chagas Program immediately suspended 
treatment of Chagas patients older than 10 years old.  
     Treatment for this age group subsequently recommenced, but there were now strict 
requirements for both providers and patients. A rigorous system of follow-up was implemented 
to ensure patients were checked for signs of adverse reactions at least weekly, and to ensure this, 
patients only received a week’s worth of medication at a time (National Chagas Program 2013). 
Patients also had to sign consent forms in which they agreed to come to weekly checkups and 
stop taking the medication immediately upon signs of an allergic reaction, such as fever or rash. 
Furthermore, patients were restricted from eating spicy food, chocolate, canned food, alcohol, 
pork, fried food, citrus, tomato and egg, and to avoid exposure to the sun (National Chagas 
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Program 2013). The latter requirement would be nearly impossible for an agricultural worker or 
ambulatory vendor in Bolivia to maintain, while the dietary restrictions impacted a host of foods 
that are typically consumed in rural Santa Cruz (especially pork, fried food, citrus, tomato and 
egg). These types of restrictions caused patients to drop out of treatment in Mastrangelo’s 2009 
study in Argentina. 
     Finally, patients had to complete a series of clinical evaluations in order to be eligible for 
treatment, including an EKG, testing of kidney and liver functions, and analysis of cholesterol 
and triglyceride levels. Although diagnosis and treatment for Chagas is covered by the program, 
these additional tests are the financial responsibility of the patient (personal communication, Dr. 
Susana Rios). A consultation with a cardiologist for an EKG costs a minimum of $40 in Bolivia 
(National Chagas Program 2013), which would represent almost a third of the monthly earnings 
of someone making minimum wage.  
     Consequently, even though treatment for Chagas is free, other costs, such as laboratory 
analyses and travel to different cities to access level two and three centers, still make treatment 
difficult to accede. Even when treatment can be initiated, Bolivians with Chagas must severely 
limit their physical activity and diet for a period of two months, and face a strong possibility of 
adverse reactions from the medication. While the government has every intention of treating 
people with Chagas as part of its broader social agenda, it is constrained by the lack of reliable 
medication due to an almost complete inattention to tropical diseases by the international 
pharmaceutical industry.  
 
     Using financing from the Interamerican Development Bank, Bolivia made substantial 
progress in eliminating infestation of homes by vinchucas; the infestation rate dropped from 55% 
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to 3.1% in endemic areas from 1999 to 2008 (National Chagas Program 2009). Because 
improving housing conditions in rural areas would have represented an enormous investment of 
resources at a time when the Bolivian state was in crisis, the government opted for a more cost-
effective, short-term solution (pesticides) rather than a more durable but costly long-term 
solution (large-scale housing improvements). This necessitates an ongoing dependence on 
pesticides, while in some areas pesticide resistant vinchucas have flourished (Lardeux et al. 
2010). Because vinchucas are present in the wild (Cortez et al. 2007), authorities will need to be 
constantly vigilant to ensure reinfestations of homes are kept at bay, yet the Chagas Program has 
had to curtail resources because of the end of the Interamerican Development Financing. 
     Treatment of Chagas disease in Bolivia has made strides as well. Programs to end vertical 
transmission have achieved substantial impacts (Alonso-Vega et al. 2013). While the Chagas 
Law of 2006 makes eliminating the disease a priority, the current biomedical treatment is a 
tenuous option at best (Bern 2011), and research and development for new Chagas medications 
is insufficient (MSF 2009, Guedes et al. 2010). With any possibility of a new, safer medication 
still years away, Bolivians with latent Chagas disease face a choice of two risks: the side effects 
from taking the medication, or the one in three chance of developing chronic symptoms if they 
leave the disease untreated.  Additionally, a lack of financial resources constrains the program’s 
ability to provide treatment. There are not enough resources to extend treatment options to 
smaller communities and rural areas, where a significant segment of the population unknowingly 
lives with Chagas disease.  Most Bolivians with Chagas disease are still unaware of their 
infection (Justiniano 2013).  
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CHAPTER SEVEN 
QUALITATIVE INTERVIEW RESULTS, PART 1: 
ACCESS TO BIOMEDICAL CARE 
 
     This chapter describes the characteristics of the 68 participants in the qualitative sample, and 
outlines some of the difficulties they face in accessing treatment for Chagas disease (Research 
Objective 1c). Furthermore, participants’ views on the role of government are discussed. Overall, 
participants confront considerable economic, geographic, and informational barriers to accessing 
biomedical care. Participants proposed three main types of solutions for eliminating Chagas 
disease: 1) biological (through pesticides), 2) biomedical (through expansion of care provision), 
and 3) social (via programs to help the poor and improve housing). The names of participants 
have been changed to protect their anonymity.  
 
Sample Characteristics 
     The sample consisted of 68 patients of the Centro Medico Humberto Parra (CMHP). The 
majority of the patients served by the clinic are female adults, and the sample composition 
reflects this (Table 7.1). While 78% of the sample is female, 56% of participants listed their 
occupation as homemaker. Nearly half the sample had only had some primary education (1-5 
years), while others had not gone to school at all. The majority of participants identified 
ethnically as camba, or natives of Santa Cruz department, but others had been born in Quechua-
speaking departments (Chuquisaca, Cochabamba and Potosi). 
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Table 7.1: Characteristics of the 68 Qualitative Interview Participants 
  N PERCENT* 
EDUCATION None or NA 8 12 
 Some primary school  33 49 
 Some middle school 13 19 
 Some high school 10 15 
 More than high 
school 
4 6 
GENDER Male 15 22 
 Female 53 78 
ETHNICITY Camba 54 79 
 Quechua 14 21 
OCCUPATION Agricultural Laborer 5 7 
 Construction, 
transportation or 
services 
11 16 
 Homemaker 38 56 
 Microenterprise or 
informal economy 
7 10 
 Professional or 
business owner 
7 10 
CHAGAS STATUS Positive 
Negative or unknown 
63 
5 
93 
7 
* Due to rounding, not all totals add up to 100%. 
 
Overview: Obstacles to Treatment 
     Despite the government’s efforts to provide free treatment for Bolivians with Chagas disease, 
people with Chagas are doubtful of the possibility of receiving care, and confront a host of 
difficulties in accessing treatment, which begin with the difficulties in diagnosing the disease 
during the chronic stage. None of the 68 people I interviewed were aware that the government 
offered free treatment for adults with Chagas disease, and only one person had experience with 
the National Chagas Program (which treated her son). In the qualitative portions of the 
interviews, participants discussed two principal types of impediments to treatment. The first 
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obstacle is, on the surface, ideological: the prevailing belief that Chagas disease cannot be cured, 
an idea often imparted by medical providers. The second class of obstacles is overtly structural, 
and comprises not only the limited resources of poor Bolivians to purchase expensive treatments, 
but difficulties in acceding treatment due to distance, limited time, and related factors.  
 
The Confusing Process of Testing for Chagas Disease 
     The biomedical system of diagnosing Chagas disease creates confusion for Bolivians who 
want to know if they are infected, or if they have been successfully cured following a treatment. 
The National Chagas Program, following the current recommendations of the WHO, requires a 
positive diagnosis on two different tests. This is necessary because the presence of antibodies to 
Trypanosoma cruzi is very difficult to detect during the chronic phase of the disease (Bern 2011). 
The first type of test can be a rapid assessment such as Chagas Statpak. If this test is positive, a 
second test is administered, either an IHA (indirect hemagglutination assay) or ELISA (enzyme-
linked immunosorbent assay). While the former tests can easily be administered in a field or 
rural setting, the latter require laboratory facilities. If the results of the first and second tests are 
discordant, a third analysis must be performed (National Chagas Program 2013).  
     This system, rendered necessary because of the complexity of the disease and the limits of 
available diagnostic tests, creates further impediments for patients. For instance, the CMHP in 
Palacios uses the Chagas Statpak, which gives a result to patients in a matter of minutes. In an 
investigation with Bolivian migrants living in Switzerland, the Chagas Statpak had a positive 
predictive value of 99% (Chappuis et al. 2010). While this is quite high, it still leaves the 
possibility that one of every hundred people who test positive actually do not have the disease.  
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     Of the 68 people I interviewed, the greatest number (25) found out they had Chagas disease at 
the CMHP, which is not surprising given that all interview respondents were CMHP patients 
(Table 7.2). The clinic provides free testing using the Chagas Statpak, and often screens groups 
of patients with the participation of medical students from the United States. The CMHP, despite 
its rural location, is able to purchase Chagas tests from a private supplier in Santa Cruz, thanks to 
funding from the Hamant Foundation in the United States. It also receives periodic influxes of 
volunteers and medical students through its affiliation with Northwestern and Loyola 
universities. Its capacity to offer extensive testing for Chagas is thus atypical for rural Bolivia. 
The clinic does not have the equipment to conduct the confirmatory IHA or ELISA analyses 
which the National Chagas Program requires in order to treat patients. These have to be ordered 
from the nearest hospital in Portachuelo, approximately 30 km from Palacios. The results would 
usually be ready 2-6 weeks later. 
     The second most frequent diagnosis (n=11) occurred when respondents wanted to donate 
blood for family members. This is usually the most common way for Bolivians with Chagas who 
are not yet symptomatic to find out they have the disease (Justinano 2013). Others were 
diagnosed in hospitals, clinics, or CENETROP, the National Center for Tropical Diseases in 
Santa Cruz. Three women received testing as part of their prenatal treatment, while two were 
screened by employers.  
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Table 7.2: Place of Diagnosis (n=68) 
Centro Medico Humberto Parra, 
Palacios 
25 
Blood donation 11 
Clinic or doctor’s office 9 
Hospital 7 
Center for Tropical Diseases, 
Santa Cruz 
5 
Prenatal exam 3 
Employer 2 
Public health campaign 1 
n/a (negative or undiagnosed 
participants) 
5 
 
     With blood transfusion being a major route of transmission for Chagas disease, Bolivia has 
sharply increased its screening of donated blood for Trypanosoma cruzi infection. The 
percentage of donated blood screened for Chagas disease rose from only 29.4% in 1993 to 86.1% 
in 2002, (Schmunis and Cruz 2005) and by 2010 Bolivia reported 100% screening of the blood 
supply (PAHO 2010).  
     Nonetheless, six respondents expressed doubts about the effectiveness of blood screening. 
One man who tested positive for Chagas disease at CMHP had donated blood to his daughter 
over a decade ago, and at that time the infection was not detected-probably because his blood 
was not screened. Hugo, a 62 year old teacher from Portachuelo, discovered he had Chagas 
disease when donating blood for his brother. “They didn’t take my blood because it had Chagas,” 
he said. “But before that I had donated 14 times.” Magaly owns a ranch and raises livestock with 
her husband, who also has Chagas disease. She did not believe the blood bank in Santa Cruz 
when they told her she had Chagas. “All my life I donated blood… I always donated. And all of 
a sudden, 3 years ago, it came out that I had Chagas. But I didn’t pay it any mind.” Her diagnosis 
occurred at a laboratory that was closed for “irresponsibility… They worked irresponsibly, and 
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gave blood with AIDS or HIV to healthy patients.” When she took another Chagas test at 
CMHP, the result was negative. 
     Magaly’s experience typifies the suspicion which Bolivians hold for certain health 
institutions. For example, Eduardo is a 54 year-old former oil worker who now makes his living 
working in agriculture and selling empanadas.  When a public hospital told him that he could not 
donate blood to his mother because it screened positive for Chagas, he did not initially believe 
the results. “I said why is it coming out positive? I went to that clinic, El Niño Jesús. It’s more 
expensive, and I went there too. And it also came out positive. Then I realized I had [Chagas] as 
well.” Eduardo felt skeptical of the analysis at the public hospital where he first received a 
diagnosis of Chagas, but accepted it as fact after confirming the diagnosis at a more “expensive” 
clinic. In a similar narrative, Pancho, a 50 year-old welder, asks his relative about testing for 
Chagas in the local clinic in his community, Minero. “In Santa Cruz, there are only three reliable 
laboratories. But the thing is the analyses are expensive. So I said, what if I do the analysis in 
Minero? Minero is cheap.” Pancho’s relative responds that in the “reliable” laboratories, “they 
will know the truth, if you have it or not. But in the other one, there could be some change in the 
laboratory, and [the test] is going to come out negative. But actually you have [Chagas]. And 
you’re going to be tranquilo [calm] thinking you don’t have it, but you really do have it.” Again, 
the notion is that the more expensive facilities are more reliable. 
     Blanca is a 62 year old grandmother from Warnes. Her suspicion was even deeper than 
Eduardo’s or Pancho’s when a blood bank diagnosed her son with Chagas. “They told my son he 
has Chagas, but it’s a lie. So, in the Blood Bank, you know what they try to do is get blood.” She 
felt the blood bank in Santa Cruz deliberately told her son his blood was infected in order to keep 
the blood he had intended to donate for a relative.  
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     Two respondents, Amelia and Doris, described undergoing treatment and subsequently testing 
positive for Chagas disease. In both cases, they were unaware that they would continue to test 
positive after undergoing treatment. Amelia even underwent a second course of treatment. This 
may have been unnecessary, but there was no way of knowing whether the test results were 
positive because of the years it takes for the blood to convert to seronegative (free of T. cruzi 
antibodies), or because the treatment itself did not work (Bern 2011).    
 
Chagas Can Be Controlled but Not Cured 
     The idea that Chagas is an incurable disease is widespread. During the interviews, when I 
asked respondents how they would describe Chagas disease, twenty one stressed its incurability. 
When I specifically asked respondents during the quantitative interviews whether Chagas could 
be cured, 54% answered negatively. Three people compared it to other incurable diseases like 
diabetes or cancer. “Chagas is like a cancer for me, no?” says Jairo, a 47 year-old taxi driver 
from Santa Cruz. “It doesn’t have a cure.” Some consider that Chagas can only be “controlled” 
rather than cured, much like diabetes. “It’s a disease that doesn’t have a cure, I think” states 
Nora, who runs a small store or tienda in Buena Vista. “The only thing you can do is just control 
it. I think Chagas is like the illness of diabetes or cancer. It is, you know? And if you don’t 
control it, you still pass away one day.” Observes Pancho, “it’s a disease that, I think it doesn’t 
have a cure. It’s like diabetes, you know? Diabetes you can just control. It can’t be cured, right? I 
think [Chagas] is the same. Once you’re infected, they can’t cure it. It can be controlled, but you 
always have the virus.” 
149 
 
     Yet some of these respondents did not harbor much hope that their Chagas could successfully 
be controlled. “It’s a disease with no cure,” affirms Elsa, who also owns a tienda in Buena Vista. 
“It can just be controlled. But with time it gets worse, it gets worse, until death. You see, my 
father had it.” According to Dayana, a homemaker from Yapacaní married to an agricultural 
laborer, “Everybody is sick [with Chagas] but we don’t know how to cure it. What I wouldn’t 
give to be cured, but I don’t know how. Well, they told me it can’t be cured. So well, I gave up, 
I’m just going to wait until my time comes to leave this world.” Similarly, Alma, the wife of an 
agricultural laborer from Minero, states “Well, when there is no cure, you have to die.” It would 
be incorrect to assume that these women had given up or resigned themselves. All three took 
steps to manage their Chagas disease, but to do so they drew on ethnomedical knowledge rather 
than biomedical treatment. The notion that biomedical providers could not provide a cure 
discouraged them from seeking assistance in that sector of the health care system. 
     On the surface, this appears to be an ideological barrier. Patients believe there is no cure, thus 
they do not seek treatment. However, the notion of Chagas as an incurable disease originates 
within the biomedical system itself. In fact, Chagas disease was considered incurable in the 
chronic stage until studies emerged in the 2000’s indicating some value in treating with 
benznidazole (Viotti et al. 2006). The CDC (2007), Doctors without Borders (2008) and Pan 
American Health Organization (2009) only recently began recommending treatment of adults 
with chronic Chagas disease. While some doctors may be unaware of this development, others 
are reluctant to prescribe benznidazole or nifurtimox due to the danger of side effects. According 
to Dr. Tom Ellman, head of the MSF in Bolivia, “Doctors do not treat children, let alone adults, 
for fear of side effects.” He goes on to argue that “leaving patients untreated is no longer ethical” 
(MSF 2009). The Departmental Chagas Program in Santa Cruz affirms that “Chagas has a cure if 
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it is detected on time, especially for children” (Autonomous Departmental Government of Santa 
Cruz 2013). However, Bolivian doctors I spoke with expressed concerns about how patients in 
remote rural areas would be able to manage adverse drug reactions. Treatment posed risks, while 
a “cure” was not guaranteed.  
     Even the international media continues to characterize Chagas as “incurable.” A 2012 article 
by the New York Times ran the title: “Chagas Disease, an incurable infection, called the ‘new 
AIDS of the Americas'”. The Times article, in turn, was merely summarizing an editorial from 
PLoS Neglected Tropical Diseases (Hotez et al. 2012). Thus, while certain international health 
organizations (the WHO, MSF and CDC) promote treatment strategies for adults with Chagas 
disease, it continues to be viewed as “incurable” by researchers and physicians who still question 
the efficacy of treatment. This situation is perpetuated by the lack of safe, effective drugs for 
chronic Chagas disease, as well as the inability of current assessments to detect a cure.  
     Of the individuals I interviewed, seven were told by doctors that Chagas disease could not be 
cured, only “controlled.”  “There isn’t a cure, no?” says Daniel, a 39 year-old agricultural laborer 
from Yapacaní. “There are doctors who can control it but they aren’t curing it. So, Chagas 
doesn’t have a cure.” Yoana is a 64 year-old homemaker whose husband works in a mill in 
Warnes. When she went to a clinic in Santa Cruz, the doctor told her, “there is no cure, you just 
have to take care of yourself.” And in another clinic the doctor said, “Don’t worry, it’s asleep.” 
Tatiana, a young mother of 33 years, recalls, “They told me they couldn’t give me any treatment 
because I was already an adult… That no, almost everybody had it, and that anyway it’s one way 
to die. Kind of funny. A slow but sure death, they told me.” In all these cases, an encounter with 
biomedical providers leaves the individual feeling that there is no option for eliminating the 
disease.  
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     The idea of Chagas as an “incurable” disease has its origin with the biomedical establishment. 
Yet the fact that Chagas disease is viewed as incurable hinges on the inattention it has received 
in international drug development, and the difficulties associated with using the current 
medications – which do still offer a cure for many groups of patients. This is the case of a major 
structural process (the profit-driven model of international pharmaceutical development) 
affecting the biomedical explanatory model of a disease, which is then conveyed to patients 
through providers.   
The High Cost of Biomedical Treatment for People with Chagas 
     Despite the much lower per capita earnings in Bolivia ($2,868 US) compared to the United 
States ($53,363 US) (World Bank 2014 http://data.worldbank.org/indicator), medicines can often 
cost more in Bolivia. The IFPMA affirms “developing countries, especially least-developed 
countries, often have high mark-up costs that inflate unnecessarily the prices of essential 
medicines.” Examples of these costs are import tariffs, importers’ and retailers’ profit margins, 
and port fees. Levison and Laing (2003) found that on average, these costs drove up prices of 
medicine in developing countries by 68.6%. In Brazil, the only South American country in their 
sample, the total mark-up was 82.4%. This cost could be even higher in land-locked Bolivia, 
which must also absorb port fees from neighboring countries. It is telling that Bolivia spends a 
greater portion of its health budget on medicine than the United States (17.6 vs 12.4%) (WHO 
2011).  
     Nineteen respondents mentioned that treatment for their Chagas disease was too costly. Of 
these, six specifically cited the high cost of medication. According to Betty, a 46 year-old 
homemaker from Warnes, a prescription for her Chagas-related cardiac symptoms cost “three 
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pesos, which was costly for us. Each tablet. And I would take them for a while, of course when 
you feel bad, I have to buy my tablets. And we would buy them. And then I quit taking them. I 
said, I’m not going to take them, let whatever happens be God’s will.” Each pill cost Betty three 
bolivianos ($0.43 US), and the doctor told her she needed to take them every day for the rest of 
her life. Assuming she took one a day, Betty would spend about 90 bolivianos per month. This is 
9% of the individual monthly minimum wage, and nearly half the sample reported their entire 
household earned less. Betty’s husband, a bus driver, actually earned more than 1,000 bolivianos 
monthly, but she still found the medication to be too costly to continue taking it. What is more, 
the doctor told her that the medication was only to control her Chagas, not to cure it. Thus, it did 
not seem like a worthwhile investment to her. 
     Interestingly, Betty was the only respondent who had experience with the National Chagas 
Program, which gave treatment to her son. She described the treatment as being free of charge, 
“But there were two occasions when there was no medicine. They told me there, ‘we don’t have 
any now, you’ll have to go buy it.’” This likely occurred during the shortage in the benznidazole 
supply in 2011-2012. While Betty was able to see her son cured of the disease, she remained 
with the idea that her own Chagas was incurable, as doctors had told her. This also reflects that 
free treatment for children was offered in Warnes, where Betty lives, but not for adults. The 
system of care thus helped shape her explanatory model with regards to the curability of the 
disease.  
     Josefina, who worked cleaning houses in Minero, similarly complained of having to pay 2.5 
bolivianos for each tablet of a medication. “There is just not enough money to be, each month, 
buying and buying it,” she noted. Tatiana found that taking a fiber supplement helped with the 
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gastrointestinal symptoms she believed came from her Chagas disease. But she stopped taking it 
because “it was very expensive.”  
     Although the National Chagas Program now offers free medication for Chagas disease, other 
providers still charge for it. This is the case even in other public institutions, such as 
CENETROP, the Center for Tropical Diseases in Santa Cruz. Leticia, a widowed single mother 
who had an irregular EKG, travelled the 70 kilometers from her rural home in El Pilar to Santa 
Cruz in order to get treatment for her Chagas disease. She remembers paying over 100 bolivianos 
for one bottle of medication. “I didn’t continue,” she says, “because there wasn’t enough money. 
I stopped going to do the checkups for Chagas. And now I feel very sick.” Leticia felt that her 
only option was to allow her Chagas disease to worsen, because she could not afford the 
treatment even at a public health institution. 
     In another instance, Pancho, a 50 year-old Chagas-positive welder, had to stop taking the 
medication a cardiologist had prescribed for him. “Those tablets are very expensive. And he told 
me I have to take them for the rest of my life. So that is going to leave me on the street 
[destitute].” Pancho was in relatively good health, with a stable job that paid comparatively well. 
Yet even the basic medication he needed to maintain an active life and prevent a rapid 
deterioration of his Chagas disease was difficult to afford. 
     Alma, a 55 year-old homemaker married to an agricultural laborer, details the high cost of 
going to the city (Santa Cruz) for treatment and medication: 
The truth is, our resources just aren’t enough to go to the doctor and do analyses. No, it’s 
expensive, Santa Cruz is very expensive… Twenty-four tablets cost 965 bolivianos ($140 
US). And the drops, that are taken once a day, are another 950 ($138 US). Poor people 
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don’t have that kind of money. Each tablet, said the pharmacist, each tablet cost 35 pesos 
($5 US). Each tablet… So what poor person is going to go see the doctor, get checked by 
a doctor, if they don’t even have 1,000 ($145 US) pesos saved up at home. Because what 
they have is basically just for food. Because you earn very little as well, at least my 
husband doesn’t earn much, and sometimes there’s not enough money. Many people live 
like this.  (Alma, Minero) 
     Each bottle of medication in Alma’s account cost nearly the individual monthly minimum 
wage in Bolivia, which was 1,000 bolivianos ($145 US) at the time. Yet according to the CMHP 
(www.cmhp.org), the average agricultural worker in Palacios earns only about $40 US a month. 
Thus, this type of expense could be catastrophic for a family like Alma’s, and does not even take 
into account the money she had to spend to see a provider in the city, as well as the cost of travel.  
     In Susy’s experience, the various limitations in the biomedical treatment of Chagas disease 
converged. A 58 year-old homemaker from Minero, she first detected her Chagas disease in 
Santa Cruz and underwent treatment. However, when she later underwent testing in 
Cochabamba, the results came out Chagas positive. Unbeknownst to her, this could have been 
due to the inability of current laboratory tests to detect a cure (Bern 2011). Feeling that the first 
treatment had failed, she decided to consult a private cardiologist in Cochabamba. He put her on 
a regimen of Chagas medication (she could not remember the name) for three periods of three 
months’ duration, with rest intervals of three months in between. She says the medication 
“attacked my nerves”, and she had to take tranquilizers in order to get through the treatment. 
Later, the cardiologist also prescribed “vitamins”, which she feels were crucial in helping her 
overcome the medication’s side effects. Yet this entailed a great deal of expense. “Those 
vitamins and those things, they cost a lot,” she observes. “Each one ended up costing 35 
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bolivianos. And in ten days, it adds up to 350! You see? Yes, imagine, 90 days, 90 days, 90 
days.” Treating her Chagas disease thus represented long periods of physical suffering and an 
enormous financial investment.  
     In addition to medications, fees for providers and specialists can be prohibitively expensive 
for most Bolivians. Nora, the wife of an agricultural laborer who runs a small store out of her 
home, spent 1,800 bolivianos ($260 US) in one visit to the hospital when she lost sensation in 
her arm and chest and her “brain fell asleep.” She was discharged without receiving any 
explanation as to what was wrong. “They did all these labs, but they never gave me any 
treatment, not one tablet, nothing.” She vowed, “No, but that is the last time that I go to the 
doctor, because the truth is, well, you just pay and you don’t get better. There are no results.” 
Nora’s narrative demonstrates her loss of faith in biomedical providers; now, she relies solely on 
ethnomedical remedies for her Chagas disease.  
     Norberto, a 58 year-old bus driver from Queranda, also laments the high costs of medical 
care. “Ooh, for 300, 400 each visit always. Then with medicine it’s 500 [$72 US]. Where are we 
going to get that money? You just die.” The expense of treatment is a barrier between life and 
death in his view.  
     The more advanced an individual’s chronic Chagas disease, the more expensive the required 
treatments. For example, Josefina’s family was trying to raise $5,000 to buy a pacemaker for her 
brother, who suffered from Chagas-related heart enlargement. Mario’s family had to hospitalize 
his uncle in Santa Cruz after a heart attack due to his advanced Chagas disease. At 51 years of 
age, Mario concurrently dealt with his own heart problems which may have stemmed from his 
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Chagas disease. Even though his uncle was interned in the National Chagas Program’s 
designated level three care center, they still had to pay $1,000 for tests and treatments.  
     Aside from the costs of paying for providers and medications, rural Bolivians incur other 
expenses from transportation and lost wages. “We live far away from everything, and the 
earnings aren’t much,” said Olivia from El Pilar, a community only accessible from the main 
highway by several kilometers of dirt road. To go to Portachuelo, the nearest city with a hospital, 
she had to pay 130 bolivianos ($19 US). “I have to pay for my doctor visit. I have to pay for the 
tests they order. Then, I don’t have a place to sleep there, I have to return to the countryside.” 
Getting time off from work can pose another barrier. Vivian from Warnes, worked for mushroom 
and flower companies. “When you work, they don’t give you any time off for anything,” she 
states. “One, two, three hours they give you, and then you have to go back to work.” For this 
reason, she never sought treatment for her Chagas or any other health problem.  
     Another barrier to accessing care is the difficulty of navigating the often complex health 
system, especially for rural Bolivians who are travelling to large cities. Mario, who lives in 
Buena Vista, describes the hospital in Santa Cruz as “a labyrinth. They don’t attend you for a 
long while. Until you are practically dead… If I go, I lose the whole day. And sometimes you 
don’t have any days off… It’s a lot of cash you have to spend there. Everything is money.” 
Marta, a 39 year-old homemaker also from Buena Vista, notes, “For us in the countryside, it’s 
the lack of a place to go to [for care]. The distance. Sometimes you don’t have the budget. And 
then if they send you to CENETROP, you have to go at 4 in the morning to get in line.” Buena 
Vista, a small community on the edge of the Amboró National Park, only has a level one clinic, 
which currently has no capacity to provide treatment for people with Chagas disease. Instead, 
they must travel 105 kilometers (66 miles) to Santa Cruz. 
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     The expense of getting care in Santa Cruz causes Alma to see providers as pitiless and thirsty 
for profits. 
In all of Santa Cruz, there is no pity, no regret, no thoughtfulness, there is nothing in 
Santa Cruz. Instead for everything they want to charge you an arm and a leg, no? Just a 
one-time consultation is sometimes 200 [bolivianos or $29 US]. The cheapest 
consultation that you can get is 40 [$6 US]. And you know, a mammogram, or something 
for your bones, they charge a ton of money, imagine. (Alma, Minero) 
      Again, while the fees Alma describes seem very reasonable by US standards, they represent a 
significant chunk of earnings for rural Bolivians who are already hard pressed to meet daily 
expenses. Even the cheapest fee she mentions, 40 bolivianos, is equivalent to a day’s wages for 
agricultural laborers in the area – and does not take into account tests, medications, 
transportation and other associated costs of seeking care. 
 
Opinions on the Role of Government 
     Respondents expressed mixed opinions of the government’s efforts to combat Chagas disease, 
ranging from marked criticism to praise of the current administration of Evo Morales. Two 
respondents express a sentiment of being abandoned or misled by the government and healthcare 
system. Alma criticizes government programs which are supposed to alleviate the health needs of 
poor Bolivians, such as the health insurance program for mothers and children, the SUMI.  
     Sometimes people die. Because there is nowhere for them to go. Sometimes the 
sickness is tremendous, and there is no money. These salaries are not enough, barely to 
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half-eat… Children die, for no other reason. Because supposedly children have the SUMI 
[National Maternal and Child Health Insurance] but the SUMI doesn’t cover anything. 
They just give you ibuprofen… They say the SUMI is children’s insurance, but that’s 
kind of a lie. It’s just for fever and diarrhea. Then there are other sicknesses where the 
mothers have to buy the medicine themselves. So that’s not what I call help. (Alma, 55, 
Minero) 
     While raising many of the same criticisms of the SUMI expressed by Silva and Batista 
(2010), Alma expresses feelings of abandonment by the government in the face of inadequate 
earnings and high costs for health care.    
     Meanwhile, Rosa from Buena Vista questioned why an adequate cure for Chagas had not 
been developed. “I think the results of the investigations they do aren’t made known.” I asked 
her whether “they” in her statement referred to medical researchers or government. “Doctors,” 
she answered, “and government too. With so much money they should have done some 
investigations on [Chagas]. Or if they have, we don’t know about it.” Like Alma, Rosa feels 
abandoned by both government and the health sector, which in four decades has been unable to 
provide a reliable treatment for Chagas disease.  
     Despite the existence of the National Chagas Program and the advances it has made, nine 
respondents expressed doubt that the government was combatting the vector and disease. 
According to Magaly, “There has never been control by our authorities” to eliminate Chagas 
disease. “We don’t have people with vision and we don’t have the resources to do it. But if I had 
my way, I would get rid of all the corrupt [politicians] and appoint people who are capable and 
knowledgeable.” Ricardo, who works as a mechanic in Buena Vista, “has no idea if there is any 
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program. There are a lot of things in Bolivia that should be done, and the government doesn’t 
even have any idea. The municipal government should have a health program, with treatment 
and all that, and this is not seen.” Buena Vista only has level one health centers without 
sufficient funding to test, much less treat Chagas. Eduardo from Yapacaní feels the government 
“doesn’t pay attention” to Chagas disease because “it’s all politics. They fight like dogs over a 
bone. They just fight for their own possessions. They don’t care about the wellbeing of the 
people.” He notes the continued presence of vinchucas in the Chaco region of southern Santa 
Cruz. “There isn’t any plan… Up to now I haven’t heard that they are spraying in such-and-such 
a place. From Gutierrez and beyond, that area is full of [vinchucas].” The area he refers to is the 
same area where the National Chagas Program encountered insecticide-resistant vinchucas.  
     Interestingly, the four respondents who spoke positively of Evo Morales’ administration all 
came from Quechua-speaking departments. The cambas of Santa Cruz have traditionally 
opposed Morales, who came to office as the movement for regional autonomy from the national 
government reached a head. This movement was led by elite business interests in Santa Cruz that 
had little interest in Morales’s agenda of social reform (Hertzler 2010). While Morales won 64% 
of the national vote in the 2009 elections, he only received 41% in Santa Cruz, although this was 
a significant improvement from the 33.2% he earned in 2005 (Zandvliet 2010).  
     Daniel, who like many Bolivians had lived and worked in Spain, decried the lack of an 
agenda to improve health. In Spain, he noted, “in every corner of the country, they always had 
basic services, 100%... And in our country, we don’t have that. We lack electricity in the 
countryside. We don’t have potable water. We don’t have a place to go the bathroom… We don’t 
have good health care.” However, he does not blame the situation on the current government, 
which he believes is taking steps to improve social conditions. “Thank God, things are getting 
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better with this government… Before, the salary was 650 bolivianos [$94 US] monthly. It wasn’t 
enough for anything. And now at least the wages are a little better. And if you bring up a 
grievance they listen to you. If you did that before, they kicked you out.” 
     Freddy, a 48 year-old construction worker originally from Sucre, contrasts Morales with 
former presidents of Bolivia. “Before, the presidents didn’t care about poor people. They just 
worried about rich people. They were bought by money. There was no help for poor people. 
Now that has changed.” He also describes how this has affected Chagas control. “Now that this 
President has come on the scene, they have sprayed everywhere, they have made this plague of 
Chagas disappear now.” In a similar manner, Norberto, a 58 year-old bus driver born in Potosí, 
affirms “This President is always improving things. Before the Presidents weren’t from here, 
they were from another nation. They took all the money. And the Bolivian people, we don’t 
know them, forget about them. Before, the Spanish came, they took a ton of gold from Potosi.” 
Norberto’s assertion that prior presidents were “from another nation” likely refers to Sanchez de 
Lozada, who presided over extensive neoliberalization of the economy. Educated in the United 
States, he spoke Spanish with a “gringo” accent, and fled to the U.S. in 2005 amidst widespread 
protests and charges of corruption. Morales, who speaks Quechua, is also the first President who 
is truly “Bolivian” for Norberto; prior Presidents were elites who identified more with Europe 
and the United States than with indigenous cultures in Bolivia.  
     Marisol, a 65 year-old homemaker who migrated to Warnes from Cochabamba, also 
characterizes Morales as transformative. In the past, she observes, “Very little money reached the 
countryside, those in government didn’t send it. It was more for the city. But with this President 
we have now, he is more for the countryside than the city.” She added that now there was 
spraying for vinchucas in the countryside, which was unknown before. She identifies Morales as 
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having the interests of rural Bolivians at heart, whereas previous governments were “more for 
the city.” The intensification of efforts to control vinchucas, for Marisol, is evidence that 
Morales champions rural areas, whereas prior presidents had an urban orientation. 
 
Table 7.3: If You Were President of Bolivia, How Would You Eliminate Chagas Disease? 
Idea n % 
Vector control, spray for vinchucas 20 29.4 
Help the poor 11 16.2 
Provide treatment 10 14.7 
Improve housing conditions 9 13.2 
Provide more or better medicine 9 13.2 
More hospitals/doctors 6 8.8 
Health campaigns 5 7.4 
Education 4 5.9 
Other (natural medicine=1, get rid of corrupt 
politicians=1, help people feel tranquilo=1) 
3 4.4 
Don’t know or not answered 6 8.8 
 
     In order to get an idea of what respondents felt the government should do about Chagas 
disease, I asked them how they would eliminate the disease if they were President of Bolivia. 
Table 7.3 shows the results. (Some respondents provided more than one idea, so the percentages 
do not add up to 100). The most commonly proposed idea was to eliminate vinchucas with 
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pesticides. Eleven individuals affirmed they would help the poor, while nine others proposed 
improving housing conditions. Thus twenty individuals recognized and wanted to address social 
causes of Chagas disease. Twenty-five responses focused on the medical infrastructure; ten 
people said they would offer treatment, nine wanted to bring in more or superior medicine, and 
six recommended increasing the number of health centers or physicians. In sum, roughly a third 
of the ideas focused on a biological solution (vector control), another third emphasized a 
biomedical solution (through expanding healthcare), and another third targeted social factors.   
      
      In conclusion, respondents faced multiple barriers to treating their Chagas disease. 
Informational barriers included the idea that Chagas could not be cured, which is often 
perpetuated by doctors, and a lack of awareness of free treatment options. All but one respondent 
were unaware of the free treatment provided by the National Chagas Program. Structural barriers 
comprised the high cost of medication and treatment, as well as secondary expenses such as 
travel and lodging. The narratives of the respondents indicate how difficult it is for adults with 
Chagas to access medical care, despite the intention of the government to provide such treatment.  
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CHAPTER EIGHT 
QUALITATIVE INTERVIEW RESULTS, PART 2: 
CAUSES, SYMPTOMS AND PROGRESSION OF CHAGAS DISEASE  
 
     This chapter contains an analysis of qualitative data related to explanatory models of Chagas 
disease gained through semistructured interviews. A total of 68 interviews took place (the 20 
initial interviews used to help design the consensus analysis questionnaire, and 48 subsequent 
interviews of the consensus analysis participants). The chapter explores participants’ explanatory 
model of Chagas, including perceptions of the etiology, symptoms and progression of the disease 
(Research Objective 1a). These are all major components of the explanatory model of a disease, 
according to Kleinman (1980). In particular participants’ insights on the relationship of structural 
factors to Chagas disease are examined (Research Objective 5b).  
 
The Explanatory Model: Etiology 
     In discussing why they believed they or people they knew had become infected with Chagas, 
interview respondents described various intertwining themes. All 68 respondents identified the 
vector, the vinchuca, as the principal transmitter of Chagas. Moreover, their narratives of 
vinchucas were closely linked to themes of housing conditions, rural poverty, and economic 
underdevelopment in Bolivia’s recent past (Figure 8.1). In analysis of causes of Chagas disease 
in Atlas.ti, I coded 42 quotations where respondents talked about “the past”, 39 quotations 
related to housing conditions, 34 quotations discussing poverty, and 31 instances where 
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respondents discussed vinchucas infesting their homes. Secondary causal themes involved 
heredity (12 quotations), nutrition (4 quotations), vices (2 quotations) and humoral notions about 
the role of hot and cold factors (6 quotations).  
 
 
Figure 8.1: Network View of Qualitative Themes on Causes of Chagas Disease  
 
     I asked respondents two open-ended questions related to causality. First, I asked the 63 
Chagas-positive respondents why they felt they had gotten Chagas disease. Next, I asked all the 
respondents why they felt that there were a lot of people with Chagas disease in their region of 
Bolivia. In response to the first question, the majority of people with Chagas (n=37, 58.7%) 
talked about being bitten by vinchucas as the reason they had the disease (Table 8.1). A 
significant number (n=23, 36.5%) also blamed the fact that they lived in traditional homes of 
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adobe and motacú palm leaves. Of these, 13 only mentioned their homes as the cause of their 
disease, without citing vinchucas. Thus, while they realized that the vinchuca transmitted the 
disease, they blamed their illness directly on the condition of their home rather than the insect 
itself. Sixteen (25.4%) felt they had gotten Chagas because they had lived at least part of their 
lives in the countryside. Other factors such as heredity, nutrition, and stress were less frequently 
mentioned.  
 
Table 8.1 Why Did You Get Chagas Disease?  
Reason n % 
Bit by vinchucas 37 58.7 
Lived in traditional housing 23 36.5 
Lived in the countryside 16 25.4 
Heredity 3   4.8 
Other (nutrition, stress, couldn’t afford pesticides) 3   4.8 
 
          When discussing why Chagas disease was prevalent in the region, a third of the 
participants cited the ubiquity of vinchucas, and another third mentioned the traditional housing 
construction prominent in rural Bolivia (Table 8.2). Eight people blamed the climate, specifying 
that it allowed vinchucas to proliferate. Six people mentioned poverty, and the same number 
discussed living conditions in the countryside. Heredity and lack of pest control were only 
mentioned twice. Taking a different view, “natural” causes: vinchucas, climate and heredity, 
were mentioned a combined 34 times, compared with 38 mentions of “social” causes: housing 
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conditions, poverty, rural living conditions, lack of vector control, cleanliness and vices. This 
demonstrates the high awareness among respondents of the role of social factors in abetting the 
spread of the disease. 
 
Table 8.2: Why is there a lot of Chagas Disease in this part of Bolivia? 
Reason n % 
Lots of vinchucas in the area 24 35.3 
Housing conditions 22 32.4 
The climate 8 11.8 
Poverty 6 8.8 
Living conditions in the countryside 6 8.8 
Lack of pest control 2 2.9 
heredity 2 2.9 
Other (vices, cleanliness) 2 2.9 
 
The Vector: Vinchucas 
     All respondents recognized the vinchuca or kissing bug as the main vector of the disease. 
During the interviews, 42 respondents recalled being bitten by vinchucas. Three claimed they did 
not remember ever having had vinchucas in their homes, suggesting they might have received 
the infection congenitally or through blood transfusion, or were misdiagnosed. Since vinchucas 
are nocturnal and shy away from light, it is also possible they never noticed the vinchucas living 
in their homes, or they may have been bitten at a very young age without having formed a 
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memory of the event. Regardless, all participants knew that the bite of the vinchuca was the 
principal cause of the spread of the disease. There were 115 codings related to vinchucas in the 
interview transcripts in Atlas.ti, making this the most frequently discussed topic.  
     Twelve participants distinguished between different species of vinchucas. They pointed out 
that one species in particular caused Chagas, which they referred to as the “brown”, “red” or 
“blonde” vinchuca.  
They say in that time there was a vinchuca that was a different color. Another color, sort 
of brown, these are the ones with Chagas. It’s not all [vinchucas]. (Matilde, 54, Minero).  
I’ve heard it’s the one that has a little bit of red, you know? Those are the ones that bite 
and spread Chagas. Those are the most venomous. (Lisbét, 54, Warnes).  
There are two, you know? One that is blonde and one that is kind of black. The blonde 
one is the most venomous. (Pancho, 50, Warnes).  
     The quotes show some disagreement about which species of vinchuca causes Chagas. In fact, 
there are multiple vector species in the study area, although one of them (Triatoma infestans) 
accounts for 98% of Chagas infections. Two lesser vectors (Triatoma sordida and Rhodnius 
robustus) have similar coloring but slight differentiations in marking. The key point of emphasis 
is that participants recognized the existence of one particularly dangerous species.  
     Two respondents further elaborated that the “dangerous” vinchuca could be easily 
distinguished by smell. Doris, a micro-business owner in Buena Vista, associates the infectivity 
of a vinchuca with its odor. Her comments about menstruation in the following quotation may 
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stem from the way in which vinchucas tend to leak blood after they have fed, often leaving trails 
that stain walls. 
When it smells bad is when it carries the disease. Yes, I remember, they stank. Some, not 
all. It’s when they are in their menstrual cycle. That’s when they get you sick. That’s 
what my mom said, and other people besides. (Doris, Buena Vista) 
     Mario, a service worker in Buena Vista, also asserts that the dangerous, Chagas-infected 
vinchucas are noted by their smell: “You recognize [the Chagas-carrying vinchuca] by its odor. 
It smells like stinky feet. A strong odor. When it’s killed, it emanates a foul odor.” Rocío, a 63 
year-old Quechua migrant living in Yapacani, connected different species of vinchucas with the 
different varieties of Chagas disease. “Some have Chagas in the intestines. And some in the 
blood, and some in the heart. So it can’t be just one kind of vinchuca, right?” As with the other 
respondents, Rocío sees a natural link between the vinchuca itself and the subsequent severity of 
the disease. 
     Respondents noted that vinchucas have certain qualities that allow them to proliferate rapidly. 
First, they can fly in order to spread from one home to another. “All of the sudden, the vinchuca 
can appear,” notes Edgar, a 53 year-old construction worker from San Carlos. “Because, you see, 
the vinchuca flies.” Juana, who owns a small store in Buena Vista, adds, “The vinchuca flies. It 
goes wherever it wants.” Sara, a 61 year-old homemaker from Warnes observes that the vinchuca 
“…comes flying, you see, like a butterfly. You clean, you spray, but they still come.” 
Respondents also noted that vinchucas can multiply at an alarming rate. “It reproduces very 
rapidly,” says Cristina, the 49 year-old owner of a salon in Santa Cruz. “Like the tick, right? 
From just one, millions appear. And that’s how the vinchuca is too.”  
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     In addition, three respondents recognized the role of reservoir species, including rodents and 
poultry. Said one respondent, “I know that mice have Chagas. Even rats. The vinchuca bites the 
rat and then the rat walks on some type of, you know, food. It was on television.” Again, this 
idea coincides well with the biomedical model, where certain mammal and bird species can act 
as reservoirs for Chagas disease (see Chapter 4).  
     The vinchuca itself emerges as a fast-reproducing insect that relentlessly pursues its human 
hosts, especially once darkness falls. Participants describe finding vinchucas full of blood under 
mattresses and pillows, or slowly climbing back up the walls to hide in palm-leaf roofs. Doris 
recalls sleeping as a child in a vinchuca-infested home: 
In my house there were many, many vinchucas… You turned off the light, at eleven 
o’clock where you slept, and the vinchucas came down like ants. And when we checked 
we were already covered with vinchucas and bites. I have three brothers with Chagas. 
The other one died. (Doris, 60, Buena Vista) 
Thus, she readily correlates the swarming nocturnal attacks of the vinchucas, streaming down the 
walls like ants, to the high incidence of Chagas in her family.  
     Iris remembers her mother waking at night to kill the vinchucas that were biting her and her 
siblings. In the morning, the walls would be stained with blood.  
And she said those were vinchucas, that’s all, that drink blood. And I heard her say that 
they carry Chagas. And later my mom became sick with that disease, her heart became 
ill… Twice they had to put in a pacemaker. (Iris, 39, Carmen Surutú).  
170 
 
     Iris made an immediate link between the gravity of the vinchuca infestation in her childhood 
home, and the severity of her mother’s subsequent heart disease. 
     Eight participants blamed the presence of vinchucas on climate or geography. People born in 
Santa Cruz department who considered themselves ethnically camba felt that there were many 
vinchucas in the area because of its hot climate. Santa Cruz “is very hot,” said one respondent, 
“and it’s easier for the vinchucas to live here. Because there are a lot of vinchucas.” (Griselda, 
Yapacani) Another asserted that “Santa Cruz is where you hear the most about Chagas. Why? 
Because of the climate.” Vinchucas “proliferate a lot due to the climate” in Santa Cruz. (Wanda, 
Warnes).  
     In contrast, migrants from western Bolivia associated vinchucas more with their native 
departments. Norberto from Queranda, who grew up in Potosi, felt there was “little” Chagas in 
Santa Cruz. Rather, “In Potosi, Sucre, Oruro, there in the countryside is Chagas… There are 
always poor people there. That vinchuca—there are a lot of them there.” He thus links Chagas 
with the pervasiveness of poverty in the rural areas of western Bolivia, by noting “there are 
always poor people there.” 
    Daniel, an agricultural worker originally from Sucre, linked his Chagas-positive status with his 
geographic origin: 
“Those of us who are most affected are from the West… I am sure I have this disease, 
because I come from that area where there were a lot of vinchucas. So I cannot say, ‘I 
don’t have [Chagas]’, because I lived among the insects, so I have to accept it.” (Daniel, 
39, Yapacani) 
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     Thus, he feels his diagnosis of Chagas is inevitable given that he grew up in an endemic area. 
The next section demonstrates that some respondents locate vinchucas not just spatially, but 
temporally and socially as well. 
 
The Spatial, Temporal, and Structural Origins of Chagas Disease 
     During the interviews, respondents linked vinchucas with specific moments and places in 
time. Twenty seven people spoke of vinchucas as part of their personal history, not their present 
reality. In addition, 18 respondents reported that there were far fewer vinchucas than in the past, 
which corresponds with the data reported by the National Chagas Program (see chapter 6). Six 
respondents continued to live in traditional housing that was susceptible to infestation. Thirty-
seven others reported that they had lived in traditional housing at some point in the past, but no 
longer did. Although these respondents no longer lived in a world where vinchucas crawled out 
of walls and roofs to feed on their blood in the evenings, Chagas disease served as an ever-
present reminder of childhoods marked by rural poverty, whether in Santa Cruz or other 
departments of Bolivia.  
     In participants’ narratives, vinchucas are discussed in three ways; spatially, temporally, and 
economically. Spatially, vinchucas are a consequence of living in el campo, the countryside, 
where poverty necessitates traditional housing that often allows these insects to thrive. 
Vinchucas are also part of the past (más antes), a time marked by inadequate vector control and 
very limited access to “modern” housing. Respondents recall childhoods spent in the 
countryside, in a time before vector eradication programs existed. Thus, vinchucas are a part of 
their personal past, but also of a greater sociohistorical past when vinchucas thrived. Finally, 
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participants who could still not afford homes of modern materials and regular pesticide 
applications continue to experience vinchucas as part of daily existence. Respondents readily 
link vinchucas to structural processes which affect the way their homes are constructed.  
     The traditional housing that predominates in rural Bolivia has been well documented as a risk 
factor for vinchuca infestation (Campbell-Lendrum et al. 2007, Saunders 2009), and respondents 
were acutely aware of this based on personal experience. Thirty-seven respondents mentioned 
they had lived in a traditional type of housing earlier in life and subsequently moved into a home 
of modern material. Six continued to live in traditionally constructed homes.  
     In the study area, particularly in Palacios and other nearby rural communities like El Pilar or 
Carmen Surutú, traditional homes with mud or adobe walls and thatched palm-leaf roofs, made 
from the motacú palm (Attalea phalerata), were still quite common, as they once were throughout 
the region. Of the ethnically camba respondents, 70% mentioned they either lived in this type of 
home currently or had at some time in the past. Five described homes made completely of palm 
leaves. One respondent who came from the drier, Chaco region of southern Santa Cruz described 
a house made of sticks or cane plastered with mud. Two Quechua migrants from western Bolivia 
mentioned homes of adobe, while one had lived in a house made of stones. In every case, these 
traditionally constructed homes were favored by vinchucas. In contrast, respondents noted that 
modern housing with tile roofs, cement floors and plastered walls repelled vinchucas.  
     I asked Leticia from El Pilar if she still found vinchucas in her home. She replied “Yes, 
because the roof is motacú (palm leaves). And the vinchuca runs to motacú.” Vinchucas are not 
found in houses with “tile roofs, more comforts and plastered walls of modern material. On the 
other hand, our house has walls of mud with cracks. And the bugs put their eggs there.” Leticia 
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recognizes that her home puts her family at risk for vinchuca bites, but the cost of a home with 
plastered walls and a tile roof is out of reach. Consequently, she is relegated through economic 
processes to the domain of vinchucas. Many of her neighbors are in the same predicament; in a 
walk-through of El Pilar, I found eight of eleven homes had motacú roofs, while seven had walls 
of adobe. In Palacios, roofs of motacú are also still common.  
     Thirty-seven respondents associate the traditional forms of housing that vinchucas prefer with 
the past. “Before, many years ago, the houses were of mud,” said Hugo, a school teacher from 
Portachuelo. “And the houses would have cracks, and the vinchucas would get in them.” A 
career as a public servant had long since enabled Hugo to move to a sizable town and construct a 
home with plastered walls. For Hugo, vinchucas are part of the past, and no longer figure into his 
present.  
     These respondents described at-risk housing and vinchuca infestation as part of their personal 
historical experience, a memory from childhood.   
Well, I remember when I was a girl, my house was of motacú [palm leaves], with 
walls of mud, and the walls would crack, and in the cracks there would be great 
quantities of vinchucas. (Jacinta, 61, Palacios)  
Where I lived, as a girl, there were a lot of vinchucas. My house was of mud, with 
a motacú roof, and there were a lot of vinchucas. And they used to bite us. 
(Porfiria, 54, Palacios) 
     Norberto, a bus driver who had migrated from Potosi in western Bolivia, described 
“huinchucas” from his childhood. (A Quechua speaker, his pronunciation reflects the original 
Quechua word for the vector.) The vector infested their home because it was not of modern 
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material, but “pure stone. So, in the holes the huinchucas multiplied like cockroaches… On the 
floor we slept, so it pursued us. When we were poor, we didn’t even have a mattress.” For 
Norberto, living with vinchucas is a part of his past, in a traditional home made of stones. 
However, he also points out how his family’s poverty makes them susceptible to vinchuca bites, 
by forcing them to sleep on the floor.  
     Lidia, the 48 year-old wife of a taxi driver, talks of the poverty she experienced as a child. 
“They have told me [Chagas] is from the bite of a bug. There were a lot of them in the 
countryside. You know, my folks always had a house of motacú. We were really poor. So that 
was the reason, when I was little. That’s why [I have Chagas]. After years, it makes itself 
known.” Lidia’s comment unites the themes of rural poverty, the past and the countryside; all 
three represent the source of her Chagas disease.  
     Traditional homes and vinchucas are situated not only in “the past”, but in a particular space – 
the country, as the following quotes illustrate.  
Always in the country the majority of the houses are motacú [palm-leaf thatch]… 
The palm fronds are cut and left to dry, and that’s when the vinchucas get in them. 
(Ricardo, 71, Buena Vista) 
I lived in the countryside. The houses were of mud with leaves of motacú. As kids 
we would see vinchucas on the wall, full of blood. (Rosa, 63, Buena Vista) 
When I was a girl, I remember the house where I lived with my parents was, as they say, 
rustic. The walls were mud. There were always cracks, and the vinchucas gathered 
there… there would be vinchucas full of blood under the mattress and all that. That’s 
where we got infected. (Wanda, 46, Warnes) 
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     These quotes describe the main routes by which vinchucas infest homes in the countryside of 
Santa Cruz. First, when the motacú palm fronds are laid out to dry, vinchucas hide in them and 
thus gain entry into people’s homes. Many respondents describe vinchucas “descending from the 
roof” at night. Some wild vectors, like Rhodnius robustus, already live in motacú palms, so they 
might easily come to colonize homes during the construction of roofs from the fronds. Second, 
cracks in mud or adobe walls provide refuges where vinchucas lay their eggs and hide during the 
light of day. At night, they emerge to drink the sleeping inhabitants’ blood, then crawl back into 
the crevices in the walls or the spaces between the palm leaves in the thatched roofs. 
     Respondents clearly articulate the relationship between rural poverty, housing and Chagas 
disease. When I asked Carmen from Warnes why she felt many people in the area had Chagas, 
she replied, “Due to poverty, many times. Because there is not enough money for us to build a 
house of modern material.” Iris answered “because there are a lot of people with few resources, 
and their houses are not of modern material. The majority are just sticks and mud, at least in the 
country.” Added Alejandro, a 54 year-old driver from Minero, “It’s due to the poverty that we 
undergo in the countryside. That’s why. Because few of us have houses of modern material, 
there are just adobe houses with holes [in the walls]. That is where those creatures live, and that 
is why we are all sick with Chagas.”  
     Furthermore, those living in traditional housing have limited possibilities of improving their 
homes. According to Irene, a 49 year-old from Palacios dealing with symptoms of advanced 
Chagas, “Right now the situation doesn’t allow you to build a home of modern material, so you 
have to find whatever is cheaper. That is what causes the problem of Chagas.” Alma shares a 
similar view on housing. “That’s what causes the problem of the vinchuca. Sometimes, your 
wages don’t even give you enough to buy 2,000 bricks so you can build your house, no? The 
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wages aren’t enough, you can barely get by each day. There’s no way to save money.” Rural 
Bolivians are therefore trapped in a cycle of poverty that continues to put them at risk for 
vinchuca infestation. 
        Iris, 39, who lives in the remote rural community of Carmen Surutú, discusses how poverty 
prevents rural Bolivians from making the necessary improvements in their homes to combat 
vinchucas.  
In a house of motacú, that bug enters all the time… It would be a nice dream to help 
those people, or that they could get loans to improve their homes. But how would they 
pay? All they can do is gather rice and yuca (cassava) to sell, working in the country. 
And to export it, to get it to market in Montero or Yapacani, is not cheap. 
     As Iris describes, the residents of her community are unable to make enough profit from 
farming to improve their homes. Much of what they earn goes to transportation to take crops 
across a river (with no bridge) and into distant market towns. Thus, they continue to live in 
houses of adobe and motacú, where vinchucas thrive. In other words, the way they are situated in 
the regional economy continues to put them at risk for vinchuca infestation and thus Chagas 
disease.  
     In many cases, it is not only the lack of resources that causes people to live in high-risk 
housing, but their actual position in the economy. “It’s because we sleep wherever, I think,” says 
Josefina. “There are a lot of people who go to work in the countryside, and they stay there to 
sleep. Because that’s what happened to us. Because the three elder siblings have Chagas. 
Because we were in the countryside more often.” Similarly, Elisa, a 44 year-old homemaker 
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from Warnes, links the subordination of the rural poor to the risk of vinchuca bites, based on her 
childhood experience. 
Most people work in the countryside and live in the countryside. When you are a worker, 
the owners make you little houses of mud, and that’s where the most vinchucas 
accumulate. They are not houses of modern material, it’s always mud. The vinchucas 
always accumulate there. When I lived in the countryside that’s how it was. It was a roof 
of motacú, walls of mud, not painted or anything, just mud. I woke up and felt that they 
were biting me. There was no light, electricity there. It was candles and flashlights to see 
in the dark. I looked in the bed, and there were vinchucas… And the owners, they didn’t 
care.  
     Elisa feels her Chagas originated in the hacienda where her family worked during her 
childhood. The housing provided by the owners put poor rural workers at high risk of vinchuca 
bites, and they became ill with Chagas. This is the same process described by Briceño-León 
(2009) in his discussion of historical processes that gave rise to endemic Chagas disease. 
 
Other Causes of Chagas Disease 
     Respondents report other factors that might attract vinchucas to homes, increasing the chances 
of an infestation. Two people mentioned vinchucas were attracted to livestock and poultry. 
Numa, 55, a homemaker from Warnes, observes that vinchucas are attracted to “animals, birds. 
That sleep close to the home. The vinchucas come after them.” This is consistent with public 
health messages about the disease; vinchucas are known to infest chicken coops, corrals and 
other peridomestic structures, feeding on blood from livestock and poultry.  
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     Four people affirm that vinchucas are attracted to electrical light. “I have noticed they come 
to the house with a lot of other bugs due to the lightbulb,” says Lisbét from Warnes. According 
to Zaida, 48, wife of an agricultural laborer in Palacios, “The vinchuca comes from the forest, 
right? And using light, it comes and goes flying. Due to the light. Because in my house, when the 
light is turned on, there are a lot of bugs of every kind. Due to the light. Especially electric light.” 
Eduardo from Yapacaní notes, “[t]hey spray, but it’s just the house. Well of course, what point in 
spraying if those things fly? At night, they fly around. And they come after the light.” The 
vinchuca is able to navigate from one home to another, or to emerge from the woods to find 
human habitations, using electric lights as beacons.  
     Certain plants can also attract vinchucas. Yeni, a 64 year-old homemaker from Warnes, 
considers the urucú, a common fruit tree in the region, as a potential attractor. “They say you 
shouldn’t have urucú trees near the home. They say from the urucú comes the vinchuca. I heard 
this from my parents and grandparents.” Daniel, originally from Sucre, mentions another plant 
found in the drier region known as the “Chaco” south of the study area: “… it is called kallara, 
almost like pineapple. There are always, I mean a lot [of vinchucas]… If you stay the night and 
light a fire, it’s amazing how these insects come out of the brush. They come. Life is really hard 
there.” My father-in-law, who grew up in this area, also states that vinchucas live in kallara 
plants. 
      While vinchucas are the predominant cause of Chagas discussed in the interviews, four 
respondents felt Chagas was hereditary or could be passed from parents to children. “If there is a 
vinchuca that has the disease it infects the person it bites, right?” said Santiago, a driver from 
Yapacani. “When this person becomes sick, the children get it through inheritance.” Alejandro 
from Minero thought his children “must have Chagas, because I think it passes through the 
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blood.” Elsa, 34, a micro-business owner from Buena Vista, thought “Maybe my father gave me 
Chagas, by inheritance.” Inheritance is perceived as a viable route of transmission because 
Chagas is a disease of the blood, and parents pass their blood to the children. This is a fairly 
close approximation of congenital transmission, except that a few respondents also felt fathers 
could pass the disease to their children. 
     Stress can also play a role in increasing susceptibility to Chagas disease. According to Blanca 
from Warnes, she became sick due to difficulties in her marriage: “… when they found out I had 
Chagas, I had my husband. [Now] I am a widow. I had my husband, he was a womanizer. 
Sometimes I think that’s why I got Chagas and diabetes.” While she recognizes that vinchucas 
transmit the disease, she still ties her initial diagnosis to personal difficulties that were 
simultaneously occurring in her life.  
     Although heat or cold were not commonly mentioned as causal factors, Bolivians often 
employ a humoral interpretation of sickness (Bastien 1985), and this occasionally became 
evident in descriptions of Chagas disease. For instance, one person explained that vinchucas are 
attracted to motacú “because it is hot, and they like that” (José, 82, Palacios). Another observed 
that Chagas is common in Santa Cruz “because it is hot and cold. Due to the climate” (Natalia, 
29, San Ignacio). For many Bolivians, fluctuations or extremes in temperature are often causes of 
increased susceptibility or worsening of symptoms.  
     Finally, some respondents named other fauna as vectors of Chagas. Pura, a 67 year-old 
homemaker from Palacios with advanced Chagas, describes an invasive species of lizard: 
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It comes from Brazil, in boxes and merchandise… It brings disease. It’s another kind of 
creature that wasn’t here before. Possibly it spreads other diseases that scientists do not even 
know about yet. I’m afraid of this creature. I don’t want it to bite me, or I’ll get its disease.  
     Pura’s comments hint at an intrinsic suspicion of globalization and development. In her 
lifetime, the Bolivian economy opened to virtually unregulated trade, Brazilian goods flooded in, 
and disease-spreading lizards proliferated along with the imported merchandise. On a more basic 
level, the lizard is seen as an intrusive pest, and for many Bolivians this naturally links it with the 
spread of disease. Pura mentally links negative concepts – economic change that victimizes 
Bolivia, the spread of a non-native pest, and Chagas disease.  
     In a similar example, Yeni from Minero associated another blood-sucking insect with Chagas. 
“Before there were some bugs called chinches [chiggers]. They were bugs like vinchucas, but 
red. They also drank blood… But it was much smaller.” I asked her if it transmitted Chagas as 
well. “It spreads Chagas,” she affirmed. “All those kinds of diseases.” Jacinta from Palacios 
reported hearing that rats and cockroaches carried Chagas, but she was not sure if it was true. 
The common thread in these examples is that some respondents understandably associated the 
vinchuca with other types of unwanted pests, and it was then only a small step further to 
associate the vinchuca’s most undesirable quality – spreading Chagas – with these animals as 
well. Again, negative concepts are grouped together.  
    In sum, while the main route of transmission described by interview respondents with Chagas 
may not precisely follow the biomedical model, the differences are minor. Bolivians are aware 
that the vinchuca spreads Chagas, are familiar with the possibility of reservoir species, and 
recognize the possibility of mother-child transmission, which they view as hereditary more than 
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congenital. More central to the research question in this study, respondents readily describe a 
social model of the Chagas causation, in which rural residence, poverty, and housing 
construction directly contribute to infection by vinchucas. The domain of the vinchucas is at 
once spatial (it is most prevalent in the countryside, or in certain regions of Bolivia), temporal 
(there were many more vinchucas in the past), and structural (those who cannot afford the right 
type of housing are still at risk of vinchuca infestation).  
 
Symptoms 
     Respondents characterize Chagas as a fatal disease with a wide range of symptoms. Every 
participant mentioned the impact of Chagas disease on the heart, while thirteen also spoke of the 
gastrointestinal version, and five described its effects on the blood. While three respondents 
expressed that Chagas disease could be asymptomatic, this did not frequently come up in the 
interview narratives. Figure 8.2 is a visual representation produced in Atlas.ti of  the symptoms 
domain, showing the relationships between different primary themes that were coded in the 
interview texts.  
     Five respondents emphasize the role of the blood in allowing the pathogen to circulate 
through the body. They often describe Chagas as a “virus” in the blood. Alejandro, a 54 year-old 
truck driver from Minero, affirms that after the initial infection via the vinchuca, “[t]he blood is 
contaminated with a virus that attacks the heart.” Leticia from El Pilar, describes Chagas as “a 
disease that is in the blood, in the whole body let’s say. It’s an infection from the bite of that bug 
that spreads through the body…” Porfiria, the wife of an agricultural laborer from Palacios, 
characterizes Chagas as “a virus that sometimes goes to the intestines, sometimes to the heart.” 
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Magaly, a landowner, affirmed “the vinchuca causes [Chagas]. It creates problems in the heart, 
and in others it affects the blood, in others the intestines.” 
 
 
Figure 8.2: Network View of Qualitative Themes on Symptoms of Chagas Disease 
 
     In this regard, the respondents’ explanatory model closely approximates the biomedical 
model (see Chapter 4), in that they recognize the disease as microorganisms circulating in the 
blood. In turn, Chagas also affects the circulation of the blood: “Chagas… is basically from the 
bite of the vinchuca. From there the blood goes to the heart. And in that way the blood stops 
circulating well” (Josefina, Minero). Norberto, a Quechua migrant, describes the blood becoming 
“thick” due to Chagas: “It seems that the blood doesn’t circulate well. It becomes thick.” 
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Moreover, “when it is thick, the pipes become clogged.” The image is of blood that can no 
longer circulate freely through the body. 
     Thirteen participants spoke of both the cardiac and gastrointestinal versions of the disease: 
There are two kinds of Chagas. Sometimes it goes to the heart, sometimes to the intestines, 
especially the colon. (Wanda, 46, Warnes) 
It’s a disease in the blood, you know? That’s it. I realize that it attacks the heart, but not me. 
With me it’s the intestines. (Hugo, 62, Portachuelo)  
They say there are two kinds of Chagas, one that attacks the intestines, and another that 
attacks the heart. But I think both are scary. They are deadly, because in the end, the one that 
goes to the heart, once it gets there, it’s all over. And the one that goes to the intestines, and 
dries out I believe the intestines, and also it’s all over. (Pancho, 50, Minero)  
     Thus, they are aware that Chagas disease can have repercussions either in the heart of the 
intestines and, as Pancho’s quote indicates, is ultimately fatal. Even if respondents did not have 
symptoms themselves, they often spoke of family members with either intestinal or heart 
conditions due to the disease. Of the respondents who complained of symptoms, most were 
heart-related, with only a few describing gastrointestinal symptoms. However, while conducting 
participant observation and providing Chagas education at the clinic, I often heard patients 
express anxiety that Chagas disease might be responsible for episodes of constipation. When 
questioned, they did not usually have the severe, prolonged constipation associated with 
intestinal Chagas disease, although one person did report undergoing surgery on the intestines. 
Among those with cardiac symptoms, one person had a pacemaker, and at least four had 
irregular EKG’s during the study period.  
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     Some of the most common symptoms that respondents attribute to their Chagas disease are 
chest pain, fatigue, swelling, difficulty breathing, high blood pressure, dizziness, and pain in the 
legs, arms or back (Table 8.3). Fatiga, a term for an irregular or accelerated heartbeat which 
produces a debilitating effect, is also mentioned frequently. The bulk of the symptoms mentioned 
in the interviews related to the cardiac version of Chagas disease, whereas only four 
(constipation, swollen belly, upset stomach and diarrhea) were gastrointestinal. Also, the seven 
most frequently mentioned symptoms all related to heart conditions, whereas constipation, the 
most commonly discussed gastrointestinal symptom, appears ninth on the list.  
The following quotes describe the experiences of people with advanced Chagas disease.  
Sometimes I feel bad. There are times when I’m in pain. Just that, that pain in the heart. 
There are times when my heart gets fatigued. And sometimes my pressure goes up. 
Sometimes when I’m walking I fall, several times I’ve fallen. I get dizzy. (Yeni, 64, 
Minero) 
I felt like tired, I felt tired. And also my arm couldn’t move. My arm, heart and [being] 
tired. I couldn’t breathe deeply. (Irene, 49, Palacios) 
I had pains. Above all, I couldn’t walk. I walked one or two blocks, and I started to feel 
discomfort. I had to sit down. Wherever it was, I had to sit down, so that I wouldn’t fall. 
(Pura, 67, Palacios) 
He was very tired, and he couldn’t walk, not even half a block. He was very tired. And he 
would start to sweat and sweat. And he turned pale… And then, all of a sudden he had a 
heart attack. And he died, he passed away. (Cristina, 49, Santa Cruz) 
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Table 8.3: Symptoms Mentioned in the Interviews 
Symptom n 
chest pain 21 
tiredness 19 
swelling of the hands, feet, legs, face, or neck 17 
fatiga 14 
difficulty breathing 14 
high blood pressure 11 
pain in the arms, legs or back 9 
dizziness 9 
constipation 8 
headache 8 
heart enlargement 7 
cough 7 
loss of sensation 4 
fainting 4 
vomiting 4 
upset stomach 4 
swollen belly 3 
poor circulation 3 
sadness 3 
others (diarrhea =2, heart failure=2, palpitations =2, fever=1, 
stroke=1, irregular heartbeat=1) 
9 
186 
 
      The common denominator in these examples is the extreme tiredness that ensues once the 
circulatory system is affected. The sufferer is impacted in a way that makes it difficult to 
continue their daily lives; they lack energy, have pain, or are unable to walk. And ultimately, the 
disease is fatal after the onset of chronic symptoms.  
     One of the most frequently mentioned symptoms, described in fourteen interviews, is fatiga. 
This did not mean “fatigue” in the sense of tiredness. When I asked what fatiga meant, I was told 
it refers to when the heart races or beats irregularly, often causing shortness of breath. Fatiga 
debilitates the sufferer, preventing them from going about daily activities.  
     Hortensia, 54, the wife of an agricultural laborer, uses fatiga when talking about the impact of 
Chagas disease on her body. “My body hurts, sometimes I feel fatiga.” She goes on to state, “I 
walk a little and [sigh] I’m tired.” Thus, fatiga is symptomatic of the weakening of her body; she 
becomes short of breath after only walking a little. Another respondent talks about feeling fatiga 
after walking. “I get like a fatiga. Shortness of breath. Sometimes a headache as well.” Still 
another person mentions suffering from “tiredness and fatiga. Late at night, I cannot shut the 
window. There must always be air flowing through my window. If not, I get up, short of breath.” 
For these individuals, fatiga implies pain and difficulty breathing, and prevents otherwise routine 
activities such as sleeping or walking.  
     For another respondent, fatiga creates extreme weariness by preventing sleep. She notes that 
it centers on her chest. 
I felt tired. I couldn’t sleep; I had to use a high pillow. I couldn’t sleep at night, I had a lot 
of fatiga. I was tired, I was tired, I was tired, even just to walk. And I went to Santa Cruz, 
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and my nephew said ‘What’s the matter?’ I have Chagas, I can’t go on, I have a lot of 
fatiga. And fatiga in my chest. (Jacinta, 61, Arboleda) 
     Fatiga, in this example, is much graver than mere tiredness or shortness of breath; it is a state 
of being unable to function. Anita describes “a complete decline of the body. There are days 
when I stay the whole time in bed without getting up. I have no energy.” Anita’s narrative brings 
to light that the physical impact of Chagas on the body prevents the most basic functioning of the 
individual, who stays in bed all day.  
     It is important to emphasize that Chagas takes an emotional as well as a physical toll on its 
victims. For instance, according to Mario from Buena Vista, “…my heart hurts, my stomach 
burns. And I get a feeling like I want to cry. I don’t know why it comes, this feeling of wanting 
to cry. I say I want to cry, but a man is macho and shouldn’t cry [laughs]”. For Mario, the feeling 
of needing to cry is experienced as another symptom of the disease.  
     Daniel describes a similar event where emotional and physical symptoms simultaneously 
occur: 
Five or six years ago, I felt like a tiredness, an uncertainty, a sighing [he takes a deep 
breath]… I wanted to scream or something. It feels like a great fright [susto]… 
Sometimes I get a tiredness or something like that. 
     Again, this exemplifies a state, like fatiga, where the body as well as the emotions are worn 
down.  
     Fourteen respondents affirm that to worry or become stressed is one of the main ways to 
aggravate the disease. Describing an acquaintance with Chagas, Consuelo from Palacios 
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observes, “When she gets upset, she becomes short of breath, she can’t breathe. And once, her 
whole face swelled up. That’s how it is when you are sick with [Chagas].”  
     Marta, a 39 year-old Chagas-positive homemaker, cares for a bed-ridden mother as well as an 
uncle, both with debilitating cardiac symptoms from Chagas disease. “I feel pain,” she states, 
“but maybe it’s due to the stress, the worry that I have. My feet swell. Sometimes I can’t walk.” 
Nilda, a market vendor from Yapacaní, notes her Chagas symptoms become worse when she 
“has a lot of stress tending people in the market.” She feels pain in her back and chest, and her 
feet become swollen. Nilda, age 55, works in a demanding role preparing and selling food in the 
busy Yapacani market; her husband is no longer able to work due to debilitating pain from an 
accident. She became saddened and wept as she described her struggle.   
     Often, a stressful life event can trigger the symptoms of the disease. Elisa and her husband in 
Warnes both have Chagas disease. She discusses an instance where stress made her husband’s 
symptoms much worse. “It attacks his heart a lot. His chest hurts. And he gets like these 
attacks… It seems that when he’s worried, this kind of thing happens. When my grandson got 
lost, he almost fainted. He had an attack. And then we found out he had Chagas.” Leticia, who 
incidentally had an abnormal EKG, describes feeling “as if an electrical current passed through 
this side of my heart. And then it’s gone. This always happens… sometimes when I’m worried, 
thoughts I have and all that.” In a similar vein, Blanca, a Chagas-positive diabetic from Warnes, 
describes the impact of stress on her diabetes.      
Sometimes my sugar increases. It’s not because I don’t take care of myself. Sometimes 
it’s due to a worry that I have. Sometimes it’s not because of food. Sometimes it’s a 
worry that you have. (Blanca, 62, Warnes) 
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     Aside from stress, other factors can also aggravate the effects of Chagas disease, according to 
the interview narratives. Foremost among these are nutrition, imbalances in hot and cold, and 
“vices.” Alma feels that “…for Chagas to become more serious, I think poor nutrition 
[contributes] also. Because if you take care of yourself, the disease does not get worse.” Says 
Norberto, “You have to eat well. For lack of nutrition, people get sick like this.” Pura associates 
lack of nutrition with the demands of rural life: 
With Chagas, I think a lot of it is weakness, eating well. Eating vegetables. Because in 
the countryside, they eat little, but those who have a freezer, a refrigerator, can keep fruit. 
Their vegetables. And drink milk, and eat eggs. Take care of themselves a little better, to 
be healthy. Because the people who work in the fields, they eat whatever, so there is 
weakness. The work. Disease comes when there is more weakness. (Pura, 67, Palacios) 
     In Pura’s narrative, weakness and poor nutrition do not simply stem from behavior choices, 
but are consequences of poverty. On the one hand, the rural poor can often not afford 
refrigerators or freezers, and on the other, the necessities of work make it difficult for them to eat 
well. This brings about “weakness” which makes them more susceptible to Chagas and other 
diseases.  
      Pura also contrasts the poor nutrition in the countryside today with healthier diet she 
observed in her childhood.  
Before people ate corn, a lot. Yuca and plantains have vitamins. And fruit has vitamins. 
They satisfy you. And now people just eat rice. It’s cheaper. Because now, nobody plants 
their own crops. In all these lands, when I was a girl, there was rice, plantains, yuca, 
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banana, everything… You didn’t buy anything but salt. You had it all, meat. Not now, 
everything is bought. And so everything is with disease if that’s all you eat. 
     Thus, the transition to packaged foods replaced the healthier, more balanced diet of years 
past, increasing the presence of disease.  
     According to four participants, personal predilection for “vices” such as drugs and alcohol 
can increase one’s susceptibility to Chagas disease. “There are a lot of vices,” Pura affirms. A lot 
of vices… It’s the men, when they go out hunting, they pick up these vices. Alcohol. Coca. 
Cigarettes. And now it’s drugs, marijuana among them. And then, they don’t eat well. So the 
body does not function, and they end up getting some disease.” Constanza from Warnes relates, 
“…the thing is that people drink, you know? That makes it worse. Drinking, you see? And now 
that they are chewing coca, that too.” Iris from Carmen Surutú, affirms “when they have Chagas, 
and they drink a lot of beer, they die, I’ve heard. They get a heart attack.” Jorge, a 42 year-old 
teacher from Portachuelo, opines that “It is bad for you not to drink too much. I asked a doctor, 
and if you have Chagas, it becomes worse.” When someone with Chagas drinks alcohol, “The 
chest [heart] can’t bear it, it starts palpitating, and it feels like there’s no air.” Thus, drugs or 
alcohol can activate or worsen the heart-related symptoms of Chagas disease. 
     Others feel that variations in hot and cold impact their Chagas symptoms. Amelia from 
Palacios suffers from “Poor blood circulation, and I can’t be in the sun. My head hurts a lot when 
I am in the sun. This part of my face, my eyes, all that hurts when I am in the sun or heat. And 
well, the doctors tell me this is because of Chagas…” Raquel from Warnes experiences 
sensitivity to heat: “Usually when the sun is hot, it affects me.” Josefina, who used to work 
baking and selling bread, speaks of getting “fatiga from the heat. Worse if the sun is out. I 
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wanted to faint from the heat. I had to quit [baking], because it seems my vision was being 
damaged.” In contrast, Jacinta’s symptoms worsen with cold. “Sometimes I can’t even wash my 
clothing. I wash and it makes me – when I touch the water, my nerves become hardened. My feet 
too. I can’t handle cold water, nor do I drink it. Nor do I bathe in cold water, I can’t.” The 
common theme for these Chagas-positive women is that any fluctuation from normal 
temperature touched off their inherent Chagas symptoms.  
 
Progression: Chagas as a Fatal Disease 
     Twenty-five respondents (37%) specifically characterize Chagas disease as ultimately life 
threatening. In some cases, death might come after prolonged suffering, while in others it is 
quick and unexpected. This knowledge, in turn, adds to the impact of the disease. Even people 
who do not otherwise experience symptoms must live with the fear that the disease could claim 
their life at any moment.  
     In some cases, death occurs as the culmination of a process where the functioning of the body 
collapses. For instance, two respondents describe death after swelling of the body. In the first 
example, Alma also compares Chagas to diabetes, emphasizing the idea of a gradual and 
inevitable death. 
I have always heard that Chagas attacks the chest, the heart. It gives you fatiga. After 
that, [the victims] swell up. And eventually they swell up and die, you see? It’s the worst 
disease, like that other one about sugar… (Alma, 55, Minero) 
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Shoot, that disease is, well, serious. Well, once that bug sticks you, the face gets all 
swollen, the feet. So, if it goes on, all you can do is lay down in the cemetery. (Rocio, 58, 
Yapacani) 
      Eight respondents characterize death from Chagas as sudden, unexpected, and often 
painless. “It’s a fatal disease,” says Rosa, an artisan from Buena Vista, “because I have seen 
people just drop dead.” Walter, 56, an agricultural laborer from Yapacaní, reports seeing “several 
people who have died of Chagas, just while walking or working sometimes, they have dropped 
dead.” “I am afraid of this disease,” says Maite, a housewife from Warnes. “Because a friend 
died of Chagas, she was fine one moment and then she fell. She got a heart attack and that was 
it.” In these examples, Chagas is not a long, drawn-out process, but a sudden, unexpected attack 
on an apparently healthy person. 
     Two people tell of otherwise healthy men suddenly dying while playing soccer.  
A friend that I knew died, or two [friends] that I knew died playing soccer… They died 
playing sports… So you can say that Chagas attacks and kills at an unexpected time. 
(Santiago, 53, Yapacani) 
They said that there was a young man playing soccer who died. Playing in the field, with 
the ball, and he died right on the playing field. And the doctors said he had Chagas. 
(Amelia, 55, Palacios) 
     In other words, Chagas is a disease that can strike someone down even in the pinnacle of their 
health. This is exemplified in the stories because at the moment the person dies, they are playing 
soccer, Bolivia’s favorite sport, and one that requires considerable stamina. If Chagas can kill a 
healthy athlete on the field, then it can take a life at any moment, even when least expected.  
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     However, two respondents consider the unexpected death to be a “good” death, as opposed to 
the previous examples where the victim suffers swelling and gradual, painful decline. Walter 
jokes that he is not worried, “because they say you don’t have a lot of pain with Chagas. It just 
kills you, they say.” Marta, a housewife from Buena Vista, tells the story of a young woman she 
met in the hospital: 
‘I have Chagas, too, Señora,’ she told me. She was 26, young. ‘The good thing is I’m 
single, I don’t have kids. You know what?’ she told me. ‘It’s nice to have Chagas 
because you die sitting or lying down. My mother and father died of Chagas. My mother, 
6 months ago and my father, 3 years ago. And my aunt died of Chagas,’ she said. ‘And I 
am going to die of Chagas. And it’s nice, because my mother died sitting down. She was 
watching TV and boom! She died.’ 
     In the story, the young woman takes the tragedy of losing her parents and her aunt to the 
disease, and stands it on its head using humor. There is a sense of resignation to an inevitable 
death, but at least it is a “nice” death, preferable to one of prolonged suffering.  
     Yet humor can be a mask that hides the emotional toll of the disease and the inherent 
possibility of death. I asked respondents how they felt when they were diagnosed with the 
disease. Twenty replied that they felt frightened, worried or emotionally devastated. “I felt bad,” 
said Jacinta, “it affected me a lot to know I had that disease. I didn’t eat, I didn’t sleep. I felt bad, 
thinking that I was going to die.” When Betty from Warnes found out she had Chagas, she cried 
and “became frantic. It was the saddest thing, to have Chagas, because they said it was 
dangerous, that you died from it.” Constanza, a 62 year-old supervisor from Warnes described 
becoming upset, “because I have family with Chagas. And of course, when they said I have 
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Chagas, and at any moment I could die, of course I became sad. I thought a lot about the disease. 
I worried a lot.” Constanza’s sadness and worry stems on the fear that her life could end 
unexpectedly. 
     People who receive a diagnosis of Chagas must live with the gnawing worry that at any 
moment their lives could end. This feeling is evident in the words of Daniel from Yapacaní: 
There are a lot of times when it worries you, right? One, for the work you do. You have 
the thought that at any moment you can end up dead. And all the work you are doing 
might be for nothing.  
     In sum, Bolivians are well aware that Chagas disease can have fatal consequences, often 
through stories they have heard, or from the personal experience of losing loved ones with the 
disease. While some victims of the disease succumb after a lengthy battle with debilitating 
symptoms, others fall unexpectedly, even when in apparently good health. This in turn creates 
one of the major challenges for Chagas-positive people in living with the disease: coping with 
the idea that death may strike at any time.  
 
    Findings from the qualitative interviews show that participants describe structural, cultural and 
biological factors in their etiology of Chagas disease. Social causes such as poverty, traditional 
housing, and lack of vector control were identified slightly more often than natural causes 
(insects, climate and heredity) as reasons for the widespread prevalence of the disease in the 
region. In participants’ narratives, vinchucas are frequently associated with “más antes”, a time 
in the past, “el campo”, the countryside, and with poverty and traditional housing materials. 
Participants describe a very diverse range of symptoms including chest pain and tiredness, and 
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emphasize the role of stress or emotional agitation in worsening the effects of the disease. The 
toll of Chagas disease on the body is often expressed as fatiga, an irregular acceleration of the 
heart accompanied by lack of breath. Finally, participants tend to view Chagas as a fatal disease 
which can strike unexpectedly, in some cases, while gradually wearing down the body, in others. 
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CHAPTER NINE  
QUALITATIVE INTERVIEW RESULTS, PART 3: 
ETHNOMEDICAL TREATMENTS 
     All 68 respondents free listed treatments for Chagas disease. I also asked participants to free 
list treatments that were “good for the heart.” This is because the majority of Bolivians are 
undiagnosed, and may interpret symptoms of Chagas disease as related to another type of heart 
problem. I wanted to have an idea of what treatments Bolivians would use to treat the symptoms 
of Chagas disease. Many of the treatments mentioned in these categories overlapped. While I did 
not have respondents free list treatments for gastrointestinal symptoms, several remedies were 
mentioned during the semistructured interviews. The results indicate that participants have 
extensive knowledge of ethnomedical treatments, which is transmitted through social networks 
as well as media. Ethnomedical treatments are not necessarily in competition with biomedical 
care, but they are often the only accessible option for respondents with Chagas disease.  
 
Treatment in the Popular, Folk and Professional Sectors 
     In addition to etiology, progression and symptoms, another dimension of the explanatory 
model of a disease is treatment, which can occur in the popular, folk and professional sector 
(Kleinman 1980). Whereas the folk sector involves traditional healers and the professional sector 
consists of biomedical practitioners, the popular sector involves how patients, often with the help 
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of family and friends, treat their illness. This is where most treatment takes place (Kleinman 
1980). I asked all 68 respondents about how to treat Chagas disease, and had them free list 
potential treatments for the disease and its symptoms. This chapter primarily describes how 
Bolivians treat Chagas disease in the popular sector, although in some cases respondents talk of 
interactions with traditional healers. People’s experiences with the biomedical system are 
described in Chapter 7.  
     Chagas is an “incurable” disease for adults in the chronic stage because biomedical treatments 
are controversial and, in any case, usually inaccessible, despite the government’s efforts to the 
contrary (see Chapter 7). Thus, despite the recent historical arrival of awareness of Chagas 
disease, Bolivians have taken it upon themselves to develop and utilize a host of ethnomedical 
treatments aimed at either curing the disease entirely or alleviating its symptoms. Additionally, 
Bolivians aim to reframe their perception of the disease from one fraught with fear and concern 
to one of peace and calm, enabling them to continue with their lives despite the specter of 
potentially unavoidable death. Interview respondents have a much more extensive familiarity 
with ethnomedical than biomedical treatments, chiefly due to their greater accessibility.  
 
Traditional Knowledge of Vinchuca Prevention 
     The first line of defense in fighting a disease is prevention, and for Chagas disease this means 
deterring the vinchuca. As discussed in the previous section, respondents are well aware that 
certain types of housing discourage vinchuca infestation. When asked how they would eliminate 
Chagas, several respondents recommended helping the poor improve their homes. Iris stresses 
the need for “a strategy to say, well, this is how we eliminate this bug. Every house of modern 
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material… Because in this type of house, that bug cannot live in the walls.” Alejandro says he 
would help people “improve their homes, at least so they could sleep peacefully, without that 
bug getting in.” Jacinta recommends “Building a lot of houses from modern materials, for us 
poor people who don’t have enough to build modern homes.” Natalia, a 29 year-old domestic 
worker from San Ignacio, would “Help the poorest people, with their homes.” These quotes 
underscore Bolivians’ awareness of the structural causes of the disease, and the need for 
solutions that address those causes.  
     In addition to construction of housing, respondents also emphasize the need for cleanliness. 
This coincides with public health messages about vinchuca prevention, suggesting these have 
had some success in the study area. One should “have a lot of neatness in the home, no?” asserts 
Pura. “Get rid of old stuff lying around, and have a lot more cleanliness and order. To prevent 
the disease, so you don’t have that bug.” “Keep the house clean,” advises Piedad, a 39 year-old 
homemaker from Warnes. “Vinchucas are drawn to humidity and dirtiness.” According to 70 
year-old Teresa from Minero, “They say you can prevent Chagas by doing a thorough cleaning 
of your house, you see? So that, if there are vinchucas there, they will leave.” This is an effective 
prevention measure, since vinchucas are known to hide in old boxes or piles of clothing.  
     Five respondents also draw on ethnobotanical knowledge to prevent vinchucas. Certain plants 
have the capacity to prevent or even kill vinchucas when burned. One respondent notes that 
burning the seeds from chili peppers will drive any living creature (including humans) out of the 
house. Leticia states “Something we use to get rid of bugs is the smoke of corn silk. You burn 
that, and it drives off the bugs.” Blanca reports burning the branches of a local tree, gabetilla, to 
ward off insects, including mosquitoes and vinchucas.   
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     One respondent mentioned plastering walls with jumbacá as an effective preventive measure. 
Jumbacá consists of cattle dung mixed with straw, lime and clay. Using this on the walls of a 
traditional home can help prevent vinchucas from entering. The ingredients are readily available 
in rural Santa Cruz. In addition, the burning of cattle dung inside the home can deter vinchucas 
and other insects, according to a resident of El Pilar.  
     The use of commercially available pesticides, such as “Bay-gon”, a popular brand, is also 
widely reported. Sixteen respondents mentioned that they used such pesticides, while only eleven 
spoke of authorities coming to spray for vinchucas. According to one respondent, commercial 
products could in large part be replacing traditional methods: 
The municipal government sprays, but you can also spray your own house with Bay-gon. 
So those bugs aren’t around anymore. Before, no one sprayed or anything, they just used 
smoke [from plants]. Chalita, gabetilla, motacú, nothing else. That was in the 
countryside. But now in the city, no one is going to use smoke anymore. Now there is 
Bay-gon to spray, you see? So those bugs aren’t around anymore. (Blanca, 62, Warnes) 
     In Blanca’s opinion, burning plants is old-fashioned and rustic, something used in the 
countryside. The widespread use of Baygon, however, has helped eliminate vinchucas in the 
cities of today. This does not mean that Blanca opposes traditional use of plants; she makes use 
of a wide variety of natural remedies. However, based on her experience, burning plants did less 
to curtail the assault of vinchucas than use of conventional pesticides.  
     Still, nine respondents point out that the cost of pesticides is often prohibitive for poor people 
living in the country. Chagas only affects the poor, says Freddy, because “Rich people spray 
insecticides.” According to Lidia, “no matter how much you spray, [vinchucas] still come into 
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the house. Above all if you live in poverty.” Thus, traditional forms of insect control might be 
the best available options for poor people who are unable to afford store-bought pesticides.  
     In sum, respondents feel that vinchucas can be prevented through a variety of measures. On a 
structural level, respondents suggest helping the poor improve their homes. On a household 
level, cleanliness and good housekeeping are recommended. Bolivians can also make use of 
store-bought pesticides as well as traditional knowledge of certain plants with repellent 
properties. The latter might be the only alternative for some of Bolivia’s rural poor. 
      
Learning to Live with Chagas-the Notion of “Tranquilidad” 
     One of the most frequently coded themes in the qualitative interview transcripts, with 54 
related quotations, was the concept of tranquilidad. Literally this translates to calm, 
peacefulness, or contentment. Bolivians with Chagas consider tranquilidad a desirable state of 
consciousness. In part, this is because freeing the mind of worry allows them to continue with 
their daily lives. Moreover, it is necessary to keep emotions calm, since an agitated emotional 
state will worsen the symptoms of Chagas and is deleterious for overall health. Consequently, 
tranquilidad in some ways opposes the state of fatiga, where the heart is agitated and the body’s 
functioning is disrupted. Unlike a person suffering from fatiga, an individual who is tranquila 
can function normally and fulfill their social roles. They are in control of worries about 
impending death or debilitation from Chagas disease.  
     Attaining a state of tranquilidad is critical for combatting the disease. “Foremost is being 
tranquila [calm], no?” explains Pura. “Being tranquila. Not thinking that you are sick. Getting 
your mind focused on some other thing, right..? Because if you constantly worry about the 
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disease, it becomes worse.” Hortensia, the 54 year-old wife of an agricultural laborer, also 
describes the importance of being calm. “I have been told that I cannot be troubled. I cannot be 
worried. And if someone is arguing or there is some kind of problem, you have to get away from 
it, they say. If not, you are going to get fatiga. To be tranquilita [calm].” We have to calm down 
(tranquilizarnos),” says Betty, “because if we become upset, it is another ill at the same time.” 
“The first thing, you know what it is?” asks Constanza. “One’s tranquilidad. That’s right. 
Because that way, the heart is not much affected, you don’t get fatiga. Tranquilidad is the main 
thing, because there are times when you get fatiga, no?” These examples underscore the need to 
be calm-tranquilo-not only for one’s emotional wellbeing, but to lessen the effects of Chagas 
disease.  
     Even otherwise positive emotions might be destructive if they impact the tranquilidad of a 
person with Chagas. “I can’t get excited,” says Pura. “I avoid anything like that. I can’t go to 
parties. Sometimes I get mad, I get really happy, and all that does damage. It does damage, so 
you have to be just normal.”  
     Ten respondents, while indicating they initially felt very worried upon receiving a diagnosis 
of Chagas, describe a shift where they take control of their feelings and become tranquilos. “I 
felt so bad, thinking that I was going to die,” says Jacinta. “It affected me a lot. So then, I asked 
the Lord and the Virgin to take those thoughts away. And I got rid of them, and I forget that I 
have Chagas.” For Doris, “When a person gets the disease, a lot of the times it’s psychological. 
Because when I first find out I wept. ‘How could I get sick with [Chagas], and I’m not even 30?’ 
Then I said, bah, and I lived my life and I forgot about it.” In Betty’s case, talking to a friend 
helped her overcome the initial anguish over her diagnosis: “…my friend told me, ‘don’t worry 
because all of us have Chagas. I have Chagas and look at me.’ From that I felt a little more 
202 
 
tranquila.” In each instance, the individual overcame worry about Chagas disease, while 
emphasizing that this helped them live their lives normally.  
     In three other cases, respondents describe doctors reassuring them and calming them when 
giving the diagnosis. If their disease is latent and asymptomatic, doctors will tell them their 
Chagas is sleeping. “You have Chagas, but it’s no cause for alarm,” the doctor told Elisa from 
Warnes. “Don’t worry, it’s asleep,” the doctor told Yoana from Warnes. When Fernanda, 57, a 
homemaker married to a carpenter from Yapacani, received her initial diagnosis, she felt “really 
scared. They told me, ‘No, no, no. It’s asleep.’ So I calmed down.” In these examples, 
practitioners are concerned with ensuring patients feel calm upon receiving their diagnosis.  
     Thirty participants affirmed that they felt calm – tranquilo – and did not think or worry about 
their Chagas disease. Alma from Minero, while contrasting the tranquilidad she feels with others 
she knows who experience fatiga, likens the state of tranquilidad to not having Chagas at all.  
Until now I feel that I don’t have Chagas. Tranquila, I don’t feel fatiga in my heart. I 
think that – it’s like I don’t have the disease, no? So, I feel calm (tranquila) because 
others say they have Chagas and feel fatiga in their hearts.  
     In part, the peace she feels is due to her lack of symptoms, but just as importantly, she does 
not permit herself to worry about the possibility of developing a more severe, symptomatic form 
of the disease. Such worrying would act as a trigger that aggravates her Chagas disease. In a 
similar example, Porfiria says, when she was first told she had Chagas, “it didn’t affect me… I 
didn’t say, ‘Oh no, it’s going to kill me,’ or anything. Well, you’ve got Chagas, tranquila, 
nothing more. As if it were nothing.”       
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     Tranquilidad entails not denial or avoidance, but acceptance of the possibility of death. Hugo 
avows that he feels, “Tranquilo. Because we have arrived in this world, and I am conscious that 
we have to depart as well. It’s not forever. Tranquilo. Tranquilo.” Elsa, a Quechua speaker from 
Buena Vista, also considers herself “tranquila. Anyway, you’re going to die of something. You 
just have to wait for it.” Josefina, who works cleaning houses in Minero, asks, “Why are we 
going to get upset? Tranquila, you have to die from something.” 
     For five respondents, faith in God or the Virgin helps bring about acceptance of the disease 
and tranquilidad.  
I was sad a long time. I told my children and my husband that I had this disease, and they 
told me you have to have faith that God will protect us and care for us. From then on we 
always ask God and the Virgin to protect us and care for our health. (Leticia, 47, El Pilar) 
      Constanza “worried a lot” when she first found out she had Chagas, but later came to accept 
it, something she attributes to “God. Because God comes first, you see? And that gave me more 
courage with this disease.” In all these examples, faith helps individuals come to terms with 
having the disease, and in particular enables them to put an end to worrying.  
     Two people mentioned they use work as a means of putting their minds at ease. “I felt 
tranquilo, even though I had Chagas, I didn’t give it a lot of importance,” says Eduardo. “That 
was the good thing.” When asked what helped him feel calm, Eduardo responded, “being able to 
work, do something, clean or straighten up, I feel happy. And well, you get used to it.” “They 
told me it was better not to worry about the disease that I had,” recalls Anita, a 47 year-old 
vendor of salteñas, a local delicacy similar to an empanada. “I know it can get worse very 
quickly. I spent my whole life working, and in that I keep things normal. It’s as if I didn’t have 
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the disease. I work and work and work, and I don’t even know if I’m sick or anything.” For these 
individuals, being able to continue functioning normally is the key to tranquilidad. At the same 
time, it is essential not to become too worried or upset, since this might set off the symptoms of 
Chagas disease.  
     It would be incorrect to state that the desire to feel tranquilidad stems from avoidance, on the 
part of infected Bolivians, of dealing with Chagas disease. In an illustrative example, Blanca 
states that while she does not worry about her Chagas disease, she does pay attention to her 
diabetes: “No, I don’t think about [Chagas]. I think of it as nothing. What I think about is just my 
sugar, that it doesn’t go up on me.” Blanca’s Chagas disease is asymptomatic, so in part this 
might reflect a pragmatic choice on her part about where to focus her time and attention. On the 
other hand, there are specific actions she feels she can take to combat her diabetes, such as 
watching her sugar and controlling her diet. She is able to do something about her diabetes. With 
Chagas disease, often the only viable action is to avoid stress and worry.  
     Leticia, who is also both diabetic and Chagas-positive, states that “the only thing I do is try to 
stay tranquila. Yes, because I can’t take any type of medicine. Here in the countryside we use 
sweetened teas to calm down and I can’t because of my sugar (diabetes).” Leticia feels she is 
unable to avail herself of local medicinal teas because they are typically prepared with sugar. So 
trying to stay tranquila is the only option left to her. Importantly, her comment expresses the 
idea that medicinal teas themselves can help a person feel tranquilidad. 
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Ethnomedical Knowledge and Chagas Disease 
     In the interviews, respondents describe a considerable pharmacopeia of ethnomedical 
remedies. Fifty-eight of the 68 respondents, or 85% of the sample, was able to mention at least 
one ethnomedical remedy for Chagas disease or its related symptoms. The average number of 
ethnomedical remedies mentioned by respondents was 3.25. The figure below was produced in 
Atlas.ti, and shows the major themes and relationships for the ethnomedical domain that 
emerged from analysis of the qualitative interview texts.  
 
 
Figure 9.1: The Ethnomedical Domain and Chagas Disease 
 
206 
 
     Ethnomedical treatments can be divided into two main groups: those that directly target 
Chagas disease, and those that alleviate either its cardiac or gastrointestinal symptoms. With 
available treatment options from the biomedical system often unavailable, ineffective, unsafe or 
too expensive, Bolivians turn to ethnomedical treatments for a variety of reasons. Ethnomedical 
remedies are more accessible, address respondents’ emotional needs, and often give hope of a 
cure for a disease that, according to what biomedical practitioners have often told them, is 
incurable for Western medicine. Ethnomedical treatment for Chagas is influenced by various 
forces, including beliefs about faith and tranquilidad, as well as structural barriers to biomedical 
treatment (Figure 9.1).  
     Ethnomedical knowledge related to Chagas disease comes from different sources. On the one 
hand, there is traditional knowledge which is often passed down from parents to children, or 
from older to younger members of a community. Seven respondents reported hearing about a 
particular plant or remedy from their parents. Fourteen individuals specified they learned of 
remedies from friends or acquaintances, as in the following examples: 
Not long ago a man told me to take jasmine flower for Chagas…He said either way, it 
could be dried or fresh. Make tea, he said, of jasmine. You have to drink it every day. 
(Yoana, 64, Warnes) 
Tilde’s husband said that garlic was very good. He takes three cloves, cuts them up and 
puts them in his food, then he eats. Three cloves of garlic. And he says that he doesn’t 
have Chagas anymore. (Paola, 34, Buena Vista) 
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I have a friend who married a Peruvian woman. And those Peruvians are from the jungle, 
the Amazon. And the girl’s father told my friend, because he’s also sick with Chagas, he 
gave him a remedy of garlic in alcohol. Blended. (Pancho, 50, Minero) 
    As these examples underscore, Bolivians transmit knowledge of remedies for Chagas through 
social networks that involve extended families as well as neighbors and acquaintances. Usually, 
they do no seek consultation from a yerbera or traditional healer unless they feel their symptoms 
have become grave. 
     However, knowledge of Chagas treatments goes well beyond “traditional” ethnomedical 
knowledge. This stems in part from the fact that diagnosis with Chagas disease is a fairly recent 
phenomenon. Although Chagas disease certainly existed since pre-Columbian times, it was only 
identified by Carlos Chagas in the twentieth century (Chagas 1909). Only in recent decades, with 
the advent of large-scale public health initiatives to combat the disease, did Bolivians come to 
understand it as a major cause of sickness and mortality. 
      Four respondents describe a past when vinchucas were considered harmless nuisances and 
were not associated with disease. 
In the past people didn’t get alarmed when there was a vinchuca. Now they get alarmed 
because they know the vinchuca brings Chagas. (Blanca, 62, Warnes) 
We didn’t have any knowledge that, that insect, the vinchuca, transmitted a disease. 
Nobody knew, fifty years ago. (Hugo, 62, Portachuelo) 
In years past, you didn’t hear about any campaigns against Chagas. (Jairo, 47, Santa 
Cruz) 
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          Another respondent describes testing for Chagas disease as a relatively recent 
phenomenon: 
In the past, very few did those tests [for Chagas] that people do now. There weren’t any. 
Now, thank God, with science, everything is improving. (Zaida, 48, Palacios) 
     Consequently, Chagas disease has only emerged in the conscience of Bolivians as a major 
health threat in the space of the last two generations. Although Bolivia’s ethnomedical tradition 
draws on centuries of knowledge, it has only recently confronted Chagas disease. Yet numerous 
treatments already exist. Bolivian ethnomedicine is a dynamic body of knowledge that constantly 
grows and gives birth to new treatments, perhaps to an even greater extent than biomedicine, 
which has not been able to present new medications for Chagas disease in half a century.  
     Moreover, ethnomedical knowledge is not simply passed down orally. It circulates freely 
through mass media and current technology. When I asked Blanca, a 62 year-old homemaker 
from Warnes, where she had heard about sinini, a local fruit used to treat Chagas disease, she 
replied “The Internet. Now you can learn anything on the Internet. Even kids do their homework 
on the Internet. Before we didn’t have all that. Before you were dumb, you didn’t know 
anything.” Blanca’s example shatters the stereotype of ethnomedical knowledge as something 
that is traditional and antithetical to modern technology. Access to the Internet is widely 
available in Bolivia. People who do not have computers can make use of Internet cafes and go on 
line for a very small hourly fee (usually 2 Bolivian pesos, or 28 cents US). There are also 
Bolivian websites dedicated to ethnomedical healing, such as “Medicinal Plants” which contains 
a blog on locally available curative plants (http://plantas-medicinales-bolivia.blogspot.com).  
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     In addition, printed pamphlets on medicinal plants are produced in Bolivia’s major cities (La 
Paz, Santa Cruz and Cochabamba), and sold at markets or by ambulatory vendors on local buses. 
They often have titles such as “Plantas Que Curan” (Plants that Heal), and usually feature 
pictures of light-skinned models either taking a specific remedy or suffering from symptoms that 
a given remedy can help cure. Many of the treatments they describe reflect imported knowledge 
from Europe, the U.S. and Asia, such as drinking green tea to combat cancer. However, they also 
describe how to use locally available produce or herbs. For example, one contains a remedy 
using lemons and garlic to get rid of intestinal parasites, while another tells how to use potatoes 
to make a facial mask for acne.  
     Bolivian ethnomedical knowledge can thus adapt seamlessly to modernity and development. 
It is transmitted through family relations, wider social networks, and print and electronic media.     
Another reason ethnomedical treatments continue to flourish is due to their accessibility.     
Ethnomedical treatments are widely available, and can be directly harvested from animals or 
plants that are common in the study area, such as mandarin orange, soursop (guanabana), garlic 
or papaya. Others can be purchased at very low cost in local markets. Several of the remedies 
respondents listed could be obtained by walking a few minutes outside of the clinic in Palacios, 
including mandarin buds, tipa bark, sirari seeds, lemon tree flowers, tajibo bark, the fruit of the 
totaí palm, and annatto flowers. When patients come to the clinic, they sometimes walk to the 
woods nearby to harvest a particular plant for a remedy. They thus return home with prescribed 
medicines from the clinic as well as ethnobotanical remedies.  
     Respondents emphasize the accessibility of ethnomedical treatments in interviews. Yoana 
notes that “natural medicine… is often right there. You say ‘I need this,’ and you take it. Because 
it’s closer at hand, more accessible.” According to Pura, “A lot of the times the remedies are 
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right there in your home.” Dayana, a 59 year-old Quechua-speaking homemaker from Yapacaní, 
adds that their lower costs makes ethnomedical remedies more accessible. “Herbs and such in the 
countryside, I don’t believe they’re expensive. But getting treatment from a doctor, a hospital, 
that can be expensive.” 
     Many respondents have plants in their gardens which they harvest to use for treatments. For 
instance, Blanca grew sinini trees, and harvested the fruit in order to make medicinal teas (agua 
de sinini), which she drank daily. Most had mandarin orange, annato or avocado trees, the leaves 
or buds of which are also ingredients for Chagas remedies. Some said they had colonia or 
lemongrass plants, other common ingredients for Chagas and cardiac symptoms. These plants 
provided them with essentially free, renewable sources of medication.  
      Other ingredients are sold at local markets for low cost. For example, in La Ramada, a large 
market in Santa Cruz, bunches of herbs used for Chagas treatment such as lemon balm or 
chamomille sell for two Bolivian pesos, or $0.28 US. Each bunch provides enough for several 
pots of tea. Even more expensive, manufactured remedies, such as picaflorina, an herbal remedy 
manufactured in Peru, only sell for 25 Bolivian pesos ($3.50 US) for a 500 ml bottle. In contrast, 
some biomedical prescriptions for Chagas patients cost 25 Bolivian pesos per pill.  
     Faith plays an important role in healing. “You have to believe in order to get better,” observes 
Pura, who has a vast knowledge of curative plants. “It helps a lot. Yes, the thought. You say that 
this is going to help me feel better, and you take it. Take it, and God always takes care of the 
rest.” For Olivia, 43, a homemaker from El Pilar, “They heal us because we have faith.” She then 
adds, “It’s the only medicine we can use right away.” Raquel from Warnes, age 46, describes 
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ethnomedical remedies as “things we take to help us calm down, no? You take it to calm down. 
A lot of the times you have a lot of faith. Above all it’s faith.” 
     Faith in God naturally complements faith in ethnomedical treatments. If a certain remedy 
works, it is not only because of individual belief, but because the hand of God has worked 
through the particular treatment. The following story indicates how faith in God, combined with 
an ethnomedical treatment (chamomile), was able to take the place of a risky biomedical 
procedure.  
     They gave me a sonogram, and my intestine was twisted. I needed another surgery. I 
cried a lot. And the doctor told me, the operation will be this afternoon. There is nothing 
else to be done. And I said to God, ‘Lord, it can’t be… Help me. I don’t want this 
operation. You will operate on me,’ I said to God. And I told my husband, ‘Give me your 
hand. Help me to pray, to ask God. He is my father and He is going to heal me now.’ 
Then I told him, ‘I want you to give me that cup of chamomile tea. I’m going to drink it.’  
     ‘But the doctor said don’t drink anything [the husband protests].’  
     ‘No, but God said I should drink it.’ So I took the cup, and I said ‘In the name of Jesus 
Christ, may this tea that I am going to drink help fix my intestines. And I drank it. And 
when I drank it, I felt that my intestines [makes a gesture of straightening out]… I was 
healed by this miracle…  
     Then the doctor came, and sat by my side, and said ‘How are you?’  
     ‘I am fine, doctor.’ 
     ‘No, you are not fine, you are sick, and we need to operate on you.’ 
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     ‘No, doctor, you no longer need to do the operation, I have already been operated on. 
You will never again put your hands on my belly, or your knife. Because God has healed 
me.’ 
     And he said, ‘What are you saying?’ And I told him the story.  
     ‘Well,’ he said, ‘That’s good. I congratulate you. Because that is having faith.’ And he 
discharged me. (Amelia, 55, Palacios) 
     In this story, it is abundantly clear that the power of healing comes directly from God, yet the 
means with which He heals is a natural remedy, chamomile tea, which fixes the respondent’s 
intestines as it passes through. This spares the individual not only from a painful intestinal 
condition, but from an also dangerous intestinal surgery. Faith, supplemented by an 
ethnomedical treatment, provides a preferable alternative to biomedicine.  
     Chagas patients who find the means to afford biomedical treatment often discover that it is 
unsafe or does not produce results. For example, the medications which might cure Chagas, 
nifurtimox and benznidazole, can also produce dangerous side effects, and their effective use in 
adults has not been conclusively demonstrated (Pinazo et al. 2010, Guedes et al. 2010, Jackson et 
al. 2010, Bern 2011). Biomedical providers are thus often limited to palliative treatments, such as 
surgeries to fix intestinal complications, or pacemakers to correct coronary enlargement. 
Ethnomedical treatments are a less invasive, less costly alternative which typically do not 
produce life-threatening or debilitating side effects.  
     In a related example, another respondent with diabetes and Chagas describes an ethnomedical 
healer who comes from La Mansion, a Catholic lay organization.  
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A lady who has the gift of healing and comes here to cure, from La Mansion, told me to 
stop taking insulin when the mara fruit is in season. ‘Stop taking insulin for 40 days. And 
take one seed a day, just take the pit out. Take it mixed with lots of water because it is 
extremely bitter. Do it,’ said the lady, ‘and you will remember me. And check your sugar 
every two, three months. And you are going to see that your diabetes is controlled.’ 
They say that everyone who she has helped is doing well. She goes to people’s homes, 
because they say she has the gift of healing. (Doris, 60, Buena Vista) 
     This is another case of faith and ethnomedical healing converging. The healer comes from a 
religious organization, and the implication is that her gift of healing stems from her faith, or that 
God is working through her. Again, the narrative shows faith and an ethnomedical treatment 
(mara seeds) can take the place of a biomedical alternative (insulin). 
     Another key role of ethnomedical treatments is to help Bolivians restore their calm and peace 
of mind, or tranquilidad. Thus, they address the emotional agitation that can often set off cardiac 
symptoms. Olivia from El Pilar mentions several herbs that “we use here in the country when, 
say, my heart hurts, but you don’t know why. Maybe it’s emotion, it could be happiness, it could 
be sadness, I don’t know. Then we get some herbs and we make tea. They help us to feel 
tranquilizadas (calm).” Olivia indicates that ethnomedical remedies for the heart (she mentions 
lemongrass and colonia, a local flower, among others) not only address pain, but focus on the 
emotional causes that might have triggered that discomfort:  
     Numa from Warnes also recommends drinking tea from medicinal plants to help with fatiga, 
the shortness of breath and agitation of the heart described by many respondents. “Sometimes 
you feel frantic,” she observes, “and that calms you.” Porfiria makes herself tea from colonia and 
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mandarin buds. “I feel like taking these teas helps calms me down. I am a little more tranquila.” 
By helping manage their emotions, ethnomedical remedies allow participants to continue 
functioning in their normal lives while avoiding the debilitating fatiga that often emerges from 
Chagas disease. 
 
Remedies that Target Chagas Disease 
     During the interviews, I asked respondents to free list treatments they felt specifically targeted 
Chagas disease. In all, respondents listed 33 different treatments. Furthermore, via participant 
observation, I found out the names of six additional ethnomedical treatments. This brings the 
total number of ethnomedical Chagas treatments identified in this small, exploratory study to 
thirty-nine. The actual number of treatments used throughout Bolivia could be far greater. I ran 
the free list procedure in Anthropac (Borgatti 1996) in order to calculate Smith’s salience. This is 
a measure which takes into account both the number of times an item is mentioned, and the 
average rank it is given in the free lists (See Chapter 5).  
 
Table 9.1: Chagas-Specific Remedies: Frequency, Rank and Salience 
Remedy  
(Local name) 
English or scientific 
name 
Frequency Average 
Rank 
Smith’s S 
ivomec ivermectin 7 1.143 0.25 
ajo garlic 6 2.333 0.174 
colonia Alpinia speciosa 5 2.6 0.113 
cogollo de mandarina mandarin buds 4 2 0.123 
noni Morinda citrifolia 3 1.333 0.108 
paja cedron lemongrass 3 3 0.067 
tipa Tipuanu tipu 3 3.667 0.054 
ajo en alcohol garlic in alcohol 2 1 0.077 
sinini Annona muricata 2 1.5 0.064 
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Table 9.1 (Continued) 
vinagre de manzana 
verde 
green apple vinegar 2 2 0.062 
flor de jasmin jasmine flower 1 1 0.038 
lecho con palillo milk with turmeric 1 1 0.038 
miel con ajo honey with garlic 1 1 0.038 
papaya verde green papaya 1 1 0.038 
picaflorina n/a 1 1 0.038 
sangre de murcielago bat blood 1 1 0.038 
tajibo morado Tabebuia 
impetiginosa 
1 1 0.038 
pelo de choclo corn silk 1 2 0.032 
valeriana valerian 1 2 0.029 
agua de coco coconut milk 1 2 0.026 
sangre de grado Croton lechleri 1 2 0.019 
extracto de verenjena eggplant extract 1 3 0.027 
hoja de palta avocado leaves 1 3 0.026 
iel de jochi pintado spleen of Cuniculus 
paca 
1 3 0.019 
sangre de zucha vulture blood 1 3 0.013 
extracto de rabana radish extract 1 4 0.022 
hoja de urucú annatto leaves 1 4 0.019 
iel de toro negro spleen of a black bull 1 4 0.01 
extracto de lechuga lettuce extract 1 5 0.016 
canela cinnamon 1 5 0.013 
jengibre ginger 1 5 0.008 
semilla de sirari seeds of Ormosia 
nobilis 
1 5 0.008 
cebolla onion 1 7 0.006 
resina de uvilla Pourouma 
cecropiifolia 
Identified in fieldwork as Chagas treatment 
cascara de mango mango peel Identified in fieldwork as Chagas treatment 
llantén Plantago major Identified in fieldwork as Chagas treatment 
manzanilla chamomile Identified in fieldwork as Chagas treatment 
toronjil lemon balm Identified in fieldwork as Chagas treatment 
uña de gato cat’s claw Identified in fieldwork as Chagas treatment 
  
    The most frequently mentioned remedy for Chagas disease is ivomec. Seven respondents 
identified it as a Chagas treatment, and it has the highest Smith’s salience for all the Chagas 
treatments (Table 9.1). This treatment is distinct from the others in that it does not come from a 
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locally available plant or animal species. Rather, it is a veterinary treatment for livestock and 
dogs. It is also known as ivermectin, the active ingredient it contains. A web advertisement 
indicates ivomec controls liver flukes, gastrointestinal roundworms, lungworms, lice, and mange 
(http://www.jefferspet.com/ivomec-plus-injectable/camid/liv/cp/17180). Dog owners in the U.S. 
sometimes use it as a low-cost alternative for treating heartworms 
(http://www.vetinfo.com/ivomec-for-dogs.html).  
     The use of ivermectin is not unknown in humans. In fact, ivermectin can treat river blindness 
or onchocerciasis in humans; the WHO recommends its use, under the brand name of Mectizan, 
and asserts that the drug has “single-handedly transformed the lives of millions of people 
suffering from onchocerciasis since its introduction in 1987” 
(http://www.who.int/apoc/cdti/ivermectin/en). There has only been one study assessing its 
effectiveness against Chagas disease. Pinto Dias et al. treated a group of Chagas-infected dogs 
and determined that ivermectin “showed no apparent effect on the dogs nor on their trypanosome 
infection” (2005, p. 829). 
     In Bolivia, ivomec is used for veterinary purposes. The seven respondents who described 
ivomec as a treatment for Chagas disease realized it was a veterinary drug. “We inject dogs to 
eliminate parasites in them with ivomec,” explains Susy, a homemaker married to an electrician 
in Yapacani. “So some have said that you can also deparasitize a human.” According to Amelia, 
“Ivomec is an antiparasite medication from the veterinarian. But I think it could work. Who 
carries [Chagas]? Cattle carry it. All animals. If they give [ivomec] to animals for parasites, it 
could also work for us. It could work.” Jairo affirms that “ivomec, from what I know, I inject my 
dogs with it for mange and all that. It is very good for that. So it must be very strong.” These 
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narratives indicate that respondents consider ivomec a veterinary medication for cattle or dogs, 
but they are transforming it for use in people.  
     This is why ivomec, despite being a pharmaceutical product, is classified here as an 
ethnomedical remedy. People are learning about ivomec not from doctors, or even traditional 
healers, but within the popular sector – from friends and acquaintances. The most probable 
hypothesis is that Bolivians have observed the effectiveness of ivomec for certain parasites in 
their pets or livestock, and upon realizing that Chagas also comes from a parasitic infection, have 
decided to use the drug on themselves.  
     Five of the respondents also indicate that ivomec is administered differently to people than to 
animals. While ivomec is injected in animals, people with Chagas should consume it orally. 
“One centimeter,” says Porfiria, “You have to take it, I believe, twice a year… You always have 
to take it. Always.” One person states the dose was “5 drops,” while another recommended “one 
or two millimeters,” but all agree it should be taken orally. Marta warns that consuming ivomec 
could damage the liver. Take it “only if you’re not sick in the liver,” she says. “Because if you 
are sick in the liver, you are going to have problems.”  
     Four respondents share stories of people who have cured their Chagas after taking ivomec. “I 
have a friend from Camiri who took it,” affirms Jairo. “He says that afterwards he did the test 
and he didn’t have [Chagas].” Marta also tells of a friend who cured his Chagas with ivomec: 
A man here, he showed us his Chagas test results, and he couldn’t walk from Chagas. He 
couldn’t walk, he says. After four steps, he felt like dying. And doctors and doctors and 
doctors. They couldn’t do anything for him. And someone told him to take [ivomec]. And 
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he took it, he says, this man. And he says he went back to take a Chagas test and he does 
not have Chagas. (Marta, 39, Buena Vista) 
     Marta’s story illustrates how ivomec offers hope of a cure for Chagas when biomedical 
treatment fails to do so. The man goes from not being able to walk due to his Chagas symptoms, 
to becoming healthy with a negative Chagas test after taking ivomec.  
     Several Chagas remedies involve eating certain foods. Garlic is the most common of these. 
Eating garlic is the second most common recommended treatment for Chagas. Other remedies 
involve drinking pureed garlic in pure alcohol, or mixed with honey. As with ivomec, stories 
circulate of individuals who have cured their Chagas with garlic, such as one related by Paola. A 
friend of hers “takes three cloves of garlic, minces them and mixes them in his food, and then 
eats it. Three cloves of garlic. But he says he no longer has Chagas. He said he went to test 
himself, and he doesn’t have it anymore, and he continues eating garlic to this day.” For Paola, a 
young mother with Chagas, this provided hope of a cure after doctors told her there was no 
treatment for the disease.  
     Whereas Paola’s Chagas is still asymptomatic, Jacinta has suffered from cardiac symptoms 
including fatiga. When her nephew found her short of breath due to her fatiga, he urged her to 
eat garlic three times a day. She relates, “I spread it on bread and had it with coffee or tea. Before 
breakfast, before lunch and before dinner. I did that for a long time. That helped me a lot.” 
     Many Chagas treatments utilize local plants. In particular, three plants are renowned for 
aiding with heart-related ailments in Bolivia: the buds of mandarin orange trees, lemongrass, and 
colonia, a locally grown flower related to ginger. Anita learned about these remedies while at 
work in a bakery. “I suffered a pain that caused me to fall down. And a woman there helped me 
219 
 
up. She told me, drink mandarin with lemongrass. She made me drink it right then, and the pain 
subsided.” Others describe the calming effects of these plants. Colonia “helps the heart,” 
observes Rosa from Buena Vista. There are times when it beats quickly, you feel fatigado. And 
you drink a colonia tea, and it calms the nerves, no?” These plants help address the symptoms of 
Chagas by providing calm. They are seen as palliative more than curative. 
     Noni is another plant which can help with the symptoms of Chagas. Also popular as a health 
food item in the United States, noni is a tropical fruit which grows well in Santa Cruz. 
Respondents report that it helps with swelling. “I was really ill, I couldn’t even get up,” relates 
Fernanda, a bilingual Quechua speaker from Yapacani. “And with [noni] I got a lot better. Now 
my foot doesn’t hurt, it doesn’t swell up… It is used for all kinds of medicine, for asthma, for 
Chagas, for cancer they say it is good. For everything.” Nilda, also from Yapacani but of camba 
ethnicity, boils noni and drinks the water when she runs out of her heart medication. She says it 
is also good for tingling or itching in the skin.  
     Four respondents list animal-based remedies, which are purported to cure Chagas. “I have 
heard you should drink bat’s blood,” says Kleber, 58, a Quechua migrant from Yapacani. “I have 
heard. You have to bite it while it is still alive. They say it cures [Chagas]…” Fernanda had 
heard that vulture’s blood would cure Chagas. Other cures involve eating the spleen of a 
particular animal, sometimes the jochi, a small mammal (Cuniculus paca) that is often consumed 
at the dinner table.  “What they told me is good for Chagas, to heal, is the spleen of the jochi,” 
says Nora from Buena Vista. “That is to cure it, they say. They say you dry it, cut it into pieces 
and drink it in tea.” Eduardo, who comes from the southern end of Santa Cruz department where 
the jochi is not as common, tells of a similar remedy with the spleen of a bull. 
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Another guy, do you know what he told me? You have to get a black bull… Then he says 
take out the spleen. And you’re going to put it in the freezer and freeze it. Take out a 
piece, a little bit, and cut it. Raw, it has to be raw. Eat it and drink a glass of water. 
During a week or so. Then stop for a week, then start again. And he says that heals 
[Chagas]… It can’t be another color. It won’t work. There was a guy, I don’t know if he 
was Cuban or French, I don’t know if he did it or his relative, but he was positive. And he 
was cured, they say. (Eduardo, 54, Yapacani) 
     In all of these cases, an unknown property either in the blood or spleen of certain animals has 
a curative effect on Chagas disease. 
     While most of these treatments emerge from the popular sector, four respondents indicated 
they had consulted healers, or naturistas. Cristina’s husband, who eventually died from Chagas 
disease, had consulted naturistas. One gave him extracts made of certain vegetables like radish 
and eggplant. 
With that he felt better for a good while, for three years. He felt better, he could walk, and 
he was fine. But then, we didn’t keep up with it. He said, ‘I will go to Santa Cruz to get 
some more, because it has been a while that I haven’t been taking them. But when he 
wanted to go, it was already too late. (Cristina, 49, Santa Cruz) 
     Treatment from natural healers could sometimes be expensive. Jacinta once paid nearly a 
thousand Bolivian pesos to a European immigrant who sold natural remedies. He gave her drops 
that came in a small vial whose label simply said “Chagas.” 
     Certain clinics in the study area specialize in natural medicine. During my fieldwork I 
inquired at one in the medium-sized city of Montero. They required Chagas tests from a 
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biomedical doctor before they would begin treatment, and in fact the clinic was run by a doctor. 
Treatment would involve a medication called Chagaspar, which came in a bottle of pills much 
like a pharmaceutical prescription. A 90-day course of treatment cost 750 Bolivian pesos, or a 
little more than $100 US. 
     Local healers often prescribed or sold remedies out of their homes, for much more reasonable 
fees. Edgar, a construction worker from San Carlos, knew of a healer who charged about 30 
bolivianos for a bottle of medicine for Chagas. In the market in Yapacani, a vendor with Chagas 
recommended making tea from a mixture of local plants: uña de gato (cat’s claw), llantén 
(Plantago major), colonia and sangre de grado (Croton lechleri). These ranged in price from 
two to fifteen pesos. She also sold prepared remedies for 25 pesos a bottle.  
      In sum, the folk sector involved in treating Chagas ranges from community members with 
special knowledge of herbs, to market vendors, to sophisticated operations that mimic 
biomedical clinics. Natural treatments can in some cases be just as costly as biomedical ones. 
This underscores the fact that patients are willing to pay for the hope of a cure – something 
biomedical practitioners cannot always give them. However, the vast majority of ethnomedical 
treatments are easily accessible and affordable, with some freely available in the garden or forest.  
 
Remedies for Cardiac Symptoms of Chagas Disease 
     Often respondents could not identify specific treatments for Chagas, or affirmed that there 
were none. Yet the same respondents could list various remedies that would alleviate the heart-
related symptoms that often accompany advanced chronic Chagas. This occurred during 24 of 
the interviews. “I haven’t heard of anything,” answered Magaly when I asked her what was good 
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for treating Chagas. "For the heart, there is a whole world of things.” Similarly, Alma told me: 
“For Chagas, there is no remedy. I haven’t heard of any remedy for Chagas.” However, when I 
asked her what helped with heart problems, she mentioned several ethnomedical remedies: 
mandarin orange, lemon grass and lime tree leaves.  
     Respondents may consider that a particular remedy is not “for Chagas,” if they feel it does not 
specifically attack the root cause of the disease. Or perhaps when they originally learned about a 
particular remedy, it was presented to them as being “good for the heart” rather than for Chagas. 
This is corroborated by the fact that remedies which respondents frequently listed as “good for 
the heart,” such as colonia and mandarin buds, also have a high salience on the list of Chagas 
remedies. Thus, to capture the whole range of ethnomedical treatments someone suffering from 
Chagas might use, I first asked what treatments were effective for Chagas, and then which were 
effective for heart symptoms. I focused on heart symptoms because these are the most common 
complications for people with advanced chronic Chagas disease, although I also made note of 
several gastrointestinal treatments.  
     In total, participants mention 66 treatments that are either used specifically for Chagas disease 
or for its cardiac symptoms, such as chest pain and fatiga, the irregular heartbeat and shortness of 
breath that Bolivians with Chagas often describe (Table 9.2). Often, remedies that some 
respondents indicate help with Chagas disease are the same others mention as “good for the 
heart,” such as colonia, lemongrass and garlic. Ivomec, on the other hand, is specifically for the 
treatment of Chagas disease; its purpose is to kill the organisms that cause the disease, rather 
than to fortify the heart. There are four additional treatments that I heard about in talking to local 
people, but that never came up in free listing: uña de gato, llantén, resina de uvilla and mango 
peel, all Chagas remedies. This brings the total number of remedies for treating Chagas or its 
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heart-related symptoms to seventy. Of these, four are not strictly ethnomedical: antibiotics, 
vitamins, pills, and blood pressure pills. This still leaves a total of sixty-six remedies that come 
from outside the biomedical domain. 
     By far the most salient and frequently mentioned remedies are mandarin buds, colonia, and 
lemongrass, all of which also appear on the list of remedies that are effective for Chagas. Often, 
the three ingredients are mixed together and used for tea. One of the principal effects of these 
plants is to calm the body, thus helping avoid agitation which might worsen heart problems. “I 
feel that drinking these teas calms me down. I feel a little more clam (tranquila),” notes Porfiria. 
Rosa drinks colonia tea, but “not for Chagas. For the heart it helps. There are times when it beats 
rapidly, you feel fatiga, and drinking a colonia tea maybe calms the nerves.” Even though Rosa 
has Chagas, she believes the colonia is not for her Chagas, but to address the fatiga she 
experiences (which she understands could well be a consequence of her Chagas disease). In the 
same sense, an American with bronchitis might take an ibuprofen to help with the fever or pain, 
but does not consider the ibuprofen as something you take for bronchitis. Moreover, Rosa 
specifies that colonia addresses the problem of fatiga, which is one of the principal heart 
symptoms that afflicts Bolivians with Chagas.  
     Table 9.2 lists all the remedies respondents free listed for Chagas disease and its heart related 
symptoms. The purpose is to show the universe of all the possible treatments that a person with 
chronic Chagas and the more common cardiac complications might utilize. I analyzed the results 
of the free lists in Anthropac to determine Smith’s salience.   
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Table 9.2: Remedies for Chagas and/or Related Cardiac Symptoms 
Remedy (Local 
name) 
English or scientific 
name 
Frequency Average 
Rank 
Smith’s S 
cogollo de mandarina mandarin buds 31 2.194 0.389 
Colonia Alpinia speciosa 30 2.633 0.314 
paja cedron lemongrass 24 3 0.229 
Ajo garlic 11 2.364 0.141 
Ivomec ivermectin 7 1.571 0.097 
Tabletas pills 4 1.5 0.056 
Toronjil lemon balm 4 1.75 0.055 
cogollo de naranja orange tree buds 4 3.5 0.042 
Manzanilla chamomile 4 3.25 0.040 
semilla de sirari seeds of Ormosia 
nobilis 
4 3.5 0.026 
Noni Morinda citrifolia 3 1.667 0.045 
uña de hanta tapir claw 3 3 0.033 
tipa bark bark of Tipuanu tipu 3 3.333 0.030 
ajo en alcohol garlic in alcohol 2 1 0.034 
Sinini Annona muricata 2 2 0.030 
vinagre de manzana 
verde 
green apple vinegar 2 2 0.027 
Aspirina aspirin 2 3 0.026 
Canela cinnamon 2 3.5 0.021 
iel de jochi pintado spleen of Cuniculus 
paca 
2 2.5 0.021 
Cedrón cedar 2 3 0.019 
Valeriana valerian 2 5.5 0.016 
hoja de boldo leaf of Peumus boldus 2 5.5 0.008 
hoja de lima lime tree leaf 2 6 0.012 
agua de totaí tea made from 
Acrocomia aculeata 
1 1 0.017 
Antibióticos antibiotics 1 1 0.017 
flor de jasmin jasmine flower 1 1 0.017 
leche con palillo milk with turmeric 1 1 0.017 
miel con ajo honey with garlic 1 1 0.017 
Picaflorina n/a 1 1 0.017 
sangre de murcielago bat blood 1 1 0.017 
Suero whey 1 1 0.017 
tajibo morado Tabebuia 
impetiginosa 
1 1 0.017 
te verde green tea 1 1 0.017 
pelo de choclo corn silk 1 2 0.015 
sangre de grado Croton lechleri 1 2 0.015 
cogollo de lechuga new lettuce heads 1 2 0.014 
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Table 9.2 (Continued) 
Siemprevive hen and chicks 1 2 0.014 
tabletas para la 
presion 
pills for high blood 
pressure 
1 2 0.014 
vitaminas vitamins 1 2 0.013 
agua de coco coconut milk 1 2 0.011 
chancapiedras Phyllanthus niruri 1 2 0.008 
hoja de palta avocado leaves 1 3 0.013 
extracto de verenjena eggplant extract 1 3 0.012 
ani anise 1 3 0.011 
te de manzana apple tea 1 3 0.011 
cogollo de tamarindo tamarind buds 1 3 0.008 
mate de coca coca tea 1 3 0.008 
canchalagua Schkuhria pinnata 1 3 0.006 
papaya verde green papaya 1 3 0.006 
hoja de urucú annatto leaves 1 4 0.011 
sangre de zucha vulture blood 1 4 0.011 
extracto de rabana radish extract 1 4 0.010 
cogollo de inojo bud of Foeniculum 
vulgare 
1 4 0.008 
semilla de urucú annatto seeds 1 4 0.007 
eucalipto con 
mentisán 
eucalyptus balm 1 4 0.004 
iel de toro negro spleen of a black bull 1 4 0.004 
extracto de lechuga lettuce extract 1 5 0.007 
jengibre ginger 1 5 0.003 
naranjo agrio bitter orange 1 5 0.003 
romero rosemary 1 6 0.008 
hoja de limon lemon tree leaf 1 6 0.003 
ruda rue 1 7 0.006 
lima lime 1 7 0.004 
cebolla onion 1 7 0.002 
manzana apple 1 8 0.004  
resina de uvilla Pourouma 
cecropiifolia 
Identified in fieldwork as Chagas treatment 
cáscara de mango mango peel Identified in fieldwork as Chagas treatment 
llantén Plantago major Identified in fieldwork as Chagas treatment 
Uña de gato Cat’s claw Identified in fieldwork as Chagas treatment 
 
     Importantly, respondents rarely mentioned biomedical treatments. Even when they did list 
biomedical treatments, they did not tend to use specific names. For example, some respondents 
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affirmed that their “tablets” helped with their heart symptoms. This does not mean, however, that 
the respondents did not utilize biomedical treatments. In fact, all were patients of a biomedical 
clinic (the CMHP) and many took prescribed medication for diabetes and other ailments. 
Nonetheless, when I asked what treatments helped with Chagas or heart symptoms, respondents 
understood the question as pertaining to the popular sector. In other words, what do people 
recommend to each other? Thus the use of biomedical treatments is probably underrepresented in 
Table 9.2, but the table does illustrate the much greater familiarity and specificity of 
nomenclature used for ethnomedical versus biomedical treatments. This is because ethnomedical 
treatments often come up in conversations with family members, neighbors and friends, and 
utilize readily recognizable items from respondents’ surroundings, such as herbs and fruits.  
     Ye this is not simply a cultural or ideological phenomenon. Respondents report that 
ethnomedical treatments are generally more available, accessible and inexpensive than 
biomedical alternatives, which means marginalized Bolivians are in more frequent contact with 
them. Furthermore, they address aspects of Chagas disease, such as fatiga and tranquilidad, 
which pharmaceutical products have little ability to impact. Finally, they provide hope of a cure 
for a disease that has largely been neglected by pharmaceutical research. In sum, the extensive 
pharmacopeia of ethnomedical treatments for Chagas at least partially depends on the structural 
components that shape the disease.  
 
Treatments for Gastrointestinal Symptoms of Chagas Disease 
     When someone suffers from intestinal complications due to chronic Chagas disease, they can 
experience enlargement of the intestine or megacolon, resulting in the appearance of a swollen 
belly, and accompanied by severe pain and constipation. Cambas in Santa Cruz might not always 
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attribute this to Chagas disease, though. Constipation is often attributed to eating fruits with too 
many seeds, observes Olivia. These include passion fruit and guava, which are common in the 
area. “My grandson gets constipated,” says Constanza, “because he eats a ton of fruit, and he 
gets constipated. Guapurú, achaicherú [local fruits], those all cause constipation.” According to 
Olivia, pain in the stomach might stem from “sitting somewhere on something hot,” like a park 
bench in the sun, or from “humidity. When it rains and then the sun comes out, and it evaporates, 
that can also be harmful.” Thus, constipation is thought to stem from dietary causes, while pain 
in the abdomen may have environmental origins.  
     Although I did not ask respondents to free list treatments for gastrointestinal Chagas disease, 
these sometimes came up during the interview. Papaya was the most frequently mentioned. The 
list in Table 9.3 is not comprehensive, but it gives an idea of some of the ethnomedical remedies 
a Bolivian with intestinal complications from Chagas might take. None of these appear on the 
lists of medications for Chagas and heart symptoms, except for chamomile. This suggests, as 
Crandon’s (1981) research demonstrates, that Bolivians have an extensive repertoire of 
treatments for each area of the body, or for each type of health condition.  
 
     Respondents in the sample utilize a wide range of ethnomedical treatments for Chagas disease 
and its symptoms. I learned about 33 remedies that target Chagas disease through free listing 
during the interviews, and an additional six through participant observation, bringing the total 
number to 39. In analysis of the free lists, the most salient treatment was ivermectin. Moreover, 
even when participants are unaware of a specific treatment that is “good for Chagas,” they can 
draw on a host of remedies to combat the cardiac or gastrointestinal symptoms that accompany 
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the disease. I learned of 66 ethnomedical treatments related to the cardiac symptoms of the 
disease (62 from the free listing exercises and 4 from participant observation). During the 
interviews, respondents mentioned 21 potential treatments for gastrointestinal complications 
related to the disease.  
 
Table 9.3: Potential Remedies for Gastrointestinal Complications of Chronic Chagas 
Local name English or scientific 
name 
Method Symptom 
Ciruela plum eaten constipation 
Cuajadilla cheese curds eaten constipation 
cuatro canto Pluchea sagittalis tea from the leaves constipation 
Grey grapefruit eaten constipation 
Jabón soap enema constipation 
leche con alcohol milk with alcohol drink constipation 
Manzanilla chamomile enema constipation 
Naranja orange suck the juice constipation 
Papaya papaya eaten or in juice constipation 
Sen Cassia angustifolia tea from the leaves constipation 
Tacuo Acanthospermum 
hispidum 
tea from the roots constipation 
Lima lime suck the juice Stomach 
inflammation 
Totaí Acrocomia aculeata chew the fruit Stomach 
inflammation 
Caré Chenopodium 
ambrosioides 
tea from the leaves stomach pain 
coca del monte Erythroxylum coca tea from the leaves stomach pain 
flor de papaya con 
miel 
papaya flowers with 
honey 
tea stomach pain 
limón con 
bicarbonato 
lime with baking 
soda 
drink stomach pain 
Manzanilla chamomile tea from the flowers 
and leaves 
stomach pain 
piñón con manzanilla pine nut with 
chamomile 
tea stomach pain 
yerba buena mint tea from the leaves stomach pain 
aní anise tea from the seeds stomach swelling 
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     Ethnomedical treatments are learned about through family relations, interactions with friends 
and neighbors, and even through print and electronic media. They provide a much more 
accessible alternative than biomedical treatment for Chagas, because the ingredients are often 
readily accessible in household gardens, orchards, or nearby forests, or can be cheaply purchased 
in markets. This contrasts with narratives of biomedical treatments which describe hardships in 
terms of costs, travel, and debilitating side effects, while on other occasions doctors inform 
patients that there are no cures for Chagas disease (see system of care chapter).  
     Although the effects of ethnomedical treatments on Chagas disease and related symptoms 
have not been empirically studied, respondents describe intangible benefits, such as an increased 
feeling of tranquilidad. In part, ethnomedical remedies provide the emotional calm which 
respondents feel is critical to preventing a worsening of the symptoms of the disease. 
Respondents feel that there is at least one type of action they can take to combat Chagas disease, 
since oftentimes the biomedical system fails to provide this avenue.  
 
  
230 
 
 
 
 
CHAPTER TEN 
QUANTITATIVE RESULTS: CONSENSUS ANALYSIS  
 
     I administered a structured consensus analysis questionnaire to 48 CMHP patients with 
Chagas disease. This questionnaire contained 52 yes/no or true/false questions, following the 
format recommended by Weller (2007), in order to gain data amenable to the consensus analysis 
procedure. Consensus analysis provides three key types of information: 1) a test of whether a 
shared explanatory model exists in the sample, 2) answer keys of culturally correct responses to 
each question, and 3) the average “score” or competence of each individual when measured 
against the culturally correct answer key (Weller 2007, Miller 2011). Importantly, consensus 
analysis is not a test of participants’ biomedical knowledge of the disease. The model that the 
procedure provides is determined by the answers of the participants themselves, and individual 
participants are then compared against the group’s overall model. This chapter describes the 
results of the quantitative interviews. The results are compared with the biomedical model of 
Chagas disease, which is fully described in Chapter 4. 
 
Testing for a Shared Model of Chagas Disease 
     Forty eight people with a self-reported positive test for Chagas disease responded to the 52-
item consensus analysis questionnaire, in addition to completing a semistructured interview. 
Respondents ranged in age from 29 to 82 years old, with a mean age of 52. The majority of the 
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participants only had a few years of primary school, although nearly a quarter of the sample had 
at least a high school diploma (Table 10.1). Three quarters of the participants were female, and 
four-fifths were of the local camba ethnicity. Ten participants had migrated from Quechua 
speaking areas of Bolivia, including the departments of Sucre, Cochabamba, and Potosi. Nearly 
half the participants reported a household income less than the minimum wage (for one person), 
which was 1,000 bolivianos (roughly $145 US) at the beginning of the study. The minimum 
wage increased to 1,200 bolivianos ($174 US) in April, 2013 during the period of field research, 
following a national strike. The largest segment of respondents were homemakers, while others 
worked in agriculture, services, the professional sector or the informal economy. Some owned 
microenterprises or businesses. 
 
Table 10.1: Characteristics of the 48 Consensus Analysis Participants 
  N PERCENT 
EDUCATION None or NA 3 6 
 Primary school only 26 54 
 Middle school 8 17 
 High school 8 17 
 More than high school 3 6 
GENDER Male 12 25 
 Female 36 75 
ETHNICITY Camba 38 79 
 Quechua 10 21 
OCCUPATION Agricultural Laborer 5 10 
 Construction, transportation 
or services 
8 17 
 Homemaker 21 44 
 Microenterprise or informal 
economy 
7 14.5 
 Professional or business 
owner 
7 14.5 
INCOME >1,000 bs monthly 25 52 
 <1,000 bs monthly 23 48 
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     The consensus analysis data was tabulated in a spreadsheet and analyzed in Ucinet 6.491 
(Borgatti 2002) using the covariance method. This yields three principal pieces of information: 
1) the eigenvalue ratio, which indicates how much of the agreement between respondents can be 
attributed to a shared cultural model; 2) a culturally correct answer key; and 3) individual 
competence scores for each participant.  
     Eigenvalues are factors that explain variation in the consensus analysis responses. The first 
eigenvalue represents variation based on a shared cultural model, while the second is attributed 
to other factors (Miller 2011). When the ratio of the first and second eigenvalues is greater than 
three, it suggests the responses reflect a shared cultural model (Weller 2007). The first 
eigenvalue from this procedure was 20.179 and the second largest 2.145, resulting in a ratio of 
9.41. This substantially exceeds the minimum ratio of three recommended by Weller (2007), 
suggesting strong evidence of a shared cultural model of Chagas disease. The mean competence 
(on a 0 to 1 scale) was 0.64, with a standard deviation of 0.11. There were no negative individual 
competence scores, which combined with the fairly high mean competence gives further 
evidence of a shared cultural model (Weller 2007).  
     Weller (2007) recommended that between 30-70% of all items in a consensus analysis 
questionnaire should be “reasonably answered” as either yes or no. The culturally correct answer 
key generated by the procedure consisted of 31 affirmative and 21 negative responses. Thus, the 
proportion of “yes” responses in the answer key was 60% and “no” responses reached 40%, 
which suggests the items in the questionnaire achieved Weller’s recommended balance.  
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Domains of the Explanatory Model 
     Following the procedure used by Miller (2011), I divided the data into four different 
submatrices or domains, and analyzed each of these in Ucinet v. 6.491. The four domains 
encompassed questions relating to knowledge of the vector, ethnomedicine, symptoms, and 
social factors related to Chagas disease (Table 10.2). Each of these produced eigenvalue ratios 
superior to three, suggesting each domain represented an area of shared cultural knowledge. 
However, none of the ratios were as high as that of the overall sample. The ethnomedical domain 
produced the highest ratio (4.94), followed by vector (4.17), social factors (3.32), and symptoms 
(3.2). Mean competence was highest in the vector domain (0.74), followed by ethnomedical 
(0.73), social (0.59) and symptoms (0.49).  
 
Table 10.2: Consensus Analysis Results 
Domain Eigenvalue ratio Mean 
competence 
Ethnomedical 4.94 0.73 
Vector 4.17 0.74 
Social 3.32 0.59 
Symptoms 3.2 0.49 
Overall 9.41 0.64 
 
Social Factors 
     One of the main research objectives was to determine the extent to which structural factors 
played a role in the shaping of explanatory models. Thus, certain items in the questionnaire 
234 
 
probed respondents’ attitudes about various social aspects of Chagas disease in order to 
characterize the social component of the explanatory model. A fairly high mean consensus on the 
social questions (0.59), combined with a sufficiently high eigenvalue ration in this domain 
(3.32), suggest that these structural components do play a role in participants’ explanatory 
model. 
 
Table 10.3: Culturally Correct Answer Key, Social Factors 
Question Answer 
Chagas is only in the countryside.  No 
There are a lot of vices in the country, and for this reason there is a lot 
of Chagas. 
No 
Medicine for Chagas is very expensive. Yes 
Most people who have Chagas are rich.  No 
There are many programs and campaigns against Chagas in Bolivia.  No 
Sometimes they say you have Chagas but it’s just to get your money.  Yes 
It’s easy to get medical treatment for Chagas. No 
It’s hard to find work because I have Chagas. Yes 
Chagas is sometimes caused by witchcraft. No 
If I had money, I would have already cured my Chagas. No 
Chagas mainly affects poor people. Yes 
 
     The model indicates a clear understanding of the relationship of poverty to the disease; 
participants agreed that Chagas mainly affects poor people, not the rich (Table 10.3). Further, 
Chagas disease is not attributed to the noneconomic factors of “vices” and witchcraft. The shared 
model indicates suspicion of authorities and the biomedical establishment. Practitioners might 
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give a false diagnosis of Chagas simply to profit from a patient. Respondents did not believe 
there were many programs combatting Chagas in Bolivia, and they affirmed treatment for 
Chagas was expensive and difficult to access. However, even with sufficient financial resources, 
they doubted they would have cured their Chagas. Finally, the disease represented a potential 
barrier to employment. 
 
The Vector 
     Several items in the questionnaire pertained to vector knowledge of the kissing bug (scientific 
name Triatoma infestans), or the vinchuca as it is known in Bolivia. (Table 10.4). An analysis of 
just these items produced an eigenvalue ratio of 4.17. The ratio being greater than three indicates 
a coherent explanatory model pertaining to the vector. Mean competence was higher for the 
vector domain than overall (0.73 vs. 0.64). The participants’ knowledge corresponds well with 
the biomedical model of how Chagas disease is transmitted by vinchucas.    
    In the vector model, participants agreed that vinchucas, rats and mice all spread Chagas 
disease. This correlates well with biomedical knowledge (see Chapter 4), since mammals and 
poultry are known to act as reservoirs of Trypanasomi cruzi (Cecere et al. 1997, Rojas et al. 
2006). Participants identified adobe homes and palm-thatch roofs as potential risk factors for 
vinchuca colonization, whereas cement-brick houses prohibit infestation. Although vinchucas are 
in decline compared to years past, they have not been totally eliminated by government spraying 
programs. Interestingly, the model affirms that vinchucas also colonize the homes of the wealthy, 
even though in the social domain Chagas is seen as mainly affecting the poor.  
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Table 10.4: Culturally Correct Answer Key, Vector Domain 
Question Answer 
Does someone get sick from Chagas because they have been bitten by 
a vinchuca? 
Yes 
Do rats and mice spread Chagas? Yes 
Do vinchucas live in palm-thatch roofs? Yes 
The most venomous vinchuca is the red one. Yes 
There are many more vinchucas today than there used to be. No 
There are also vinchucas in the homes of rich people. Yes 
Vinchucas prefer houses of adobe and palm-thatch. Yes 
Vinchucas prefer cement-brick houses.  No 
All the vinchucas have died thanks to pesticide spraying programs.  No 
 
Symptoms 
     In the biomedical model (see Chapter 4), the symptoms of Chagas are diverse, variable and 
often hard to pinpoint (Rassi et al. 2010, Bern et al. 2011). There was agreement on the 
symptoms of Chagas in the sample, though it was not as strong in the other domains, perhaps due 
to the wide variability in how people experience the disease. The eigenvalue ratio (3.21) still 
exceeded three, but the mean competence in this area was only 0.49, compared to 0.64 for the 
entire questionnaire. In the explanatory model (Table 10.5), Chagas causes a wide range of 
symptoms, including constipation, swelling, fatigue, and chest pain; these are also major 
symptoms in the biomedical model for the chronic stage of the disease. Participants also 
correlated Chagas with symptoms outside of the biomedical understanding of the disease (see 
Chapter 4), including liver and vision problems. The model did not associate Chagas with lung 
cancer or fainting. Chagas was not considered a temporary condition, and the fact that Chagas 
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can be asymptomatic was recognized. The model affirmed that emotional stress, such as 
argument with a loved one, could worsen the effect of the disease.  
 
Table 10.5: Culturally Correct Answer Key, Symptoms Domain 
Question Answer 
Does Chagas affect the liver? Yes 
Can Chagas cause lung cancer? No 
Can Chagas cause constipation? Yes 
Does Chagas cause swelling in the body? Yes 
Does Chagas feel like a cold? No 
Do people with Chagas have difficulty breathing? Yes 
Do people with Chagas have difficulty seeing? Yes 
Does Chagas produce tiredness and fatigue? Yes 
Does Chagas produce pain in the chest? Yes 
Do some people with Chagas faint? No 
If I argue with my significant other, my Chagas gets worse.  Yes 
Some people have Chagas in their blood but don’t get sick.  Yes 
Chagas only lasts a while and then gets better. No 
Chagas mainly attacks the heart. Yes 
 
Ethnomedicine 
     The ethnomedical questions (Table 10.6) produced the highest eigenvalue ratio of the four 
domains (4.94), as well as the second highest mean competence score (0.73). In interviews, 
participants mentioned garlic, tipa bark, mandarin tree buds, lemon grass, colonia, eucalyptus 
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balm, and numerous other treatments for Chagas and its symptoms. The model accepted all of 
these except for tipa bark and eucalyptus balm. Eating papaya seeds, a local remedy for intestinal 
parasites, was not accepted as a treatment for Chagas, nor was drinking Coca Cola. Participants 
did not expect that antibiotics would cure Chagas, but affirmed that a pacemaker would 
eventually be necessary for anyone with the disease.  
 
Table 10.6: Culturally Correct Answer Key, Ethnomedical Domain 
Question Answer 
You can ease the effects of Chagas by drinking garlic puree. Yes 
If you have heart pain it is good to drink a tea made from mandarin 
buds. 
Yes 
The bark of the tipa tree is very good for people with Chagas.  No 
If you have heart pain, you should eat papaya seeds.  No 
Chest pains can be eased with lemon grass tea. Yes 
Chagas gets better if you drink Coca Cola. No 
Chagas gets better if you drink colonia tea.  Yes 
To cure Chagas you need antibiotics. No 
If you have Chagas, you will need a pacemaker sooner or later.  Yes 
When someone has chest pain, they should rub the chest with 
eucalyptus balm.  
No 
 
     In sum, the results show a shared explanatory model of Chagas disease based on a high 
eigenvalue ratio (9.41) and a strong mean individual competence score (0.64). Further, the 
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assumption of a shared cultural model continues to hold when looking at separate knowledge 
domains for ethnomedicine, the vector, symptoms and social factors. 
 
Differences in Answer Keys based on Social Variables 
          In order to explore group differences, I ran separate analyses based on different 
demographic factors. These included gender, household income (higher or lower than individual 
minimum wage), ethnicity (camba or highlander), and occupation. For the latter category, I 
created four groups: agricultural laborers, professionals, services (including transportation and 
construction), and microenterprise/informal economy. For homemakers, I used the spouse’s 
occupation to assign a category. Running the consensus analysis procedure in Ucinet provided a 
culturally correct answer key for each group; I then compared these for differences. Some of the 
subgroups had small sample sizes (<10), so the results should be interpreted with caution. 
However, for each of the subgroups, the average competence is higher than 0.5. When average 
agreement is higher than 0.5, a small sample size can be justified (Weller 2007). Moreover, the 
purpose of this study is exploratory, so examining group differences even with small sample 
sizes can illuminate possibilities for more comprehensive future investigations.  
 
Differences Based on Gender 
     Eight of the 52 items on the questionnaire (15.4%) produced differences between the 12 
males and 36 females in the sample (Table 10.7). In all but one case, males were more likely to 
agree with a statement. Males did not feel that Chagas disease could spread from inadequately 
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washed fruit (a biomedically identified transmission route) but females did. In the male 
explanatory model, Chagas could be cured, a process which required antibiotics and money. 
Females found Chagas incurable, even with money. In the male model, Chagas disease could 
lead to lung cancer, but females felt that it did not. Males believed there were many campaigns 
against Chagas in Bolivia but females did not.  
 
Table 10.7: Gender Differences 
Item Females Males 
Can Chagas cause lung cancer? No Yes 
Can I get Chagas from eating fruit that is not 
adequately washed? 
Yes No 
Is there a cure for Chagas? No Yes 
Do some people with Chagas faint? No Yes 
To cure Chagas you need antibiotics. No Yes 
When someone has chest pain, they should rub the 
chest with eucalyptus balm. 
No Yes 
There are many programs and campaigns against 
Chagas in Bolivia. 
No Yes 
If I had money, I would have already cured my 
Chagas. 
No Yes 
 
Differences Based on Income Level 
     While most respondents were poor, nearly half were abjectly so, with a total household 
income below the individual minimum wage of 1,000 bolivianos monthly. The poorest category 
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(n=23) differed from the rest of the group (n=25) on 7 of the 52 items (13.5%) (Table 10.8). In 
each case, the very poor were more likely to agree with a statement. The very poor identified 
more potential causes of the disease (not eating well and rodents), and their model included the 
possibility of lung cancer and fainting. In the model of the very poor, both antibiotics and 
eucalyptus balm could be effective treatments. 
 
Table 10.8: Differences by Income Level 
Item Below 
Minimum 
Wage 
Above 
Minimum 
Wage 
Can people get sick from Chagas because they do 
not eat well? 
Yes No 
Do rats and mice spread Chagas? Yes No 
Can Chagas cause lung cancer? Yes No 
Can I get Chagas from eating fruit that is not 
adequately washed? 
Yes No 
Do some people with Chagas faint? Yes No 
To cure Chagas you need antibiotics. Yes No 
When someone has chest pain, they should rub the 
chest with eucalyptus balm. 
Yes No 
 
Differences Based on Ethnicity 
     Most respondents were cambas, the ethnicity of the original but nonindigenous population of 
Santa Cruz. It is akin to mestizo in Mexico, but with strong regional customs and expressions 
that differ sharply from other ethnicities in Bolivia. Ten of the 48 respondents, who I will refer to 
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as “Quechua”, had migrated from western Bolivia and settled in the study area, and appeared to 
be bilingual Spanish and Quechua speakers, or at least came from areas of Bolivia where 
Quechua is commonly spoken. Differences between the two ethnic groups occur on ten items, or 
19.2% of the questions (Table 10.9).  
 
Table 10.9: Differences Based on Ethnicity 
Item Camba Quechua 
Can people get sick from Chagas because they do 
not eat well? 
No Yes 
Can Chagas cause lung cancer? No Yes 
Can I get Chagas from eating fruit that is not 
adequately washed? 
Yes No 
Is there a cure for Chagas? No Yes 
Do some people with Chagas faint?  No Yes 
There are a lot of vices in the country, and for this 
reason there is a lot of Chagas. 
No Yes 
To cure Chagas you need antibiotics. No Yes 
When someone has chest pain, they should rub the 
chest with eucalyptus balm. 
No Yes 
There are many programs and campaigns against 
Chagas in Bolivia. 
No Yes 
If I had money, I would have already cured my 
Chagas. 
No Yes 
 
     The Quechua group considered malnutrition and vices as causes of Chagas; cambas did not. 
The camba model allowed for unwashed fruit as a potential cause of Chagas, but this was not 
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part of the Quechua model. The Quechua group affirmed that Chagas could be cured (with 
money), but this was not possible in the camba model of the disease. The Quechua model also 
saw antibiotics and eucalyptus balm as beneficial, but the camba model did not.  
 
Differences Based on Occupation 
     The purpose of comparing answer keys according to different occupation groups was to gain 
insight on how structural links and class differences might impact explanatory models. The 
groups were determined based on the occupation of the respondent or, in the case of 
homemakers, the respondent’s spouse. The most respondents (n=20) were in the services 
category, which consists primarily of workers or spouses of workers in construction and 
transportation. This was followed by agricultural laborers (n=12), people with microenterprises 
or engaged in the informal economy (n=9), and professionals (n=7). The occupation categories 
produced differences in 16 items, or 30.8% of the questionnaire (Table 10.10), compared to 7 
differences when comparing income levels. 
     The professional participants’ explanatory model differs the most often from the other 
occupation groups. For example, there are 11 differences between the professional and 
agricultural laborer model, 11 disagreements with the service worker model, and 13 differences 
with the microenterprise/informal economy participant model. In contrast, the 
microenterprise/informal model only disagrees with the agricultural laborer model 4 times, and 
with service workers 7 times.  
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Table 10.10: Differences Based on Occupation 
Item Ag. 
Labor 
Prof. Services Micro./ 
Informal 
Can people get sick from Chagas because they do 
not eat well? 
Yes No No Yes 
Do rats and mice spread Chagas? Yes No Yes Yes 
Can Chagas cause lung cancer? Yes No No Yes 
Is Chagas caused by a bug that lives in the blood? Yes No Yes Yes 
Can I get Chagas from eating fruit that is not 
adequately washed? 
No No Yes Yes 
Do people with Chagas have difficulty seeing? Yes No Yes Yes 
Is there a cure for Chagas? Yes Yes No No 
Do some people with Chagas faint?  Yes No Yes Yes 
There are a lot of vices in the country, and for this 
reason there is a lot of Chagas. 
Yes No No Yes 
There are also kissing bugs in the homes of rich 
people. 
Yes Yes No Yes 
Chagas mainly affects the heart. Yes No Yes Yes 
You can ease the effects of Chagas by drinking 
garlic puree. 
Yes No Yes Yes 
To cure Chagas you need antibiotics.  Yes Yes No Yes 
When someone has chest pain, they should rub the 
chest with eucalyptus balm. 
Yes No No No 
Sometimes they say you have Chagas but it’s just 
to get your money. 
Yes No Yes Yes 
If I had money, I would have already cured my 
Chagas. 
No No No Yes 
 
     In the model formed by professional respondents, malnutrition and rodents were not causal 
factors for Chagas, nor did Chagas lead to lung cancer, fainting or vision problems. Professionals 
were also the only group to disavow garlic as an alleviant of Chagas (although professionals did 
tend to agree with the other groups on the effectiveness of other ethnomedical treatments). Only 
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the professional model disagreed that Chagas mainly affects the heart – many of these 
respondents pointed out that Chagas also affects the digestive system. Only the professional 
model did not harbor suspicion of providers giving a false diagnosis of Chagas simply to get 
patients’ money. 
     Agricultural laborers saw various causes and outcomes for Chagas, but affirmed that the 
disease could be cured. However, the agricultural model also purports that respondents would 
not have gotten a cure, even if they had money to do so. Only the agricultural model saw a 
benefit to using eucalyptus balm for chest pain. Both agricultural laborers and 
microenterprise/informal economy participants deemed not eating well and vices as possible 
causes of Chagas, and felt that Chagas would lead to lung cancer. The microenterprise/informal 
economy model disagreed with the statement that there was a cure for Chagas, yet participants 
also felt that with more economic resources they would have cured their Chagas.  
     In the service worker model, Chagas was seen as incurable, even with money. Service 
workers agreed with professionals that Chagas did not cause lung cancer, but agreed with 
microenterprise participants that Chagas could be spread by eating inadequately washed fruit. 
Only the service worker model disagreed that antibiotics could be effective in curing Chagas.  
 
Overview: Differences in Culturally Correct Answer Keys 
     When comparing culturally correct answer keys of different groups, there were seven 
differences based on gender, and eight different items based on income level being higher or 
lower than minimum wage. Ethnicity produced ten differences. Cambas were less likely to 
identify malnutrition and vices as potential causes of Chagas disease than Quechua participants, 
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and the camba model did not see a progression from Chagas disease to lung cancer, while the 
Quechua model did. However, the Quechua model was more optimistic about the existence of 
government programs to combat Chagas disease. This could in part stem from the way Quechua 
speakers tend to identify with the government of Evo Morales, a Quechua speaker who worked 
in the agrarian sector prior to rising to power. In the interviews, four Quechua participants spoke 
highly of the Morales government and specifically attributed improvements in vector control to 
his administration. In contrast, those who identify ethnically as camba tend to oppose the policies 
of the national government in distant La Paz, and strong secessionist and regionalist tendencies 
continue to ferment in Santa Cruz (Hertzler 2010). 
      Comparing the culturally correct answer keys of different occupational groups illuminates 
further differences. Differences in models emerge in proportion to how highly each group ranks 
in Bolivia’s socioeconomic hierarchy. For instance, the professional model stands out for 
differing more frequently with the other occupations. While the professional model differs with 
every other group on more than 20% of items, the differences between the other groups only 
vary from 8-15%.  The microenterprise/informal economy and agricultural laborer model are the 
most similar, with only four differences.  
     These two groups represent the most marginalized participants, and consequently the least 
likely to have medical care for Chagas disease. The microenterprise/informal economy group 
consisted exclusively of women who ran small shops (generally out of the home) or sold food as 
ambulatory or market vendors. Both groups reported limited options for medical care – and 
typify the segments of the Bolivian work force that are unable to avail themselves of the 2009 
Constitution’s guarantee of healthcare (Silva and Batista 2010). Service workers, though still 
marginalized in the economy, had slightly better earnings and in some cases more access to 
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medical insurance. This group differed moderately with the agricultural laborers and 
microenterprise/informal participants, but more frequently with professionals. The latter group, 
with the greatest earning potential and greater reported access to medical insurance, produced the 
most distinct model, one that identified fewer causes, negative outcomes, and ethnomedical 
treatments for Chagas disease.  
     In the consensus analysis results, the more marginalized participants created a dire portrait of 
the disease. In their model, a host of social problems, including rampant vices, rodents and 
malnutrition, contribute to the spread of the disease. The effects of the disease are perceived as 
more severe, resulting in fainting, loss of vision, and even lung cancer. Providers cannot always 
be trusted to provide a reliable diagnosis; they may be unscrupulous. In short, Chagas disease is 
associated with the conglomeration of ills that form part of the daily experience of these 
participants. It is just another thread which, when pulled, can unravel the fabric of daily 
existence. For professionals, however, Chagas disease has a specific, biological cause (the 
vinchuca), a more limited progression, and a better possibility of a cure.  
     Nonetheless, it is important to note that the different occupational groups still agreed on most 
items, even on the majority of the ethnomedical questions. Professionals still avowed the 
effectiveness of the three major ethnomedical treatments for Chagas symptoms: colonia, 
lemongrass, and mandarin buds. Still, a comparison of the models show that structural factors do 
produce key differences in subthemes of explanatory models for Chagas disease.   
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Statistical Comparisons between Groups 
     In addition to comparing the culturally correct answer keys produced by different groups, I 
also analyzed for differences based on mean individual competence scores. In this case, for the 
purpose of comparison, the competence scores for each individual are taken from the consensus 
analysis results of the entire sample (not from the analyses run on different groups).  
 
Table 10.11: Test of Uniform Competence 
Domain Mean 
competence 
Standard 
deviation 
Test cutoff  Decision 
Ethnomedical 0.73 0.25 0.18 Reject Ho 
Vector 0.74 0.21 0.18 Reject Ho 
Social 0.59 0.24 0.18 Reject Ho 
Symptoms 0.49 0.24 0.20 Reject Ho 
Overall 0.64 0.11 0.125 Accept Ho, 
borderline 
significance 
 
      Hruschka and Maupin (2012) provide a test for determining whether there is uniformity in 
competence scores. When the standard deviation exceeds certain levels in relation to the number 
of questions and participants, and the mean competence of participants, the null hypothesis that 
there is no difference between participants can be rejected. This provides evidence in favor of 
making comparisons based on individual competence scores between individuals within a 
sample.  The standard deviations and the outcome of Hruschka and Maupin’s tests are shown for 
each domain and for the whole sample (Table 10.11). In each of the four domains the null 
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hypothesis was rejected. For the entire sample, the standard deviation approached the cutoff but 
was slightly lower. Hruschka and Maupin state that this can be treated similar to “a marginally 
significant p value of around .05.” 
     The results of Hruschka and Maupin’s test provide evidence in favor of comparing mean 
competence scores, particularly in the four domains or submatrices. Consequently, I tested for 
differences based on education, income level, gender, ethnicity, community of residence, and 
occupation category. 
     First, I checked for correlations between years of education and mean overall competence as 
well as ethnomedical, vector, social and symptoms competence (Table 10.12). The four domains 
were all significantly correlated with overall competence, but years of education was only 
significantly correlated with symptoms competence, with a Spearman’s rho of 0.369. Of the four 
domains, the social and ethnomedical were significantly correlated (Spearman’s rho=0.31).   
 
Table 10.12: Spearman’s Correlation Coefficients 
 Competence Ethno-
medical 
Social Vector Symptoms Education 
Competence 1 0.575** 0.574** 0.501** 0.357** 0.033 
Ethno-
medical 
0.575** 1 0.310* 0.184 -0.012 -0.262 
Social 0.574** 0.31* 1 0.145 0.125 -0.013 
Vector 0.501** 0.184 0.145 1 -0.002 0.157 
Symptoms 0.357** -0.012 0.125 -0.002 1 0.369** 
Education 0.033 -.262 -0.013 0.157 0.369** 1 
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     Next, I compared mean competence scores both overall and in the different domains 
according to social variables, including income level, gender, ethnicity, occupation and 
community of residence. Based on a Kolmogorov-Smirnov Test, the domains failed to meet the 
assumption of normality. Thus, a Kruskal-Wallis test was used to check each of these categories, 
and then individual comparisons were made using Mann-Whitney tests.  
      Comparisons based on gender, ethnicity and income did not produce statistically significant 
differences. While competence scores in all areas except for the symptoms domain were higher 
for women, the differences did not prove statistically significant (Table 10.13). The difference in 
overall competence would have been significant with a 90% confidence interval. 
 
Table 10.13: Mann-Whitney Test Results, Gender 
Gender n Competence Ethnomedical Social vector symptoms 
Females 36 0.66 0.76 0.62 0.74 0.48 
Males 12 0.58 0.64 0.5 0.73 0.52 
p value  0.08 1.21 0.121 0.504 0.943 
 
     Mean competence scores were very comparable between the camba and Quechua participants 
(Table 10.14), except that the Quechua group had higher social competence and the cambas had 
higher vector competence. However, this finding did not attain statistical significance. 
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Table 10.14: Mann-Whitney Test Results, Ethnicity 
Ethnicity n Competence Ethnomedical Social vector symptoms 
Camba 38 0.64 0.73 0.58 0.75 0.5 
Quechua 10 0.63 0.75 0.64 0.69 0.49 
p value  0.77 0.85 0.46 0.27 0.61 
 
     To test for differences based on income, the sample was divided between those households 
earning less than the individual minimum wage of 1,000 bolivianos (n=23) and those earning 
more (n=25). The mean competence scores were highly similar, without any significant 
differences (Table 10.15). However, the majority of the respondents even in the category earning 
more than minimum wage tended to be poor, and the categories did not take into account 
household sizes.  
 
Table 10.15: Mann-Whitney Test Results, Income Level 
 n Competence Ethnomedical Social vector symptoms 
< min. 
wage 
23 0.63 0.71 0.6 0.76 0.46 
>min. 
wage 
25 0.64 0.75 0.58 0.72 0.52 
p value  0.79 0.37 0.93 0.86 0.44 
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Differences in Mean Competence by Occupation 
     Since income levels did not provide a strong basis for comparisons, I instead used occupation 
categories as proxies for testing differences in mean competence based on social class. These 
were the same categories I used in comparing the consensus analysis answer keys; homemakers 
were assigned to a category depending on their spouse’s occupation. To assure meaningful 
comparisons, mean competence scores were derived from scores in the overall consensus 
analysis sample (not from the consensus analysis procedures performed on the different 
categories to test for answer key differences).  
 
Table 10.16: Differences in Occupation Categories 
 n Competence Ethnomedical Social vector symptoms 
Ag. Labor 12 0.57* 0.63* 0.59 0.58** 0.46 
Microenterprise 9 0.71 0.86 0.69 0.82 0.45 
Professional 7 0.6*** 0.52* 0.44 0.81 0.61 
Services 20 0.66 0.81 0.59 0.77 0.5 
p value  0.03 0.007 0.534 0.034 0.534 
* significant difference (p<0.05) compared to microenterprise and services categories 
** significant difference (p<0.05) compared to all other categories 
*** significant difference (p<0.05) compared to microenterprise category 
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     The microenterprise/informal category had the highest mean competence scores overall, and 
scored highest in every domain except for symptoms (Table 10.16). The professional category 
was lowest in ethnomedical and social factor knowledge, but highest in symptoms knowledge 
and second-highest in vector competence. Ethnomedical competence was very high in both the 
microenterprise and services occupations (0.86 and 0.81). Using a Kruskal-Wallis test, 
significant differences emerged in overall, ethnomedical, and vector competence, but not in 
social or symptoms competence.  
     The significant differences were pinpointed using Mann-Whitney tests comparing each 
occupation category to the other. Agricultural laborers differed significantly from the other three 
categories based on vector competence, and from the services and microenterprise/informal 
categories in terms of overall and ethnomedical competence. The professionals had significantly 
different mean ethnomedical competence than the services and microenterprise/informal 
category, and significantly different overall competence from the microenterprise/informal 
category. There were no significant differences between the microenterprise/informal and 
services group.  
     The microenterprise/informal participants ranked highest in overall, ethnomedical, social and 
vector competence, while professionals ranked highest in symptoms competence. Professionals’ 
higher competence in the symptoms domain could stem from their potentially greater access to 
biomedical care and knowledge. Ethnomedical competence for the microenterprise group was 
extremely high (0.86), although it was second fewest in number of participants. The 
microenterprise group scored significantly higher than agricultural laborers and professionals in 
overall and ethnomedical competence. While the women of this group are largely marginalized 
from the formal economy, their positions as storekeepers or vendors puts them into frequent 
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contact with other members of the community, potentially exposing them more often to 
opportunities to exchange knowledge. This may be why competence scores for the 
microenterprise group tend to be higher than those of agricultural laborers, whose role restricts 
them from being in frequent contact with different members and sectors of society. 
     While professionals scored highest in symptoms knowledge, this was the least coherent of the 
four domains, and the differences between groups in this category were not statistically 
significant. Interestingly, professionals scored lowest for social knowledge (0.44), but again the 
comparison failed to show significance. Professionals also scored substantially lower in 
ethnomedical competence (0.52) than the other groups, and this was significant when compared 
with the microenterprise and services categories. Although professionals appear to accept the 
value of ethnomedical treatments, as noted in analysis of their culturally correct answer key, the 
information they have in this area is limited compared to the other groups. Their higher social 
status serves to distance them from the poor majority in Bolivia, while concurrently their greater 
access to medical care makes them less dependent on ethnomedical treatments as the only viable 
alternative. They are more likely to have health insurance and thus access to biomedical care 
than the other occupation groups.  
     Agricultural laborers scored lowest in overall and vector competence, with significant p 
values in both areas. Their ethnomedical competence was also significantly lower than the 
microenterprise and services participants. It may be that the necessity of working in rural areas 
isolates this group from the currents of knowledge that are readily accessible to 
microentrepreneurs, and to a lesser extent services workers, many of whom drive taxis.  
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Differences in Mean Competence by Community 
     Lastly, participants were grouped according to community of residence, and the four largest 
groups were compared (Table 10.17). Warnes had the most participants (12), followed by Buena 
Vista (9), Palacios (9) and Yapacani (7). There were 11 participants from other communities who 
were not included in the analysis since the group sizes would have been too small. A Kruskal-
Wallis detected initial areas of difference, and specific differences were identified using Mann-
Whitney comparisons.  
 
Table 10.17: Differences in Communities 
Community n Competence Ethnomedical Social vector symptoms 
Buena Vista 9 0.75 0.94 0.71 0.81 0.63 
Palacios 9 0.55** 0.54** 0.49 0.66 0.37* 
Warnes 12 0.68* 0.81* 0.62 0.8 0.44* 
Yapacani 7 0.56** 0.55** 0.57 0.62 0.51 
p value  0.001 0.001 0.39 0.167 0.078 
* significant difference (p<0.05) compared to Buena Vista 
** significant difference (p<0.05) compared to Buena Vista and Warnes 
 
     Buena Vista had the highest overall mean competence score (0.75) and the highest scores in 
the four domains. Buena Vista’s mean overall competence differed significantly from the mean 
scores of Palacios (0.55), Warnes (p.68), and Yapacani (0.56). Ethnomedical competence for 
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Buena Vista was extremely high (0.94), and differed significantly from the second-highest 
group, Warnes (0.81). In addition, the much lower mean ethnomedical competence scores from 
Palacios (0.54), and Yapacani (0.55) differed significantly from Warnes as well as Buena Vista. 
Mean competence in symptoms tended to be lowest of the four domains, and the scores in 
Palacios (0.37) and Warnes (0.44) were much lower than those of Buena Vista (0.63, p<0.05).  
     Analysis by community reveals the highest competence overall and in every domain for 
Buena Vista, while Palacios is lowest in every category except social factors. Buena Vista’s high 
overall competence (0.75) is driven by an extremely high mean ethnomedical competence (0.94). 
Indeed, the community appears to have a reputation for high knowledge of healing plants 
(Autonomous Departmental Government of Santa Cruz 2011). In both the overall and 
ethnomedical categories, Buena Vista’s differences with the other three communities are 
statistically significant. 
     The four communities have distinct socioeconomic profiles. Palacios is the only community 
without a paved road, and lies five kilometers from the main highway that connects the 
metropolis of Santa Cruz with the next largest Bolivian city, Cochabamba. It is the most rural of 
the four communities, as well as the poorest, but it is also home to the CMHP and the free 
medical services it provides. Yapacani lies squarely on this highway and is a major destination 
for migrants from the interior, as well as a center of coca and fruit production. Warnes is a mid-
sized city in close proximity to the much larger city of Santa Cruz, and hosts several key 
industries, including Santa Cruz’s international airport, breweries, and major agroindustrial 
processing plants. Buena Vista is geographically in the center of the four communities, and 
easily accessible to the main highway. It is smaller than Warnes and Yapacani, and has 
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experienced limited economic boosts from tourism and coffee production, as well as nearby 
hydrocarbon reserves.  
     Educational status is comparable in the four communities, with participants attaining a fourth 
or fifth grade level on average (Table 10.18). The median years of education are highest for 
participants from Palacios, and lowest in Warnes and Yapacani. Mean years of education are 
highest in Yapacani and lowest in Buena Vista. Although the differences in education levels are 
minor, the communities with the lowest mean and median years of education (Buena Vista and 
Warnes) had the highest mean competence. One possible explanation for this is that people with 
higher years of education tend to become more isolated from the prevailing explanatory model in 
the sample, which would also account for professionals’ relatively low mean competence.  
 
Table 10.18: Education Levels by Community 
Community Mean years of education Median grade attained 
Buena Vista 4.8 4th 
Palacios 5.5 6th 
Warnes 4.5 3rd 
Yapacaní 5.7 3rd 
 
     Palacios’s lower mean competence could reflect its greater isolation compared with the other 
communities. Another impact could be the presence of the CMHP. The availability of free or low 
cost services and medication in a community so small is a rarity in rural Bolivia, and could 
certainly influence the way people in the community think about Chagas disease. However, in 
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Miller’s (2011) study, proximity to biomedical health centers was associated with higher cultural 
competence for Ariaal women. The lower scores in Palacios and Yapacani could also reflect the 
sample composition; the bulk of the participants from these communities were agricultural 
laborers, with no microentrepreneurs. In contrast, nearly all the participants from Warnes and 
Buena Vista were microenterprise/informal participants and service workers – the two 
occupation groups with the highest mean competence.  
     Thus, the main way the samples from Yapacani and Palacios differ from those of Buena Vista 
and Warnes is that they are more closely tied to agricultural labor (Gobierno Autónomo 
Departmental de Santa Cruz 2012). As a whole, while cash crops form an important component 
of the economies of Buena Vista and Warnes as well, these communities are not as wholly 
dependent on agriculture as Palacios and Yapacani. In sum, this provides more evidence that 
structural factors influence explanatory models; the way individuals are linked to the economy 
has an impact on their cultural knowledge. 
 
The Impact of Socioeconomic Differences on Competence in the Social Domain 
     Having discussed the impact of social differences on culturally correct answer keys and mean 
cultural competence, a related question is whether agreement on the social items in the 
questionnaire is affected by participants’ socioeconomic characteristics, such as gender, ethnicity 
and occupation. In the consensus analysis procedure, mean social competence was fairly similar 
when comparing based on ethnicity and income (Table 10.19). Females had notably higher social 
competence than males (0.62 vs. 0.50). The microenterprise/informal group had substantially 
higher social competence than professionals, and people from Buena Vista had higher social 
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competence compared to Palacios, but the results were not statistically significant. Still, this 
raises the possibility that such differences exist and might be detected at a statistically significant 
level in a follow-up study with a more comprehensive sampling strategy.  
     The lower social competence score among professionals suggests they do not share the same 
model of sociopolitical influences on Chagas disease as the other occupational categories. 
Having more resources to cope with the impact of the disease could play a role in this. 
Professionals could also have fundamentally different opinions on how government programs 
and economic processes impact the disease, when compared with the other groups.  
    Palacios had substantially lower social competence than Buena Vista and Warnes. This could 
reflect Palacios’s greater isolation from the highway system, or the preponderance of agricultural 
laborers in the Palacios subsample. Respondents from Palacios may also have less interaction 
with the public health system, in part because of the presence of the CMHP in their community, 
and in part because there is only one level one health center, which is only open part time. In 
contrast Buena Vista has several level one health centers, while Warnes and Yapacani have 
larger level two facilities as well. Five of the nine participants from Palacios were diagnosed 
with Chagas disease in the CMHP, compared with only one of nine from Buena Vista and two of 
twelve from Warnes. All participants were patients of the CMHP, but the clinic is much easier to 
access for people from Palacios. This accessibility to free or low-cost care from a foreign NGO 
may ameliorate some of the social impacts which people from Palacios might otherwise 
experience, giving them a different sociopolitical picture of Chagas disease compared with the 
other communities. 
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Table 10.19: Mean Social Competence in Different Social Categories 
Category Subcategory Mean social competence 
Gender Female 0.62 
 Male 0.50 
Ethnicity Camba 0.58 
 Highlander 0.64 
Occupation Agricultural labor 0.59 
 Professional 0.44 
 Microenterprise 0.69 
 Services 0.59 
Income > minimum wage 0.6 
 < minimum wage 0.58 
Community Buena Vista 0.71 
 Palacios 0.49 
 Warnes 0.62 
 Yapacani 0.57 
 
     The consensus analysis results indicate the sample shares an explanatory model of Chagas 
disease, based on the high eigenvalue ratio (9.41) and relatively high average competence (0.64). 
There is also substantial agreement between participants on the ethnomedical, vectoral, and 
social aspects of Chagas disease, but only tenuous agreement on symptoms. While this model 
shares some features with the biomedical model described in Chapter 4, participants identify a 
broader range of etiological factors, including structural forces and stress. There are some 
differences in subthemes based on gender and ethnicity; for example, in the male and Quechua 
model Chagas could be cured, whereas it was incurable in the female and camba model. 
Variations in culturally correct answer keys are strongest based on occupation categories- which 
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contributes to differences in 30% of items. Yet there is considerable agreement between different 
social groups on ethnomedical aspects of Chagas disease. When comparing average competence 
scores, significant differences emerged based on occupational category and community of 
residence, but not for ethnicity, gender and income. However, occupation and community are 
two primary ways in which people are socially organized and linked to the economy. Therefore, 
the quantitative findings support a clear explanatory model of Chagas disease in the study 
population, one that has a strong social component.  
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CHAPTER ELEVEN 
DISCUSSION OF THE RESEARCH FINDINGS 
 
     This project investigated explanatory models of Chagas disease in a highly endemic region in 
the department of Santa Cruz, in tropical eastern Bolivia. The aim of the project was to gather 
qualitative and quantitative data on explanatory models of Chagas disease, using the mixed-
method strategy advocated by Garro (1996), as well as to describe the local system of care for 
Chagas disease and identify barriers or opportunities for biomedical treatment faced by people 
suffering from the disease. Another goal of the study was to compare both qualitative and 
quantitative data on Chagas disease with the current biomedical model described in Chapter 4. In 
this chapter, the results pertaining to each research objective are comprehensively discussed. The 
main research objectives are stated below: 
1) Gather qualitative data on explanatory models of Chagas disease.  
2) Gather quantitative data on explanatory models of Chagas disease.  
3) Compare qualitative data on explanatory models of Chagas disease with the 
biomedical model. 
4) Compare quantitative data on explanatory models of Chagas disease with the 
biomedical model. 
5) Assess the structural context of Chagas disease in the study area. 
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Qualitative Data on Explanatory Models of Chagas Disease 
 This study gathered three main types of qualitative data on explanatory models of Chagas 
disease: responses to semistructured interviews (n=68), free lists of treatments for Chagas 
disease and its symptoms (n=68), and participant observation data from March-June 2013. While 
Kleinman (1980) identified five main components of explanatory models (etiology, time and 
mode of symptom onset, pathophysiology, course of sickness, and treatment), for analytical 
purposes I have simplified these to four main areas: etiology, symptoms, progression and 
treatment. Qualitative findings on each of these components, including comparisons with the 
biomedical model of Chagas disease from Chapter 4, are discussed below.  
 
Etiology 
     The main cause of Chagas disease that emerges in respondents’ explanatory model is the 
vector, the vinchuca. This concurs with the biomedical model. Respondents discuss vinchucas 
more frequently than other causes of the disease.  It is evident from the 68 qualitative interviews 
that respondents unanimously blame the vinchuca for the spread of Chagas disease. All 
respondents recognized the vinchuca as the principal vector, and 115 comments about vinchucas 
were coded in Atlas.ti, more than any other topic.  
     While participants affirm the vinchuca is the principal transmitter of Chagas disease, they 
tend to view the vinchuca as part of both the natural and social landscape they inhabited at the 
time they became infected. In the interviews, respondents strongly associate vinchucas with past 
history, living in “el campo”-the countryside, and being poor. These themes frequently co-
occurred during coding of the interviews. This is visually represented by the Venn diagram in 
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Figure 11.1. The presence of the vinchuca is strongest where the circles overlap. This also means 
that respondents who were poor and lived in the countryside in traditional housing – an aspect of 
the past – were currently the most likely to continue being at risk for vinchuca infestation.  
 
 
Figure 11.1: The Location of Vinchucas in the Interview Narratives 
Respondents associate vinchucas with past experience, being poor, and living in "el campo"- the 
countryside. 
 
          Findings from the semistructured interviews indicate some shared ground with the 
biomedical model of Chagas disease. The biomedical model stipulates that Chagas disease can 
be transmitted congenitally (Azogue et al. 1993) and via rodent reservoirs (Rojas et al. 2006). 
The explanatory model in the study supported rats and mice as carriers for Chagas, and this was 
occasionally mentioned during interviews. Moreover, the explanatory model agreed that Chagas 
The past
Poverty
El 
Campo
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could be passed from parents to children. However, two interview respondents stipulated that 
fathers could pass the disease to their children, whereas the biomedical model only recognizes 
congenital transmission. In the interviews, eight people attributed the high prevalence of Chagas 
disease in the region to climate. This is compatible with the biomedical model, since the 
vinchuca is known to prefer certain ecotopes (Cortez et al. 2007).  
     However, respondents identified a much broader range of causes for Chagas disease when 
compared with the biomedical understanding. The biomedical model stresses biological routes of 
transmission: contamination of the blood with vinchuca feces infected with T. cruzi, blood 
transfusion or organ transplant, congenital transmission, and most recently, oral transmission 
through contaminated food (Moncayo and Silveira 2009, Rassi et al. 2010). Although 
respondents would not necessarily reject any of these causes, they also stressed the importance of 
other causes. As Farmer found in his investigation of move san explanatory models in Haiti, 
“illness was often conceived in broad terms of misfortune” (Farmer 1988, p. 80). Farmer noted 
that respondents described episodes of illness in the context of a much wider range of complaints 
that are not easily reduced and classified into discrete categories such as “social” or “emotional.”   
Similarly, Tapias (2006) emphasizes the relationship between structural inequalities, social 
suffering, and the development of debilidad in a rural Bolivian sample. Oths (1999) traces 
debilidad in a Peruvian sample to the stressful conditions of daily life for rural Peruvian women.  
In my investigation, respondents viewed Chagas disease as a result of social processes, and 
described similar feelings of extreme tiredness.  
     Participants considered the social environment as an integral part of the causation of their 
Chagas disease, even though they recognized the vinchuca as the natural vector. When asked 
why they thought they had Chagas disease, 58.7% mentioned vinchucas, but living in traditional 
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housing (36.5%) and living in the countryside (25.4%) were also common reasons. Furthermore, 
when asked why there is a lot of Chagas disease in their area of Bolivia, only slightly more 
respondents blamed vinchucas (35.3%) than housing conditions (32.4%). Other respondents 
directly attributed Chagas disease to labor conditions on haciendas in the countryside. 
Consequently, for respondents, the vinchuca is merely part of the rural, marginalized 
environment where they acquired the disease.       
     Other causes of Chagas disease found during the qualitative interviews differ with the 
biomedical model. A few respondents discussed hot-cold fluctuations, although only one person 
described this as a cause of Chagas disease. Vices was another infrequently mentioned cause. 
Finally, respondents mentioned plants (urucú) and other factors, such as light, that could attract 
vinchucas to homes. Respondents’ consideration of etiological factors is thus broader than that of 
the biomedical model, and places a greater emphasis on the social environment.  
 
Symptoms 
     The range of symptoms discussed in the qualitative interviews was diverse. Cardiac 
symptoms of the disease were the most frequently discussed during the interviews, although 
thirteen people mentioned the gastrointestinal variation of the disease. The five most frequently 
mentioned symptoms were chest pain, tiredness, swelling, fatiga--a shortness of breath 
associated with an accelerated heartbeat, and difficulty breathing. In fact, most of these also 
appear on a list of heart disease symptoms from the American Heart Association: 
Common symptoms of heart failure are difficulty in breathing when lying down (this is a 
specific symptom of heart failure), necessity of propping up the head of the bed with 
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many pillows, wakefulness at night with shortness of breath, cough at night or when lying 
down, shortness of breath with activity, swelling of ankles or legs, unusual fatigue with 
activity, and fluid weight gain. (Bozkurt & Mann 2003, p. 2) 
 
     Consequently, the most common symptoms discussed by participants are compatible with the 
biomedical understanding of heart failure – a potential consequence of chronic Chagas disease. 
The fact that heart-related symptoms dominate the respondents’ list also corresponds with the 
biomedical model, since up to 90% of people who develop chronic Chagas symptoms are 
impacted in the coronary system (Rassi et al. 2010). The most common gastrointestinal 
symptoms respondents mentioned, constipation, is only ninth on the overall list (see Chapter 8).  
     In the biomedical model, the aforementioned symptoms are aggravated by damage to the 
heart muscle from heart attacks, smoking, viral infections of the coronary muscle, and in some 
cases congenital defects (Bozkurt & Mann 2003). However, in this study, respondents 
emphasized the emotional component of the disease. More to the point, the emotional aspect of 
the disease was not disentangled from other aspects in participants’ narratives. Similarly, Farmer 
described Haiti’s move san as “a disorder of experience, without a great deal of Cartesian 
anguish as to whether it is more somatic than psychological” (Farmer 1988, p. 79). In this study, 
Chagas disease has an emotional toll, yet emotions also have a multiplicative effect on the 
disease’s intensity. Over 40% of respondents indicated they felt emotionally distraught open 
being diagnosed with the disease. At the same time, drastic changes in emotions can activate the 
symptoms of the disease and have to be avoided. Extreme worry, or even extreme happiness, 
were reported as potential triggers of heart conditions. In Tapias’ (2006) study of Bolivian 
market vendors, and in Oths’ (1999) investigation in rural Peru, stress brought on by social and 
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economic marginalization contributed to the condition of debilidad, an extreme tiredness that is 
not unlike that described by some of the people with Chagas disease in my sample. Similarly, 
Poss and Jezewski (2002) found in their study of explanatory models of diabetes that a stressful 
life event or susto could trigger the onset of diabetes symptoms. Malnutrition, alcohol/drugs, and 
fluctuations in temperature are other factors mentioned as aggravating Chagas symptoms.  
     In contrast to Bastien (1998) and Vanderbroek at al. (2008), I did not find that folk illnesses 
were mentioned in association with Chagas disease. However, in Bastien’s work, the folk 
illnesses susto, empacho, and cólico miserere were mentioned in association with the 
gastrointestinal symptoms of Chagas disease, while few of the participants in my sample were 
suffering from major gastrointestinal symptoms. Also, Bastien encountered cólico miserere in a 
Quechua-speaking community in Potosí department, whereas 85% of participants in this study 
were ethnically camba and from Santa Cruz department. There are major historical, linguistic 
and cultural differences between these two groups. Bastien (2003) suspected Chagas disease was 
really interpreted as several different types of folk illnesses, including cólico miserere and 
liquichado. Vanderbroek at al. (2008) speculated that the Quechua folk illness of madre might be 
used to explain Chagas disease. In the present study, none of these folk illnesses were mentioned, 
even by the ten Quechua participants, and all participants recognized Chagas as a single disease. 
This may be because respondents in this study were patients of a biomedical clinic, or were less 
isolated than those in Bastien (1998, 2003) and Vanderbroek et al. (2008). Moreover, an in-depth 
study of folk illnesses in camba communities may turn up potential illnesses which would 
overlap with the effects of Chagas disease.  
      Respondents also describe the disease’s impact on their ability to function socially. The 
symptoms of “tiredness and fatiga” are frequently mentioned in interviews. Thus, those who 
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endure the disease and experience advanced symptoms find they can no longer function as 
before; they experience a reduced social role, diminished earning power, and decreased energy. 
Often, they summarize the debilitating effects of the disease in the concept of fatiga. This is 
when the heartbeat and breathing of an individual are suddenly imperiled, leaving the individual 
weak and out of breath. This prevents them from exerting themselves and carrying out tasks, 
either in the home or in their place of work. Participants experience symptoms not only as 
physical suffering but as barriers that cut them off from their normal social roles.   
     Thus, while respondents largely agree with the biomedical model in terms of what Chagas 
disease does to the body, they tend to have a wider view of why this happens. When participants 
describe the symptoms of Chagas disease, there is not a Cartesian separation of emotional 
wellbeing and bodily functioning. Like Tapias (2006) and Oths (1999), I found that social 
structure, emotional duress, and physical suffering were interlinked for people with Chagas 
disease. Crying or sadness was even described as a symptom of the disease by three participants, 
while fourteen respondents emphasize the impact of emotional agitation on the course of the 
disease. Further, it is not only negative feelings which can affect the symptoms of the disease, 
but any strong emotion.  
 
Progression 
     The incurability of the disease emerged as a key theme in the qualitative interviews. Twenty-
five respondents, or 37% of the sample, spontaneously described Chagas as a life-threatening 
disease, with eight emphasizing the potential unexpected suddenness of that death. A common 
theme in the interview narratives was that Chagas can only be “controlled”, not cured.  
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     Yet the origins of the idea of “incurability” come from within the biomedical establishment. 
Even recent articles in the New York Times termed Chagas disease “incurable.” This is an area 
of controversy within biomedicine. Practitioners often disagree over whether to provide 
treatment with the available medications – and risk potentially fatal side effects – or leave 
patients to manage the disease in the hope they will remain asymptomatic. Treatment is often 
effective in children, but the medications are more dangerous for adult patients, and their benefits 
have not been conclusively proven (Bern et al 2011). In the U.S., the CDC currently opts to treat 
patients with the disease up to age 50. While the Bolivian government now offers free treatment 
for adults using the controversial medications, this service is only available in the city of Santa 
Cruz, and is virtually impossible for adult patients in the study communities to access. A 
brochure from Santa Cruz’s Departmental Chagas Program states “Chagas disease has a cure if it 
is detected on time” (2013, p. 3). Nonetheless, many doctors continue to tell patients that there is 
no cure (MSF 2009). In this study, seven participants indicated their doctors had told them the 
disease was incurable. In Friedl’s (1982) study of explanatory models of black lung, coal miners 
tended to reject public treatment options aimed at managing the condition since providers had 
told them black lung was incurable. 
     Consequently, the notion of Chagas disease as incurable is influenced by structural factors. In 
his analysis of explanatory models of vodou in Haiti, Vonarx concludes that “representations of 
certain illnesses are not a purely local construction that lies within the bounds of Haitian culture” 
(2007, p. 27). He argues that global, historically rooted socioeconomic processes have shaped 
models of illness in Haiti. In the case of Chagas disease, the pharmaceutical industry has failed to 
develop effective medications, or indeed any medications, in the last 40 years because of the lack 
of a profitable market. The government, with severely constrained resources, has been slow to 
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introduce treatment for adults in rural areas, where there is a lack of medical infrastructure. Thus, 
the fact that Chagas disease is viewed as “incurable” is in many cases a product of sociopolitical 
context. 
 
Treatment 
     The qualitative interviews indicate extensive knowledge of ethnomedical treatments for 
Chagas disease and its related systems. For Crandon (1986), medical pluralism in the rural 
highlands of Bolivia was an arena for negotiation of social identity, and preference for 
ethnomedical treatments was directly tied to historical and political processes. Vanderbroek at al. 
(2008) proposed that, in rural Bolivia, “the fact that plant remedies are directly available from 
the surroundings might be a good strategy to avoid costly long-lasting biomedical care, 
especially for chronic health conditions” (2008, p. 10).  Similarly, Greene (2004) found that use 
of ethnomedical treatments for Aymara tuberculosis patients in La Paz was more a product of 
structural barriers and hidden costs in the free biomedical treatment program, rather than an 
innate preference for ethnomedical healing. In the present study, I found, similar to Greene 
(2004) and Vanderbroek et al. (2008), that accessibility and structural barriers influenced the use 
of ethnomedical treatments. 
     In the interview narratives, participants describe biomedical treatment as costly and difficult 
to access, and no one in the sample was familiar with the government’s efforts to provide free 
treatment for adults. Some described crippling expenses for medication and hospitalizations 
related to their Chagas disease, and were frustrated with the unavailability of treatment options in 
their towns. When confronted with high costs, lengthy travel, and doubtful prospects for a cure, 
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most participants preferred to utilize ethnomedical treatments. Although participants often 
mentioned taking doctor-prescribed medication for diabetes and other ailments, few had 
experience with medications for Chagas disease. Participants could also not recall specific names 
for biomedical medications with as much accuracy as ethnomedical treatments.  
     Respondents mentioned a wide range of ethnomedical remedies that specifically targeted 
Chagas disease. During free-listing exercises, 33 remedies for Chagas were named, with the most 
salient being ivomec. In addition, six other remedies were revealed through participant 
observation, bringing the total to 39. Because participants were likely to take remedies in 
response to heart-related symptoms they might experience in relation to Chagas disease, I also 
asked which remedies were good for the heart. Respondents free-listed 62 remedies for Chagas 
cardiac symptoms, and I learned of four more through fieldwork, yielding a total of 66. The most 
salient were a triumvirate of plant-based remedies which were often taken together in teas: 
mandarin buds, colonia and lemongrass. These were also highly salient in the Chagas-specific 
free lists. Based on interviews with ethnomedical healers, Vanderbroek et al. (2008) identified 
181 types of medicinal plants for various uses in a Quechua community in rural Bolivia, but 
stated they did not find treatments for a “heart condition”, nor any mention of Chagas disease. 
However, Vanderbroek et al. gathered ethnomedical data from healers, whereas I spoke directly 
to patients. Still, patients in the study did mention that healers had provided them with remedies 
for Chagas disease. It may be that ethnomedical treatments for Chagas disease became more 
common in the time between Bastien (1998) and Vanderbroek et al’s (2008) research and my 
investigation in 2013, perhaps as a response to public health efforts to raise awareness of the 
disease during the major vector control initiatives of the early 2000’s. The present study suggests 
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that ethnomedical treatments for heart symptoms as well as Chagas disease are quite common in 
the study area north of Santa Cruz, Bolivia.  
     The most salient treatments that directly target Chagas disease were ivomec (Smith’s S=0.25) 
and garlic (Smith’s S=0.17). In the case of ivomec, people with Chagas disease are expropriating 
a biomedical treatment from the professional to the popular sector. Still, ivomec is more readily 
accessible than most biomedical treatments. A veterinary medication, it can easily be purchased 
at local markets, and one respondent mentioned administering it to his dogs to prevent worms. 
Thomas et al.’s (2008) study of susto among the Trinitario of eastern Bolivia identified 39 
medicinal plant remedies, the same number found in this study for Chagas disease. Some of the 
plants used to treat Chagas disease or heart symptoms are also utilized by the Trinitario for susto, 
including mandarin buds, lemongrass, garlic, lime, lemon, urucú, sinini and caré. However, in 
Thomas et al.’s study the Trinitario primarily used these plants externally, in herbal or smoke 
baths, while in this investigation treatments were primarily ingested in teas. In Bourdy et al.’s 
(2003) study of the pharmacology of Bolivian Izoceño-Guaraní, of 189 medicinal plants and 
animal parts identified by the authors, five pertained to heart conditions, and one of these was 
tapir claw, which was also reported in this study as a heart-related treatment. This suggests that, 
to treat Chagas disease, the patients in this sample draw on ethnomedical knowledge also used by 
indigenous people in the region. 
     During the interview narratives, 19 ethnomedical remedies for gastrointestinal remedies were 
mentioned. In their study of plant knowledge among the Tsimane’, Calvet-Mir et al. (2008) 
identified a similar number of gastrointestinal remedies (16) through free listing. Similar to 
Calvet-Mir et al., I found that papaya seeds were a common treatment for gastrointestinal 
parasites.   
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     Knowledge of ethnomedical treatments primarily came from friends and family members, 
although some respondents utilized books or even the Internet. A handful of individuals had 
experiences with ethnomedical healers. Ethnomedical remedies such as mandarin buds, colonia, 
and lemongrass are often freely available in gardens, or can be purchased very cheaply in local 
markets. Furthermore, ethnomedical treatments provide hope of alleviating the disease and are 
unaccompanied by painful side effects. They are far more salient in participants’ free lists than 
biomedical treatments, which hardly receive mention. However, this does not mean participants 
did not utilize biomedical treatments. In a study comparing ethnomedical and biomedical 
knowledge in the Tsimane’ of eastern Bolivia, Calvert-Mir et al. (2008) found that, when asked 
about treatments, respondents did not tend to mention biomedical options, but that in daily 
practice, they did combine ethnomedical and biomedical treatments. In this study, the fact that all 
respondents were patients of a biomedical clinic (the CMHP) underlies their willingness to make 
use of biomedical options, when available. Ethnomedical remedies for Chagas disease are more 
frequently mentioned not necessarily because of a deep seeded cultural preference, but because 
they are more accessible and because biomedicine does not offer a suitable alternative. Again, 
structural factors such as poverty, pharmaceutical company profits, and lack of medical providers 
in rural areas have effectively limited the reach of biomedicine in the lives of respondents with 
Chagas disease.  
     At the same time, the rich production of knowledge of ethnomedical treatments about Chagas 
disease serves as a reminder that local agency takes place in the face of severe structural 
constraints, as Ortner (1984) proposes. Moreover, knowledge of ethnomedical treatments is 
dynamic. Vanderbroek et al. (2008) found that knowledge of medicinal plants in a rural Bolivian 
Quechua community, while traditional in origin, was also highly adaptive to changing health and 
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socioeconomic conditions. While suffering from a disease that they realize is structurally driven, 
and confronting a dearth of assistance from the biomedical system, respondents in the present 
study have simply chosen to develop alternative solutions, drawing on culturally constructed 
knowledge from a system that predates biomedicine in Bolivia, yet continues to evolve 
dynamically and refuses to be subsumed.  
     The ethnomedical concept of health that participants shared in the interviews was closely tied 
to the concept of tranquilidad, or calmness. When analyzing interview texts in Atlas.ti, I coded 
54 quotations related to this theme, making it the second most frequently discussed topic after 
vinchucas. Tranquilidad is a state of even-keeled emotions where neither joy, anger nor sadness 
reach extremes, since this could disrupt the fragile state of the body with Chagas disease and 
trigger otherwise latent symptoms, or worsen chronic symptoms that had already begun to 
manifest themselves. According to some respondents, ethnomedical treatments such as teas of 
colonia and mandarin buds were good for the heart because they helped provide a state of calm.  
Tranquilidad entails not only peace, but acceptance. Anguish over the diagnosis of Chagas 
disease would only serve to worsen an individual’s health. The disease, and its life-threatening 
implications, had to be accepted in order for a respondent to feel tranquilo and continue with 
their normal routines.  
     In sum, participants share a wealth of knowledge on ethnomedical treatments for Chagas 
disease and its symptoms. This knowledge emerges not necessarily from opposition to 
biomedical treatment of the disease, but to fill the vacuum left by the lack of effective 
biomedical options for curing Chagas, as well as the limited ability of the Bolivian health system 
to provide what risky options are available to rural areas and small towns. It is a clear example of 
marginalized people showing agency in the face of severe structural constraints. 
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Quantitative Data on Explanatory Models of Chagas Disease 
     A major goal of the study centered on determining if an overall explanatory model existed for 
residents of the department of Santa Cruz, Bolivia (Research Objective 2a). I administered a 52-
item structured questionnaire to 48 respondents with Chagas disease. The consensus analysis 
procedure provides strong evidence that a shared model exists. First of all, the eigenvalue ratio 
given by the procedure (9.41:1) exceeds the minimum ratio of three needed to substantiate the 
existence of a shared model (Weller 2007). Furthermore, there is a fairly high mean competence 
score (0.64), and there were no negative individual scores.  
     Having identified a shared explanatory model, an important follow-up question is what forces 
might shape the model and drive its coherence? I divided the questions in the structured 
questionnaire according to different subthemes, or domains, and analyzed these separately. The 
different domains were the vector, symptoms, ethnomedicine, and social factors (Research 
Objective 2b). The findings in each of these domains are discussed below and then compared 
with the biomedical model from Chapter 4 (Research Objective 4).  
 
The Vector 
     Based on the quantitative interviews, there was a high level of consensus on knowledge about 
the vector, as indicated by the first eigenvalue ratio of 4.17:1. Furthermore, mean cultural 
competence (0.74) was higher for the vector than the other domains. For the overall sample, 
there was agreement that the bite of a vinchuca causes Chagas disease, the “red” vinchuca is the 
most infectious species, vinchucas prefer houses of adobe and palm-thatch, and rats and mice 
spread Chagas. All of these statements are compatible with the biomedical model (Chapter 4). 
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From a biomedical standpoint, vinchucas cause Chagas disease, although it is the infected feces 
rather than the actual bite which transmits the parasite (WHO 2010). Still, this is a merely 
academic difference that would not complicate public health interventions; in terms of preventive 
programs, the key idea is that the vinchuca needs to be eliminated. Also, the biomedical model 
supports the idea of one more dangerous type of vinchuca (Triatoma infestans) among the 
several species found in Bolivia (Moncayo & Silveira 2009). Rodents are known reservoirs for 
Chagas disease (Rojas et al. 2006), and homes of adobe and palm leaves have been verified as 
risk factors for vinchuca infestation (Campbell-Lendrum et al. 2007, Saunders et al. 2012).  
     Thus, the findings for the vector domain indicate participants have high agreement on how the 
vector transmits Chagas disease, and the consensus model of the sample does not differ 
substantially from the biomedical model. The results also provide some insight on the trajectory 
of vector control; while respondents agree that there are less vinchucas compared with the past, 
they do not believe that pesticide spraying has completely wiped out all vinchucas. Respondents 
have experienced the impact of the government’s large-scale spraying in the early 2000’s, but 
still have doubts that the danger from the vector has been totally eliminated.  
 
Symptoms 
      In the symptoms domain, there is more divergence between the explanatory and biomedical 
models. In fact, in the consensus analysis results, the symptoms domain was the weakest of the 
four submatrices, with an overall competence of 0.49. The eigenvalue ratio for the symptoms 
domain was still greater than three, but it was weaker than the ratios for the social, vector, and 
ethnomedical domains. However, variability of symptoms is a key feature of Chagas disease in 
the biomedical model, and may be related to the genetic diversity of Trypanosoma cruzi (Lages-
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Silva et al. 2006). It can also be difficult for biomedical practitioners to detect whether cardiac 
symptoms are a consequence of Chagas disease or other factors such as obesity, diabetes and 
high blood pressure (Gilka et al. 2012). Furthermore, given the absence of a viable biomedical 
cure for chronic Chagas disease, participants often felt compelled to manage its effects 
independent of the biomedical system and thus did not always learn the biomedical version of 
Chagas symptoms from health providers. Patients in this sample had diverse symptoms. While 
the majority were asymptomatic, two people had undergone surgeries and two others had 
irregular EKG’s during the study period. More coherence in the symptoms domain might emerge 
in a sample of patients who all had pacemakers due to Chagas disease, for example. 
     However, participants agreed with many biomedically recognized symptoms of the disease, 
such as constipation and chest pain. Participants considered Chagas a disease of long duration, 
and felt it was incurable, even with financial resources to pay providers. Although the patient 
model affirmed that many people with Chagas disease remained asymptomatic, it also asserted 
that people with Chagas were likely to need a pacemaker eventually. 
     Many facets of the explanatory model disagree with the biomedical model, although there is 
convergence in other areas. For example, the model asserts that Chagas disease can cause lung 
cancer, liver problems, vision impairment and other afflictions which biomedical practitioners 
would typically associate with other ailments. Respondents agree that the symptoms worsen due 
to stress in daily life (arguing with a significant other). Again, this mirrors Poss and Jezewski’s 
(2002) findings for the relationship between susto and diabetes in a Mexican-American sample. 
In Scheder’s (1988) research with Mexican-American migrant workers, stressful life events were 
significantly associated with diabetes. Farmer (1988) describes a “rhetoric of complaint”, where 
individual illness episodes are interpreted within a broader narrative of intertwined physical, 
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social and emotional ills. In this study, patients with Chagas disease acknowledge the 
inseparability of emotional and physical wellbeing. 
 
Ethnomedical Knowledge 
     According to the quantitative interviews, the area of treatment represents a major divergence 
between the patients in the study and the biomedical system. In fact, agreement in the 
ethnomedical domain appears to be a driving force in the overall model. Ethnomedical 
competence (0.73) is the second highest of the four domains behind vector competence (0.74), 
and is stronger than overall competence (0.64). Further, there was strong agreement on 
ethnomedical concepts even when comparing by gender, occupation, ethnicity and income. One 
of the only items that produced any disagreement pertained to the use of eucalyptus balm for 
chest pain, which agricultural laborers, low income and Quechua participants felt was effective 
while other groups did not. Participants were correctly able to identify ethnomedical treatments 
that were not intended for Chagas symptoms, such as eating papaya seeds (a remedy for 
intestinal parasites).  
     Whereas the weak consensus in the symptoms domain may stem from the lack of patients’ 
involvement with the biomedical system, the high agreement in the ethnomedical domain could 
partially stem from the greater accessibility of ethnomedical remedies. It also suggests that 
knowledge about Chagas remedies is actively shared in the study area. There is wide agreement 
on the value of certain remedies, although some regional differences emerged in qualitative 
interviews. The model affirms the value of colonia, mandarin buds, and lemongrass for 
alleviating heart symptoms. Respondents agree on the value of garlic, but disavow the 
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effectiveness of antibiotics for Chagas disease. Furthermore, respondents express distrust of 
biomedical providers, who may provide a false diagnosis of Chagas disease simply to get their 
money.  
     The results do not necessarily imply that participants in the study are disconnected from 
Western medicine. Hunt, Arar and Akana found that ethnomedical treatments did not compete 
with biomedical care in a study of Mexican-American diabetics, and that those who utilized 
ethnomedical remedies were “also very actively using biomedical methods; they were using all 
the resources encountered” (2000, p. 216). In Miller’s (2011) study of Ariaal women in Kenya, 
ethnomedical knowledge was highly correlated with knowledge of Western medicine. Calvet-
Mir et al. (2008) found that the bulk of Tsimane’ respondents in their sample used both Western 
and traditional medicine, rather than strictly utilizing one of the other. In the present 
investigation, the respondents were all patients who utilized a biomedical clinic to some degree, 
but also saw value in various ethnomedical treatments for Chagas disease. It may be that people 
in this sample simply think more about their health, which in turn leads to a higher consensus on 
ethnomedical topics. This suggests strong potential for future Chagas treatment programs that 
integrate ethnomedical and biomedical care.  
 
Social Factors 
     This study aims to understand how social factors tie into explanatory models of Chagas 
disease. Several items in the consensus analysis questionnaire pertained to social or political 
aspects of Chagas disease. The mean competence of participants on these sociopolitical 
questions was fairly high, at 0.59. When looking purely at these questions, the consensus 
analysis procedure produced an eigenvalue ratio of 3.32, which suggests a shared cultural model. 
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In addition, social competence was significantly correlated with overall competence (Spearman’s 
rho=0.57) and ethnomedical competence (Spearman’s rho=0.31). The implication is that the way 
people think about the social context of Chagas disease not only affects their overall explanatory 
model, but also is related to their beliefs about how Chagas should be ethnomedically treated. 
     The culturally correct answer key generated by the consensus analysis procedure indicates 
strong agreement on certain social dynamics of Chagas disease. In the model, respondents did 
not attribute Chagas disease to witchcraft or vices, but they did agree that it primarily affects the 
poor. There was also agreement that medicine for Chagas disease is expensive, and that 
treatment for Chagas disease is hard to find. Chagas disease was seen as a potential impediment 
to finding work, and the sample rejected the idea that extensive government programs for Chagas 
disease existed. Chagas is identified as a disease of the poor, whereas access to biomedical 
treatment is deemed a difficult proposition.  
     Previous explanatory model studies have identified sociopolitical components. In Farmer’s 
(1990) study of explanatory models of AIDS in Haiti, narratives emerged linking the illness to 
the United States government. Similarly, Hewlett and Hewlett (2008) reported that respondents 
in Uganda and the Congo blamed ebola outbreaks on U.S. or European missionaries, 
conservationists, and researchers. While this provides evidence that lay people can develop 
elaborate, politically oriented disease etiologies, the stories are reported anecdotally, so it is 
unclear what narratives might be prevalent in the general population. The consensus analysis 
results here indicate that respondents agree on a structural model of the disease: it affects the 
poor, especially those in traditional housing, and it is exacerbated by government and provider 
neglect and inaccessible biomedical treatments. One limitation of the questionnaire is that it did 
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not include more historically oriented questions on the origins of the disease; this would be a 
promising area for future studies to investigate.  
 
Comparison of the Quantitative and Qualitative Findings 
     Like Garro (1996), I found that utilizing a quantitative questionnaire for consensus analysis in 
conjunction with semistructured qualitative interviews helped provide a more detailed analysis of 
the explanatory model of Chagas disease in the study sample. In this section I compare the model 
of Chagas disease provided by the consensus analysis results with the narratives of Chagas 
disease in the qualitative interviews. The discussion is once again divided based on the main 
components of etiology, symptoms, progression and treatment.  
  
Etiology 
     Both the quantitative and qualitative results support the biomedical model in which the 
vinchuca is the transmitter of the disease. Mean competence for the vector was high in consensus 
analysis (0.74), and vinchucas were also the most frequently coded item in the qualitative 
interview analysis. However, infestation by vinchucas is not viewed as a random act of nature. In 
the consensus analysis model, the vinchuca prefers homes of adobe and palm-thatch over 
cement-brick structures. However, the qualitative narratives provide more elaborate views of 
respondents’ etiology of the disease. Respondents describe the vinchuca as part of an overall 
social environment of rural poverty. They tended to blame poverty and housing construction for 
the prevalence of Chagas disease in the area as much as vinchucas. Interestingly, in the 
consensus analysis results, respondents agreed that vinchucas primarily affected the homes of the 
poor, but also felt vinchucas were in the homes of the rich. One respondent explained that this 
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was because vinchucas could easily fly from one home to another. Neither set of results provided 
much support for humoral, moral, or supernatural etiologies. In the consensus analysis results, 
respondents disagreed that vices, withcraft, or hot/cold were causal factors. In the qualitative 
interviews, these causes were mentioned, but very infrequently. 
 
Symptoms 
     In the area of symptoms, the mean competence (0.49) was very low in the consensus analysis 
results, suggesting there is significant agreement on the symptoms of the disease. However, this 
is not an unexpected result given the great variability of the symptoms in the biomedical model. 
In the consensus analysis model, Chagas caused symptoms such as swelling, difficulty breathing, 
tiredness, chest pain, and constipation. These were all mentioned in the qualitative interviews as 
well, with difficulty breathing and tiredness being the most frequent symptoms. These all 
correspond well with the biomedical model of symptoms for chronic Chagas disease.  
     Stress and emotions were important in both models. The consensus analysis model supported 
the idea that arguing with a significant other would worsen the disease. Similarly, in the 
qualitative results, participants spoke at length of how strong emotions could worsen the 
symptoms of the disease. Through the qualitative interviews, the importance of tranquilidad or 
calmness became apparent. This concept was the second most frequently coded in Altas.ti after 
vinchcuas. Thus, in the symptoms arena, both sets of data support the emotional component of 
the disease, but this becomes especially clear in the analysis of the qualitative interviews.  
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Progression 
     In the consensus analysis results, respondents agreed that Chagas disease was of long duration 
and incurable. This seems to be an idea from the biomedical model, with treatment of chronic 
Chagas disease being a very recent innovation (PAHO 2010). In the qualitative interviews, seven 
participants indicated their doctors had told them Chagas could not be cured. Moreover, different 
versions of Chagas morbidity surface in the interviews. While some warn that Chagas can strike 
suddenly and unexpectedly, others describe a slow, downward spiral in which the body 
progressively weakens.  
 
Treatment 
     Both sets of data demonstrate the strong presence of ethnomedical knowledge in the sample. 
In the consensus analysis procedure, competence was very high in this domain (0.73). The 
sample was practically unanimous in supporting the value of colonia (95% agreement), 
lemongrass (96% agreement), and mandarin buds (98% agreement), and these were also the most 
salient heart-related remedies from the free listing data. There were virtually no differences in 
the culturally correct answer keys even when analyzing by various social categories. However, in 
the free listing data indicated, there are many kinds of remedies which are only mentioned once, 
resulting in a long list of treatments for both Chagas disease (33) and its heart-related symptoms 
(66). This could reflect local patterns of the impact of social networks, which are one of the main 
ways respondents report hearing about remedies in the qualitative interviews. Thus, there seems 
to be a core group of remedies which are heavily favored, including colonia, lemongrass, 
mandarin buds, garlic, and to some extent ivomec, and then a wide domain of treatments which 
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are only utilized within specific families, communities or social networks. Interesting, the items 
in the core group, with the exception of ivomec, are also used by indigenous groups in Bolivia 
(Broudy et al. 2003, Calvet-Mir et al. 2008, Thomas et al. 2009). 
     In the consensus analysis model, biomedical care was seen as expensive and difficult to 
access, and doctors were viewed with some suspicion, in that some might provide a false 
diagnosis only to get a patients’ money. In the qualitative interviews, participants describe why 
biomedical care is difficult to access, citing high costs, lack of facilities, and geographic distance. 
Both sets of data also support the idea that medications are expensive.  
     Thus, the model of Chagas disease based on consensus analysis and that provided through the 
qualitative interviews is largely similar. However, rather than being identical, the two sets of data 
are complementary, with each filling in gaps in the other. The qualitative data provides richer 
detail in explaining certain dynamics and concepts, but the consensus analysis provides for 
statistical measurements and comparisons that would not be possible using only a qualitative 
study design.  
 
Explanatory Models and Structural Factors 
     This study found that structural factors were integrally linked to the formation of explanatory 
models of Chagas disease, based on both the qualitative and quantitative data. Furthermore, 
social differences appear to be important in determining some of the differences in subthemes 
and cultural competence found in the sample.  
     Previous research has identified the potential impact of social differences in shaping 
explanatory models. In Weller et al.’s (2012) investigation of explanatory models of diabetes in 
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physician and lay samples in the U.S. and Mexico, the greatest differences occurred between 
providers and patients rather than across national lines. The authors proposed this could have 
been because “formal educational levels and class differences may play an important role in 
patient understanding of diabetes and patient-provider differences” (Weller et al. 2012, p. 8). In 
Chavez et al.’s (1995) study of models of breast and cervical cancer, the model of Latina 
immigrants differed substantially with U.S. physicians. Further, there was a continuum of models 
in which chicanas and especially Anglo women were increasingly similar to U.S. physicians. 
With regards to explanatory models of Chagas disease, I was unable to detect significant 
differences based on education or income, but occupational status proved significant. Further, 
unlike Chavez et al. (1995) and Weller et al. (2012), I compare various lay social groups rather 
than utilizing biomedical practitioners.  
     However, other work has shown that social differences have an impact on folk illnesses. For 
example, Carey (1990, 1993) found that folk illnesses had a greater incidence and prevalence in 
the poorest of three Quechua communities he surveyed in rural Peru. Thomas (2012) describes 
how the historical trajectory of the Trinitarios, including forced migration through eastern 
Bolivia, impacted their use of medicinal plants compared to the Yuracaré, who have 
continuously occupied the same territory since preColombian times. Based on Carey’s (1990, 
1993) results, I would have expected the poorest community in the sample (Palacios) to have had 
a higher ethnomedical competence, based on more frequent folk illnesses. Palacios instead had 
the lowest ethnomedical competence, but this could be due to its proximity to the CMHP. Also, 
more morbidity in folk illnesses might not necessarily translate into higher levels of cultural 
competence in the ethnomedical domain. The other communities (Warnes, Buena Vista, and 
Yapacani) all had health facilities as well, but these were unlikely to be as affordable as the 
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CMHP in Palacios, which dispenses free medicine. Traveling to the CMHP for care places a 
greater burden, in terms of travel time, on people in these communities than for someone in 
Palacios. Buena Vista, which has the least developed health infrastructure, also had the highest 
ethnomedical competence. Thus, it may be accessibility to biomedical care, even more than 
poverty, which drives ethnomedical knowledge. People in Buena Vista may have greater 
ethnomedical competence because they rely more heavily on the ethnomedical sphere for 
treatment. 
     For McEwen (2005), it was the dominant position of U.S. physicians which, through medical 
encounters, ultimately shaped the explanatory model of latent tuberculosis for Mexican migrants. 
I saw some evidence of this, in that seven patients indicated providers had told them Chagas 
disease was incurable. Like the patients in McEwen’s sample, respondents in this study often did 
not have visible symptoms and faced uncertainty about whether they would actually develop 
symptoms in the future. However, the consensus analysis results show that patients would not 
automatically trust information from a physician, since the model supported physicians 
potentially giving false information. Moreover, if physicians dominated respondents’ 
explanatory model, one would expect to see much less discussion of ethnomedical treatments in 
the sample. On the other hand, the high level of ethnomedical competence may hinge on the fact 
that patients do not believe there is a biomedical cure for the disease. Moreover, the Bolivian 
respondents I interviewed were not under the type of pressure to assimilate to a repressive host 
society as the Mexican migrants in McEwen’s study.  
     Other research has investigated narratives of powerful foreigners as instigators of disease. For 
example, such narratives emerged in Hewlett and Hewlett (2008), where some respondents tied 
ebola outbreaks to conspiracies by foreign interests. In Farmer’s (1992) research, some Haitians 
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attributed the spread of AIDS to the U.S. government. There is a precedent for this in Bolivia; 
Bastien (2003) believes the cultural illness of liquichado may be associated with Chagas disease. 
Liquichado is caused by the fat-stealing kharisiri, who often assumes the form of a priest, gringo, 
or other powerful foreigner (Bastien 2003, Crandon 1991, Canessa 2000). In Nash’s 
ethnography, El Tio was a symbolic figure who caused misfortune in Bolivia’s tin mines, and 
appeared in the form of a gringo overseer.  However, respondents with Chagas disease in this 
study put forth a less symbolic, more straightforward version of the social processes behind their 
illness. Their etiology accepts the biomedical view that the vinchuca transmits Chagas disease, 
yet they define the vinchuca itself as a part of the social environment in rural Bolivia. Bad luck, 
supernatural factors, taboos and similar causal explanations were not encountered in this study. 
What emerges instead is a clear social epidemiology of the disease based on lived experience.  
     Both Farmer (1992, 1996) and Dressler (2001) have called for research that integrates a 
constructivist and structuralist perspective. Dressler urges anthropologists “to make fundamental 
contributions to culture theory, by understanding how culture works in relation to structural 
constraint” (2001, p. 463). In rural eastern Bolivia, people with Chagas face major impediments 
to attaining basic needs. Poverty and marginalization can make biomedical services and 
medications unaffordable, while decades of international neglect means that only toxic, semi-
effective medications are available to treat Chagas disease.  
     Yet this has neither resulted in a crushing of the human spirit nor a total submission to the 
dominant discourse, as Bourdieu (1982) implies. Rather, healthcare is a domain of “conflict and 
struggle” (Singer 1989, p. 1199). In my study, the struggle is not necessarily one of patients 
versus physicians, but of people against a constellation of factors that makes it difficult to stay 
healthy and access biomedical treatment. Similarly, Heyman et al. describe a “web” of “indirect 
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barriers” (Heyman et al. 2009) confronted by migrants in El Paso. Rather than one explanatory 
factor, there is an entire “web of exploitation” (Farmer 2004, p. 317) that creates health 
disparities. 
     People with Chagas disease in this study take small but meaningful actions to overcome these 
constraints and confront their sickness, even if they feel bereft of aid from the biomedical succor. 
Drawing on social networks or social media, and using what is readily accessible in the 
environment, Bolivians find their own ways to manage the disease ethnomedically, often 
drawing on knowledge that is ultimately indigenous in origin, but finding new pathways as well. 
These actions are the equivalent of Scott’s (1985) weapons of the weak for the domain of 
healthcare.  
     Farmer observes that while the poor are the most likely to suffer the effects of structural 
violence, “they are also more likely to have their suffering silenced” (1996, p. 280). As Farmer 
urges, this study is an effort to give voice to the poor who suffer in a specific region of tropical 
Bolivia, by presenting their explanatory model of Chagas disease, one of the main causes of 
morbidity in the country. Their model of the disease demonstrates not only what they perceive as 
the social and other factors which cause it, but their opinions on how it should be confronted.   
 
Obstacles and Opportunities for Biomedical Care 
 
     With the signing of the National Chagas Law by Evo Morales in 2006, the state made 
elimination of Chagas a “national priority.” Bolivia has aggressively expanded treatment, 
implementing a program to treat adults almost immediately after this was recommended by the 
Pan American Health Organization (2010). Moreover, the state committed to providing free 
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medication for people with Chagas, in an effort to ensure treatment for the poorest sectors of the 
population who are most affected by the disease.  
     Nonetheless, Bolivia must confront cold realities despite its desire to eliminate Chagas 
disease. The first is that it currently does not have an extensive medical infrastructure, 
particularly in rural areas. The second is that the medications for Chagas disease produce 
dangerous side effects (Pinazo et al. 2010, Tornheim et al. 2013), while there is not a clear way 
to measure whether a cure has been achieved (Bern 2011). Finally, the efforts of the National 
Chagas Program are sensitive to the availability of financing. For example, once the program 
could no longer count on Interamerican Development Bank financing in 2008, its screening of 
children for Chagas disease decreased dramatically. There was a drop of 81% for screening of 
children 5-15 years old, and 70% for children 1-5, from the last year of funding in 2007 to 2011.  
     The impact of free treatment on people with Chagas disease in the current study was 
extremely limited. Only one person was familiar with the program, which had treated her son. 
No one was aware that free treatment was available for adults, because such treatment was not 
offered in their communities. Nineteen respondents described medications or treatments for their 
Chagas disease as being too costly, sometimes representing severe financial burdens.  
     The necessity of working with a dangerous medication that can produce potentially fatal side 
effects has forced Bolivia’s Chagas program to adapt strict control measures. Patients who opt 
for Chagas treatment have to sign waivers agreeing to restrict a wide range of foods from their 
diet. Similar restrictions in a rural Argentinian community caused patients to drop out of 
treatment for Chagas disease (Mastrangelo 2009). Furthermore, patients must produce a series of 
laboratory results which have to be paid for out of pocket. Upon completion of treatment, they 
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will have no way of knowing for certain if they have been cured because of the lack of a reliable 
diagnostic.  
     In addition to prohibitive costs for medications and services, respondents in the study detailed 
other barriers to care, including distance, long waits, and inability to get time off from work. In 
one community, El Pilar, there was no health post available, while in Buena Vista, a larger town, 
only level one health centers offering basic care operated. The public clinic was unable even to 
test for Chagas disease because of budgetary constraints. Traveling to other towns or to Santa 
Cruz for healthcare requires additional money and missed time from work.  
     Thus, while providing free medication for Chagas treatment seems on the surface like an ideal 
way to help poor people with the disease, the need to offer protection from side effects and the 
lack of clinics and providers to administer medication makes this service nearly inaccessible to 
many respondents in the present study. As in Greene’s (2004) study of Bolivia’s free treatment 
program for tuberculosis, these types of “hidden” costs can represent substantial barriers to 
accessing care and lead to drop-out and noncompliance. Heyman et al. found that undocumented 
migrants seeking healthcare in El Paso, Texas faced a series of direct and indirect “barriers that 
reinforced each other in a constraining ‘web of effects’” (2009, p. 19). Direct barriers were legal 
prohibitions on the undocumented, while indirect barriers included practical difficulties in 
getting to and from care. In contrast, the Bolivian government has sought to expand care for 
Chagas disease, yet these efforts are still insufficient to overcome a host of indirect barriers that 
are local as well as global in origin. 
     This situation is likely to persist until a new drug is developed, which may be decades away. 
Tarleton et al. (2007) describe considerable lack of interest in following up on leads for new 
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drugs for Chagas disease. Interest in new drugs for tropical diseases is quite low. Only 4 of 1223 
new drugs developed between 1975 and 1996 specifically targeted tropical diseases in humans 
(Trouiller and Olliaro 1999). The economics of international drug development assure that this 
situation will persist. Drug sales per capita are only $21 annually in Bolivia, 1.9% of what the 
average American spends on pharmaceuticals (WHO 2011). Meanwhile, the United States, 
Europe and Japan make up 85% of the market for pharmaceuticals, and when defining a research 
and development agenda, “drugs for use in the industrialized world are prioritized over ones for 
use in the South.” Developing a new drug costs on average $1.38 billion (IFPMA 2012). At the 
current level of funding for Chagas drug development, $37.1 million in 2012 (G-Finder 2013), it 
would take 37 years to develop one new drug, yet only 10% of new drugs eventually earn 
approval (Hay et al. 2014).  
     Because of this dynamic in international economics, programs for treating Chagas disease 
must continue to work with potentially toxic medications developed over 40 years ago. This has 
affected the explanatory model of the disease; 54% of participants in the study felt Chagas 
disease was incurable, and three respondents even compared it to cancer and diabetes. Seven 
people indicated their doctors had told them the disease was incurable.  
     In sum, even though the Bolivian government under Morales has expressed its desire to 
improve healthcare access, this is very difficult to implement in practice. While the 2009 
Constitution guarantees access to healthcare, this measure in reality fails to impact up to 70% of 
Bolivia’s workforce (Ledo and Soria 2011). Similarly, the participants in this study, half of 
whom earned less than the minimum wage, were unable to avail themselves of the free treatment 
for Chagas offered by the government, and in fact reported calamitous expenses associated with 
the disease. The availability of this treatment was widely unknown. An even more dire concern 
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is that only 1% of Bolivians who have Chagas are aware of it (Steinbach 2013). Without 
adequate financing, the government is largely unable to provide the amount of screening 
coverage necessary. Even in a national political climate that favors increasing healthcare access 
for the poor, the realities of global economics constrain this vision severely.  
 
     The data from the qualitative and quantitative interviews suggests that patients’ interpretation 
of Chagas disease differs in important ways from the biomedical model. Whereas public health 
efforts to eliminate the disease focus on vector control, monitoring of blood and organ supplies, 
and efforts to halt congenital transmission (Moncayo & Silveira 2009), respondents view the 
etiology of the disease as a broader issue associated with the system of structural inequalities in 
which they are embedded. In respondents’ etiology, both the qualitative and quantitative data 
indicate social factors, including poverty and rural living, are integral to understanding how 
Chagas disease spreads. However, this does not preclude them from accepting the biomedical 
model in which the vinchuca is the primary transmitter of the disease. They simply view the 
vinchuca as part of a wider set of social ills, and not as merely a biological phenomenon. This is 
important because the current prevention model in place in most of Latin America focuses on 
elimination of the vector but does not address the social environment which has allowed the 
vector to thrive.  
     Based on both the qualitative and quantitative interviews, respondents’ views on the 
symptoms of the disease are essentially compatible with the biomedical model. Contrary to what 
Bastien (1998, 2003) and Vanderbroek et al. (2008) found in rural Quechua communities, this 
largely camba sample in Bolivia’s tropics had an understanding of Chagas disease as a single 
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entity, and did not appear to interpret it in the context of cultural illnesses. Although there was 
not strong agreement on symptoms knowledge in the consensus analysis results, the qualitative 
interviews indicate that respondents’ model of the disease’s symptoms are compatible with the 
biomedical model.  
     Despite this, respondents appear much more likely to treat Chagas disease ethnomedically. 
Respondents free listed ethnomedical remedies far more often than biomedical ones, although 
this could stem from how they chose to share health information, much as Calvet-Mir et al. 
(2008) observed with a different Bolivian sample. Respondents’ high familiarity with 
ethnomedical remedies for Chagas disease contrasts significantly with Vanderbroek et al.’s 
(2008) survey of Bolivian Quechua ethnomedical healers. This does not represent a culturally 
oriented preference for ethnomedicine over biomedicine so much as a lack of accessibility to 
Western medicines for Chagas disease, which in any case are not highly efficacious in the view 
of both doctors and patients. Evidence from ethnopharmacological studies (Thomas et al. 2009, 
Broudy et al. 2003) suggests many of the remedies used for Chagas disease originate in Bolivia’s 
indigenous groups. However, ethnomedicine in this study is also dynamic in that respondents 
reported learning about it not just through social networks, but through the Internet and print 
publications. Moreover, people in the popular sector have expropriated a biomedical treatment 
(ivermectin), albeit a veterinary one in this setting, and have redefined it in their own terms in 
order to treat their Chagas disease.  
     Similar to Greene (2004), I found that the existence of a free program of treatment did not 
necessarily translate into a situation of easily accessible care. Heyman et al. (2009) proposed that 
a web of various types of barriers prevented the undocumented people living in El Paso, Texas 
from accessing care. Whereas the U.S. government is often adamant about limiting healthcare for 
295 
 
migrants, I encountered the opposite situation in Bolivia. However, even though Bolivia’s 
socialist government has been a proponent of free treatment for Chagas disease, there are still 
indirect barriers which are difficult to eliminate. In both the qualitative and quantitative data, 
patients considered the disease incurable. Friedl (1982) found that the notion of incurability 
discouraged Appalachian miners from accessing free treatment for black lung. However, even 
willing patients with Chagas disease in Bolivia might not have treatment available in their 
community, and might not be able to travel the distances needed to access it elsewhere. Some 
institutions which seemed public in character, such as CENETROP, still charged for treatment. 
No respondents in the study were aware of the government’s free treatment program for adults, 
and only one person had obtained free treatment for her child. Even if respondents had known 
about it, the free treatment program still entailed secondary costs for extensive laboratory and 
cardiological analyses. The medication itself produces side effects, and the dietary restrictions 
imposed by the Chagas program, though meant to protect patients from the toxic effects of the 
medication, were very difficult to adhere to for a rural Bolivian, which is similar to what 
Mastrangelo (2009) found in Argentina. Thus, a web of indirect impediments often prevented 
patients from accessing biomedical care. Programs which intend to increase accessibility of 
treatment to marginalized populations must be prepared to confront an entire system of obstacles. 
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CHAPTER TWELVE 
CONCLUSIONS AND RECOMMENDATIONS 
Implications for Anthropology: Syncretization of Constructivist and Structuralist 
Approaches 
     This project began as an effort to determine whether explanatory models could serve as a 
useful tool for erasing what Bourdieu (1988) terms a “false dichotomy” in social science: the 
divide between structural and constructivist interpretations of reality. In medical anthropology, 
this dichotomy is embodied in the decades-long hegemonic struggle between critical medical 
anthropology (CMA) and applied medical anthropology. While the former emphasizes the global 
socioeconomic forces that shape health, the latter focuses on locally constructed perceptions of 
reality. Yet Dressler (2001) argues that most anthropologists are “theoretical pragmatists” who 
borrow from both schools, and several medical anthropologists have called for a more unified 
approach (Ortner 1984, Marcus and Fischer 1986, Lock and Scheper-Hughes 1990, Farmer 
1992).  
     Explanatory models are a heuristic tool that emerged from the constructivist camp. From 
Kleinman’s original formulation as a tool for patient-provider communication, the concept has 
transformed into a method for examining broader understandings of health in different contexts, 
at the level of communities and populations (Baer et al. 2004). With the statistical capabilities of 
consensus analysis, explanatory model hypotheses can be tested and measurable data can be 
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compared. This evolution has made the explanatory models framework a useful one for 
measuring and analyzing the impact of social factors on ideas about health  
     Previous studies began to make inroads in this area (Farmer 1988, McEwen 2005, Vonarx 
2007, Hewlett and Hewlett 2008). These studies provided rich qualitative data, but they suffered 
from certain limitations that prevented them from achieving a fully integrated approach. The 
main way in which structural factors are accounted for in Farmer (1988), Vonarx (2007), and 
Hewlett and Hewlett (2008) is through exploration of historical processes pertaining to their 
research questions. Farmer (1990) and Hewlett and Hewlett (2008) both encountered narratives 
of disease etiology where respondents attributed the appearance of new diseases to U.S. or 
European actors. Bastien (2003) alludes to something similar with Chagas disease, which he 
claims may be an outcome of the cultural illness liquichado. This affliction is brought on by a 
supernatural figure, the kharisiri, who often appears as a U.S. missionary or doctor. In all of 
these narratives, the etiology is rich with cultural and political symbolism. However, what is 
lacking is a more systematic examination of how respondents view social factors related to 
disease.  
     This study is able to achieve a multi-level analysis of how social factors fit into explanatory 
models, first and foremost, because it sets out to do so. As Farmer (1988) alludes to in his study 
of move san, respondents do not separate social, psychological and cultural ideas into neat 
categories. Rather, these are intertwined into a broader narrative in which illness goes hand in 
hand with marginalization, stress, alienation and a host of other complaints. Thus, 
anthropological investigation needs to look into all of these areas in order to begin to understand 
how patients’ experience of disease is formed. Critical, as well, is an understanding of historical 
processes, as both Vonarx (2007) and Farmer (2004) affirm. In his study of vodou in Haiti, 
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Vonarx asserts that “representations of certain illnesses are not a purely local construction…The 
conditions that create these representations extend well beyond Haiti” (2007, p. 27). Thus, how 
local history is tied to global dynamics plays a crucial role in anthropological inquiry, as Wolf 
(1982) understood well.  
     In order to fully integrate a structuralist and constructivist approach, and to capture all the 
dynamics involved in the creation of an explanatory model of a major disease, I relied on 
qualitative analysis, structured data collection and consensus analysis, and historical inquiry. 
Moreover, I explicitly included attention to social components of the disease in both the 
qualitative and quantitative interviews. As Garro (1996) found in her investigation of Ashinaabe 
explanatory models of diabetes, using both these formats in conjunction enabled me to get a 
much broader picture of the explanatory model of Chagas disease than relying on a single 
method. 
     The results of the study support the idea that social factors are deeply integrated into 
explanatory models of Chagas disease. This is evident in the consensus analysis results, where 
the social component of the questionnaire had a high eigenvalue ratio (3.32:1) and mean 
competence (0.59). Furthermore, respondents’ position in the social environment, as marked by 
community and occupation, produced significant differences in mean cultural competence. In 
addition, qualitative interviews revealed extensive talk about Chagas disease as a phenomena of 
poverty and rural life. Chagas disease is not merely a biological process, as in the biomedical 
model, but nor is its construction entirely symbolic. Rather, respondents demonstrate a firm 
understanding of how their own marginal position in society contributed to their sickness, and 
continues to impact the course of their disease.  
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Contribution to Medical Anthropology 
     This study adds to the anthropological literature on explanatory models by describing the role 
of social factors in etiology, treatment and levels of agreement. I found that participants’ views 
on structural processes are integrated into their explanatory models of Chagas disease, largely 
because illness is situated within a larger context of social suffering (Farmer 1988). What is 
more, this study represents an effort to demonstrate how social divisions other than lay/provider 
differences might impact cultural competence. In this study, occupation and community of 
residence proved statistically significant when assessing differences in mean cultural 
competence. Gender, education and ethnicity did not produce significant differences in cultural 
competence. Agricultural laborers and people living in the most rural community (Palacios) had 
the lowest mean cultural competence. Microentrepreneurs and service or construction workers 
had higher competence than professionals, however. It may be that professionals’ greater access 
to biomedical care makes them different from the rest of the group, whereas agricultural 
laborers’ marginalization and isolation achieves a similar result. What is clear is that the way 
structural processes impact individuals might also contribute to shaping their explanatory models 
of health. 
     This study also contributes to the literature on ethnomedical systems. Whereas previous 
investigations in Bolivia (Bastien 1998, Vanderbroek et al. 2008) did not uncover ethnomedical 
treatments for Chagas disease, respondents in this sample reported 33 remedies, and another 6 
were encountered during participant observation. This is strong evidence that ethnomedical 
knowledge can adapt to historically recent health conditions, with Chagas disease only 
discovered in 1909. However, some of the treatments in this study were also encountered in 
other indigenous groups, albeit for different uses (Broudy et al. 2003, Thomas et al. 2009) As in 
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Calvet-Mir et al. (2008) and Miller (2011), I found that knowledge of ethnomedical treatments 
seemed to complement rather than compete with use of biomedical care. Medical pluralism and 
recurrence to ethnomedical treatments are worldwide phenomena, so the high knowledge of 
ethnomedical treatments in this study may not be unique. The WHO (2002) estimates that 80% 
of the population in the global south relies on traditional medicine, while another study found 
42% of people surveyed in the US made use of alternative medicine (Eisenberg et al 1998). 
Socioeconomic processes have also been implicated in the expansion of alternative medicine in 
the United States (Baer 2005).  
     Use of ethnomedical treatments in the current study’s population is influenced by 
socioeconomic factors, including the profit-driven model of pharmaceutical research and 
development, the high cost of importing medicine in developing countries, and the demands of 
export agriculture in Santa Cruz for informal, unsindicated labor. Yet many of the ethnomedical 
treatments that emerge are uniquely local responses to Chagas, from drinking coca tea to 
grinding the seeds of the sirari tree to eating the spleen of the jochi. What is more, utilization of 
such treatments demonstrates that even the very poor and marginalized can put forth creative 
responses to structurally imposed limitations.  
     This study also provides evidence of the role of somatic factors. Similar to previous 
explanatory models studies (Farmer 1988, Poss & Jezewski 2002), I encountered a strong 
emotional dimension to experiences of Chagas disease. Emotional health was not neatly 
separated from the physical effects of the disease. The consensus analysis procedure 
demonstrated that stress could have an impact on Chagas symptoms, and respondents also 
reported the need to avoid emotional agitation in the qualitative interviews.  
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Applications of the Research 
     This study has implications for improving care for people with Chagas disease. The results 
point to potential problems in patient-provider communication that could occur in the diagnosis 
and management of Chagas disease. For example, based on the qualitative interviews and 
participant observation at the CMHP, I noticed that patients sometimes interpreted the meaning 
of “having Chagas” differently than providers. In the biomedical model, “having Chagas” means 
being infected with the pathogen, which begins in the acute phase. The parasite then lies dormant 
during an indeterminate phase, and for about a third of patients, produces morbidities later in life 
(Rassi et al. 2010). However, patients often understood “having Chagas” as referring specifically 
to advanced chronic symptoms. Thus, patients who I knew had tested positive for Chagas disease 
would affirm they did not “have Chagas.” Sometimes, this resulted in unnecessary use of testing. 
What the patients really meant was that their infection had not reactivated, or that they were not 
suffering from chronic symptoms.  
     Healthcare workers communicating with patients in the study area may need to pose follow-
up questions when asking about Chagas status. It might be more useful to ask patients if they 
have ever had any positive test for Chagas, or if they have the type of Chagas that is “asleep.” In 
addition, patients often want to take the test for Chagas to see whether the condition is 
advancing. The IHA test will provide a number, much like a glucose test in diabetes, that 
indicates reactivation if it is too high. However, the Chagas Statpak, which is commonly used in 
rural clinics, only provides a yes/no response. This can also result in wasted resources, so 
providers should explain beforehand what type of information the test will convey.  
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     With regards to management of the disease, the emotional component is quite important to 
patients, while a diagnosis of the disease can be devastating. The concept of tranquilidad – 
remaining emotionally calm – appears to be an important dimension of wellbeing for the study 
population. The Bolivian physicians I observed were well aware of this and made efforts to 
reassure patients. In contrast, health communication in the United States sometimes relies on 
dramatic messages in an attempt to frighten target audiences into behavior change (Young 2004, 
Matthews, Peden, & Rowles 2009). Such an approach could alienate patients in Bolivia. 
Messages about Chagas disease targeted to this population should be phrased in positive terms, 
providing concrete steps for patients to follow without relying on fear as a motivator.  
     Whether Chagas disease is curable or incurable is problematic even in the biomedical 
literature (Bern 2011), at least until the results of the BENEFIT trial are made public (Marin-
Neto et al. 2009). The general consensus is that the current medications can prevent chronic 
symptoms from worsening (Viotti et al. 2006), which is a de facto cure. The problem is that such 
a cure is difficult to measure through current laboratory methods (Bern 2011). During interviews 
and participant observation, I encountered young adults and even children with Chagas disease 
who were not receiving treatment, but who would have been good candidates based on their age. 
In the quantitative interviews, 54% of respondents felt Chagas was incurable. However, most of 
the Chagas health education I encountered in Bolivia was only aimed at pregnant mothers. 
Campaigns focusing on raising awareness of Chagas treatment options should focus on the 
possibility of a cure. The benefits in targeting young adults, in terms of avoided mortality, should 
more than compensate for treatment costs.  
     While there were diverse ethnomedical treatments, these do not appear to compete with 
biomedical care. In fact, people who use ethnomedical treatments may be more likely to utilize 
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any type of healthcare (Hunt et al. 2000, Calvet-Mir et al. 2008, Miller 2011). This suggests 
integrated care that combines ethnomedical and biomedical treatment could work well for 
Chagas disease. Yet at least three respondents in this study reported high costs involved in 
consulting ethnomedical healers. Involving professionalized ethnomedical healers in treatment 
programs thus may not necessarily increase access for Bolivia’s rural poor. The vast majority of 
ethnomedical treatments in this study were self-administered and learned about through family, 
friends, neighbors, or electronic and print media. Word of mouth communication, through local 
health promoters, in combination with printed materials and even social media would be an ideal 
way to spread word of Chagas treatment programs in specific communities.  
     Most of the ethnomedical treatments listed should appear innocuous to biomedical providers. 
Uncontrolled use of ivomec, the most salient ethnomedical remedy for Chagas disease in this 
study, could be a source of concern, but the WHO considers the medication free of serious or 
fatal side effects (WHO 2014). However, the FDA warns against human use of ivomec, the 
veterinary version of ivermectin sold in Latin America. Potential side effects could include 
headaches, muscle pain, nausea or diarrhea (http://www.webmd.com). Other ethnomedical 
practices that might have harmful effects include drinking raw animal blood or pure alcohol. 
However, these practices were infrequently mentioned.  
 
Implications for Public Health and Chagas Disease 
     While this study demonstrates the importance of social factors in respondents’ perception of 
Chagas disease etiology, public health programs continue to treat Chagas disease as a biological 
phenomenon, while occasionally giving lip service to how it is a disease of poverty. The 
campaign against Chagas disease in Latin America has focused on vector elimination through 
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pesticide application (Gurtler 2009). While this has resulted in interruption of transmission of the 
disease in Uruguay, Chile, Brazil, and other parts of Latin America, I encountered some 
fundamental problems with this approach at the local level. First of all, Bolivia is the native 
habitat for many species of vinchuca, including Triatoma infestans (Cortez et al. 2007). 
Conversely, Triatoma infestans is not native to Uruguay, but spread there through centuries of 
trade and other human activities, where it infested homes (Briceño-León 2009, Cortez et al. 
2010). Thus, the idea of wiping out the vector in Uruguay is quite plausible, since once spraying 
eliminated the vector in human habitations, there was no likely candidate to emerge from the 
natural environment and reinfest homes once the pesticides degraded. Moreover, Uruguay’s 
higher per capita earnings ($16,351 US) compared to Bolivia ($2,868 US) means Uruguayans 
are much better positioned to afford plaster walls, tile roofs, and other construction materials that 
effectively discourage home infestation (The World Bank 2014).  
          While economic development in Warnes, Yapacaní and Santa Cruz has spurred 
improvement of housing in these cities, more remote communities that are removed from the 
main highway have benefitted little from this progress. By necessity, residents of these 
communities, who supply the agricultural labor needed for the vast sugarcane plantations in the 
region, must continue to utilize traditional housing materials that are readily available in the 
environment. This population is the most at risk for infection of the disease and the least 
diagnosed.       
     In several communities in the study area (Palacios, El Pilar, Santa Barbara, Carmen Surutú), 
traditional housing continued to predominate. In Palacios and El Pilar, I observed various 
structures made of adobe and/or palm leaves, including homes as well as peridomestic areas. 
Furthermore, I collected two samples of vinchucas in the sleeping area of a home of “modern” 
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construction. These were identified as Rhodnius robustus by entomologists at CENETROP, a 
species capable of transmitting the parasite. They tend to live in palm trees but are willing to 
invade homes to feed, something which is probably facilitated by the extensive use of palm 
leaves for roofs. In addition, in the qualitative interviews, respondents reported spraying by 
authorities as sporadic. Thus, a scenario in which vinchucas reemerge as major transmitters of 
the disease in communities like Palacios seems very possible.  
     Another application of the study results is to gain insight on respondents’ views of public 
health programs and perceived needs. The quantitative results indicate respondents do not 
perceive much impact from government programs against Chagas disease, even though they 
agree that there are less vinchucas than before. In the qualitative interviews, respondents put 
forth three main types of solutions for eliminating Chagas disease. The sample was about equally 
divided between spraying with pesticides, helping the poor and improving housing, and 
providing more doctors and treatment facilities. This suggests that a mixed strategy focusing on 
all three of these areas would be politically appealing to the study population.   
     For governments, use of pesticides is much more cost effective than improvement of at-risk 
housing in the short-term (Tarleton et al. 2007), yet ultimately does not guarantee elimination of 
the vector. One flaw of the present strategy is that control of the vector through pesticides 
requires sustained application efforts, particularly in areas where the vector is already part of the 
natural ecosystem. Pesticides for vinchucas are also less effective in homes made of traditional 
materials (Gurtler 2009). A study in Paraguay (Rojas de Arias et al. 1999) compared three types 
of vector control interventions. Housing improvement alone (96.4%) and pesticide spraying 
alone (97.6%) did not completely eliminate the vector after 18 months’ follow-up, but a 
combined approach did.  
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     In Bolivia, housing improvement programs have been limited and slow to materialize, despite 
the support of Morales’ government (Achtenberg 2009). In the present study, 37 of 68 
participants (54%) mentioned they had once lived in at-risk traditional housing, while 6 
continued to do so (9%). The actual proportions may be higher, since I did not specifically ask 
about prior housing construction during either type of interview. The presence of people living in 
traditional housing in the study was severely restricted because few individuals who lived in this 
type of housing had actually had a diagnosis for Chagas disease. Thus, they could not meet the 
inclusion criteria for the study. Indications from the interviews are that follow-up pesticide 
applications are infrequent.  
     Another major finding pertinent to public health is that provision of free treatment of 
medication does not equate to accessibility of care. Manne et al. (2013) recently investigated 
barriers to treatment for Chagas disease in Mexico, based on qualitative interviews with officials 
and key informants. To increase access, the authors proposed easing restrictions on the 
importation of benznidazole and nifurtimox, increasing education for providers and patients, 
including Chagas disease in the national insurance plan, and creating standard guidelines for 
treatment. One irony is that in a study aimed to increase accessibility, the authors did not 
interview patients. I found that patients with Chagas disease encountered significant difficulties 
in accessing care even when free medication was theoretically available. Education did not 
appear to be a major impediment to access, as patients’ understanding of the disease was largely 
compatible with the biomedical model. Moreover, the existence of standard guidelines for 
treatment in Bolivia tended to impose more impediments to utilization of care, instead of 
increasing accessibility. The availability of free medication was certainly helpful, but hidden 
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costs and transportation difficulties still made treatment programs effectively unaffordable for 
rural Bolivians. 
     Providing treatment for adults and even children with Chagas disease is made extremely 
challenging by the adverse effects produced by the current medications, which increase with age. 
This necessitates a very strict control by providers, including dietary restrictions and extensive 
laboratory analyses. Maintaining a diet without fruit or fried foods is challenging for people in 
rural Bolivia, and affording cardiological and other exams is even more difficult. Yet even if a 
more effective medication is eventually developed and marketed, people in some communities 
will still face challenges in acquiring treatment. Chief among these is the great distance some 
people must travel to avail themselves of medical care. This factor makes it difficult for people 
even to get the confirmatory second diagnosis for their disease. 
     Increasing access to treatment for Chagas disease in the study area would involve several 
steps. First of all, dispensing medications and monitoring treatment in primary health centers, or 
“level one” facilities in Bolivia, is a crucial step. Currently, respondents living in Buena Vista 
and Palacios had to travel to Santa Cruz or Portachuelo to access public treatment. A second 
necessary step would be simplifying the Chagas diagnosis process to just one analysis with 
Chagas Statpak, as the WHO now recommends. This is because the more advanced ELISA and 
IHA tests that are currently required are only available in major hospitals in Portachuelo and 
Santa Cruz. Third, the extensive laboratory analyses required under the current program should 
be provided for free along with the medication. This would remove an important hidden cost.   
     As Bastien recommends (1988), Chagas treatment programs should incorporate ethnomedical 
practices. Ethnomedical remedies might even complement biomedical treatment or help manage 
the side effects of the medications. Ethnomedical treatments might be especially important for 
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individuals who are in the more advanced chronic stage of the disease and no longer qualify for 
treatment with benznidazole and nifurtimox.      
     Finally, it should be noted that the extensive use of ethnomedical treatments by participants in 
the study does not pose a barrier to provision of biomedical care. Under Morales’s government, 
Bolivia has taken steps to formally recognize and support traditional and natural medicine. In 
2006, the Vice Ministry of Traditional Medicine and Interculturality was created as part of the 
Ministry of Health (http://www.vmti.sns.gob.bo:81/index.htm). The results of the present study 
suggest that ethnomedical treatments help with stress reduction and emotional wellbeing for 
people combatting a chronic and often fatal disease. Encouraging patients to self-medicate with 
colonia, lemongrass and other remedies can only complement efforts to provide treatment with 
biomedical products.  
 
Limitations 
     This was an exploratory study using a convenience sample of patients of the CMHP. As such, 
the sampling strategy was not ideal for testing differences between different groups, and the 
conclusions drawn should be considered preliminary insights. While I originally intended to 
sample patients from only two communities, once I was in the field I considered it worthwhile to 
talk to as wide a number of respondents as possible. A primary interest was to analyze 
differences in explanatory models according to social class. The majority of respondents in the 
study were economically disadvantaged, with only 7 individuals (10.3% of the sample) who 
could be considered middle class. With a different sampling strategy, perhaps utilizing a group of 
patients from urban Santa Cruz, I may have been able to find more middle or upper class 
participants. Another issue is that the very poorest people with Chagas disease who live in the 
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remotest communities have little interaction with the medical system and are undiagnosed. My 
sample reflects the patient composition of the clinic in that most respondents (75%) are female 
and the majority (60%) are older than 50. However, the average age of Bolivia’s population is 
21.9 (Instituto Nacional de Estadisticas 2010). I only had 10 participants who were migrants 
from other departments of Bolivia. Thus, my sample is not highly representative of the Bolivian 
population.  
     A larger sample size would have allowed me to make more definitive comparisons. My 
sample size was limited to some extent by the availability of patients with a positive diagnosis 
who came into the CMHP. In some cases, I was unable to get interviews with patients because of 
time constraints. Interviews would sometimes be interrupted because it was a patient’s turn to 
see the doctor or go to the lab, and patients’ time in the clinic was dependent on their collective 
transportation. Thus, there were people I wanted to interview but was unable to connect with 
simply due to circumstances. I compensated for this to some extent by traveling to Buena Vista 
and Warnes to conduct some of the interviews, with the invaluable help of CMHP health 
promoters. For some of my inter-group comparisons, I had to rely on very small subsamples. The 
numbers were adequate for being able to run the consensus analysis procedure, but the ideal 
would have been to count on at least thirty participants in each subgroup (Weller 2007).  
     After completing my research I realized there were important questions I should have 
included. I should have asked respondents about their health insurance coverage, and I should 
have specifically asked them to free list possible remedies for gastrointestinal complications of 
Chagas disease. My interest in ethnomedical remedies probably led me to ask participants more 
follow-up questions in this area, to the detriment of focusing more on biomedical treatment. I 
would also have liked to collect information on symptoms more systematically, having 
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respondents go through a checklist as opposed to just an open-ended question. I realized partway 
through fieldwork that I should have asked respondents about the construction materials of their 
previous homes, not just their current ones.  
     Another limitation of this study was its short duration, with only three months of data 
collection. Spending more time in the field could have allowed me to gain access to more study 
participants and to spend more time talking to providers in clinics throughout the area. On the 
other hand, this study demonstrates that meaningful data can be collected in a relatively short 
period of time, which is an important consideration for anthropologists on time-sensitive 
projects. The notion that an anthropologist needs to spend years in the field to become immersed 
in a particular culture may have made sense in the time of Mead, Malinowski and even Chagnon, 
but it is a notion that deserves reconsideration in the post-globalization world, particularly since 
many research projects do not provide the luxury of years of a long-term immersion. Public 
health concerns related to infectious diseases can be highly time-sensitive, necessitating rapid 
data collection. 
 
Directions for Future Research 
     This was a multi-methods anthropological study of Chagas disease in Bolivia. The research 
design follows previous work with explanatory models, especially Garro 1996, Baer et al. 2004, 
Baer et al. 2008, and Miller 2011. Much work with indigenous knowledge focuses on traditional 
knowledge, such as use of medicinal plants. While this is a worthwhile endeavor, social 
knowledge is often untapped by anthropological inquiry. I define social knowledge as the 
thoughts and perceptions of research participants regarding how social factors have shaped their 
disease experience.  I wanted to hear what participants thought about the social processes related 
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to Chagas disease, rather than trying to interpret this for them based on my own theoretical 
preconceptions. 
     Farmer (1988) and others (Wolf 1982, Baer 1990, Lock & Scheper Hughes 1990, Ortner 
1999, Vonarx 2007, have observed that individual and local narratives are embedded in larger 
contexts which involve historical and social processes. Even Kleinman (1980) acknowledged the 
importance of the broader social context. I found that patients accepted the biomedical model of 
Chagas disease in most respects, yet their view of the etiology, experience and treatment of 
Chagas disease was much broader. They situated the disease not only within structural processes, 
but within a greater context of wellbeing that encompasses their daily functioning and emotional 
state. Approaching the problem from a different angle, I found that community and occupation 
made a difference in levels of cultural competence, and this could reflect the way different 
groups are impacted by larger structural processes that affect health. 
     However, these findings were only preliminary, and there is much work to be done to assess 
the impact of structural factors on an explanatory models. Future studies using a more 
comprehensive sampling strategy can compare cultural competence between social classes. For 
example, by administering the consensus analysis questionnaire to a group of agricultural 
laborers in Palacios and teachers in urban Santa Cruz, I might have gained more insight into how 
social processes differentially affect cultural knowledge and explanatory models. Another future 
direction would be to test for different explanatory models among cambas and migrants from 
other parts of Bolivia. This study had too few migrants in the sample to make this an option, but 
clues from the interviews suggest there may be some interesting differences.  
     Agreement on social or political statements can also be explored in future explanatory model 
studies. It is probable that respondents have opinions and models of how social factors have 
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shaped their health status in multiple contexts. Investigating this can not only provide insight on 
how symbolic interpretation and structural context intermesh, it can shed light on what 
respondents believe are major healthcare issues and pertinent solutions. It was extremely helpful 
to use a mixed-methods approach combining qualitative interviews, consensus analysis, and free 
lists to get the full extent of information on the explanatory model of Chagas disease in this 
study. 
     Chagas disease is a research area that merits more attention from anthropologists. With 
treatment for adults with Chagas disease becoming more widely available, anthropologists can 
examine the processes that make accessing such treatment smoother or more difficult for various 
communities. Anthropologists are uniquely equipped to maintain a neutral perspective and gather 
input from both providers and constituents while analyzing issues at a systemic level. Treatment 
of Chagas involves systems at regional, national and international levels, yet the dynamics of 
accessing such treatment will differ in each local setting. Anthropologists can be involved in 
efforts to treat Chagas by governments and NGO’s, because of our ability to operate on multiple 
levels while treating different perspectives in a relative manner.  
     Given their widespread use, it would also be of interest to examine the use and impact of 
some of the more salient ethnomedical treatments from this study, especially lemongrass, 
mandarin buds, colonia and garlic. Long-term studies could compare health outcomes for people 
with Chagas disease who make use of these remedies compared with those who do not. While 
other research has focused on the pharmacological properties of traditional medicine in Bolivia 
(e.g. Carter et al. 1981), it is also possible that such remedies provide an emotional benefit that 
helps with disease management. Combining these remedies with biomedical treatment options 
may prove effective for Bolivian patients.  
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     Future public health research in Santa Cruz, Bolivia should focus first on ascertaining 
prevalence of Chagas disease in remote communities that are removed from paved highways 
such as El Pilar. Vector surveillance is also needed in such communities, as the possibility of 
reinfestation may be high. Current vector surveillance methods are largely imperfect (Abad-
French et al. 2011), and a sustained vector control strategy would require more comprehensive 
involvement of community leaders so that vinchucas can be identified and countered more 
rapidly. 
     Longitudinal studies are needed to measure the effectiveness of treatment, since success 
cannot be measured through traditional laboratory measures. An MSF study demonstrated that 
cure rates for Chagas disease were much lower in Bolivia compared to sites in Central America 
(Yun et al. 2009). Thus far, evidence for treating patients with benznidazole has primarily come 
from other research settings such as Argentina and Brazil (Bern et al 2011). A way to gauge the 
effectiveness of adult treatment and weigh this against the risk of adverse reactions is needed for 
the Bolivian context, regardless of the outcome of the multisite BENEFIT trial to assess the 
efficacy of benznidazole for adults with chronic Chagas disease (Marin-Neto et al. 2009).  
 
Summary 
     The present study demonstrates that structural processes play a role in shaping explanatory 
models of disease. Furthermore, this study presents a way to simultaneously examine cultural 
knowledge and political economic factors in a single framework, using a combination of 
qualitative and quantitative methods. The study unites the competing structural and constructivist 
currents of medical anthropology by exploring how social divisions shape explanatory models, 
and by investigating how people account for structural factors within their explanatory models. 
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Previously, anthropologists have largely guarded social interpretation of disease as their 
exclusive domain, gathering locally specific information from respondents, but constructing their 
own interpretation of broader social factors. In contrast, this study directly gathers qualitative as 
well as quantitative data on social aspects of Chagas disease, including the role of government, 
class and poverty. In the consensus analysis results, the eigenvalue ratios indicated participants 
had a coherent explanatory model of Chagas disease with a social, ethnomedical, vector, and to a 
lesser extent, symptoms domain.   
     In the consensus analysis procedure, explanatory models differed based on several social 
divisions, especially occupation, which served as a proxy for class differences, and community 
of residence. Cultural competence was significantly different between agricultural workers, 
service workers, professionals and those involved in the informal economy. Nonetheless, all 
these groups made extensive use of ethnomedical remedies for treating Chagas disease. Through 
free listing in the qualitative interviews, as well as participant observation, I found 66 remedies 
for managing cardiac symptoms of Chagas disease and 39 which directly targeted the disease.  
     In the qualitative interview narratives, participants articulated how poverty, traditional 
housing, and living in rural areas put them at risk of infection. Moreover, they described 
difficulties in accessing treatment for the disease, especially related to hidden costs and physical 
distance. There is a prevailing notion that Chagas disease is incurable, something which several 
participants heard from doctors. Participants gave even more importance to social than natural 
causes of Chagas disease. A third of participants felt programs to help the poor improve housing 
would eliminate the disease, while another third emphasized the need for more medical 
infrastructure.  
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     Bolivia is a nation with a reform-minded president who grew up in a traditional adobe home. 
Even though the Morales government has championed policies aimed at eliminating Chagas 
disease and providing free treatment, these goals are difficult to achieve because of constraints 
that are largely beyond its control, principally funding limitations and inadequate medications. 
These global forces limit programs for combatting Chagas disease in Bolivia, making them 
inaccessible to individuals and communities, who feel their best option is to utilize ethnomedical 
remedies or to calmly accept their fate. For the people in this study, Chagas disease is 
intrinsically linked to the political economic processes that put them and their loved ones at risk 
for infection, make treatment inaccessible, and ultimately render a treatable disease incurable.  
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APPENDIX 1: 
FINAL REPORT: CMHP CHAGAS PROJECT, JUNE 2013 
 
Background 
The project sought to gain a better understanding of how patients at Centro Medico Humberto 
Parra (CMHP) understand, experience, and seek treatment for chronic Chagas disease. In 
addition, the project investigated the system of care in place for Chagas at the regional level in 
the communities served by the CMHP to provide insight on how to enhance strategies for coping 
with the disease. An epidemiological survey of Palacios during the initial year of CMHP (2001) 
indicates approximately 70% prevalence of Chagas disease. Chagas test results of patients from 
various communities between 2006 and 2011 indicated an overall prevalence of 57%; however, 
this figure only represents patients who sought or agreed to have testing. In Bolivia, 30-40% of 
people with Chagas develop chronic symptoms. By combining an estimated 57% prevalence 
with a conservative estimate of 30% of patients with symptoms, we can project that 
approximately 17% of CMHP patients may experience the potentially fatal chronic symptoms of 
the disease, e.g. myocardial infarction or megacolon.   
 
Methods 
During an initial exploratory phase, I conducted ethnographic interviews with 20 patients at the 
clinic. Patients were asked to list all the possible causes and treatments they identified for 
Chagas, as well as describe their experiences with the disease and opinions on how it might be 
eliminated. Seventeen of the patients were Chagas-positive, whereas three were close family 
members of Chagas-positive patients.  
Based on the exploratory interviews, I developed a structured 52-item questionnaire on Chagas 
disease in order to make statistical comparisons of patient perceptions based on social and other 
factors (analysis forthcoming). I also continued to ask patients to identify causes, symptoms and 
treatments of the disease, and to discuss what they would do to combat Chagas in Bolivia. The 
second set of interviews involved 48 patients. Many interviews were conducted in-clinic; the rest 
took place during visits to Buena Vista, Yapacani and Warnes.  
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Additionally, I met with key figures involved in Chagas disease at the regional level in Santa 
Cruz, including Dr. Roberto Vargas O., the head of the National Chagas Program; Dra. Zaira 
Barja, the head of entomology at the Center for Tropical Diseases (CENETROP), and Dr. Carlos 
LaFuente, head of Epidemiology at the Hospital Japonés. The National Chagas Program 
provided training in Chagas treatment at CMHP on April 19th. I also visited local hospitals in 
Warnes and Montero to look at options for referral of patients with Chagas.  
 
What is Chagas? 
The concept of “tener Chagas” or “having Chagas” differs widely among patients, and patients’ 
idea of what it means to have Chagas often diverges from the biomedical paradigm. The 
biomedical version of “having Chagas” encompasses the entire period from the initial infection 
through the chronic phase. While patients typically understood the transmission and progression 
of the disease, some used the phrase “tengo Chagas” to describe the onset of chronic symptoms. 
“Tengo Chagas” or “I have Chagas” thus refers only to the period of cardiomyopathy or 
intestinal complications in the chronic phase, whereas an infected person who is asymptomatic 
does not necessarily “have Chagas.” Many medical students at CMHP are admittedly unfamiliar 
with Chagas disease upon arrival to Bolivia, though several made tremendous efforts to become 
more knowledgeable. Because students learn the biomedical version of what it means to “have 
Chagas”, they should be made aware that patients may sometimes only use the term “having 
Chagas” to describe the chronic symptomatic stage. This sometimes results in unnecessary 
testing.   
 
Testing 
False positives 
Diagnosis of chronic Chagas disease through serologic testing is often problematic, and no single 
test is sufficiently sensitive and specific to confirm diagnosis on its own (Bern 2011). The WHO 
and the Bolivian National Chagas Program thus require two positive laboratory results to 
establish a positive diagnosis of Chagas disease: an initial screening test such as HAI or Chagas 
Statpak, and a more specific confirmatory test, either ELISA or PCR. CMHP uses the Chagas 
Statpak test, which is convenient and efficient and provides a positive/negative result. The 
CMHP does not currently have the capacity to offer the ELISA test. However, blood samples of 
patients can be taken and sent to a laboratory in Santa Cruz for analysis. Also, patients can be 
referred to nearby public hospitals for an ELISA test. The Chagas Statpak manufacturer reports a 
sensitivity of 98% or higher and a specificity of 95% or higher based on three studies, none of 
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which took place exclusively in Bolivia. This would give the test a positive predictive value of 
97% (of every 100 people who are positive on the test, 97 actually have Chagas disease). 
However, the studies used ELISA results rather than absolute confirmation of the disease to 
calculate these figures. The National Chagas Program reported a specificity of approximately 
80% for the Chagas Statpak test in Bolivia. Thus, the expected false positive rate for the test is 
between 5 and 20%. Very few patients reported undergoing the confirmatory test (ELISA). 
Bolivia has the highest prevalence of Chagas disease in the world (approximately 20%); 
consequently, the negative predictive value of tests is likely to be lower when compared with 
other Latin American countries. In other words, the probability that people who test negative for 
Chagas disease are actually without the disease could be lower in Bolivia than in other countries.   
 
HAI vs. Statpak results 
Many patients are already familiar with HAI testing, which is offered at CENETROP and several 
area hospitals. The HAI test provides a quantitative description of the progression of the disease 
based on antibody levels, which can indicate whether a patient is in the acute, latent, or chronic 
symptomatic (reactivated infection) phase. Many patients requested testing for Chagas at CMHP 
even though they had already previously tested positive, because they expected a result similar to 
the HAI which would tell them something about their progression to chronic symptoms. This 
sometimes results in unnecessary testing. Patients may also refer to EKG’s and other tests as 
“Chagas tests” because they are aware that these types of analyses give an indication of the 
degree of severity of the disease. Patients need to be told up front that they will only get a yes/no 
result from the Chagas Statpak, and that the Statpak test can produce false positives. When 
someone asks for a Chagas test, a few follow-up questions are necessary to determine what 
specifically the patient is expecting: 
 Have you been told before that you have Chagas? 
 What do you want the test to tell you? 
 
Vectoral Transmission 
While not as extensive or effective as campaigns in Chile, Uruguay and Brazil, Bolivia 
conducted a fairly extensive campaign to eliminate the primary vector (Triatoma infestans) in the 
department of Santa Cruz. SEDES reports that the department-wide rate of infested homes has 
fallen to less than 5% (April 10th, 2013). Most patients report that authorities had sprayed their 
communities with pesticide at least once in the previous ten years, and the majority spray their 
own homes with Baygon or other commercially available pesticides. It is assumed that the 
presence of the main vector, Triatoma infestans, is significantly reduced. However, a secondary 
vector species (Rhodnius prolixus) was observed at CMHP in Palacios. According to Dr. Barja in 
CENETROP, approximately five percent of these vectors are positive for Chagas disease. 
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Rhodnius prolixus lives in the palm trees (motacu, totai) that abound in Palacios and sometimes 
invades peridomestic or domestic areas in search of hosts. Thus there is a low but ever present 
possibility of transmission of the disease, especially in houses with peridmoestic areas that are 
close to wooded areas.  
  
Housing 
In Palacios, many primary residences are now constructed with tile roofs and drywall, yet storage 
areas or secondary structures often have palm-thatch roofs. In El Pilar and Santa Barbara, most 
homes are constructed of adobe and palm thatch roofs, and residents reported observing 
vinchucas. Thus, the possibility of reinfestation by pockets of vinchucas who survived initial 
spraying campaigns is high in these communities. Recent studies in Bolivia have demonstrated 
insecticide resistance is fairly common among populations of Triatoma infestans (Lardeux et al. 
2010, Abad-Franch et al. 2011, Germano et al. 2012).  
 
Treatment 
The Ministry of Health through the National Chagas Program (PNC) currently offers free 
treatment for all children up to 15. By law all expectant mothers who give birth in hospital are 
screened for Chagas, and infants of positive mothers are checked for congenital Chagas. In 2010, 
the PNC began offering treatment for adults with chronic Chagas. The treatment is currently only 
available for adults who are asymptomatic or with mild cardiac symptoms. Patients must be 
under 60 years of age and must not have any other severe health conditions. To establish a 
positive diagnosis, patients must have two positive laboratory results, one from HAI or Chagas 
Statpak, and a confirmatory ELISA. Liver and kidney functions as well as cholesterol and 
triglyceride levels must also be satisfactory. Currently, treatment for adults is not available 
outside of Santa Cruz except in Yapacani. Despite the free program, few adults have yet 
completed treatment.  
CMHP patients under 15 with Chagas can be referred to the PNC’s treatment network depending 
on their community of residence: 
 
Warnes:  Hospital Nuestra Senora de Rosario, Dr. Zambrana 
Montero: Hospital Gumucio Reyes, Red de Salud Obispo Santiesteban, Lic Pilar Villaroel 
Mineros: Hospital Gumucio Reyes, Red de Salud Obispo Santiesteban, Lic Pilar Villaroel 
Portachuelo: Hospital Municipal Nicolas Ortiz Antelo, Hospital San José Obrero 
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Buena Vista: Hospital Municipal Nicolas Ortiz Antelo, Hospital San José Obrero 
Yapacani: Hospital de Yapacaní, Dr. Barba 
 
The following institutions provide treatment for adults (who meet certain criteria) as well as 
children in Santa Cruz. 
 
Centro de Salud Santa Rosita: Av. Piraí Barrio Santa Rosita – Telf: 352 - 4833 
Centro de Salud Lazareto: Barrio Lazareto – calle Corumbá esq. Pailón – Telf.: 346 
-1151 
Centro de Salud 18 de Marzo: Av. Cumavi, pasando el 5to. Anillo – Telf: 349 – 3919 
Hospital de referencia a nivel departamental 
Hospital Francés: Av. Santos Dumont 8vo Anillo. – Telf: 356 – 9090 
Hospital Japonés: Dr. Carlos Lafuente  3er anillo avenida Japón  
Telf: 347-3197 
 
Possibility of Treatment at CMHP: 
Although evidence is currently limited, some studies indicate a benefit in decreased 
cardiomyopathy and mortality for adult patients treated with benznidazol (Viotti et al 2006). A 
large multi-site trail (BENEFIT - http://clinicaltrials.gov/show/NCT00123916) is currently 
nearing completion and will examine the impact of trypanocidal therapy on various outcomes for 
Chagas patients. Currently, the CDC in the United States and the Spanish Ministry of Health 
provide treatment to adult patients with chronic Chagas. The CDC recommends that adults under 
50 without severe cardiac complications be offered treatment. In Bolivia, Doctors with Borders 
as well as Universidad Mayor de San Simon (in cooperation with the autonomous region of 
Catalonia, Spain) are treat 5,000 people with Chagas annually, including adults. Additionally, the 
National Chagas Program in the Department of Santa Cruz began offering treatment for adults 
with Chagas in 2010. The current evidence does not support offering blanket treatment to all 
adults with chronic Chagas’ disease (Marcos Matta-Guedes et al. 2012). However, the CDC and 
Doctors without Borders recommend offering treatment as an option to adults under 50 who are 
asymptomatic or only have mild symptoms.  
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The National Chagas Program provided training in treatment for acute and chronic Chagas on 
April 19th, 2013. Patients from Palacios and nearby communities may be able to receive 
treatment with benznidazol at CMHP once it can be confirmed that these communities’ level of 
vector infestation is <3%. (This needs to be accomplished in conjunction with SEDES and the 
Red de Salud Provincia Sara in Portachuelo). Currently, CMHP is able to provide all the required 
laboratories except for the ELISA; for this test patient samples will need to be sent to the 
Hospital Municipal in Portachuelo. The PNC provides reagents for laboratories as well as 
medication. Patients are asked to sign an informed consent form, and following the laboratories 
and a medical examination treatment can proceed. Only 2 weeks of medication are provided to 
ensure patients return for checkups to monitor possible side effects. Patients are given additional 
laboratories at 30 days. Treatment lasts for 60 days in chronic patients and 30 days in infants 
with congenital Chagas.  
 
Safety of Benznidazole 
The PNC reports only having 3 serious cases of side effects since it implemented strict control 
measures in 2010. A Brazilian study of benznidazole safety for chronic Chagas patients reported 
a higher incidence of side effects (49%), but most were classified as mild skin or gastrointestinal 
reactions. The authors considered treatment with benznidazole safe, when strictly monitored by 
medical staff, because drug reactions subsided when medication was interrupted (Hasslocher-
Moreno et al. 2012) 
Effectiveness of treatment is difficult to diagnose through serologic testing (Bern 2011). 
Conversion to seronegative results takes 10+ years in adults and only occurs in a small portion of 
patients. Patients need to be informed that while treatment will help halt the progression of 
cardiac symptoms, it should not be considered a complete “cure”.  
 
What to tell patients with Chagas:  
 Congenital: Expectant mothers should be tested for Chagas and, if positive, referred to 
local hospitals or clinics involved in the National Chagas Program. 
 Latent phase: Patients under 15 can be referred to the nearest provider in the network of 
the National Chagas Program. Patients 16-60 may be able to receive treatment in Santa 
Cruz. They should receive a baseline ekg in order to monitor for cardiomyopathy. 
 Chronic phase: Patients with mild to moderate cardiac or intestinal symptoms may be 
able to receive some forms of ameliorative treatment through CMHP (e.g. aspirin, 
betablockers – see Gilka et al 2010, Biolo et al 2010, Bern 2011). More severe 
complications should be referred to the Hospital Japonés in Santa Cruz. 
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Recommendations 
1) Continue dialogue with National Chagas Program, coordinating with Dr. Guido, director 
of the Red de Salud, Provincia Sara in Portachuelo. Next steps: Laboratory training and 
certification of vector infestation level in Palacios. 
2) Begin by offering treatment to CMHP staff, then gradually expand to promising 
candidates in Palacios (such as young healthy adults). Treat very small numbers (<5) at 
any given time to facilitate monitoring. The evidence does not currently support offering 
routine treatment to every adult patient, but rather offering treatment as an option to 
adults who meet certain criteria and who are fully aware of the risks and benefits. 
3) Create a CMHP Chagas program headed by a CMHP staff member. This person will be 
in charge of ensuring proper forms are filled out and patients receive proper checkups and 
medications. They will also coordinate with the PNC in Santa Cruz to order medication 
and testing supplies.  
4) Explain to patients requesting the Chagas test that they will only get a yes/no result. 
Confirm specifically whether patients want the initial Chagas test or a test to indicate 
whether their Chagas is “advancing”. Also, explore ways to more efficiently indicate 
which patients are positive for Chagas through Amazing Charts. 
5) Perform on-site Chagas screening in communities that have less access to services, such 
as El Pilar and Santa Barbara. These communities are likely to have high numbers of 
undiagnosed Chagas patients. 
6) Explore possibility of providing ELISA at CMHP, perhaps through external funding 
sources. This is a key missing link in being able to eliminate false positives and provide 
treatment options for patients. 
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APPENDIX 3: 
Informed Consent Script 
Explanatory Models of Chagas Disease in Bolivia 
 
Investigator: Colin Forsyth 
February, 2013 
 
 I am a doctoral student at the University of South Florida working under the guidance of 
a faculty advisor.  This is a research study with the goal or learning about people’s opinions and 
experiences related to Chagas disease in Bolivia. This information will help future programs that 
want to prevent and eliminate this disease in Bolivian communities. The research is subject to 
review by the University of South Florida and the U.S. Department of Health and Human 
Services. Your participation is completely voluntary, and your decision to participate or not in no 
way affects the services you receive from the Centro Medico Humberto Parra. I will ask you 
some questions about Chagas disease, and if you give me permission, I will record the interview. 
I will also ask you to complete an oral survey and I will ask you some questions about your 
home.  There is no physical risk from participating in the study, but you may feel uncomfortable 
talking about a serious disease like Chagas. If you feel you need to stop the interview at any time 
you are free to do so. All your personal information such as your name and address, and any 
other information you give me will be kept confidential.  
You may contact the Centro Medico Humberto Parra at 351-5147 or the Institutional Review 
Board of the University of South Florida at 011-1-813-974-5638 with any questions or concerns 
about the study. 
 
The interview will take around an hour of your time. Would you like to participate? 
 
If no:  thank you for your time.  
If yes: Thank you for agreeing to participate. May I tape the interview? 
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APPENDIX 4: 
SEMISTRUCTURED INTERVIEW QUESTIONNAIRE 
 
Explanatory Models of Chagas Disease in Bolivia 
 
 Colin Forsyth 
January 2013 
Interview #_________ 
Part A: Demographic Information 
Gender _____ 
Age: ________ 
Education completed  _________ 
1) Do you work? ___________Yes, full time (go to 1a)     _________ Yes, part time (go to 
1a)  
__________No  
1a) Occupation _________________  Spouse’s Occupation ____________________ 
1b) What is the range of your household monthly earnings:   < 1,000 bolivianos 
         1-2,000 bolivianos 
         >2,000 bolivianos 
 
2) Do you own or rent your home? 
3) In which town do you currently reside? 
4) How long have you lived there? 
5) Where were you born? 
6) How many people live in your home? 
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7) As far as you know, how many of them have Chagas? 
 
Part 1: Ethnographic Questions 
8) In your words, what is Chagas disease?  
9) When were you first told you had Chagas disease? How did you feel at this time? 
10) Why do you think you got the disease? 
11) Have you suffered any symptoms from the disease? Which? 
12) Has being diagnosed as positive with Chagas disease caused any complications in your 
work or other area of your life? 
13) Tell me about all the things you have done to try to treat or cure the disease? 
14) What are the greatest difficulties in trying to treat or cure Chagas disease? 
15) What would make it easier for you to cure your Chagas? 
16) Why do you think many people in this area suffer from Chagas disease? 
17) If you had the power or authority, what would you do to eliminate Chagas disease in 
Bolivia? 
18) Is there any other information or experiences regarding Chagas disease that you would 
like to share? 
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APPENDIX 5: 
CULTURAL CONSENSUS ANALYSIS QUESTIONNAIRE 
Explanatory Models of Chagas in Bolivia 
 
Version 1 
April 9, 2013 
 
PI: Colin Forsyth 
 
1. Answer yes or no to the following questions. There are no right or wrong answers. 
Respond based on your opinion.  
2.  
 
    Yes       No 
1. Can people get sick from Chagas because they do not eat well? 
    Yes       No 2. Does someone get sick from Chagas because they have been 
bitten by a kissing bug? 
    Yes       No 
3. Do rats and mice spread Chagas? 
    Yes       No 4. Can you get Chagas from touching another person who has 
Chagas? 
    Yes       No 
5. Do kissing bugs live in palm-thatch roofs? 
    Yes       No 
6. Does Chagas affect the liver? 
    Yes       No 
7. Can Chagas cause lung cancer? 
    Yes       No 
8. Can Chagas cause constipation? 
    Yes       No 
9. Is Chagas caused by a bug that lives in the blood?  
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    Yes       No 10. Can I get Chagas from eating fruit that is not adequately 
washed? 
    Yes       No 
11. Is Chagas hereditary? Do parents pass it to their children? 
    Yes       No 12. Can you get Chagas from spending too much time in the sun 
or in hot places? 
    Yes       No 
13. Does Chagas cause swelling in the body? 
    Yes       No 
14. Does Chagas feel like a cold? 
    Yes       No 
15. Do people with Chagas have difficulty breathing? 
    Yes       No 
16. Do people with Chagas have difficulty seeing? 
    Yes       No 
17. Is there a cure for Chagas? 
    Yes       No 
18. Does Chagas produce tiredness and fatigue? 
    Yes       No 
19. Does Chagas produce pain in the chest? 
    Yes       No 
20. Do some people with Chagas faint? 
    Yes       No 
21. If I have Chagas, is it good to eat a lot of fried food? 
 
 
2. Respond true or false to the following questions. 
 
     T          F 
22. Chagas is only in the countryside.  
T          F 23. There are a lot of vices in the country, and for this reason there 
is a lot of Chagas. 
T          F 
24. The most venomous kissing bug is the red one. 
T          F 
25. There are many more kissing bugs today than there used to be. 
T          F 
26. There are also kissing bugs in the homes of rich people. 
T          F 
27. Kissing bugs prefer houses of adobe and palm-thatch. 
T          F 
28. Kissing bugs prefer cement-brick houses.  
T          F 29. All the kissing bugs have died thanks to pesticide spraying 
programs.  
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T          F 
30. If I argue with my significant other, my Chagas gets worse.  
T          F 
31. Some people have Chagas in their blood but don’t get sick.  
T          F 
32. Chagas only lasts a while and then gets better. 
T          F 
33. Chagas mainly attacks the heart. 
T          F 
34. You can ease the effects of Chagas by drinking garlic puree. 
T          F 35. If you have heart pain it is good to drink a tea made from 
mandarin buds. 
T          F 
36. The bark of the tipa tree is very good for people with Chagas.  
T          F 
37. If you have heart pain, you should eat papaya seeds.  
T          F 
38. Chest pains can be eased with lemon grass tea. 
T          F 
39. Chagas gets better if you drink Coca Cola. 
T          F 
40. Chagas gets better if you drink colonia tea.  
T          F 
41. To cure Chagas you need antibiotics. 
T          F 
42. If you have Chagas, you will need a pacemaker sooner or later.  
T          F 43. When someone has chest pain, they should rub the chest with 
eucalyptus balm.  
T          F 
44. Medicine for Chagas is very expensive. 
T          F 
45. Most people who have Chagas are rich.  
T          F 46. There are many programs and campaigns against Chagas in 
Bolivia.  
T          F 47. Sometimes they say you have Chagas but it’s just to get your 
money.  
T          F 
48. It’s easy to get medical treatment for Chagas. 
T          F 
49. It’s hard to find work because I have Chagas. 
T          F 
50. Chagas is sometimes caused by witchcraft. 
T          F 
51. If I had money, I would have already cured my Chagas. 
T          F 
52. Chagas mainly affects rich people. 
 
